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PREFACE 
This treatise is the product of an investigation that was made 
possible by help from many sides The need for the 
investigation was felt when in 1977 gentamicin-PMMA 
beads became available for clinical study in the Nether­
lands It was desired to test obtained elsewhere and to 
enquire more thoroughly in the safety of the preparation 
The clinical part of the study was carried out in the 
department of orthopaedics of the St Radboud Hospital of 
the RC University of Nijmegen ( R C U N ) The 
investigation was initiated by the head of this departement, 
Prof Dr Th J G van Rens Prof Dr G С J van der Ploeg 
provided aid and advice on matters of bacteriology Their 
stimulating interest was a great support to the author and 
contributed much to the value of the study 
In the processing of the many data of the retrospective part 
of the clinical study, H A Dekkers has been extremely help­
ful The preparation of the data for the computer and the 
dialoque with it were performed very accurately by A 
Reintjes, and their statistical analysis was carried out 
thoroughly and profoundly by J A M van Druten 
( R C U N Department Medical Statistical Advisory 
Service) 
The pharmacokinetic and nephrotixicologic parts of the 
investigation have become an essential element of the 
study, owing entirely to the inspiring contribution by Dr 
TB Vree, Head of the departement of clinical pharma­
cokinetics and toxicology of the departement of clinical 
pharmacology (Head Prof Dr E van der Kleijn) of the 
R C U N Due to his critical and original approach, this part 
of the study went beyond the mere determination of some 
concentrations The other members of his laboratory team 
were equally enthusiastically helpful 
This part of the investigation necessitated a large 
number of samples of blood and urine For their collection, 
the willing cooperation of test subjects and patients was 
indispensable, and the aid of the nursing staff of the wards 
and operation rooms of the department of orthopaedics of 
inestimable value 
All assays were carried out at the central medical 
laboratory ABL of Assen, where the didication and the 
rapid, accurate work of В Jongman-Nix and Ρ J M Guelen 
rendered it possible for numerous data to be obtained in a 
short time 
The study of possible ototoxic side effects could be carried 
out with the aid and advice of Ρ L M Huygcn The 
investigation was performed with the help of M G M 
Nicolasen in the ORL department of the R C U N (head 
Prof Dr Ρ van den Broek) 
For the preparation of the manuscript, the contributions by 
the following persons were indispensable 
Marlu Ackermans drawings 
Ed Noyons drawings 
Henk Berns graphs (Chapters 2, 8, 9, 10) 
Tom Vree graphs (Chapters 3, 11, 12, 13, 15) 
Jan Meeuwissen photography 
Cor de Bruin cover photograph 
Helmi Leegstraten typed the manuscript marvellously fast, 
accurate and without loosing her good sense of humour 
The English translation was prepared by С Visser (in 
cooperation with M Henkes), Eindhoven The book was 
printed by Cliteur Printers, Amsterdam 
Many persons have helped by giving their time and 
attention to serve as sounding boards, which resulted in 
valuable additions and criticism This applies in the first 
place to the staff and assistants of the R С U N department 
of orthopaedics It also particularly holds true of Dr H 
Wahhg, Dr A Grieben, Dr К. Klemm and Dr K.H Muller 
Where nephrological aspects are concerned, it also applies 
to Prof Dr AW Mondorf and Prof Dr M E de Broe 
The support by my wife and children would have sufficed 
for several manuscripts more 
5 
CONTENTS 
CHAPTER 1. INTRODUCTION 
CHAPTER 2. OSTEOMYELITIS 
2.1 Introduction 
2.2. Histological and pathogenetic aspects of 
osteomyelitis 
2.2.1. Acute haematogenous osteomyelitis 
2.2.2. Chronic osteomyelitis 
2.2.3. Exogenous osteomyelitis . 
2.2.4. Non-pyogenous osteomyelitis 
2.3. Clinical picture and course of osteomyelitis 
2.3.1. Acute haematogenous osteomyelitis 
2.3.2. Subacute osteomyelitis 
2.3.3. Chronic pyogenous osteomyelitis 
2.4. Diagnostics 
2.4.1. Introduction 
2.4.2. Symptoms 
2.4.3. Laboratory 
2.4.4. Roentgenology. 
2.4.5. Scintigraphy 
2.5. Bacteriology . . . . 
2.5.1. Gram preparation 
2.5.2. Culture . . . . 
2.5.3. Aerobic infecting organism 
2.5.4. Anaerobic infecting organisms 
2.5.5. Cell wall deficient bacteria. 
late 
page 9 
11 
11 
11 
11 
13 
13 
14 
14 
14 
14 
15 
15 
15 
16 
16 
16 
18 
19 
19 
19 
20 
21 
21 
2.6. Treatment 
2.6.1. Historical survey up to the 
19th century 
2.6.2. Antiseptics 
2.6.3. Stabilization . 
2.6.4. Prevention of cavitation 
2.6.5. Maggot therapy 
2.6.6. Antibiotics 
2.6.7. Suction drainage 
2.6.8. Cancellous bone graft 
CHAPTER 3. THE INFECTED 
ENDOPROSTHESIS 
3.1. Introduction . . . . . . 
3.2. Fixation and loosening of the endoprosthesis 
3.3. Clinical picture and course of infection of 
endoprostheses . . . . 
3.3.1. Acute infections 
3.3.1.1. The acute superficial infection 
3.3.1.2. The acute deep infection 
3.3.2. Late infections. 
3.4. Diagnosis 
3.4.1. Symptoms 
3.4.2. Laboratory 
3.4.3. Histological diagnosis 
3.4.4. Roentgenology. 
3.4.5. Scintigraphy 
22 
22 
22 
23 
23 
24 
25 
25 
27 
27 
27 
29 
29 
29 
29 
29 
32 
32 
33 
33 
33 
34 
3.5. 
3.6. 
Bacteriology 
3.5.1. Introduction 
3.5.2. Gram preparation 
3.5.3. Cultures . 
3.5.4. Causative organism . 
Treatment . . . . 
3.6.1. Superficial infection . 
3.6.2. Acute deep infection 
3.6.3. Late deep infection . 
3.6.3.1. Conservative treatment 
3.6.3.2. Surgical treatment . 
3.6.3.3. Reimplantation 
35 
35 
35 
35 
36 
37 
37 
37 
38 
38 
38 
40 
CHAPTER 4. ANTIBIOTIC-CONTAINING 
4.1. 
4.2. 
4.3. 
4.4. 
4.5. 
4.6. 
CEMENT . . . . 
Introduction 
In-vitro s t u d i e s . . . . 
4.2.1. Qualitative assays 
4.2.2. Quantitative assays . 
43 
43 
43 
43 
44 
4.2.3. Antibiotic-bone cement combinations . 46 
In-vivo studies . 
Experiments in animals 
Clinical results . 
Conclusion 
46 
47 
48 
49 
22 CHAPTER 5. GENTAMICIN-PMMA BEADS 
5.1. Introduction 
5.2. The beads 
5.3. In-vitro research 
5.4. In-vivo research 
5.5. Clinical research 
5.6. Histological examination 
5.7. Application and technique 
5.8. Bacteriological aspects 
5.9. Indications and contraindications 
5.10. Gentamicin-PMMA beads versus irrigation 
systems . . . . . . 
CHAPTER 6. GENTAMICIN 
6.1. Introduction 
6.2. Bacteriological aspects 
6.3. Pharmacokinetics 
6.4. Side effects of gentamicin . 
6.4.1. Hypersensitivity reactions 
6.4.2. Neuromuscular block 
6.4.3. Ototoxicity 
6.4.4. Nephrotoxicity. 
6.5. Parameters for toxicity of gentamicin 
50 
50 
50 
51 
51 
51 
52 
52 
55 
56 
57 
59 
5.9 
59 
59 
59 
59 
60 
60 
60 
61 
CHAPTER 7. DEFINITION OF THE PROBLEM 62 
CHAPTER 8. TREATMENT OF INFECTIONS FROM 
1962 TO 1977, WITHOUT USE OF GENTAMICIN-
PMMA BEADS 63 
8.1. Introduction . . . . 
8.2. Treatment of infection 1962 to 1977 
8.2.1. Osteomyelitis . 
8.2.2. Infection of endoprostheses 
8.2.3. Inflammation of soft parts . 
8.3. The irrigation-drainage system 
8.4. The follow-up . 
8.4.1. Method . 
8.4.2. Material . 
8.5. Results . 
8.6. Discussion 
63 
63 
63 
63 
63 
63 
64 
64 
64 
66 
67 
CHAPTER 9. TREATMENT AFTER 1977 OF NINETY 
PATIENTS WITH GENTAMICIN-PMMA 
BEADS 76 
9.1. Introduction . . . . 
9.2. Use of gentamicin-PMMA beads 
9.3. Therapeutic complications . 
9.4. The study 
9.4.1. Introduction 
9.4.2. Material . 
9.5. Results . 
9.6. Discussion . . . . . . 
9.7. Comparison of the results of treatments with 
suction drainage and with gentamicin-PMMA 
beads . . . . . . . 
76 
76 
77 
77 
77 
77 
77 
78 
80 
CHAPTER 10. COMPARATIVE STATISTICAL 
ANALYSIS OF TREATMENT WITH SUCTION 
DRAINAGE AND WITH GENTAMICIN-PMMA 
BEADS 82 
10.1. Introduction 
10.2. Material . 
10.3. Statistical methods 
82 
82 
83 
10.4. First review of therapeutic results of intermediate 
operations and final operations . . . 83 
10.4.1. Intermediate operations . . . 84 
10.4.2. Final operations . . . . 84 
10.4.3. Conclusion 85 
10.5. Analysis of intermediate operations 
10.5.1. Definition of the problem and variables 
10.5.2. Explanatory variables of the probability 
of a recurrence-free period after an 
intermediate operation 
10.5.2.1. Method . . . . 
10.5.2.2. Results . . . . 
10.5.2.3. Conclusion 
10.5.3. Explanatory variables for the duration of 
a recurrence-free period after an 
85 
85 
86 
86 
86 
86 
intermediate operation 87 
10.5.3.1. Method . 87 
10.5.3.2. Results 87 
10.5.3.3. Conclusion 88 
10.6. Analysis of final operations . . . 89 
10.6.1. Definition of the problems, variables 
and models . . . . . 89 
10.6.2. Results of logistic regression analysis . 89 
10.6.3. Results proportional hazards model . 90 
10.6.4. Conclusion 92 
CHAPTER 11. THE RENAL EXCRETION RATE OF 
ß2-MICROGLOBULIN AS A PARAMETER OF 
THE EFFECT OF GENTAMICIN ON THE RENAL 
TUBULE IN TEST SUBJECTS . . . 93 
11.1. Introduction 
11.2. Material and methods 
11.2.1. The test subjects 
11.2.2. Blood samples 
11.2.3. Urine samples 
11.2.4. Determinations 
11.3. Results . 
11.4. Discussion 
11.5. Conclusion 
93 
94 
94 
94 
94 
94 
95 
98 
99 
CHAPTER 12. THE EFFECT OF AN OPERATION 
ON THE RENAL EXCRETION RATE OF ß2-
MICROGLOBULIN IN PATIENTS . . 100 
12.1. Introduction . 
12.2. Material and method 
12.2.1. Patients and their operations . 
12.2.2. Blood and urine samples 
12.2.3. Determinations 
12.3. Results . 
12.4. Discussion . . . . . 
12.4.1. Influence of the urine flow 
12.4.2. Influence of the surgical trauma 
12.5. Conclusion 
100 
100 
100 
101 
101 
101 
105 
105 
105 
106 
CHAPTER 13. THE INFLUENCE OF GENTAMICIN 
AND OF THE OPERATION ON THE FUNCTION 
OF THE PROXIMAL TUBULAR CELL OF 
PATIENTS WITH IMPLANTED GENTAMICIN-
PMMA BEADS 107 
13.1. Introduction . 
13.2. Material and method 
13.2.1. Patients and operations . 
13.2.2. Blood and urine samples 
13.2.3. Determinations 
13.3. Results . 
13.4. Discussion 
13.5. Conclusion 
107 
107 
107 
109 
109 
109 
113 
117 
7 
CHAPTER 14. STUDY OF PATIENTS TREATED 
WITH GENTAMICIN-PMMA BEADS FOR OTO-
TOXIC SIDE EFFECTS . 118 
14.1. Introduction . . 118 
14.2. Material and method 118 
14.2.1. The patients. . . 118 
14.2.2. Cochlear examination 118 
14.2.3. Vestibular examination . 118 
14.2.4. Ototoxicity criteria . 119 
14.3. Results . 119 
14.3. Discussion 120 
14.5. Conclusion 121 
CHAPTER 15. CASE HISTORIES 122 
CHAPTER 16. CONCLUSIONS . 123 
CHAPTER 17. SUMMARY . 138 
17.1. Introduction. 138 
17.2. Osteomyelitis . 138 
17.3. Infected endoprostheses. 138 
17.4. Antibiotic-containing cement . 138 
17.5. Gentamicin-PMMA beads 139 
17.6. Gentamicin . . . 139 
17.7. Definition of the problem . . . 139 
17.8. The treatment without gentamicin-PMMA 
beads 139 
17.9. The treatment with gentamicin-PMMA beads 140 
17.10. Statistical analyses of the treatments of 
infections . . . . . . 140 
The effect of gentamicin on the renal excretion 
of ß2-microglobulin . . . . 140 
The effect of an operation on the renal 
excretion rate of ß2-microglobulin . . 141 
17.11 
17.12 
17.13. The effect of treatment with gentamicin-PMMA 
beads on the renal excretion of 
ßs-microglobulin 
17.14. The effect of a treatment with gentamicin-
PMMA beads on the hearing and on the 
organ of equilibrium 
17.15. Case histories 
17.16. Epilogue 
CHAPTER 18. DUTCH SUMMARY / 
SAMENVATTING. 
18.1. Inleiding 
18.2. Osteomyelitis 
18.3. Geïnfecteerde endoprothesen . 
18.4. Antibioticumhoudend cement 
18.5. Gentamicine-PMMA-kralen 
18.6. Gentamicine 
18.7. Probleemstelling . 
18.8. De behandeling zonder 
gentamicine-PMMA-kralen 
18.9. Behandeling met gentamicine-PMMA-kralen 
18.10. Statistische analyse van de 
infectiebehandelingen 
18.11. De invloed van gentamicine op de renale 
excretie van ß2-microglobuline 
18.12. De invloed van een operatie op de renale 
excretiesnelheid van ß2-microglobuline 
18.13. De invloed van behandeling met gentamicine-
PMMA-kralen op de renale excretie van 
ßz-microglobuline . . . . 
18.14. De invloed van een behandeling met 
gentamicine-PMMA-kralen op het gehoor en 
het evenwichtsorgaan . . . . 
18.15. Casuïstiek . 
18.16. Slotbeschouwing . 
CHAPTER 19. REFERENCES 
141 
141 
141 
142 
143 
143 
143 
143 
144 
144 
144 
144 
144 
145 
145 
146 
146 
146 
146 
147 
147 
148 
8 
Chapter 1. Introduction 
In spite of growing knowledge of their pathogenesis and 
treatment, skeletal infections continue to cause patients to 
suffer severely, treating surgeons to experience repeated 
frustrations and the costs ol health care to rise substantially 
Notwithstanding the therapeutic possibilities offered 
by antibiotics, 15 to 30% of all cases of haematogenous 
osteomyelitis turn into chronic osteomyelitis (Norden et al, 
1970, Waldvogel et al, 1970a) 
After 'clean' orthopaedic operations, postoperative 
infection occurs in approx 1 to 5% (Lidgren, 1973''; 
Lidgren and Lindberg, 1972, 1974, Altemeier et al, 1976, 
Burn, 1979, Muller, 1981) Implantation of a hip endo­
prosthesis is followed by a deep infection in approx 2 to 4 % 
of the operations (Table 3 2) in defiance of rigorous efforts to 
avoid peroperative contamination of the wound 
Haematogenous spread is probably the reason why the rate 
of infection of endoprostheses cannot fall below 0 5 to 1 % 
The total number of infections per year increases because 
a the number of accidents involving fractures is rising, 
b increasing numbers of orthopaedic operations are being 
performed with implantation of osteosynthesis material 
or endoprostheses, 
с in spite of all efforts, infections always occur in a few 
percent of all operations on the skeleton 
In the United States in 1976, approx 80,000 total hip 
prostheses and 40,000 total knee prostheses were implanted 
(Hon et al, 1978) Huiskes estimates that in the near future 
the number of articular prostheses implanted globally each 
year will amount to 300,000 and that 2 4 million people will 
be livjng with an artificial joint (Huiskes, 1979) 
The Dutch Medical Records Foundation (Stichting 
Medische Registratie, SMR) reports that in the Netherlands 
the number of endopiostheses implanted annually is 
gradually rising The number of the principal types of 
endoprostheses implanted in the Netherlands was 11,484 in 
1980 as against 8,000 in 1977, an increase by 44% in four 
years In 1977, 5,391 hip and 643 knee protheses were 
implanted, as against 7,364 and 1,127, respectively, in 1980 
(Table 1 1) In 1977, of the total hip prostheses, 214 were 
removed in toto and 49 in part, for reasons not specified For 
1980, these figures were 357 hip prostheses removed in toto 
and 153 removed in part 
If we estimate that of all total hip prostheses 
implanted,4 % will become infected, we find that of the total 
number of hip prostheses implanted in the Netherlands in 
1980,295 are infected For the United States in 1976 we find 
3,200 infected prostheses, and globally there are at present 
96,000 patients who have to consider the possibility that 
their prosthesis is, or has been infected 
Some idea of the total number of osteosyntheses 
performed may be gained from the numbers of operations 
at which osteosynthesis material was removed These 
amounted to 12,090 in 1977 and to 15,271 in 1980, a 26% 
nse in four years 
The number of cases of osteomyelitis that has been 
treated in the Netherlands may be roughly estimated on the 
basis of the number of operations involving 'sequest­
rectomy' The principal operations are listed in Table 1 1 
From 1977 to 1980 there has been a rise from 364 to 606, or 
66% 
Operations 
ARTHROPLASTY 
elbow 
total knee 
hip cup 
head-neck 
total hip 
total extraction total hip 
partial extraction total hip 
Code 
826 2 
866 2 
856 6 
856 7 
856 8 
854 3 
854 4 
1977 
31 
643 
40 
1894 
5391 
214 
49 
1980 
41 
1127 
128 
2823 
7364 
357 
153 
SEQUESTRECTOMY 
humerus 
fingers/metacarpals 
hip/thigh 
tibia/fibula 
ankle/foot 
REMOVAL OF MATERIALS 
hip nail 
intramedullary nail 
plate + screws 
cerclage 
epyphysial staples 
other 
8104 
830 1 
850 4 
860 3 
870 5 
880 0 
8801 
880 2 
880 3 
880 4 
880 5 
+ 9 
14 
32 
109 
152 
57 
364 
779 
1112 
6492 
723 
192 
2791 
12090 
18 
46 
167 
246 
129 
606 
897 
1081 
8715 
789 
186 
3604 
15272 
Table 11 Numbers of various types of operations performed m 
1977 and in 1980 The table shows the type of operation and its 
code as used by the Netherlands Medical Records Foundation The 
numbers of the operations indicate the major and accessory 
operations performed m hospitals associated with the Medical 
Records Foundation Extrapolation enables estimation of figures 
for the Netherlands as a whole (for 1977, multiply by 111, for 1980 
by 10 5) 
Year Number 
1975 1860 
1976 1970 
1977 2146 
1978 2056 
1979 2231 
1980 2196 
Table 1 2 Numbers of cases of osteomyelitis in the Netherlands 
from 1975 to 1980 inclusive The figures refer to the main or 
accessory diagnoses at discharge recorded by the Medical Records 
Foundation, coded as acute, subacute and chronic osteomyelitis 
(codes 720 0, 7201 and 720 2), with exclusion of osteomyelitis of 
the jaw, nasal sinuses and mastoid The figures have already been 
extrapolated to 'total Netherlands' 
9 
Some impression of the number of cases of osteomyelitis 
may also be gained from the diagnoses at discharge that 
listed osteomyelitis, acute or subacute, with exclusion of 
infection of nasal sinuses, jaws and mastoid bone. As 
Table 1.2 shows, from 1975 to 1980 there has been a rise 
from 1,860 to 2,196 patients. After 1977, there has been 
hardly any rise. In this connection it should be kept in mind 
that these figures reflect just the numbers of admissions 
because of osteomyelitis, not the numbers of patients or of 
operations. 
Most skeletal infections necessitate several operations and 
as a rule they heal only after many years of treatment It is 
every surgeon's duty to do all he can to prevent infection, 
and it is a challenge to keep the proportion of postoperative 
infections at a minimum Every new therapy for which it is 
claimed that it favourably affects the results of treatment of 
an infection deserves attention and critical study This is the 
more pressing if the therapy not only improves the cure rate 
but also reduces the patients' discomfort during treatment. 
One new method of treatment for which the above 
advantages are being claimed is that with gentamicin-
PMMA beads. Their use has gained currency in the last few 
years, mostly in Germany and largely in skeletal infections. 
This study is intended to assess the value of the gentamicin-
PMMA beads as a method of local antibiotic treatment by 
comparing their effects with those of other methods of 
treating infections used up to now The study is divided into 
three parts 
The first part comprises the study of the literature 
describing the qualities of antibiotic-containing cement, of 
gentamicin and of gentamicin-PMMA beads It also 
includes a detailed discussion of the infections in which 
attention is focused in orthopaedic surgery: osteomyelitis 
and infected endoprostheses. Their pathogenesis, diagnosis 
and various methods of treatment are described and 
discussed to the extent necessary to define the role of the 
new local antibiotic treatment. 
The second part reports a study of the results of the 
treatment of infections in patients. A group of patients 
treated with gentamicin-PMMA beads and studied 
prospectively is compared with a group of patients treated 
by other methods, studied retrospectively. 
The third part of this report contains a study of the 
possible side effects of gentamicin during treatment of an 
infection with gentamicin-PMMA beads For this purpose, 
an attempt has been made to gain insight into the 
pharmacokinetics of the gentamicin-PMMA beads To be 
able to assess nephrotoxicity, we first had to evaluate, in 
experiments and at operations, a sensitive parameter, viz. 
P2-microglobulin Finally, audiological and vestibular 
examinations have been carried out in some patients to 
evaluate the effect on hearing or equilibrium. 
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Chapter 2. Osteomyelitis 
2.1 Introduction 
Infections are often compared to battles between parasite 
and host, the outcome depending on the parasites' virulence 
and number on the one hand and the host's defensive forces 
on the other (Fig. 2 1). Much then depends on the place 
where the battle is fought 
DEFENCE OF THE HOST 
sclerosing osteomyelitis of Carré 
Brodie's abscess 
osteomyelitis albuminisata of Poncet 
recurrent osteomyelitis 
acute osteomyelitis 
septic osteomyelitis 
VIRULENCE OF MICRO ORGANISM 
Figure 2 1 This figure shows schematically how the equilibrium 
between the host's defensive force and the virulence of the micro-
organism determines the type of osteomyelitis (from Fanconi, 1967). 
Osteomyelitis constitutes an autonomous, pathological and 
clinically well-defined entity. The pathophysiological and 
anatomical properties of the osseous tissue are of decisive 
importance for the occurrence and the course of the 
infection. These qualities also have important implications 
for the treatment of osteomyelitis and for the evaluation of 
the results of their treatment. 
2.2. Histological and pathogenetic 
aspects of osteomyelitis 
Bone may be regarded as an organ, in which the various 
hard and soft constructive elements constitute a functional 
unit Its inflammation is not restricted to one of these 
elements but involves all compartments of the bone· 
osteomyelitis is an inflammation of the entire osseous tissue. 
A characteristic feature of osseous tissue is that unlike 
other organs, it behaves relatively passively and reacts 
slowly to infection (Konn and Postberg, 1970, Konn and 
Böhm, 1974). 
An inflammation that starts in the medullary cavity 
will only at a relatively late stage cause histologically 
discernible signs of inflammation in the cancellous tissue, 
cortex and periosteum An inflammation that at firts 
manifests itself mostly in the periosteum becomes 
histologically visible in the medullary cavity only much 
later 
Clinically and histologically, distinctions may be made 
on the basis of the stage of the inflammation and of certain 
clinical evolutive types (Table 2.1) 
acute (§ 2 2.1) 
/ 
endogenous osteomyelitis 
\ 
chrome (§2 2.2) 
pyogenous osteomyelitis 
osteomyelitis 
acute 
/ 
exogenous osteomyelitis (§ 2.2.3) 
\ 
chronic 
non-pyogenous osteomyelitis (§ 2.2.4) 
Table 2 1 Classification of osteomyelitis by pathogenesis, indicating 
the paragraphs in which the various types of osteomyelitis are 
discussed 
2 2 1 Acute haematogenous osteomyelitis 
In acute pyogenous inflammation, we find poly-
morphonuclear leukocytes in the bone, also, as a reaction to 
the bacteria Just as in other tissues, interstitial oedema and 
rupture of capillaries occur in bone, also. This process, 
which runs its course in a few days, does not differ from 
cellular or humoral mechanisms in other infected tissues 
(Enneking, 1979). Specific of the osseous tissue, however, is 
the effect of the rising pressure of the exudate inside the 
unyielding Haversian canals. This deprives the osteocytes of 
their blood supply The rising pressure leads to rapid spread 
of the infection in the medullary canal and along the 
Volkmann's and haversian canals through the frequently 
thin and porous cortex. 
Studies by Hobo have shown that the vasa nutntia at the 
level of an epiphyseal disc make a sharp bend and widen 
into sinusoids, with the vascular diameter increasing from 8 
to 15 - 60 μ As a result, the blood flow slows down, 
producing a likely site for bacteria to settle In addition, it is 
believed that development of an infection is facilitated by 
the fact that the endothelial cells in the afferent tracts of the 
metaphyseal vessels have no or insufficient phagocyting 
properties (Waldvogel et al., 1970'') (Fig 2.2). 
The pattern of the spread of the inflammation is determined 
by the local anatomical situation which depends appreciably 
on the patient's age Trueta describes the typical course of 
acute haematogenous osteomyelitis He demonstrates that 
the evolution of the inflammation is determined by various 
vascular patterns in the bone which in their turn depend on 
the patient's age (Trueta, 1959; Trueta, 1968) On the basis 
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Figure 2.2 Schematic representation of the vascularization of the 
metaphysis (from Hobo, according to Trueta, 1968). Sinusoidal 
dilations of the vasa nutritia at the level of epiphyseal disc might be 
the sites where bacteria settle because of local deceleration of the 
bloodflow. 
of the course, three age groups can be distinguished: 
children below one year, children from 1 to 16 years and 
adults (Fig. 2.3). 
Below the age of one year, a few blood vessels enter the 
epiphyseal disc. Subchondrally, these epiphyseal vessels 
also show sinusoid dilations, just as in the metaphysis. 
Consequently, when acute haematogenous osteomyelitis 
occurs in a baby, it is often associated with arthritis 
and severe damage to the epiphyseal cartilage. Another 
characteristic finding at this age is formation of a massive 
involucrum, due to the fact that the periosteum is raised by 
the exudate, and later by pus which penetrates the thin 
cortex. The raised periosteum again forms new bone. 
Sometimes, the periosteum is separated along the entire 
length of the diaphysis (Fig. 2.3a). 
Between the ages of 8 and 18 months, an avascular barrier 
develops in the epiphysis in humans, as demonstrated for 
the femoral head by Trueta (1968). This is the reason why in 
the age group between approx. one and 16 years, the 
epiphysis remains unaffected by the inflammation (Fig. 
2.3b). A massive involucrum develops, however. 
Thrombosis of the arteria nutritia on the one hand and 
separation of the periosteum on the other deprive the cortex 
of, respectively, its endosteal and periosteal blood supply, 
resulting in large cortical sequestra. The firm fixation of the 
periosteum to the bone at the level of the epiphyseal disc 
prevents subperiosteal spread in the direction of the joint 
(Hart, 1937). Where the metaphysis extends to inside the 
articulation, as is the case in the hip and the shoulder, its 
intra-articular position after penetration of pus through the 
thin periosteum may lead to rapid development of arthritis 
(Fig. 2.4). 
Whereas in the child the site of predilection of 
haematogenous osteomyelitis is the richly vascularized 
metaphysis of the most rapidly growing long bones, in the 
adult the sites of predilection are the vertebral bodies and 
the pelvis. In adults, the rapid spread of the infection along 
the entire length of the bone and the absence of large 
sequestra with involucrum are typical. The periosteum is so 
firmly attached to the bone that it can no longer be easily 
separated from it. Also, the absence of epiphyseal discs 
Figure 2.3 Relationship of the age and the pattern of spread of a haematogenous osteomyelitis. It is 
only between the ages of approximately one year and sixteen years (b) that the epiphyseal disc constitutes 
an effective barrier against spread of the inflammation from the metaphysis to the joint. In younger 
children (a), blood vessels penetrate the epyphyseal disc. In adults (c), the epiphyseal disc is absent. 
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facilitates the occurrence of articular inflammations (Trueta, 
1959). Furthermore, there is fairly rapid spread to soft parts 
due to the exudate breaking through the periosteum. Also, 
the tendency to chronicity of the inflammation is far 
stronger than in the child (Fig. 2.3d), 
Figure 2.4 Schematic representation of the spread of a haemato-
genous osteomyelitis in the presence of an epiphyseal disc (one to 
sixteen years). The inflammation spreads to the diaphysis (b) or 
breaches the cortex. In the latter case, the site of insertion of the 
capsule determines whether arthritis develops (a) or the periosteum 
is lifted and fragmented (c). (From Hart, 1937; Tronzo and Bowling, 
1962; Lennert, 1965). 
2.2.2. Chronic osteomyelitis 
The transition from the acute into the chronic inflammation 
is gradual, without sharp histological or clinical dividing 
lines. The focus of the inflammation is encapsulated by a 
wall of granulation tissue, later by dense fibrous connective 
tissues that proliferates in the Haversian canals and in the 
medullary cavity. Intraosseously, an abscess develops which 
contains the necrotic bone, the sequestrum. Around the 
wall of the abscess, primitive mesenchymal cells are 
stimulated to form bone: new reactive bone which, also 
inside the medullary canal, may be called involucram 
(Enneking, 1979). 
The sequestrum is slowly reabsorbed by granulation 
tissue. This reabsorption is the task of phagocyting cells in 
the granulation tissue. Since the ratio of surface and mass of 
cortical bone is very low compared with cancellous bone 
(0.2 sq.cm per gram as against 9 sq.cm per gram), the 
absorption of devitalized cortical bone is a very slow process 
(Kahn and Pritzker, 1973). This constitutes another typical 
problem of osseous infection. 
Bacteria in the necrotic bone from time to time cause 
the inflammation to flare up, more bone is devitalized and a 
vicious circle may develop, not rarely with gradual spread of 
the infection. 
From the histological point of view, several stages of 
inflammation exist side by side in chronic osteomyelitis. 
Depending on the predominance of a particular histological 
image, several types of osteomyelitis are distinguished. 
Exudative-aggressive chronic osteomyelitis 
Just as in acute pyogenic osteomyelitis, there are 
concentrations of leukocytes, fibrin, exudate and abscesses. 
The trabeculae are devitalized and delimited by granulation 
tissue with predominance of the osteoclastic activity. 
Chronic persistant osteomyelitis 
Here, we find connective tissue rich in cells and fibres with 
infiltrates of lymphocytes and plasma cells. The trabeculae 
show osteoblastic activity with young fibrous bone. This 
chronic type is further subdivided into the little-active form, 
with few cells and little transformation of bone, and the 
strongly active form, which is richer in cells and constitutes 
the transition form to the exudative aggressive form. 
Cicatrized chronic osteomyelitis 
Here, there is predominance of scar tissue, with few nuclei 
and numerous fibres. Here and there, however, there exist 
small abscesses, possibly the cause of exacerbation of this 
chronic osteomyelitis (Könn and Böhm, 1974). Macro-
scopically, the soft parts surrounding the osteomyelitic focus 
contain fistulous ducts, which are frequently ramified. In the 
fistulous duct we find cavities and old small abscesses, and 
often several, mostly small sequestra. The scar tissue is most 
strongly developed close to the skeleton but extends into 
the soft parts, fairly often involving the neurovascular 
bundle. Inflammation of the vascular wall may lead to 
obliterating endangiitis or thrombosis of the vessels. 
Access to the focus of infection through the circulation 
is increasingly abolished and the inflammatory process 
is 'autonomized'. The problems of ischaemia and in-
accessibility of the chronic osteomyelitic focus are 
characteristic and of essential importance for the treatment 
(Trueta, 1968; Könn and Böhm, 1974). 
2.2.3. Exogenous osteomyelitis 
The term 'exogenous osteomyelitis' designates 
osteomyelitis caused by an external infection, a trauma or 
an operation. Histologically, there is no essential difference 
between exogenous osteomyelitis and endogenous, haem-
atogenous osteomyelitis. For exogenous traumatic osteo-
myelitis, certain authors, especially in the German 
literature, prefer the term 'osteitis' (Lexer, 1936; Popkirov, 
1971; Burri, 1979). This preference is argued by stating that 
'osteitis' indicates better that all parts of the osseous tissue 
are involved. Allegedly, to many, the term 'osteomyelitis' 
means only haematogenous osteomyelitis (Hierholzer, 
1970). However, opponents of the term Osteitis' use the 
same argument: osteomyelitis indicates better that all 
constructive elements are involved in the inflammation 
(Könn and Postberg, 1970; Rehn, 1974). This is a frequent 
topic of discussion at congresses (Hierholzer and Rehn, 
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1970; Hierholzer, 1978). We believe that the semantics is 
less important than the knowledge that osteomyelitis is not 
restricted to any single part of the bone. Therefore, we shall 
continue to use the term Osteomyelitis' also for 
osteomyelitis of exogenous traumatic origin. 
Histologically, exogenous osteomyelitis has virtually the 
same characteristics as haematogenous osteomyelitis. One 
important difference is, however, that in exogenous 
osteomyelitis there is a normergic reaction, in contrast to 
haematogenous osteomyelitis, which generally causes a 
hyperergic tissue reaction. In exogenous osteomyelitis, 
sequestra in the form of devitalized bone fragments may be 
present from the onset of the inflammation. Popkirov calls 
these 'pseudo-sequestra' (Popkirov, 1971). Here again, the 
acute and the chronic form cannot be distinguished sharply. 
No histological examination of an early stage of exogenous 
inflammation is believed to have been reported (Hierholzer, 
1970; Könn and Böhm, 1974). 
Burri states that aggressive exudative osteomyelitis 
hardly ever occurs after bone surgery: only in case of 
infection when an intramedullary nail is used. In that case, 
the infection spreads rapidly throughout the bone marrow, 
resulting in a meduallary phlegmon with sequestration of 
the interior portion of the cortex due to destruction of the 
endosteal blood supply. Infections after other osseous 
operations more often show the picture of plasmocellular 
'osteitis' (Burri, 1970). The microscopical image of this as 
described by Burri is identical to that of the above-
mentioned chronic persistent osteomyelitis. One important 
difference from endogenous osteomyelitis is that the 
exudate, produced during the acute phase of exogenous 
osteomyelitis, can escape through the defects in the cortex, 
so that the intra-osseous pressure does not rise, no 
ischaemic lesions occur and spread in the skeleton is less 
extensive. An abscess develops around the fracture or the 
osteotomy surfaces. Local reabsorption occurs. This is even 
stronger if there is interfragmentary instability. If there is 
adequate interfragmentary compression, consolidation of a 
fracture or osteotomy in the presence of an inflammation 
may nevertheless proceed fast, with formation of much 
periosteal callus (Burri, 1979). 
2.2.4. Non-pvogenous osteomyelitis 
An important category in osteomyelitis, which is different 
histologically as well, is that caused by non-pyogenous 
causative agents. These include fungi, viruses and certain 
bacteria. The most important group in this category 
is tuberculous osteomyelitis. The inflammation is 
characterized by absence of the acute response of the body 
with oedema and haemorrhage. Rather, the reaction takes 
the form of lymphocytes, plasma cells and epithelioid 
histiocytes forming giant cells. The destruction of the bone 
here is the consequence of this granulomatous reaction and 
not of high intraosseous pressure with ischaemia (Enneking, 
1979). Accordingly, no sequestra are formed. This 
granulomatous reaction is not specific of tuberculosis: 
granulation tissue with epithelioid histiocytes is also seen in 
brucellar and fungal infections (Putschar, 1976). The 
principal differences between pyogenous and non-
pyogenous osteomyelitis result from the fact that in the non-
pyogenous form the reaction is less acute so that less 
sequestration occurs, no involucrum is formed and the 
continuous destruction of the bone is pre-eminent 
(Enneking, 1979). 
2.3 Clinical picture and course of 
osteomyelitis 
2.3.1. Acute haematogenous osteomyelitis 
Three stages can be distinguished, on the basis of the degree 
of extension of the process (Trueta, 1968). 
Stage 1. Severe, constant pain is felt far below the surface 
and can sometimes be pin-pointed by the child with one 
finger. This 'one-finger' test over the metaphysis is the only 
symptom at the onset of the disease, apart from the pain. 
Occasionally, it has been preceded by a recent infection or 
minor trauma (Nade, 1974). 
Stage 2. As soon as pus is being formed in the medulla and 
sub-periosteally, the pain grows more severe and the 
tenderness on palpation more pronounced. The children 
display variable degrees of sickness, from mild malaise to 
severe toxaemia. 
Stage 3. As soon as pus reaches the surrounding soft parts, 
the classical local signs of inflammation develop, such as 
pain, warmth, redness and fluctuation. This third, decisive 
stage as a rule occurs within two to three days. Arthritis of 
the adjacent joint readily develops in a baby; also in a child, 
if the metaphysis of the proximal humerus or proximal 
femur is affected. Hydrops in an adjacent articulation may 
give rise to confusion; it often develops as the result of a 
sympathetic reaction. 
Antibiotic treatment has reduced the formerly high 
mortality from 15 to 30% to approx 1% (Ferguson, 1973). 
Since 1951, penicillin-resistant staphylococci have changed 
the situation: osteomyelitis more often becomes multi-
focal, the patients more often are younger children 
(especially neonates) and septicaemias are more severe 
(Gilmour, 1962). 
However, a major problem since the introduction of 
antibiotics is the masking of the symptoms. The diagnosis at 
an early stage is very difficult and often uncertain. As a 
result, the treatment initially is often symptomatic and 
sometimes inadequate. Antibiotics change the natural 
course of the disease. Although the mortality has admittedly 
decreased, morbidity has not. Because the correct diagnosis 
is made later, complications such as aseptic necrosis and 
destruction of the infantile hip occur more often. Making 
the correct diagnosis during the first few days is of extreme 
importance (Hart, 1937; Heekman, 1955; Trueta, 1959; 
Harris, 1960; Gilmour, 1962; Tronzo and Dowling, 1962; 
Blockey and Watson, 1970; Ferguson, 1973; Nade, 1974 and 
Molían and Piggot, 1977). 
Every case of pain in a child, associated with 
tenderness near a metaphysis and with signs of infection 
should be regarded as an acute haematogenic osteomyelitis 
until the contrary is proved. 
2.3.2. Subacute osteomyelitis 
If there is equilibrium between the parasite and the host, the 
inflammation may remain limited as to localization and 
symptoms. It is then called subacute osteomyelitis or 
primary chronic osteomyelitis. Kulowski then speaks of an 
arrestive form, in contract to the abortive form, in which the 
host wins the fight, or the suppurative form in which 
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fistulization occurs (Kulowski, 1956) Several types of 
subacute osteomyelitis can be distinguished 
a Brodie's abscess 
A small cavity develops, usually in the diaphysis of the 
tibia, without an acute clinical picture (Brodie, 1832) 
This cavity contains granulation tissue, no pus Brodie's 
abscess may also be regarded as a form of primary sub­
acute osteomyelitis ^Kandel and Mankin, 1973) (cf e) 
b Antibiotics osteomyelitis 
Also known as cold, indolent or smouldering osteo­
myelitis (Popkirov, 1971) This form of osteomyelitis has 
been desenbed by Popkirov during treatment of osteo­
myelitis with antibiotics The clinical course is mild, often 
without clinical symptoms of infection 
с Plasmocellular osteomyelitis 
Also sometimes called Poncet's osteomyelitis 
albumimsata Instead of pus a serous, viscous, oily fluid is 
formed in the medullary cavity The course is quiescent, 
the localization is usually the femur The most frequent 
causative agent is Staphylococcus aureus (Popkirov, 
1971, bxner, 1970) 
d Carre's sclerosing osteomyelitis 
This is a non-pyogenous osteomyelitis with a decisively 
chronic course A characteristic feature is thickening and 
densifica tion of the bone, sometimes leading to occlusion 
of the medullary cavity Formerly, the osteoid osteoma 
was considered to belong to this form (Popkirov, 1971, 
Kahn and Pntzker, 1973) Osteomyelitis in the jaw has 
been alleged to occur more often as sclerosing osteo­
myelitis Some clinicians doubt whether this form of 
osteomyelitis really exists 
e Primary subacute pyogenous osteomyelitis (Hams and 
Kirkaldy Willis, 1965, Brit med J , Leading article, 1969, 
Gledhil, 1973 and Kandel and Mankin, 1973) This type 
of osteomyelitis is encountered often in bast-Africa and 
Nigeria It is believed that in East-Africa, osteomyelitis 
assumes this form in approx two-thirds of all cases 
There is no acute onset and no systemic reaction The 
sub-acute course is attributed to the low virulence of the 
causative agent (usually Staphylococcus aureus, 
coagulase-positive) or to raised immunity of the host 
The cavity brought about by the osteomyelitis is 
localized in the mctaphysis and extends to the diaphysis 
It is filled with granulation tissue, usually not with pus 
Sequestra sometimes occur This subacute form may also 
be localized primarily in the epiphysis (Green et al, 
1981) 
f Chronic recurrent multifocal osteomyelitis 
This osteomyelitis develops gradually with moderately 
severe systemic symptoms of infection, and runs a 
subacute or chronic course The condition flares up from 
time to time, for an average of six years It is localized in 
the melaphyses of the long bonses The cause and patho­
genesis are unknown The histological picture sometimes 
resembles that of a monofocal plasmacellular osteo­
myelitis but no causative agent has ever been 
demonstrated The multifocal nature is reminiscent of 
salmonellar osteomyelitis or sickle-cell infarctions So far, 
no therapy has been able to influence the course The 
prognosis is favourable (Solheim et al, 1980) 
2 3 3 Chronic pyogenous osteomyelitis 
Chronic osteomyelitis is characterized by its protracted 
course and by the rarity of spontaneous recovery Its 
persistence and its recurrent character have prompted 
certain dicta that express despondence because of this 
chronic nature 'once osteomyelitis, always osteomyelitis', 
and 'osteomyelitis is a time-bomb that keeps ticking all your 
life' 
It is rare for spontaneous expulsion or reabsorption of 
a sequestrum to lead to spontaneous cure Treatments are 
characterized by a usually high recurrence rate Recurrence 
after periods of up to 80 years' duration have been reported 
in the literature (Dodt, 1962) The average duration of the 
disease is several decades, and often, numerous surgical 
interventions and long courses of antibiotic treatment are 
necessary 
The extremity has a characteristic appearance with 
several, often deeply retracted scars and one or several 
sinuses The soft parts around the osteomyelitic focus are 
greatly scarified and the skin is often dystrophic As a rule, 
pus is secreted in small quantities and most patients learn to 
cleanse the smus themselves The presence of the sinus, 
however, frequently constitutes a severe psychic stress 
(Lidgren and Torholm, 1980) 
Most patients with chronic osteomyelitis feel hardly 
any pain However, early closure of a smus resulting in 
congestion of pus causes pain as the pressure in the sinus 
rises and in addition frequent general inflammatory 
systems When pain develops m a still discharging smus, the 
possibility of malignant degeneration of the epithelium of 
the fistulous duct should be seriously considered 
Fibrosarcoma, reticulum cell sarcoma, adeno­
carcinoma, basal cell carcinoma and plasmocytoma may 
originate from a chrome fistula that has been present for a 
few decades The frequency is believed to amount to approx 
0 4% (Waugh, 1952, Sedhn and Fleming, 1963, Popkirov, 
1968, Lidgren, 1973e, Johnston and Miles, 1973, Akbarma 
et al, 1976, Brewer et al, 1976, Dranert et al, 1976) 
The bone may be locally sensitive to tapping More 
deep-seated parts of the skeleton such as the femur, 
however, are often little accessible to physical diagnostics 
Pain in a bone is not necessarily due to an inflammation It 
may also be caused by an intraosseous venous 
hypertension This higher intraosseous blood pressure 
occurs as a sequela in inactive osteomyelitis and may be 
compared to the higher intraosseous blood pressure in 
arthrosis (Lidgren and Torholm, 1980) 
There are gradual transitions to non-suppurative forms of 
osteomyelitis The diagnosis may then become difficult, 
with mild pam and some loss of function as the only 
symptoms Other clinical indications may be entirely 
absent 
2.4. Diagnostics 
2 4 1 Introduction 
To make the diagnosis, but particularly also to follow the 
evolution of the osteomyelitis, quantifiable data are 
required It is especially in cases of chronic exacerbating 
osteomyelitis that the need is felt of more objective 
observation than is possible with the clinical eye which often 
falls short Objective data are also important for the 
evaluation of the results of a treatment and for comparison 
of results Acute osteomyelitis during the first few days 
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constitutes a difficult diagnostic problem Special 
importance attaches to the symptoms described in 
paragraph 2.3 1. In addition to local symptoms there are 
systemic symptoms of infection,just as during exacerbation 
of chronic osteomyelitis. In chronic and subacute osteo­
myelitis, the diagnosis often has to be made on the basis of 
symptoms and data that are not very clear These symptoms 
and data are discussed below. 
2.4.2 Symptoms 
As the mam subjective symptom, pain might be a 
parameter, as discussed above However, this holds true 
only of acute osteomyelitis and exacerbation of chronic 
osteomyelitis. Objective symptoms that may be observed at 
clinical examination are little specific. 
Fever, also, is present only in acute or exacerbating 
chronic osteomyelitis. It is then often subfebnle. Acute 
recurrences, however, may be associated with high fever 
and shivering There exists no type or pattern of fever that is 
characteristic of osteomyelitis (Winkelman and Gobel, 
1979) 
24 3 Laboratory 
Signs of inflammation are also demonstrable in the blood, 
predominantly in the acute phase. Leukocytosis with a left 
shift occurs virtually exclusively in acute osteomyelitis or 
exacerbations of chronic osteomyelitis. The BSR, however, 
is an excellent parameter to follow the evolution of the 
osteomyelitis and its treatment. For the diagnosis, on the 
other hand, the BSR is a parameter of little value in case of 
doubt; an increased BSR namely, does support the 
diagnosis, but a BSR that shows little or no rise definitely 
does not exclude a chronic osteomyelitis If treatment is 
successful, the BSR will fall gradually. When the BSR is 
plotted against the time on a semiloganthmic scale, its 
course should be linear (Harle, 1979'') (see Fig. 2.5). 
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Figure 2 5 After an uncomplicated operation, the evolution of the 
BSR plotted on a semi-logantmic scale runs a linear course (from 
Harle, 1979a). 
Throughout the course of the osteomyelitis and particularly 
also during the postoperative stage the BSR, determined 
often enough, generally proves the only really useful 
parameter to establish the course of the healing. 
Some authors determine antibody titres in osteo­
myelitis and ascribe diagnostic value to their findings (Lack 
and Towers, 1962; Hedstrom and Kamme, 1973) The 
antibodies produced against staphylococci can be 
demonstrated by means of indirect haemagglutination 
assay (IH A), with determination of antibody titres against 
the staphylococcal antigen groups А, В and F. 
These antibodies occur in healthy subjects, but the 
titres are raised in acute staphylococcal infections. 
Hedstrom and Kamme in 20 patients found a good 
correlation between the IHA titre and the clinical course of 
exacerbation and regression (Hedstrom and Kamme, 1973) 
Interestingly, S and G. Hierholzer found that in chronic 
staphylococcal infections the function of the phagocyting 
cells is reduced. With recovery, this function of the 
phagocytes increased again (S. and G. Hierholzer, 1979, 
1980) The same authors showed that probably during the 
transition from the acute to the chronic form of osteo­
myelitis, the leukocytes are impaired in their binding to the 
particles to be phagocyted, owing to functional reduction of 
the necessary receptors They were unable to establish 
whether the reduced phagocyting function is a cause or a 
consequence of the osteomyelitis Eid in 90 patients with 
acute haematogenous osteomyelitis found an indication of 
a depression of the normal immune response to infection 
(Eid et al, 1980). 
Cartridge in 23 patients with acute haematogenous 
osteomyelitis always observed a 'neutrophil dysfunction' 
compared with a control group (Cartridge el al, 1981) 
2.4 4 RoentRenology 
Roentgenological examination is of great importance in all 
skeletal diseases In infections, however, it should be kept in 
mind that before skeletal alterations become visible, a lytic 
or osteoblastic process had been in progress for an 
appreciable length of time. Bone atrophy only becomes 
visible after loss of 30 to 50% of the minerals. For instance, 
an osteoid margin of a width of 10 μ takes 10 days to be 
formed (Waldvogel et al, 1970'') 
In acute haematogenous osteomyelitis, no roentgen 
abnormalities are present during the first few days. A 
normal X-ray of a bone in a child that has acutely become 
painful and tender suggests the diagnosis of acute 
haematogenous osteomyelitis (Trueta, 1968) 
Roentgenologically, a swelling of the soft parts at the 
level of the metaphysis becomes visible first. Sometimes, it 
includes a clear area brought about by accumulation of pus 
(Fig. 2.6). It is only on the 10th to 12th days that the first 
roentgen abnormalities of the skeleton become visible 
(Hart, 1937; Ilenck, 1972; Edeiken and Hodcs, 1973; 
Ferguson, 1973, McAllister, 1974). At that stage, irregular 
lytic areas become visible in the metaphysis, sometimes 
preceded by a 'smoky' aspect (Tachdjian, 1972). This is 
followed soon by the subperiosteal spread which leads to an 
involucrum and cortical sequestrum. The first lytic lesions 
then grow visible; sclerosis only develops after one month 
(Waldvogel, 1970''). Different causative agents allegedly 
bring about more or less distinguishable roentgen 
abnormalities (Ferguson, 1973) In general, in osteomyelitis 
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Figure 2.6 X-ray film at an early stage of haematogenous osteomyelitis of the proximal femur (a) and the distal radius (b) At this 
stage of the inflammation, only a small subperiosteal abscess is visible. 
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not influenced by antibiotics, the roentgen lesions run the 
following course: 
- rarefaction: the structure becomes less dense. 
Osteoporosis with periosteal reaction 
- destruction: loss of structure, sequestra and reaction of 
periosteum 
- repair: ossification, hyperostosis and osteosclerosis 
(Flach, 1970). 
Exogenous osteomyelitis differs from haematogenous 
osteomyelitis in that in the former, early periosseous lesions 
are diagnostically irrelevant (Burri, 1979). Medullary bone 
destruction is not clearly visible. There may be massive 
accumulation of pus in the medulla without any visible 
radiological manifestation (Butt, 1973). 
It is only when an osteomyelitis has been present for 
approx two weeks that clear areas and periosteal reactions 
occur. In florid infections, clear areas develop around 
implants (Müller, 1978), and in case of a medullary nail, 
small round lytic areas occur, followed by extensive 
destruction along the entire nail (Burri, 1979). 
In chronic active osteomyelitis, the progressive 
destruction leads to formation of sequestra. Pseudo-
sequestra, unlike true sequestra, do not retain the dense, 
sclerotic structure unless they fail to be revitalized and are 
transformed into true sequestra (Müller, 1978; Burri, 1979). 
In chronic inactive osteomyelitis there are hyperostosis and 
numerous subperiosteal bone formations. 
Antibiotic treatment causes a significantly different 
roentgenological image, due to less periosteal reaction, 
reduced sequestration and suppressed reconstructive 
changes (Flach, 1970; Müller, 1978). 
In order to obtain adequate roentgenological information in 
osteomyelitis, the plain X-rays are best made in four 
projections (Rehn, 1974). With osteosynthesis material in 
situ, it is advisable to look for the optimal projection under 
image-intensifier control. The variably sclerotic areas in the 
bone often necessitate X-rays with different exposures (Fig. 
2.7). 
In the presence of a sinus,ßslulography should always be 
performed, but sometimes the fistulous duct is inadequately 
visualized owing to contrast medium leaking away with 
insufficient pressure during the contrast injection as the 
result. Sepsis after fistulography has been reported 
(Halpern et al., 1979). The CT-scan may supply valuable 
supplementary data, just as the planigram. It is especially in 
cup-shaped and cylindrical sequestra, such as occur in pin-
tract osteomyelitis and intramedullary infections that the 
CT-scan supplies important information. Good insight may 
be gained into the circular shape of the cortex with local 
areas of thickening (Fig. 2.8). 
2.4.5. Scintigraphy 
Scintigraphy provides important information on osseous 
processes. The problem is to interpret this information. In 
the technetium scan, the distribution of Tc99m-MDP is 
influenced by the regional blood distribution and by uptake 
into the bone matrix (Kahn et al., 1979). A rapid initial 
phase reflects vascularization, a slower second phase the 
Figure 2.7 It is especially in osteomyelitis with sclerosis that 
X-ray films with different exposures provide more information, as 
in this patient with chronic osteomyelitis afier an empyema of the 
medullary cavity of the tibia. 
immature bone formation (Davies and Galasko, 1977). Thus, 
technetium reacts to remodelling of the bone, for which it is 
essential that an adequate amount of sound bone is present 
to incorporate the radionuclide (Hughes, 1980). The pricise 
mechanism of the uptake of technetium by the skeleton is 
still a mystery. A part is adsorbed to the hydroxyapatite 
crystals of the bone (Jones and Cady, 1981). Accordingly, 
the technetium scan does not constitute a specific 
parameter of inflammation. The gallium scan allegedly does 
react specifically: to the presence of leukocytes instead of to 
vascular permeability. Deysine et al. in 6 patients saw good 
correlation of the evolution to the infection with 13 gallium 
scans. Control patients showed that postoperative 
haematomas did not cause positive gallium scans. They 
found no false-negative scans in osteomyelitis (Deysine et 
al, 1975). 
As a general rule, in osteomyelitis the scan reveals 
abnormalities sooner than a roentgenogram (Scoles, 1980). 
It is believed that the increased activity in osteomyelitis is 
due to vascular hyperactivity rather than to osteogenesis. A 
raised intraosseous pressure, however, reduces the blood 
supply so that scintigraphy no longer shows increased local 
activity (Scoles et al., 1980). Sometimes, there even occurs a 
local cold spot, which turns hot again after spontaneous or 
surgical decompression (Jones and Cady, 1981). 
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Figure 2.8 CT scan of the same patient as in Figure 2.7. The transverse section provides good insight into the circular shape and 
thickness of the cortex of the long bones. This information is particularly useful if drilling out the medullary cavity is considered as 
a method of treatment. 
2.5 Bacteriology 
Bacteriological examination is an important part of the 
diagnosis and for this reason is discussed separately. 
2.5.1. Gram preparation 
Specimens collected for cultivation may yield direct 
information when examined microscopically after staining. 
The morphological findings obtained at microscopical 
examination, combined with the clinical symptoms, often 
permit a tentative conclusion concerning the identity of the 
causative agent. This permits a somewhat more informed 
choice of the antibiotics to be administered while awaiting 
the results of the culture. 
2.5.2. Culture 
The culture is the key element in the diagnosis and 
treatment of osteomyelitis. A correct collection technique 
and knowledgeable interpretation of the results of the 
culture are of great importance in this respect. 
Numerous migro-organisms are described in the 
literature as possible causative agents of osteomyelitis. The 
frequency distribution of the bacteria varies greatly from 
one group of patients to another, depending on the type of 
osteomyelitis, the localization and probably the culturing 
technique, as well (Table 2.2). 
A number of authors have pointed out that as a 
rule the bacteria present in sinuses are not the same as those 
in the more deepseated focus of infection. In the sinus 
tract, namely, contamination often leads to a mixed flora, 
whereas in the deeper layers, a mono-infection often 
persists. Accordingly, Popkirov advocates bacteriological 
examination at several levels: 'bacteriologische Schicht­
aufnahme' (bacteriological tomography) (Popkirov, 1971). 
Mackowiak et al. in an important investigation studied 
the relationship between the culture from the sinus tract 
and the culture from deep-seated tissue obtained at 
operation (Mackowiak et al., 1978). They studied the results 
of cultivation in 40 patients with osteomyelitis. Thirty-six 
patients at operation had a mono-culture. The 183 cultures 
from fistulous material of these 35 patients in only 81 cases 
(44%) grew the same bacteria as found in the deep tissue. In 
33 cultures (18%), the bacterium, although present, was 
dominated by other bacteria. The longer a sinus had been 
present, the more often the fistulous culture differed from 
the deep culture: the discrepancy rate rose from 18% to 
69%. 
It is therefore never possible to attach diagnostic value 
to any micro-organism cultured from a sinus, not even when 
the culture is pure. In Mackowiak's study, one exception to 
this rule was Staphylococcus aureus. If this species was 
present in a fistula, it was present in the deep culture as well 
in almost 80% of the cases. On the other hand, if the deep 
culture revealed Staphylococcus aureus, this species was 
demonstrable in the sinus in only 44%. If the culture from 
the sinus repeatedly contained the same species, there was 
slightly more correlation with the species in the deep tissue, 
especially when enterobacteriaceae were involved. This 
discrepancy between cultures from the fistula and the deep 
tissue has been confirmed by several authors. Robson and 
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Table 2.2 Review of literature data concerning percentages of causative agents cultured in osteomyelitis. Where authors did not state 
percentages, these have been calculated. Percentages may add up to over 100 % because the causative mechanisms of mixed infections 
are listed separately. 
Heggers (1969) in deep wound biopsies found a mono­
infection in 87% and a mixed infection in 13%. Exudate 
from the sinus revealed 52% mixed infections. Other 
authors found mixed and mono-infections at various ratios 
(Table 2.3). 
Author Total Mono Mixed Neg. 
N 
Trutz '65 421 
Linzenmeier '70 68 
П95 
Popkirov '71 { g j 
Clawson et al. '73 176 
Flaue '74 {" 
Arora et al. '77 100 
Mackowiak et al. '78 40 
Lambins et al. '79 88 
Müller et al. '79 184 
Wannske et al. '79 879 
Grieben '80 628 
Lehnhardt '80 25 
Kayser et al. '81 284 
Vecsei '81 206 
% 
80 
62 
74 
63 
67 
87 
57 
70 
87,5 
59 
81 
53 
80 
80 
79 
33 
% 
20 
38 
26 
37 
33 
13 
43 
25 
12,5 
41 
10 
12 
20 
20 
14 
73 
% 
5 
9 
35 
7 
4 
Remarks 
haematogenous 
Osteitis' 
haematogenous 
exogenous 
Table 2.3 Review of literature data concerning distribution of 
mixed and mono-infections and of sterile cultures m patients with 
osteomyelitis. 
Dingeldein found a correlation between sinus-tract culture 
and surgical culture in less than 50% (Dingeldein, 1979, 
1981). Vecsei observed a discrepancy between the two 
cultures in 30 out of 80 patients with osteomyelitis (Vecsei, 
1979). Waldvogel retracted an earlier assertion that repeated 
sinus-tract cultures are as accurate as a culture of bone tissue 
(Waldvogel and Vasey, 1980). In any case, a culture of 
material collected at operation is not always reliable, either 
(Dingeldein, 1981; Vecsei, 1981). Contamination with 
sinus-tract material may falsify the outcome, mostly by 
causing the flora to be mixed. Also, it is a known fact that all 
surgical wounds are contaminated: a wound culture is 
positive in approx 30 % even of clean operations (Ritter and 
Stringer, 1981). For this reason, some authors recommend 
taking several biopsies for culturing from the deep tissue, in 
order to gain better insight into the real nature of the 
infecting organism (Dingeldein, 1979; Lindberg et al., 1977) 
(see also Chapter 3.5.2). 
2.5.3. Aerobic infecting organism 
Staphylococcus aureus is the bacillus regarded as the most 
frequent causative agent of osteomyelitis. The frequency, 
however, varies from 35 to 90%. Several authors state that 
around 1966, a fall of the proportion of Staphylococcus 
aureus infections coincided with a rise of the proportion of 
infections caused by gram-negative bacteria, especially 
Pseudomonas aeruginosa (Koch, 1970; Linzenmeier, 1970; 
Flaue, 1974; Kelly et al, 1975,1977). E. coli and streptococci 
retained approximately the same frequency. Hedström in 
20 
Author 
OSTEOMYELraS 
Causative 
agent 
St. aureus 
St albus 
B-haem. streptoc. 
enterococci 
var. streptoc. 
Enterobacter 
Esch. coli 
Klebsiella 
Proteus 
Serratia mar. 
Pseudomonas 
Citrobacter 
Salmonella 
Bacteroides fr. 
var. anaerobics 
miscellaneous 
sterile 
unknown 
Total number of 
samples 
г-
Έ 
3 
65.4 
7.3 
1.2 
8.8 
6.8 
5.8 
10 
11.8 
0.6 
6.1 
651 
Os 
G 
'5 2 
"ω 
.1 
Q 
43 
5 
5 
9 
6 
9 
3 
9 
1 
10 
127 
ON 
•á 
ε 
ε 
Я 
62.5 
1.8 
5.3 
4.7 
2.9 
8.3 
0.6 
11.2 
169 
Γ -
:Ξ 
Ι 
79 
10 
10 
3 
4.4 
5.5 
2 
5.5 
91 
Γ-
"я 
ω 
Ui 
ω 
62 
3 
5 
5 
6 
13 
6 
165 
OS 
E-
'δ 
8 
> 
35.4 
7.9 
9.5 
3.1 
7.9 
2.4 
6.3 
9.4 
4.7 
127 
ON 
"te 
•4-* 
ω 
ω 
•У 
I 
46 
4 
6 
8 
14 
6 
7 
9 
35 
879 
о 
со 
' δ 
> 
39.3 
5.8 
2.9 
10.7 
2.9 
6.8 
2.4 
8.2 
8.3 
8.2 
4.4 
206 
с 
ω 
•с 
О 
60 
8 
2 
4 
3.5 
8 
11 
4 
750 
о 
оо 
73 
·*•» 
§ 
s 
со 
я) 
& 
49.5 
5.5 
7.7 
31.9 
5.4 
58 
о 
оо 
Ό 
Ui 
cd 
υ 
40 
8 
2 
20 
12 
25 
D
in
ge
ld
ei
n
 
'81
 
K
av
se
r 
et
 
al
.
 
81
 
61 62 
5.4 
1.9 
1.3 4.6 
7.7* 1.1 
4.5 
7.7* 3.5 
4.2 
3.2 
9.3 2.3 
0.6 
0.6 
0.3 
313 86 
* together 7.7 
patients with osteomyelitis investigated what phage groups 
occurred with Staphylococcus aureus. He observed a 
significant difference in phage types between haemato-
genous and post-traumatic osteomyelitis (Hedström and 
Kronvall, 1972). According to his findings, those staphylo-
cocci that cause chronic osteomyelitis are capable of 
incorporating fats. Fats allegedly occur frequently in an 
osteomyclitic focus (Lennert, 1956). It is believed that 
staphylococci having this property proliferate whereas other 
strains are inhibited by the fats (Hedström, 1975). 
2.5.4. Anaerobic infecting organisms 
In interpreting cultures and collecting culture material, it 
should be kept in mind that osteomyelitis may be caused 
not only by all bacteria but also by many fungi and viruses. 
A group that in recent years has been brought back from 
oblivion is that of the anaerobic bacteria. Many authors do 
not report any anaerobic infecting organisms but often they 
do report a relatively large number of sterile culture findings 
(Table 2.3). Anaerobic bacteria demand much of transport 
media and organization of transport (Dingeldein, 1979; 
Lodenkämper and Riihlcke, 1974; Nettles et al , 1969). 
In the body, anaerobic bacteria are found in the 
intestine but on many other mucous membranes, as well. 
Transient subclinical bacteriaemia caused by these 
anaerobes are believed to be very frequent (Lodenkämper 
and Löhr, 1971). Bacteria readily pass through mucous 
membranes, especially when the latter are changed under 
the influence of hormones, allergies, infections, etc. 
Haematogenous infections due to anaerobic bacteria are 
less rare than used to be believed (Lodenkämper and 
Riihlcke, 1974), but anaerobes are frequent in non-
haematogenous infections, as well (Lewis et al., 1978; 
Nettles et al., 1969). They grow slowly and have a long 
incubation period. In cultures, growth is often only to be 
observed after one week and it is believed that too many 
cultures are reported to be sterile as the result of premature 
evaluation (Nettles et al., 1969). In patients with a very ill-
smelling wound with much necrosis, the possibility of an 
anaerobic infection should be seriously considered. 
2.5.5. Cell wall deficient bacteria 
Certain bacteria under the influence of antibiotics develop 
alterations of the cell wall: protoplasts, spheroplasts and 
L-types. The absence of the cell wall prevents antibiotics 
that act on the cell wall from destroying this type of bacteria 
(penicillins, cephalosporins), whereas the bacteria can still 
be influenced by antibiotics with a different mechanism of 
action (e.g. aminoglycosides). The L-types are probably not 
pathogenic themselves, but they may survive in spite of 
antibiotic treatment, thus constituing a latent microbe. 
They can also reproduce and sooner or later return from the 
latent to the original bacterial form. Culturing these special 
bacterial types has to be done in special osmotic conditions. 
Gordon (Gordon et al., 1971) describes four patients, three 
of whom had metallic implants in situ. One patient had 
several different metals. Possibly there is a connection with 
socalled abacterial osteitis due to metallosis (Contzen, 1970, 
1973). 
Rosner describes one patient with osteomyelitis 
caused by an L-phase variant of Staphylococcus aureus 
(Rosner, 1968). 
In all patients with sterile discharge (without antibiotic 
treatment), the presence of L-forms should be suspected. 
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Since the diagnosis of anaerobic and cell wall defective 
bacteria is difficult and has frequently been inadequate, the 
role of the two types as causative agents of osteomyelitis is 
uncertain. Both bacterial types are characterized by a low 
virulence. Also, most publications report a large number of 
sterile cultures. A correlation between these sterile cultures 
and incomplete bacteriological diagnosis in ostemyelitis 
may well exist. This might be one of the explanations of the 
chronic recurrent character of an ostemyelitis with 
frequently long latent periods. 
2.6 Treatment 
2.6.1. Historical survey up to the late 19th century 
The earliest signs of osteomyelitis have been found in 
Neanderthals of the Last Glacial Age (Bishop, 1960). The 
earliest references to the treatment are to be found in the 
Smith Papyrus of 5000 to 3000 B.C. (Picket, 1935). 
Treatment at the time consisted of splints and dressings of 
various compositions. For a long time, live wood embers 
were placed on the wound to provoke a kind of defence 
reaction. Hippocrates apart from rest recommended 
application of dressings: not on but beside the wound 
(Picket, 1935); necrotic tissue should not be removed but 
allowed to slough spontaneously (Burri, 1979). Galenus 
(131 B.C.) appreciated pus as a sign of healing: pus bonum 
et laudabile. Celsus (100 A.D.) preferred a more active 
treatment, and recommended removal of the 'carious' bone 
with a red hot iron till healthy bleeding bone was exposed. 
During the subsequent centuries, intervention and 
abstinence were altematingly recommended. 
Paré (1510-1590) and Jaubert (circa 1570) urged a more 
active management than just dressing: pain, flexion, 
inflammation and defects are matters that surgeons should 
not leave entirely to nature. Due to a shortage of oil, Paré 
fortuitously detected that a dressing had an expected good 
effect on a gunshot wound and was less pathogenic and 
necrotising than boiling oil, although the dressing consisted 
of a mixture of egg-yolk, oil of roses and turpentine (Orr, 
1922). 
Burri describes how his predecessor, Secultus (1595-
1645) in Ulm treated ostemyelitis according to rules that still 
apply today, with sequestrectomy and rest with elevation 
(Burri, 1979). 
Jacob van de Haar in Holland described in the 18th century 
how 'festering and corruption in the hollow of the shinbone' 
might be cured by 'trepanning'. He considered 
decompression of the wound essential as long as 'bone 
corruption' was still present, and he prevented premature 
closure of fistulae by introduction of a few grains (Van de 
Haar, 1797). 
William Hey (1736-1819) also preferred sequest-
rectomy and open drainage to cauterization (Picket, 1935). 
Removal of necrosis and sequestra in the treatment of 
osteomyelitis appears to be generally accepted, and 
constitutes a symptomatic therapy, where lack of insight 
into the cause of osteomyelitis bars the way to more causal 
treatment. Van de Haar, for instance, still thought that the 
main cause was a 'commotion' of the bone, impairing its 
blood supply by the 'internal marrow lining', the later 
endosteum. As a result, he said, the internal 'pipe' died and 
separated from the outer part (Van de Haar, 1797). 
Early in the 19th century, confusion arose about the 
differential diagnosis of the various types of osteomyelitis, 
osseous tuberculosis and various osseous tumours. Brodie 
(1783-1862) in 1832 described a tibial abscess and its 
treatment (Rang, 1968). In 1853, Chassaignac described the 
difference between osseous typhus and the more benign 
osteomyelitis, with amputation and drainage as the 
respective therapeutic consequences. Osteomyelitis was 
defind as an autonomous clinical entity by Chassaignac in 
1854 (Picket, 1935; Knapstein, 1962), but according to 
others by Lannelongue in 1879. 
2.6.2. Antiseptics 
It was only toward the end of the 19th century that a more 
causal therapy was rendered possible by two important 
discoveries: 
The first of these was Pasteur's discovery in 1864 of 
anaerobic and aerobic bacteria. In 1880, in an osteomyelitis 
abscess, he identified the same bacterium as in a furuncle: 
'Osteomyelitis is the furuncle of the bone'. 
Further progress was booked by Lister (1827-1912), 
who applied one of Pasteur's measures to inhibit the growth 
of micro-organisms: disinfection. He tried to prevent 
postoperative infection by using many antiseptics, later 
mostly carbolic acid. He gathered his first experiences with 
the treatment of complicated fractures which were treated 
locally with carbolic acid tampons and with plaster. 
In addition to this prophylactic use of antiseptics, they were 
also increasingly applied to combat existing inflammations. 
According to Orr, however, this 'listerism' has done the 
treatment of osteomyelitis no good. Surgeons neglected the 
prophylactic aspects of the infections too much, became 
confused by the multiplicity of antiseptics and regarded 
treatment of infection too much as a battle between micro-
organisms and antiseptics (Orr, 1922). This reliance on the 
hoped-for magic powers of a new method, whilst essential 
surgical principles were ignored, could be observed once 
more, with all its features, shortly after World War II, when 
antibiotics were expected to oust the problem of infection 
from the globe and to turn osteomyelitis into an 'internal' 
disease. 
While, as described above, rest and sequestrectomy as 
part of the debridement have long been accepted in the 
treatment of osteomyelitis, in the last one hundred years it 
has become clear that in addition, two factors are of decisive 
importance for that treatment: stabilization and the 
prevention of cavitation. 
2.6.3. Stabilization 
H. Winnet Orr (1922) was the first to emphasize the 
importance of stabilization. In advocating his then new, 
personal therapy, he stressed the drawbacks of earlier 
methods, not an uncommon practice at any time: his 
scapegoat was the excessive use of antiseptics, 'listerism'. 
His therapy also comprised a solution of the cavitation 
problem. The treatment consisted of: 
1. Combating local infection by asepsis or antisepsis. 
Complete curettage was not considered necessary: the 
patient can handle part of the infection by himself. 
2. Adequate drainage. 
3. Postoperative dressing with vaseline tampons, to be 
changed only at fairly long intervals and sometimes 
introduced into the cavities as well. 
4. Rest ensured by adequate immobilization in a plaster 
cast. 
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Like so many therapies for osteomyelitis, this 'Orr method' 
also was based on war experience (Orr, 1922). Appreciable 
shortening of hispitalization and incapacity was mentioned 
as the advantage of this new method (Kulowski, 1931). The 
same arguments were to be advanced later for other new 
methods, by advocates of the suction drainage system and 
gentamicin-PMMA beads. 
Stability as an essential part of the treatment of 
infections has been and is still being emphasized by many, 
particularly by the AO-group (Arbeitsgemeinschaft fur 
Osteosynthesefragen, Association for the study of internal 
fixation) (Müller and Rehn, 1978; Burri, 1979). The 
advantage of preserved stability is considered to outweigh 
the disadvantage of the presence of a foreign body, viz. 
osteosynthesis material (Willenegger, 1973; Hierholzer et 
al., 1974; Burri, 1973, 1979; Schneider, 1979). 
Further research will be required, however, to gain 
more insight into the role of stability in the treatment of 
infections. The results of experiments in animals by Harms 
and Van de Berg to some extent support clinical experience 
regarding stability and infection (Harms and Van de Berg, 
1976), 
2.6.4. Prevention of cavitation 
The cavitation which in osteomyelitis results from the 
destructive infection itself and from the curettage has often 
been regarded as one of the main causes of recurrence. In 
the skeleton, the rigid structure of the bone keep walls from 
collapsing so that cavities persist. Many ways have been 
proposed to solve this problem. Prevention of cavities was 
achieved by smoothing the overhanging walls, changing the 
cavity into a kind of saucer (saucerization, Muldung, gutter 
procedure) (Neuber, 1896; Armstrong and Yarman, 1936; 
Springorum, 1949; Evans and Davies, 1969; Horwitz, 1973; 
Shannon et al, 1973). This method had the drawback that 
often much sound bone had to be sacrificed, so that it could 
not be applied close to articulations. Also, the resulting 
weakening of the bone sometimes led to fracturing, so that 
the osteomyelitis was replaced by an infected 
pseudarthrosis. Another technique was to cause the walls to 
collapse ('feuillet du livre = book pagc-Brunet and 
Bertaux, 1975; 'Einklappungsmethode' = folding-in 
technique-Schulten, 1896) (Fig. 2.9), or the 'Knochcn-
verschiebeplastik' (= bone displacement plasty-Popkirov, 
1971). These techniques, also, can only be applied in the 
diaphyseal region. 
Figure 2.9 'Einklappungs' (folding-in) method, applied in a chronic 
osteomyelitis of the tibia. By this technique, the existing cavity is 
closed in the diaphyseal region (from a.f Schulten, ¡896). 
Many ingenious attempts have been made to prevent 
dead space in osteomyelitis by packing the cavity. Often, use 
was made of substances intended to combat the infection 
locally or to stimulate bone growth. Thus, in the evolution of 
treatment of osteomyelitis there runs a direct line from the 
disinfected sponges used by Hamilton in 1881 (Picket, 
1935) and the packing of cavities with gentamicin-PMMA 
beads. The implanted materials may be devided into 
alloplastic and autoplastic substances (Popkirov, 1971). 
The alloplastic substances were often implanted in the 
shape of a plug, followed by primary closure of the skin. 
Dreesmann implanted plaster with a 5% carbolic acid 
solution. The stimulating effect of plaster on bone growth 
was disappointing (Dreesmann, 1893). This stimulation of 
bone growth may be better in non-infected areas (Häuptli, 
1952). Löhr mixed plaster with cod liver oil (Löhr, 1934) in 
the expectation that the oil would influence the 
mesenchymal cells more favourably than antiseptics. Some 
of the other packing materials that have been used are 
copper amalgam, iron, lead, alluminium, cement, clay, glass, 
ivory, calcium, gelatin, paraffin and vaseline (Popkirov, 
1971), 
Of the autoplastic materials the first one to be 
mentioned is the 'feuchter Blutschorf (moist blood crust). 
The earliest users of this technique were Neuber in 1896 
and Schede in 1889. For the first time, the cavity was no 
longer plugged with gauze: after removal of the tourniquet 
(in use since 1873), the cavity filled with blood. This 
coagulum was left intact to become organized beneath the 
crust. 
Failures were frequent, however (Neuber, 1896). 
Addition of antiseptics failed to improve the results. In later 
years, blood was mixed with antibiotics to form the socalled 
antibiotic plug, sometimes mixed with fibrinous products 
(Winter, 1951; Winter et al , 1953; Maday and Horvath, 
1959; Bikfalvi and Ecke, 1960; Ecke et al., 1960; Axhausen, 
1961, 1965). 
Obliteration of the cavities was also achieved by 
invagination of the skin (Neuber, 1896; Schulten, 1896). In 
the epiphyseal region, the skin had to be fixed with a nail 
(Fig. 2.10). Pedicled skin flaps, cutaneo-periosteal flaps and 
muscle flaps were also used (Knight and Wood, 1945; Kelly, 
1946; Stark, 1946; Springorum, 1949; Evans and Davies, 
1969; Ger and Efgron, 1970; Gupta, 1973; Shannon et al , 
1973; Plaue, 1974). This was often combined with 
saucerization to permit invagination without impairing the 
vascularization by kinking. 
Essential in the history of osteomyelitis are the 
development and improvement of surgical techniques in 
the early 20th century: curettage with sequestrectomy, rest, 
saucerization and packing of cavities are interventions that 
have mostly proved themselves empirically. The discovery 
of bacteria and the use of antiseptics failed to improve the 
therapeutic results in osteomyelitis to the large extent 
expected. Before antibiotics became available after World 
War II, one other curious therapy has been used side by side 
with those described above: maggot therapy. 
2.6.5. Maggot therapy 
A particular part in the treatment of osteomyelitis has been 
played by maggot therapy. Military surgeons observed on 
battlefields that wounds were covered in crawling fly grubs. 
Larrey, of Napoleon's army, reported that they did no harm 
(Picket, 1935). Similar observations were made during the 
American Civil War. Baer, however, noted that the maggots 
were not only harmless but even exerted a positive 
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Figure 2.10 Obliteration of the residual cavity in treatment of osteomyelitis 
of a femur. Invagination of skin with musculature, fixation with adhesive plaster. 
In the metaphyseal region, a nail is necessary for fixation (from Neuter, 1896). 
influence on the local appearance of the wound and on the 
patients' general condition. In 1917 he saw two soldiers with 
complicated femoral fractures of seven days' standing. Both 
patients were in good condition and the wounds showed 
fresh granulations. He kept this observation in mind for ten 
years, before in 1928 he ventured to use maggots 
therapeutically himself. He worked out a method to breed 
and feed maggots under sterile conditions. After 
debridement and haemostasis, the wound was packed with 
maggots. Since maggots retain their larval shape for only 
seven days, they had to be replaced regularly (Baer, 1931). 
The method was used on a large scale in the United States 
during the period between the two World Wars (Buchman 
and Blair, 1932; Buchman, 1934). 
The effect of the method may be due to the removal of 
necrotic tissues, although maggots cannot eat devitalized 
bone (Buchman and Blair, 1932): with this method, also, 
surgical debridement remains essential. In Europe, the 
maggot therapy apparently evoked too much disgust; it was 
hardly ever used (Schürch, 1933). The beginning of the 
antibiotic era rendered this therapy obsolete. 
2.6.6. Antibiotics 
When antibiotics are used to combat infections, they have to 
be present in the infected tissue at sufficiently high levels to 
be able to inhibit or destroy the infecting micro-organism. 
When an antibiotic is administered orally or parenterally, it 
is distributed over various types of tissues in the body. The 
levels reached in those various tissues vary, and depend 
among other things on the type of the tissue, the properties 
of the antibiotic and the vascularization. 
Generally, the antibiotic concentration attained in 
bone is appreciably below the serum level. We find, for 
instance, that after a single dose of flucloxacillin, the levels 
of the antibiotic that can be demonstrated in bone vary from 
11.6% (in the cortex) to 15.6% (in the spongy bone) of the 
serum level (Unsworth et al., 1978). This socalled serum: 
bone ratio has been reported for cefalotin and cefamandole 
as 6% and 12.8%, respectively (Schurman et al., 1980). 
Kolczun and Nelson studied the bone levels of 
oxacillin, lincomycin and cefalotin after various doses 
(Kolczun and Nelson, 1974). They found that after various 
different doses of oxacillin and lincomycin there were fixed 
serum:bone ratios of 16:1 and 6:1, respectively. In the case 
of cefalotin, this ratio was not fixed, but decreased as the 
serum level rose. It was especially with lincomycin that it 
was possible to attain a sufficiently high concentration in a 
bone, necessary to exceed the MIC (minimum inhibitory 
concentration) of staphylococci. 
Norden also observed that the bone level of antibiotics 
was lower than the serum level. In osteomyelitic bone, 
however, he frequently found higher concentrations than in 
normal bone. In the treatment of rats with osteomyelitis, he 
was able to sterilise the infected bone in one-half of the 
cases. However, this success rate was considerably lower 
when a sequestrum was present (Norden, 1971). Hierholzer 
studied fusicid acid and found that the penetration was less 
in chronically inflamed bone tissue than in sound bone. Just 
as in sequestra, the penetration of antibiotics is also less 
good in cavities filled with pus and necrotic débris 
(Hierholzer et al, 1974). 
Waldvogel saw good therapeutic results when patients were 
treated with antibiotics in large doses, resulting in 
sufficiently high serum levels. Waldvogel observed that 
when patients with haematogenous osteomyelitis were 
treated with sufficiently large doses, 96% were cured, as 
against 17 % of those treated inadequately, with insufficient 
dosage. In the treatment of recurrences of haematogenous 
osteomyelitis, these proportions even amounted to 50 % and 
0%, respectively (Waldvogel et al , 1970a). 
Some authors attach importance not only to the type 
of antibiotic, the dosage and the administration interval, but 
also to the duration of the treatment. Hedström considered 
it necessary to administer large doses of antibiotics for long 
periods of time. He subjected 41 patients to protracted 
antibiotic treatment (long-term treatment, LIT): 
cloxacillin or lincomycin was given for six months to longer 
than one year. He obtained a lower recurrence rate, which, 
however, still amounted to 29%; cure in these cases 
required secondary sequestrectomy, abscess drainage or 
removal of osteosynthesis material (Hedström, 1969,1974). 
Hagen saw frequent recurrences even with LTT (Hagen, 
1978). 
If antibiotics are administered systemically, some 
important factors are the serum level, the tissue perfusion, 
the difiusibility of the antibiotic and its affinity to the tissues 
(Wysocki, 1974). The tissue concentrations required amount 
to three to ten times the minimum inhibitory concentration 
(MIC) of the bacterium, and these high levels have to be 
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present long enough and often enough (Fields, 1977). 
Attempts have also been made to achieve this high 
concentration in bone by local application of antibiotics. 
Reference has been made above to the frequently used 
blood-antibiotic plug. Antibiotics have also often been 
sprinkled locally in the wound or mixed with a cancellous 
bone plasty (De Grood, 1947). Solutions containing 
antibiotics have also been instilled by means of drains. 
A few authors have reported results with perfusion of 
the extremity with a solution containing an antibiotic. In 
this manner, a very high local concentration in the tissues is 
attained via the vascularization (Hurley et al, 1966; 
Finsterbusch et al., 1970 and Organ, 1971). 
2.6.7. Suction drainage 
Markoe in 1880 published results of treatment of 
osteomyelitis; he also criticized 'Mr Lister' and proposed 
thorough, accurate drainage with irrigation of the wound. 
The wound was irrigated four times daily with carbolic acid 
(Markoe, 1880). 
Carrel in 1915 described an irrigation method with 
hypochlorite (NaCIO): 'Dakin's fluid'. Every hour or every 
other hour, he instilled the hypochlorite solution through 
drains, at first intermittently ('instillation intermittente'), 
later continuously (Carrel, 1915; Dakin, 1915). Smith-
Petersen in 1934 designed cannules to be inserted into the 
wounds and connected to a drain. By means of an 
instillation system he initially instilled Dakin's fluid, later a 
penicillin solution. 
The advantages of this method were the possibility of 
primary closure of the wound and loss of less serum than 
used to be lost before with the open granulating wound 
(Smith-Fetersen et al., 1945) (Fig. 2.11), 
Figure 2.11 Suction drainage system as designed by Smith-Petersen 
(1945) and used with the aid of specially designed cannulae. 
It was especially Willenegger who strongly advocated the 
use of the irrigation system. First he used penicillin but 
subsequently he recommended adding chloramphenicol to 
the irrigation fluid (Willenegger and Roth, 1962; 
Willenegger, 1963). The irrigation fluid is instilled gradually 
into the infected area and drained by a vacuum suction 
system. Some years later, he replaced physiological saline 
by Ringer solution and reduced the duration of the 
irrigation. One important effect of the irrigation system is 
the mechanical cleansing of the wound. According to 
Wllenegger and other authors the antibiotic needs only to 
be added to the irrigation fluid for two to four days. The 
total duration of the irrigation-drainage system should be 
one to a maximum of three weeks (Willenegger, 1970,1973, 
1979 ; Willenegger et al., 1970; Polster and Samimi, 1979; 
Burri and Van de Werken, 1981). The irrigation system has 
been used by many, with numerous variations: intermittent 
or continuous, with or without changes of the direction of 
the flow (Grace and Bryson, 1950; Dombrowski and Dunn, 
1965; Compere et al., 1967; Dilmaghani et al., 1969; 
Anderson and Horn, 1970; Kelly et al., 1970; Taylor and 
Mandsley, 1970; Hertel and Albrecht, 1968; Lawyer and 
Eyring, 1972; Clawson et al, 1973; Law, 1975; Meyer et al, 
1975; Fásol and Schmid, 1976; Mitra and Grace, 1956; 
Boda, 1979; Geneste et al, 1979; Kawashina et al, 1980; 
Lehnhardt, 1980). 
2.6.8. Cancellous bone graft 
The cancellous bone graft has a twofold purpose in the 
treatment of osteomyelitis: to fill the cavity and to provide 
stability. Chase and lierndon (1955) have published a very 
detailed, well-documented survey of the history of bone 
auto- and homografting and the results obtained. Oilier in 
1867 laid the scientific foundation for bone grafting, 
emphasizing the importance of the periosteum (Oilier, 
1867). During the first few years, the transplantation 
material used was mostly autologous cortical bone; later, 
use was also made of homologous or heterologous bone, 
sometimes denatured (Orell, 1937). Especially during 
World War II, cancellous bone graft was practised 
increasingly. 
Frigge in 1946 described the first use of this technique 
in osteomyelitis (Frigge, 1946). He arrived at this application 
because at sites such as the proximal tibia, the calcaneus and 
the distal radius, a muscle graft was not adequately feasible. 
The first part of the treatment consisted of debridement and 
saucerization. The cavity was temporarily packed with 
gauze, into which a penicillin solution was instilled. 
Subsequently, the greater part of the cavity was filled with 
chips of cancellous bone. The wound was then closed, 
leaving a small opening, the extremity was immobilized in a 
plaster cast and postoperatively, penicillin was administered 
systemically for one to two weeks. Thus grew up a 
combination treatment with debridement, irrigation, 
antibiotics, immobilization and packing of the cavity. 
Frigge considered the method to be not indicated in tibial 
defects larger than three centimetres, in the femur or at 
other sites where a muscle-flap graft is feasible. Coleman 
and others in 1946 published their data on cancellous bone 
grafting in osteomyelitis. They performed the operation in 
one session. The wound was closed immediately and anti-
biotics were administered systemically and locally into the 
wound, sometimes mixed in with the bone chips. They were 
of the opinion that cancellous bone, unlike cortical bone, 
offers good resistance to infection (Coleman et al, 1946). In 
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the Netherlands, De Grood in 1947 described two patients 
treated according to this technique (De Grood, 1947). 
The addition of antibiotics to the cancellous bone has 
been studied by Graig Gray and Elves: they observed that 
chloramphenicol and polybactrin spray exerted an adverse 
influence on the cancellous bone (Graig Gray and Elves, 
1981). 
Papineau in 1973 described a cancellous bone grafting 
method for osteomyelitis. He carried out this procedure in a 
minimum of two stages. In order to obtain an optimally clear 
view of structures to be excised, the debridement if 
necessary was also performed in several stages. Between 
operations, the wound was not closed but plugged with anti-
biotic-containing gauze. Irrigation was performed if 
necessary. Subsequently, cancellous bone chips were 
supplied in generous amounts and antibiotics given 
systemically for four to six months. A stable state was 
created by means of an intramedullary nail, in spite of 
existing infection (Fig. 2.12). If necessary, a skin plasty was 
performed to close the wound (Papineau, 1973). 
Figure 2.12 Cancellous bone grafting by Papineau's technique to 
bridge a diaphyseal defect in a case of osteomyelitis. Stabilization 
with a medullary nail (from Papineau, 1973). 
In the French literature, this method has regularly been 
mentioned up to the present day (Roy-Camille et al., 1974, 
1976; Lortat et al., 1977; Piganiol et al., 1979; Miné et al., 
1979). In all cases, the cancellous bone graft is only 
performed after sequenstrectomy with stabilization, 
followed by a waiting period with irrigation as required. 
The authors mentioned perform cancellous bone 
grafts not only to fill cavities but also often as a 'greffe 
intertibiopéronière' (GITP) or tibia-pro-fibula graft to create 
a dorsal bony bridge between the tibia and the fibula. 
Allegedly, this stabilization sometimes suffices to control 
the infection (Freeland and Mutze, 1976; Miné et al., 1979). 
Sudman performs cancellous bone graft and debridement at 
the same session, followed by protracted antibiotic treat-
ment: three to twelve months (Sudman, 1979). 
Burri has written a great deal about the role of the 
cancellous bone graft in the treatment of osteomyelitis 
(Burri, 1973,1974,1979; Burri et al., 1970,1973; Burri and 
Henkemeyer, 1971; Burri and Van de Werken, 1982; Spier 
and Burri, 1977; Van de Werken et al, 1980). His 
management of osteomyelitis rests on four pillars: 
stabilization, debridement, irrigation drainage (or other 
methods) and packing of the defect. The best grafting 
material is autologous cancellous bone. Homologous bone 
is slower and less effective in inducing neoformation of 
bone. Denatured bone is said to have failed in its function of 
supporter of bone neoformation, its remodelling taking 
even more time than the spontaneous refilling of an empty 
cavity of equal size (Burri, 1979). According to Burri, the 
indications for a cancellous bone graft in osteomyelitis are 
an unstable fracture or pseudarthrosis (in which the 
cancellous bone should be placed as far as possible from the 
focus of infection) and filling of a defect (after curettage and 
vitalization of the graft bed). 
Cancellous bone grafting is contraindicated in 
aggressive, purulent osteomyelitis. In this case, the infection 
should first become less active. If there is no adequately 
vascularized bed available for the cancellous bone, survival 
of the graft is insufficient. Van de Werken and others 
demonstrated that although the cancellous bone does not 
entirely fail to take in the presence of infection, more of it is 
lost than in a non-infected region (v.d. Werken et al, 1980). 
Interestingly enough, antiseptics are making a comeback 
(Gilmore, 1977). Modern antiseptics are believed to have 
better qualities than older ones (Willenegger, 1979b; Good, 
1979). One of these new disinfectants is Taurolin®*. 
Taurolin is a compound of taurine (ethylamine sulfonic 
acid) and formaldehyde. It has been reported to exert a 
favourable influence on chronic osteomyelitis in animal 
experiments (Götz and Wesch, 1981). 
Burri performs peroperative lavage with a 1 % solution 
of Taurolin® in Ringer's solution to reduce the surgical 
infection rate (Burri et al., 1980). Also, he mixes cancellous 
bone with collagen and Taurolin18 in the treatment of osteo-
myelitis (Burri and Van de Werken, 1982). This creates a 
strong resemblance between this therapy and that 
described by Buchman and Blair (1947), who packed the 
osteomyelitis cavity with a substance to be absorbed (oxygel 
with gelatin and thrombin) mixed with penicillin. 
Figure 2.13 Schematic represent-
ation of remodelling of a cancel-
lous bone graft, used, for instance, 
to pack an osteomyelitic cavity. 
Granulation proceeds from the fundus (a). Even when superficial 
granulation is still only slight, 
deeper granulation may be far 
advanced (b). It is only after the 
granulation reaches the surface 
of the cancellous bone that the 
defect is rapidly closed by epi-
thehalization (c). 
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Chapter 3. The infected endoprosthesis 
3.1. Introduction 
Infection around an endoprosthesis, for convenience's sake 
called 'infected endoprosthesis', is regarded in orthopaedics 
as one of the worst postoperative complications after 
implantation of an endoprosthesis. As a rule, namely, it 
heals only after removal of the prosthesis with all cement. 
Thereafter, restoration of the articular function is usually 
difficult, sometimes impossible Another severe post-
operative complication is loosening of the prosthesis. The 
longer hip prostheses, for instance, have been in situ, the 
higher the incidence of loosening Some of these loosened 
prostheses cause enough symptoms to necessitate 
reoperation. 
As will be discussed in this chapter, it is difficult to 
distinguish between aseptic and septic loosening, which is 
why so far it has not been possible to make an accurate 
assessment of the problem of septic and of that of purely 
mechanical loosening. The matter is further complicated by 
the alleged fact that an aseptic loosening may turn into a 
septic complication. Accordingly, both problems: infection 
and loosening of an endoprosthesis ment discussion. 
3.2. Fixation and loosening 
of the endoprosthesis 
Most research into loosening of prostheses has been 
performed in regard to the hip prosthesis. Prior to the 
introduction of acrylic cement by Charnley (Chamley, 
1960), head-neck prostheses and total hip prostheses were 
implanted without cement. Many prostheses were 
subsequently found to be inadequately anchored to the 
bone, which usually caused pain Slooff found that out of 53 
head-neck prostheses, 56% had become loosened (Slooff, 
1970), after a mean follow-up of five years. 
Acrylic cement ('bone cement') appeared to be the 
ideal means of preventing the unwanted mobility between 
prosthesis and bone. It filled the space between the 
prosthesis and the bone, enlarging the surface of contact 
between the two, thus preventing local excessive stress on 
the bone This eliminated the 'fretting' between prosthesis 
and bone which Charnley regards as the main cause of 
loosening (Chamley and Kettlewell, 1965; Chamley, 1965). 
The drawbacks of the use of acrylic cement also 
became clear, however. The heat produced at poly-
mentation of the cement (50-100oC) and the toxicity of the 
monomer lead to necrosis in the immediately adjacent 
osseous tissue (Slooff, 1971; Goebel and Ohnsorge, 1973). 
This necrosis further impairs the vascularization in the 
endosteum, already damaged during the surgical 
preparation of the proximal femur The necrotic layer grows 
two to three millimeters thick and constitutes the socallcd 
bone-cement interface between the bone and the cement. 
Feith concluded from the results of animal 
experiments that the polymenzation heat was the main 
cause of this necrosis (Feith, 1975). 
Huiskes assumes on the basis of his calculations that 
the polymerization heat has to exert its adverse action more 
indirectly, viz. by strengthening the toxic effect of the 
monomer (Huiskes, 1979) (Fig. 3.1). 
Willert distinguishes three phases in the reaction of the 
body to the acrylic cement-
- the initial phase (two to three weeks) during which the 
necrotic layer organizes itself, 
- the repair phase (three weeks to a few months or some-
times a few years), during which the necrotic layer is 
eliminated and adjacent bone remodelled, 
- the stabilization phase (the last stage). 
During this last phase, the bone-cement interface is found to 
contain a collagenous connective tissue membrane of 
variable thickness with foreign-body giant cells (Willert, 
1973) The ischaemic cortex is gradually revasculanzed, 
starting from the subperiosteal region (Slooff, 1971) 
In the radiogram, the bone-cement interface is seen as 
a halo around the cement The frequency of observation of 
this halo rises and the size increases as the prostheses 
remain in situ longer (Harris, 1978; Witt and Hackcnbroch, 
1976) Witt and Hackenbroch summanze a large number of 
studies in the literature and find proportions of aseptic 
loosening of 1.6 % after one year, 4 % after three years and 
8 % after eight years During three to six years' follow-up of 
personal cases, they saw a distinct halo around the cement 
in ?9 5 % in the acetabulum and in 28.5 % in the femur. This 
proportion is almost three times as huge as that seen 
immediately postoperatively (Witt and Hackenbroch, 
1976). 
Maier et al. ( 1977) after four to seven years saw areas of 
reabsorption in 6 7% in the acetabulum and in 17% in the 
femur. In their material, also, most rcabsorption zones were 
progressive from the operation 
Bosch et al during a follow-up of five years at least saw 
radiological signs of aseptic loosening in 15 3 % of the cases. 
Unlike others, they saw more loose femoral prostheses than 
cups, especially when the femoral prosthesis was in the 
varus position (Bósch et al., 1980). 
A possible factor in the widening of the bone-cement 
interface is disintegration of the acrylic cement by the body 
(Willert, 1973). Loosening, once started, is inexorably 
progressive. Mechanical irritation of the interface causes 
local bleeding, exudate and granulation tissue. This renders 
the connective-tissue layer thicker and less firm An 
unstable implant through this mechanical irritation brings 
about an inflammatory reaction with all the histological 
signs of an inflammatory infiltrate, often with necrosis 
(Szyszkowitz, 1973). 
A vicious circle ensues a thickened granulation layer 
weakens the anchoring of the prosthesis, increasing 
instability progressively aggravates the loosening with 
destruction of bone, which may run a rapid course owing to 
'fretting' effects of the prosthesis with the cement (Fig. 3.2). 
According to Schneider (1979) and Lidgren (Lidgren et al , 
1977), instability reduces the defense against infection, 
offering less virulent bacteria an opportunity to grow Also, 
in the presence of a foreign body, cellular and humoral 
defense allegedly are weakened in their function Elek and 
Conen demonstrated that m the presence of a foreign body, 
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Figure 3.2 Possible connection between mechanical loosening 
and infection of a prosthesis. Thermotoxic damage causes formation 
of granulation tissue that increases owing to fretting and possibly, 
contamination at operation. Ibis progressive granulation causes 
progressively increasing destruction of bone. The granulation layer 
also constitutes an area of reduced resistance to haematogenous 
infection (from Lidgren et al, 1977, modified version). 
Table 3.1 Review of literature data on infections after implantation 
of a hip or knee prosthesis without use of bone cement as reported 
by various authors. Just as in subsequent similar reviews of the 
literature, only the first author is stated where this suffices for the 
reference. Percentages, where not mentioned by the authors, have 
been calculated. 
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infection occurs with a smaller number of bacteria per 
milligramme of tissue (Salvati, 1976; Elek and Conen, 
1957). 
Consequently, the problem of the infected prostheses 
arises soon. In addition, considerations presented in 
Chapter 3.5 cause certain authors to assume that owing to 
inadequate bacteriological diagnostics, a very large 
proportion of the cases of socalled aseptic loosening are 
actually cases of septic loosening (Lindberg et al., \97T). 
3.3. Clinical picture and course of 
infection of endoprostheses 
The proportion of the endoprostheses which post-
operatively are found to be infected varies considerably; 
it is influenced by the examiner and the follow-up but 
particularly also by the ways infections are diagnosed and 
defined. Published papers differ in these respects which 
renders comparison of the proportions of infection difficult 
and sometimes useless. Prior to introduction of acrylic 
cement to fix the hip prosthesis, recorded percentages of 
infected hip arthroplasties varied from 2 % to 7 % (Table 3.1). 
Since the introduction of acrylic cement, recorded 
percentages vary even more: from 0% to 15%. 
However, in most clinics, the proportion fluctuates 
around 2 to 4 %, and limiting the rate of infection to just 
below 1 % appears to be the most that can be accomplished 
(Tables 3.2 and 3.3). 
The symptomatology of the infected prosthesis varies. 
Generally, a distinction is made between acute and late 
infections. The late infections may be further subdivided 
into latent and haematogenous infections (Ahlberg et al., 
1978). Certain German authors distinguish an early, an 
insidious and a late infection (Boitzy and Zimmerman, 
1969; Weber and Stühmer, 1973; Reichelt and Riedl, 1974). 
At the Mayo Clinic (Rochester, USA), the Coventry 
classification is used: stage 1 (acute infection), stage 2 (latent 
infection) and stage 3 (haematogenous infection) 
(Fitzgerald et al., 1977). 
3.3.1. Acute infections 
Infections are called acute when they occur at an early 
postoperative stage. A period of three to six months has 
been adopted as the dividing line from late infections 
(Charnley, 1972a; Stadler and Henche, 1976; Müller, 1976; 
Hunter and Dandy, 1977a); others use the date of discharge 
from hospital (Wilson et al., 1974). Acute infections are 
divided into superficial and deep infections. 
3.3.1.1. The acute superficial infection 
The acute superficial infection manifests itself one to two 
weeks after the operation with wound pain, local signs of 
inflammation and sometimes, fever with leukocytosis as 
well (Wilson et al., 1973; Reichelt and Riedl, 1974; Plaue 
and Städtlcr, 1975). By definition it is an infection with a 
suprafascial localization. However, spread to deeper tissues 
and to the prosthesis may be difficult to establish. An 
untreated superficial infection spreads, but it is believed that 
with adequate wound treatment the risk of a superficial 
infection leading to a deep infection is small. Out of 48 early 
postoperative superficial infections, only five were found to 
have led to a deep infection (Fitzgerald et al., 1977). 
3.3.1.2. The acute deep infection 
The acute deep infection is not very frequent and its clinical 
picture is influenced by the fact that these early post-
operative infections are caused by relatively virulent 
bacteria and are associated with more local and general 
symptoms than the late infections of prostheses. The 
condition may run a fulminating course, especially with 
beta-haemolytic streptococci (Wilson et al., 1973) and with 
staphylococci (K. Buchholz, 1979). 
The hip and thigh region may be slightly swollen; this 
is rarely accompanied by a superficial infection. The pain is 
felt deep in the bone. This early postoperative deep 
infection accounts for 12 to 50% of all postoperative 
infections according to the literature (Beson and Hughes, 
1975; Salvati, 1976; Stadler and Henche, 1976; Amstutz and 
Kass, 1977; Tönnis and Händel, 1979). 
3.3.2. Late infections 
Inflammation with late manifestation is a socalled latent or 
haematogenous infection. 
The latent infection allegedly differs from the haem-
atogenous infection in that symptoms, usually pain 
symptoms, have been constantly present from the time of 
operation. In other words, there is no symptom-free 
interval. It is believed that the inflammation has resulted 
from peroperative contamination and for various reasons 
has run a smouldering course. 
Peroperative wound contamination is a frequent 
occurrence. Cultures of wound material taken at the end of 
the operation are positive in approx 30% even of the 'clean 
operations' (Murray, 1973). According to some authors, 
wound infection results from contamination that leads to 
over 105 bacteria per gramme or millilitre of tissue 
(Altemeier et al., 1976; Brown, 1977). Presence of a foreign 
body in the wound increases the risk of inflammation by 
weakening the local defense (Elek and Conen, 1957; Wilson 
et al., 1973; Plaue and Stadler, 1975; Salvati, 1976). The 
diminished defense against infection is believed to be the 
reason why even the less virulent bacteria such as 
Staphylococcus albus and anaerobics may cause an 
infection in the presence of a prosthesis. However, infection 
caused by these less virulent bacteria is often smouldering, 
with a latent course. In animal experiments, Blomgren was 
able to infect a prosthesis in the rat using the anaerobic 
Propionibacterium acnes or a Staphylococcus aureus. In 
the anaerobic infection there were no macroscopical, micro-
radiographic or histological signs of loosening to be seen 
after seven weeks. This was in contrast to the inflammatory 
reaction that was always demonstrable four weeks after an 
infection by Staphylococcus aureus (Blomgren, 1981). 
Clinically, a latent infection manifests itself with 
usually mild pain, as a rule during weight-bearing. Usually, 
the pain symptoms are present from the operation and are 
progressive (Ahlberg et al., 1978). 
A haematogenous spread is assumed to be the cause of an 
infection of a prosthesis if there has been a-frequently 
protracted-asymptomatic period after the operation. The 
possibility of haematogenous infection was initially 
doubted, but many haematogenous infections have since 
been described with reasonable probability in the literature, 
bacteriological arguments have been advanced and the 
possibility has been demonstrated in experiments in 
animals. 
The proportion of total hip prostheses that become 
infected haematogenously is estimated in the literature at 
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Author 
1. Chamley '72 ( -'61) 
('60-'67) 
('67) 
C60-'68) 
('69) 
2. Patterson '72 
3. Almby '73 
4. Bentley '73 
5. Bergström '73 
6. Buchholz '73 ('64-?) 
7. Carón '73 
8. Chapchal '73 
9. Chamley '73 
10. Decoulx '73 
ll.Duparc'73 
12. Eftekar '73 
13. Enderle '73 
Total 
number 
118 
1723 
329 
3133 
1039 
368 
106 
101 
128 
207 
77 
3205 
273 
340 
106 
574 
264 
300 
400 
334 
14. Ericson '73 (Carlsson '79) 60 
15. Evanski '73 
16. Evarts '73 
17. Freeman '73 
18. Haraldsoon '73 
19. Harris '73 
20. Huggler '73 ('62-'65) 
21. Johnston'73 
22. Kramer '73 
23. Kyselka '73 
24. Langenskiöld '73 
25. Lazansky '73 
26. Lubinus '73 
27. Leinbach '73 
28. Meuli '73 
29. McKee '73 ('56-60) 
('61-64) 
('65-69) 
('71-..) 
30. Moczynsky '73 
31.Mulier'73 
32. Murray '73 
33. Safi '73 
34. Siegel '73 ('64-'68) 
('69-71) 
35. Slot '73 
36. Smith et al. '73 
37. Torgerson '73 
38. Weber '73 ('67) 
(Liechti '76) ('70) 
('71) 
39. Weber et al. '73 
40. Wilson '73 
41. Deutman '74 
42. Benson '75 
43. Ganz '76 
44. Gartenmann '76 
58 
102 
200 
339 
206 
127 
28 
94 
326 
251 
50 
116 
501 
1350 
700 
19 
16 
100 
300 
100 
250 
175 
106 
522 
126 
187 
1409 
2609 
100 
3482 
139 
177 
243 
215 
1042 
100 
213 
321 
2424 
198 
Follow 
up (yr) 
2 
4 
3-11 
'/4-4 
? 
І-4 
1-4 
'/2-3? 
'/2-3? 
1-9? 
'/4-4 
'/4-4 
9-10 
1-5? 
1-? 
2 
0-5 
1-1'/2 
5-6'/2 
'/2-21/4 
2 
'/2-5 
0-2'/2? 
'/2-? 
5-8 
1-4 
'/2-2 
0-3? 
? 
? 
'/2-6 
1-7? 
'/2-4 
? 
7 
8 
9 
? 
'/2-4? 
? 
1/4-4 
'/4-4 
'/4-4 
2-8 
5-9 
2-4 
1-3 
'/4-2? 
'/2-3 
7 
7 
7 
І-5 
l'/2-9 
0-5 
'/4-5 
1-2 
'/2-1'/2 
Infected 
number % 
8 
52 
4 
1 
3 
30 
2 
3 
0 
1 
13 
74 
4 
0 
7 
14 
6 
3 
6 
2 
14 
5 
3 
13 
3 
1 
3 
2 
1 
4 
0 
3 
4 
51 
7 
0 
0 
2 
12 
0 
23 
17 
3 
4 
5 
13 
44 
21 
2 
58 
4? 
12 
4 
2 
37 
1 
5 
17 
52 
0 
7 % 
3 % 
1.2% 
1.6% 
0.3% 
8.2% 
2 % 
3 % 
0 % 
0.5% 
17 % 
2.3% 
1.5% 
0 % 
6.6% 
2.5% 
2.2% 
0.4% 
1.8% 
3.3% 
24 % 
5 % 
1.5% 
3.6% 
1.5% 
0.8% 
11 % 
2.1% 
0.3% 
1.6% 
0 % 
2.6% 
0.8% 
3.7% 
1 % 
0 % 
0 % 
2 % 
4 % 
0 % 
9.7% 
10 % 
1.9% 
0.8% 
4 % 
6 % 
3.1% 
0.8% 
2 % 
1.7% 
2.9% 
6.8% 
1.7% 
0.9% 
3.6% 
1 % 
2.3% 
5.3% 
2.1% 
0 % 
Asept. loosening 
number % 
9 
7 
4 
0 
35 
3 
3 
14 
3 
2 
1 
2 
7 
5 
0 
9 
5 
2 
1 
7 
12 
2 
24 
4 
3 
1 
10 
1 
20 
32 
230 
2.5% 
7 % 
4 % 
0 % 
1.1% 
1.6% 
0.5% 
5.5% 
0.4% 
0.6% 
1 % 
1 % 
2.1% 
2.4% 
0 % 
32 % 
5.3% 
0.6% 
0.9% 
1.3% 
1.7% 
10.5% 
8 % 
1.6% 
1.6% 
1 % 
0.3% 
0.7% 
20 % 
15 % 
9.5% 
Remarks 
'dirty-air' 
59% anticoag./130 chg./h 
5%anticoag./300chg./h 
mixed group 
+ double gloves 
McKee-Farrar 
Charnley 
proph.cloxacillin 
no proph. antibiotics 
proph. tetracycline 
59% anticoagVclean air 
proph. penicilline 
proph. ampicill./oxacill. 
proph. antibiotics 
no proph. antibiotics 
proph., cefalotin 
local neomycin 
proph. antibiotics/conv. Or 
72 conv. OR/57 laminar air flow 
local neomycin 
proph. ampicill./cloxacill. 
cemented Sivash 
proph. pcnicill./streptom. 
loc. AB/230 laminar air flow 
after '71: AB. in cement 
loc. + system. AB 
without cement 
with cement 
proph. AB + local AB 
idem + after '71 AB-cement 
no antibiotics 
no antibiotics 
AB-cement 
no measures 
vaccination (staphyl.) 
id + clean air 
proph. AB + local AB 
McKee-Farrar; proph. AB 
incid. local AB, not proph. 
6% proph. AB 
vaccin. + clean air + AB-cement 
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45. Nicod '76 
46 Riedl '76 
47. Amstutz '77 
48. Carlsson '77 
49. Maier '77 
50. Houton '79 
51. Olsson'79 
52. Pollard '79 
53. Bosch '80 
54. Ha'en '80 
55. Josefsson '80 
56 Oberthaler'80 
57. Schuhtz '80 
58. Andrews '81 ('66-
('70-
('73-
59. Muiier'81 
'69) 
-12) 
-'78) 
526 
883 
800 
311 
681 
95 
1595 
238 
155 
155 
1470 
135 
812 
821 
881 
89 
105 
262 
461 
1023 
238 
3-9? 
0-7 
? 
2-8 У2 
2-8'/2 
4-7 
? 
2-7 
1-2'/2 
1-2'/2 
1-9 
2-7 
1-2 
1-2 
3-10 
2 
2 
? 
? 
7 
1-2 
8 
37 
16 
48 
14 
4 
16 
0 
2 
2 
7 
3 
13 
3 
5 
8 
1 
3 
29 
13 
0 
1.6% 
4.2% 
2 % 
15.4% 
2 % 
4.2% 
1 % 
0 % 
1.3% 
13% 
0 5% 
2.2% 
1.6% 
0.4% 
0.6% 
9 % 
1 % 
10 % 
6 3% 
1.3% 
0 % 
5 
19 
12 
14 
215 
27 
13 
86 
0 
0 
1 % 
20 % 
0.8% 
5.7% 
15.3% 
3.3% 
16% 
9.8% 
0 % 
0 % 
no antibiotics 
noproph AB 
ρ гор h. cloxacillin 
ρ гор h. AB 
proph. penicillin 
proph. cefalondine 
2 weeks flucloxacillin 
proph. cefalondine 
proph. AB + laminar flow 
proph. AB 
AB.-cement 
before '72 proph. AB 
no antibiotics 
proph. lincomycin 
proph penicillin 
no proph. AB 
locai AB. + AB.-cement 
clean air + proph. cefamandole 
Table 3 2 Review of literature data on percentages of infection of cemented total hip prostheses Percentages of aseptic loosening, where 
mentioned in the papers, have been included. 
0.3 to 0 5% (Charnley, 1972b; Hunter and Dandy, 1977b; 
Lidgren et al., 1977; Ahlberg et al ,1978; Lindberg, 1979a) 
Ahlberg et al. have collected 19 well-documented 
cases from the literature and added eight of their own. 
Blomgren supplements the literature to 61 haemato-
genously infected total hip prostheses (Blomgren, 1981). 
Three other authors have presented data on 14 additional 
patients, bringing the total to 75 documented cases 
(Deutman, 1974; Beck, 1977; Hunter and Dandy, 1977a). 
Rheumatic patients are believed to run an increased 
risk of bacteraemia allegedly, spontaneous bacteraemias 
occur more often in these patients and cause spontaneous 
arthritis. Also, defense is often weakened due to hypo-
complementaemia (Charnley, 1972b; Cristina et al, 1974; 
del Sel and Charnley, 1979; Fitzgerald et al., 1977); others, 
however, find no increased risk of infection in rheumatic 
patients (Lidgren, 1973). 
Another important cause of bacteraemia is post­
operative catheterization of the bladder, usually performed 
because of retention of urine m the bladder. Wroblcwski 
Author 
1. Petty '75 
2. Deburge '77 
3. Attenborough '78 
4. Aubnot '81 
5. Cavendish '78 
6. Lettin '78 
7. Shaw '78 
8. Sheenan '78 
9. Andersen '79 
10. Cracchiolo '79 
11. Finennan'79 
12. Insali '79a 
13. Insali '79b 
14. Kaufer '79 
15. Larsson '79a+b 
16. Moreland '79 
Total 
number 
1045 
292 
221 
183 
62 
100 
48 
135 
67 
64 
109 
211 
112 
220 
461 
134 
112 
111 
84 
Follow 
upyr. 
1-4 
7 
1-2 
1-7 
7 
2-9 
7 
1-5'/2 
7 
7 
? 
2-1 
1-? 
3-5 
1-5 
1-? 
2-? 
2-1 
V2-2 
Infected 
% 
2.0% 
6 % 
1.8% 
8.3% 
1 6%? 
3 % 
2 % 
1.5% 
0 % 
15 % 
2 % 
2.4% 
0.9% 
1.4% 
13% 
2 2% 
4 % 
5 % 
5 % 
Remarks 
geometric + polycentnc 
guepar 
attenborough 
guepar 
liverpool Mark II 
stanmore 
manchester 
sheehan 
Mcintosh (42 without cement) \ 
guepar, proph. AB \ Rh. arthritis 
marmor, proph. AB J 
geometric, polycentric 
anametric 
total condylar 
total condylar 
spherocentnc 
rheum, arthritis; guepar + gcomedic 
gonarthrosis, guepar/geomed 1st. Georg 
frccman-swanson 
Table 3.3 Review of literature data on percentages of infection of cemented total knee prostheses 
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Figure 3.3 Staphylococcus on bone cernen!from the femoral shaft seven years after implantation of a total hip prosthesis. The culture was 
negative (SEM photograph). Photograph supplied by Dr К. Draenert, Histomorphology Team of the Technical University of Munich. 
and del Sel observed a deep infection in 6.2% of 195 
patients requiring postoperative catherization, as against 
0.5 % in their material as a whole (Wroblewski and del Sel, 
1980). 
Charnley uttered doubt whether haematogenous 
infection exists, probably to emphasize the role of 
peroperative contamination, and reports 31 instances of 
successful implantation of a total hip prosthesis while an 
infection was present in the contralateral hip (del Sel and 
Charnley, 1979). Hunter and Dandy, on the other hand, did 
observe a haematogenous infection in such a patient 
(Hunterand Dandy, 1977b). 
Finally, haematogenous infection appears probable in 
case of bilateral total hip infection, caused by one and the 
same agent (Downes, 1977; Hunter and Dandy, 1977b). 
Furthermore, several investigators succeeded in infecting 
an endoprosthesis by injecting bacteria into the blood 
circulation. Bison (Elson et al., 1977) and Marks (1980) 
observed that haematogenous infections occurred more 
frequently when the injection was given shortly after the 
operation. This was confirmed by Blomgren (Blomgren and 
Lindgren, 1980). He observed that bacteraemias shortly 
after operation infected a cemented endoprosthesis as often 
as they infected a cement implant without prosthesis or 
other injured tissue (e.g. the surgical wound). A cement 
implant prevented elimination of bacteria by local defense 
(Blomgren and Lindgren, 1980; Blomgren, 1981). In 
Blomgren's experiment, in contrast to studies of Elson and 
of Marks, the prosthesis was made to bear weight 
physiologically. This resulted in a thicker layer of bone 
cement granulation beside the prosthesis, which is more 
realistic. A larger proportion of infections is believed to 
occur in this thicker interface. 
Staphylococcus aureus and the anaerobic bacterium P. 
acnes caused infection in about the same proportions of the 
cases (Blomgren, 1981). For therapeutic aspects of this 
investigation, the reader is referred to paragraph 4.4. 
3.4. Diagnosis 
Just as in osteomyelitis, making the diagnosis of'infection' is 
less difficult in acute forms than in a latent infection. 
However, a major difficulty in endoprostheses is to establish 
how far the infection extends, in view of the considerable 
implications of the diagnosis ofinfection'. Just as in chronic 
osteomyelitis, the diagnosis is difficult in latent, inactive 
infection because the symptoms are aspecific. In this 
instance, also, more objective parameters are needed. 
3.4.1. Symptoms 
If there is pain after implantation of a prosthesis (especially a 
total hip prosthesis), the possibility of an infection should be 
seriously considered (Lazanski, 1970; Fremont-Smith, 
1974; Salvati, 1976; Hunterand Dandy, 1977ь; Amstutzand 
Kass, 1977). A hip prosthesis should be painless post­
operatively (Salvati et al., 1971; Salvati, 1976; Beck, 1977; 
Ahlberg et al., 1978). Pain occurs predominantly when 
weight is put on the hip prosthesis (Fitzgerald et al., 1977). 
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Passive movements of the hip are painful, especially 
endorotation (Bosch et al., 1980), active movements cause 
even more pain (P. D. Wilson, 1974). As a rule, there is no 
local painful palpitation. In severe infection, there is also 
pain at rest. In general, the pain postoperatively gradually 
grows worse (Lazanski, 1970). 
Other symptoms occur only if the infection flares up. It 
is only in that case that symptoms such as fever, local 
swelling and other signs of infection occur, and sometimes a 
sinus develops. In the latent infection, these infection 
symptoms are absent and the pain in inflammations is 
aspecific. The same pain is felt in aseptic loosening. Fever is 
absent or subfebrile (Wilson et al., 1973; Fitzgerald et al., 
1977). The symptoms may be suppressed by antibiotics. 
Some diagnostic significance might be attributed to this, 
which the literature, however, fails to mention. 
3.4.2. Laboratory 
After every uncomplicated operation, the BSR gradually 
falls to the normal preoperative value. This decrease is linear 
on a semi-logarithmic scale (Härie, 1979a) (Fig. 2.5). After a 
total hip implantation, the BSR decreases to normal within a 
few months. Mulier et al. among 147 patients saw 
normalization after one month in 19% of the patients, after 
two months in 73 % and after four months in 93 % (Mulier et 
al, 1973). Forsterand Crawford observed that after total hip 
implantation normalization occurs after six months, that 
patients with infected prostheses virtually always have a 
BSR in excess of 20 mm in the first hour and that in aseptic 
loosening of the prosthesis, the BSR after six months is 
usually below 20 mm (Forster and Crawford, 1980). If the 
BSR remains high postoperatively, this strongly suggests a 
deep infection, and if a high BSR is observed in cases in 
which no continuous recording has been possible from the 
time of operation, a BSR higher than 30 to 40 ml in the first 
hour is also strongly suggestive of infection (Eftekhar et al., 
1973; Breitenfelder and Spranger, 1973; Fremont-Smith, 
1974; Wilson, 1974; Benson and Hughes, 1975; Stadler and 
Henche, 1976; Eftekhar, 1977; Lidgren et al., 1977; 
Suezawa and Dietschi, 1977; Hunterand Dandy, 1977" and 
1977b; Fitzgerald et al, 1977; Carlsson, 1978; Wilson et al., 
1978; Hughes et al., 1979; Lindberg, 1979a, Kamme and 
Lindberg, 1981). 
No leukocytosis is ever observed in the absence of 
acute, systemic symptoms of illness (Eftekhar et al., 1973; 
Mulier et al., 1973; Wilson et al., 1973; Fremont-Smith, 
1974; Fitzgerald et al, 1977; Lindberg, 1979a). 
3.4.3. Histological diagnosis 
Examination of tissue from the vicinity of the infected 
prosthesis includes counting of the number of 
polymorphonuclear leukocytes per square. A large number 
per square (more than 5 or: 2-3+) would constitute a reliable 
diagnostic criterium for the distinction between septic and 
aseptic loosening (Wilson el al, 1973); Mirra et al, 1976; 
Amstutzand Kass, 1977). Eftekhar pays particular attention 
to the quality of the polymorphonuclear cells (mostly 
neutrophils): lysosomal activity should be visible. Salvati 
also studies the polymorphonuclear leukocytes in the 
aspirate: if there are over 10,000 per ml, and over 25 % in a 
differentiation, this is highly suggestive of infection (Salvati, 
1976). A normal amount of attrition particles allegedly 
evokes no polymorphonuclear leukocyte response (Mirra et 
al., 1976). 
3.4.4. Roentgenology 
In an infection around a prosthesis, no roentgenological 
abnormalities are visible during the first six weeks. As a rule 
it takes three to six months for the infection to be recognized 
in the radiograph (Eftekhar, 1977). 
The plain radiographs show osteolytic foci along the cement 
with scalloping of the cortex. Lytic foci can be discerned in 
the cortex as well; sometimes there is a periosteal reaction, 
sometimes diffuse irregular cortical thickening and sclerosis 
(Lazanski, 1970; Eftekhar et al., 1973; Wilson et al., 1973; 
Benson and Hughes, 1975; Eftekhar, 1977; Dussault et al., 
1977). In addition, around the hip joint there is sometimes 
an osteoporosis that is much more marked than in the 
contralateral joint, because the pain leads to reduced 
weight-bearing and consequently to disuse atrophy of the 
skeleton (Wilson et al., 1973; Enneking, 1981). 
The loosening of the prosthesis is revealed by an 
increasingly broad halo around the cement and sometimes, 
by dislocation of the prosthesis. Reabsorption of the calcar 
also frequently occurs in an uncomplicated total hip 
prosthesis (Charnley and Cupic, 1973); it is probably due to 
disuse atrophy (Oh, 1977): the layer of cement presumably 
causes the stress of weight-bearing to bypass the calcar. In 
infection, however, the reabsorption of the calcar is said to 
be more irregular (Benson and Hughes, 1975). 
Mobility of a loosened prosthesis may be 
demonstrated by X-rays in abduction and adduction, 
revealing a 'windshield-wiper phenomenon'. Radiographs 
made under traction may also sometimes show loosening 
(Deyerle, 1967; Slooff, 1970). Selvik's technique of roentgen 
stereophotogrammetry may in the future become 
important for a more exact diagnosis of loosening of 
prostheses, since it allows more exact demonstration of 
minute displacement (Selvik, 1974; Van Dijk et al., 1979; 
Egund et al., 1981; Ilansson et al., 1981). 
Fìstulography supplies information on the course of the 
sinus tract and fills any abscesses as well. Mostly, it will show 
contact with the prosthesis (Benson and Hughes, 1975). 
However, it is not always possible to inject the sinus with 
adequate pressure; negative findings should be interpreted 
cautiously. 
Evaluations of arthrography differ. Some papers emphasize 
the useful information it may provide, others deny that it 
contributes to the diagnosis (Table 3.4). Salvati et al. (1971) 
among 31 arthrograms of the hip saw only one false-
negative and no false-positive arthrograms. Murray and 
Rodrigo (1975) performed arthrography in 25 painful and 53 
asymptomatic hip prostheses. Of the asymptomatic 
prostheses, 22.6% proved to have a loosened acetabular 
cup, as against 0 % of the femoral prostheses. In the group of 
painful prostheses, 44% showed loosening. Twelve patients 
of the symptomatic group were operated : in seven cases, the 
positive arthrogram as confirmed by macroscopical 
loosening of the cup. In three patients with a positive 
arthrogram, this finding was not confirmed at operation, 
while in three cases with negative arthrograms, operation 
nevertheless revealed loosening. To sum up : seven correctly 
positive, three false-positive and two false-negative findings. 
The authors conclude that loosening is not necessarily 
painful and that loosening revealed by arthrography is too 
often not observable at operation (three out of 10 patients). 
They also conclude that loosening is not more frequent 
among painful than among asymptomatic hip prostheses. 
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Dusbdult et al (1977) found d positive correlation between 
arthrographic and surgical findings in 19 out of 21 patients 
(90 %) Failure of contrast medium to penetrate between the 
prosthesis and the bone, however, did not exclude 
loosening in five out of 25 patients Suezawa and Dietschi 
(1977) found a positive correlation of arthrographic and 
surgical findings in 81 % on the acetabular and in 70 % on the 
femoral side 
In contradiction to Fremont-Smith (1974), Amstut? 
and Kass (1977) and Beck (1977), Lindberg considers 
arthrography to be of little value out of 20 arthrograms, he 
found only 20 % to be relevant In his opinion, arthrograms 
are often difficult to interpret (Lindberg et al, 1977ь, 
Lindberg, 1979a) (Table 3 4) 
ARTHROGRAPHY 
Valuable Not valuable 
Fremont-Smith '74 Murray '75 
Salvati '76 Lindbergh '79! 
Amstutz '77 
Beck '77 
Dussault '77 
Suezawa '77 
Turner '79 
Table 3 4 Various authors' opinions of arthrography as an aid 
in the diagnosis of a loose prosthesis 
The subtraction technique is said to enhance the quality of 
the arthrogram (Salvati et al, 1974, Turner, 1979) It 
requires optimal immobilization of the patient In addition, 
the arthrography should be carried out under strict aseptic 
conditions and intensifying-screen control Simultaneously 
with the arthrography, aspiration is carried out for 
bacteriological examination According to some authors 
(Salvati, 1976, Beck, 1977), excessive injection pressure 
may cause septicaemia, just as in fistulography The value of 
fistulography, arthrography and aspiration might be 
increased by taking into account only possitive findings, and 
considering negative findings not to exclude loosening or 
infection 
Tomography may be useful for the detection of slight lytic 
lesions that are masked in standard radiographs 
Computed tomography affords good insight in the axial 
direction into the interrelationships of the stem of the 
prosthesis, the bone cement and the cortex Beck (1977) 
found that the metal caused too much disturbance, 
eliminating the contrast between cement and bone In his 
material, only pronounced loosening was visible A 
modified technique eliminates this disturbance (Dietschi et 
al, 1979) and reveals the interrelationship clearly However, 
owing to the low resolving capacity of computed 
tomography (approx IV2 mm), small cracks in the cement 
are not shown up 
3 4 5 Scintigraphy 
The scan makes a useful contribution to the diagnosis of 
loosening So far, however, it inadequately allows the 
differentation of infection and aseptic loosening 
Just as in osteomyelitis (see Chapter 2 4 5), the Tc -
MDP scan in infection of an endoprosthesis, also shows 
heightened activity over areas with increased vas­
cularization and increased osteogenesis (Galasko, 1977, 
Davies and Galasko, 1977, Lindberg et al, 1977ь, Hughes et 
al, 1978, Khan et al, 1979, Reing et al, 1979, Pearlman 
A W, 1980) Presence of enough sound bone is a condition 
of exchange of the radionuclide material (Hughes, 1980) 
During an uncomplicated postoperative course after 
implantation of a hip prosthesis, the scan is positive due to 
local bone remodelling When no complications occur, the 
scan returns to normal after a length of time that vanes 
depending on the isotope used (see Table 3 5) 
SCAN 
Author 
Bauer '73 
Wegmann '75 
Feith '76 
Tregonning '76 
Lindbergh et al '77b 
Isotope 
85 Sr 
99mTc 
87mSr 
99mTc 
85 Sr 
Normal after 
3-10 months 
3 months 
4,3 months 
9 months 
1-3 years 
Table 3 5 Review of literature data on duration of the interval 
before the scan returns to normal after uncomplicated implantation 
of an endoprosthesis Before the end of this penod of normalization, 
scintigraphy is useless for the diagnosis m case of a painful prosthesis 
In scintigraphic examination of prostheses, use of strontium 
offers certain advantages over that of technetium The 
strontium scan admittedly presents a less clear image, 
but it is more specifically linked to bone activity The 87mSr 
scan not only has a higher activity than the 85Sr scan, but also 
has a shorter half-life so that the disadvantages of repeated 
examinations are reduced With the 87mSr scan, Feith et al 
(1976) saw very good correlation with loosening of 22 
patients with positive 87mSr scans, 16 were re-operated, 
confirming the loosening, while six others remained 
symptomatic and were still considered for reoperation Six 
patients with a negative scan were all symptom-free 
Combined use of a Tc and a 87mSr scan combines the 
advantages of the two radioisotopes 
When septic or aseptic loosening is suspected in a 
patient, a Tc scan should be carried out first it is more 
sensitive and gives a clearer image However, if this scan is 
positive, a subsequent strontium scan will nevertheless 
show a negative image in 10 to 25 % of the cases (Claessens 
and Van der Jagt, 1981) The remaining patients, with 
positivity of the technetium and of the strontium scan, 
according to the findings of Feith et al, always show 
loosening (Feith et al, 1976) 
As a general rule, the signs of loosening or infection in a scan 
should not be confused with those of periarticular 
calcifications, pseudarthrosis of the greater trochanter and 
trochanteric bursitis (Lynch, 1975, Hunter and Dandy, 
1977 b) 
Distinction between infection and loosening is 
impossible according to the majority of authors (Bauer et al, 
1973, Feith et al, 1976, Convery and Convery, 1979, Reing 
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et al., 1979), but in the opinion of Browett et al. (1980), this 
is just a matter of inadequate documentation. 
In gallium scanning, "gallium citrate is used. 
Allegedly, a scan is influenced by increased vascularization, 
by the protein binding of the gallium and particularly by the 
binding of gallium to leukocytes (Staab and McCartney, 
1978; Re'ing et al., 1979). In that case, the positive scan is 
caused by migration of the leukocytes to the inflamed area 
(Staab and McCartney, 1978). However, this migration of 
leukocytes is diminished under the influence of antibiotic 
treatment and similarly, a mild inflammation of low 
virulence, eliciting little reaction, causes a false-negative 
gallium scan (Re'ing et al, 1979). Blomgren (1981), 
experimenting in animals, examined five haematogenously 
caused infections of prostheses and observed a positive 
gallium scan in three of them. Two scans were false-
negative. 
Rushton et al. (1982), examining 51 patients with a 
painful hip prosthesis and 34 control patients, found that the 
technetium scan (Tc99m-MDP) in combination with the 
gallium scan did permit accurate distinction between 
aseptic and septic loosening of the prostheses. In their 
opinion, a difluse-in contradistinction to a focal-increase 
of the uptake in the technetium scan is indicative of an 
infection. In the 19 infected hip prostheses, the gallium scan 
was always positive. The value of these findings is reduced 
by the incomplete data on the bacteriological diagnosis. 
For the Indium scan, autologous leukocytes are linked 
to lll-indiumoxinate(Röverkampetal., 1980) and then re-
injected. Since this scan, also, depends on leukocytary 
activity, it may give a false-negative result in latent 
infections for the same reasons as the gallium scan does. 
To recapitulate, at the present stage in case of a painful 
hip prosthesis, it is advisable first to make a Tc scan. If this is 
negative, the diagnosis of loosening should be abandoned. 
If it is positive, the next step should be a 87mSr scan which 
shows good correlation with loosening. For the moment, the 
scans still appear to offer insuflicient aid in the distinction 
between septic and aseptic loosening. 
3.5. Bacteriology 
3.5.1. Introduction 
Just as in osteomyelitis, the bacteriological diagnosis is of 
great importance in the loosened and the infected 
prosthesis. That which has been stated in Chapter 2.5 
applies equally to the infected prostheses: the relative value 
of cultures from the sinus tract, the importance of 
anaerobics and the unknown role of cell wall-deficient 
bacteria. 
Where endoprostheses are concerned, correct 
techniques of bacteriological diagnosis and correct 
interpretation of the findings of the bacteriological 
laboratory are of paramount importance. If, namely, an 
infection is left untreated because the diagnosis of infection 
has not been made, rapidly progressive loss of bone will 
occur. If an endoprosthesis is reimplanted without 
treatment of the-undiagnosed-infection, reinfection is 
almost certain to occur. 
The recorded percentages of aseptic loosening, which 
rise to considerable values with the passage of years after 
implantation of the prosthesis (Witt and Hackenbroch, 
1976), might be much lower given correct bacteriological 
diagnosis. Hunter (Hunter et al., 1979) and Buchholz 
(Buchholz et al., 1981) are of the opinion that 'sterile' 
loosening is often caused by bacteria even though these are 
not cultured. Lindberg asserts that in several clinics there 
have been virtually no observations of aseptic loosening 
since anaerobic culturing was also carried out. He gives no 
figures or percentages, however (Lindberg et al., 1977a). 
In the study of the problem of loosening of prostheses, 
where extensive biomechanical research has already solved 
many mechanical problems, bacteriological examination 
should also be given more attention, certainly more than it is 
receiving at present. 
3.5.2. Gram preparation 
The gram preparation is a useful diagnostic aid according to 
Eftekhar et al. (1973). Others, however, find insufficient 
correlation with the subsequent culture findings (Hughes et 
al., 1979). Suezawa and Dietschi found that out of 26 
infected hip prostheses, only two had given a positive 
peroperative gram preparation. Furthermore, out of 15 
positive gram preparations, 11 were subsequently found to 
be negative after all (Suezawa and Dietschi, 1977). 
3.5.3. Cultures 
Material for culturing may be collected in two ways: 
puncture aspiration and open biopsy. 
Aspiration by puncturing is best done under image-
intensifying control. The puncturing should be performed 
strictly aseptically, preferably in an operating room 
(Fitzgerald et al., 1977). The material should be cultured 
aerobically and anaerobically and arthrography may be 
carried out at the same time. If the culture is negative but 
the suspicion of infection is strong, it may be necessary to 
repeat the aspiration or even to perform an open biopsy 
(Wilson, 1974; Patel et al., 1976; Hewitt, 1977). If no 
material can be aspirated, a few ml Ringer's solution may be 
injected and re-aspirated (Wilson et al., 1973; Buchholz, 
1979). At the same time, a needle biopsy may be taken from 
the peri-articular tissue, for microscopical examination 
(Buchholz et al., 1979). Patel and others considered 
aspiration a useful examination where sepsis was present 
and a hip infection suspected. After 127 punctures, which 
included hips not previously operated upon, they saw 26 
false-positive results due to contamination, mostly 
Staphylococcus albus, diphtheroids or streptococci. The 
contamination could be traced by quantitative bacterio-
logical examination with 'pour plate' culturing (Patel et al, 
1976) (Table 3.6). 
Author 
Fremont-Smith '74 
Patel '76 
P.W. Hughes '78 
M.R. Wilson '78 
Buchholz et al. '79 
Nelson '80 
ASPIRATION 
Total 
N 
34 
127 
36 
16 
205 
9 
Table 3.6 Correlation between the bacteriological findings in 
aspirated material and the findings at operation according to 
several authors. 
35 
Fremont-Smith (1974) after 34 aspirations encountered 
20% false-negative results and no false-positive cultures. It 
should be noted that of the 23 positive cultures, four were 
found only in the subculture, after 48 hours. Buchholz 
found that of the culture results after 205 aspirations, 73 % 
were confirmed at operation. There was a relatively large 
number of false-negative cultures (35 out of 205 aspirations) 
(Buchholz et al., 1979). 
The peroperative culture may be false-positive or false-
negative due to several causes (Table 3.7). 
PEROP. SAMPLES 
False-positive False-negative 
contamination during operation preop. antibiotic theray 
wrong transport media 
contamination in laboratory transport too slow 
judged too early in labor. 
sample from fistula sample not taken 
anaerobically 
no multiple samples L-forms (?) 
bacteria indicated as 'not 
pathogenic' 
no multiple samples 
Table 3.7 Causes of false-positive or false-negative results of 
cultures of material collected at operation. 
A false-positive culture may result from contamination at 
operation or in the laboratory. Cultures from 'clean' surgical 
wounds, collected at the end of the operation, are positive 
in one-third of the cases (Ritter and Stringer, 1981). 
Murray prepared cultures from 740 capsules at primary 
implantation of a total hip. Of these cultures, 233 were 
positive. However, there was no correlation at all with 
postoperative infection of these prostheses (Murray, 1973, 
1974). Fitzgerald saw 23% positive cultures after primary 
total hip implantation, but only 2 to 3 % of the implanted 
prostheses became infected (Fitzgerald et al., 1973). 
Suezawa and Dictschi (1977) observed that the 
bacteriological diagnosis that had been made pre- and 
peroperatively (aspiration and gram preparation, 
respectively) in 158 cases, subsequently was found to have 
been incorrect in 15.5 % of the cases. Kamme and Lindberg 
(1981), studying 63 infected prostheses and a control group 
of 33 hips operated earlier, also found contamination in one-
third of the cases. The contamination was not reduced by 
antibiotics administered preoperatively. Lindberg found 
38 contaminations among 319 peroperative biopsies 
(Lindberg, 1979a). However, when multiple biopsies were 
taken at operation, contamination was never found in more 
than three of them. Accordingly, he recommends taking five 
or six different biopsies for culturing, of tissue adjacent to 
the cement, for detection of the contaminants: he only 
regards the hip prosthesis as infected if at least four to five of 
the biopsies arc positive and contain the same causative 
organism (Lindberg, 1976; Lindberg et al., 1977a; Lindberg, 
1979a; Carlson et al., 1978). Ritter and Stringer, also, failed 
to find a correlation between a positive capsule culture at 
implantation and subsequent inflammation of the hip 
prosthesis. They did observe a relationship, on the other 
hand, if two cultures of material collected at implantation 
were both positive. Of patients with two positive cultures, 
32% developed a postoperative wound problem and 24%, 
an infection of the hip prosthesis (Ritter and Stringer, 1981). 
The above studies justify the conclusion that the role 
of the contaminant in culturing can be made clear by taking 
several samples for culturing. Faulty collection techniques 
increase the degree of contamination. The risk of 
contamination is minimal if the sample is taken at an early 
stage of the operation, tissue (biopsies) is examined and 
every sample is collected with a new, sterile instrument. 
Contamination by sinus material should be avoided. False-
positivity of cultures may also occur in a bacteriological 
laboratory due to contamination during the processing of 
the material. Murray sterilized 100 capsules of hips before 
submitting them. Ten positive culture results were reported 
for this material (Murray, 1973). 
A. false-negative result may be due to a number of causes. 
Delicate bacteria demand much of transport media, 
transportation speed and laboratory technique. Previously 
unrecognized anaerobic causative agents exemplify this. 
Any cell wall-deficient bacteria that may be present 
necessitate special culturing techniques (10% sucrose). 
Antibiotics administered pre-operatively increase the risk of 
false-negative cultures: for this reason, antibiotics should 
only be administered after collection of the last sample for 
culturing. Kamme and Lindberg (1981) even recommend 
cessation of antibiotic treatment six weeks prior to 
operation. 
Since some bacteria grow more slowly than others, the 
laboratory should not be rash in deciding that there is no 
growth. 
M. E. Müller in two-thirds of the cases of late infections 
found a Staphylococcus albus or anaerobics and regards 
these as non-pathogenic (Müller, 1976). Wilson mentions 
that the coagulase-negativc staphylococcus has long been 
regarded as non-pathogenic (Wilson et al., 1974). However, 
in neurosurgery and cardiovascular surgery, and later in 
orthopaedics as well, it has become clear that in the 
presence of implants these bacteria, also, are pathogenic. 
For this reason it is incorrect to regard a culture result with 
Staphylococcus epidermidis or anaerobics as negative. 
3.5.4. Causative organism 
Infection of a prosthesis is most often caused by a 
Staphylococcus aureus. Second in the order of frequency is 
usually Staphylococcus albus (see Table 3.8). Third in the 
order of frequency is the group of the gram-negative 
bacteria but this group is nevertheless important in view of 
the virulent character of the infection. Occasionally, mixed 
floras are cultured: probably, these originate mostly from 
sinus material (see Chapter 2.5). They contain as many 
gram-positive as gram-negative organisms. The percentage 
of gram-negative infections has grown with the passage of 
years (Wilson et al., 1973), possibly due to increased 
prophylactic use of antibiotics (Salvati, 1976). 
Anaerobics occur in the intestinal content in large 
numbers, some 1000 times more than coliform organisms. 
The skin around the hip as a rule is greatly contaminated by 
anaerobics (Nobles, 1973; Launder and Hungerford, 1981). 
The blood circulation also often contains anaerobic bacteria, 
suggesting the possibility of a haematogenous infection 
of .the prosthesis (Lodenkamper and Stienen, 1955; 
Lodenkamper, 1969; Stinchfield et al., 1980). According to 
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agent 
St. aureus 
St. albus 
ß-heam. strep toc. 
enterococci 
var. strep tocci 
Enterobacter 
Esch coli 
Klebsiella 
Proteus 
Serratia mar. 
Pseudomonas 
Bacteroides fr. 
var. anaerobics 
miscellaneous 
sterile 
unknown 
Total samples (N) 
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Table 3 8 Review of literature data on causative agents of deep infections of articular prostheses The figures refer to numbers or, 
where stated, to percentages. 
certain authors, it is especially among the late infections of 
prostheses that the frequency of anaerobic infections is 
high The reported percentages vary from 10 to 25% 
(Buchholz and Gartmann, 1973, Kamme et al., 1974;Nolan 
et a l , 1975; Fitzgerald et al., 1977; Carlson et al., 1978; 
Buchholz et a l , 1979, Lindberg et al., 1977a). 
Cultures of early postoperative infections are said to show 
more mixed floras and gram-negative infections Late 
infections show more gram-positive micro-organisms and 
relatively more Staphylococcus albus (Mitchell et al., 1973). 
3.6. Treatment 
In regard to the treatment of the infected endoprosthesis, 
important questions are whether an acute or a late 
postoperative infection is involved, and whether the 
infection is superficial or deep-seated. 
3.6.1. Superficial infection 
The superficial infection may be regarded as a wound 
infection and treated as such, efficacious antibiotic therapy, 
preferably preceded by identification of the causative 
organism. The treatment should include adequate relief of 
haematomas and abscesses (Wilson et al., 1973). If the 
extent of the process is uncertain, this intervention should 
preferably be performed as a surgical procedure. Letournel 
after debridement carries out thorough lavage of the 
superficial infected area, then uses another set of 
instruments to inspect the deeper articular region. 
However, assessment with the naked eye is always 
uncertain (Letournel, 1969) Examination of a frozen 
section with a count of the polymorphonuclear leukocytes 
may provide better information (Amstutz et a l , 1977, see 
paragraph 3 4 3) Beck asserts that conservative treatment 
of a subcutaneous infection will undoubtedly lead to a deep 
infection, and describes three cases of this nature. In four 
other patients, the prosthesis could be saved by rap id wound 
revision and subcutaneous suction drainage (Beck, 1977) 
3 6 2 Acute deep infection 
Letournel treats the deep, acute infection at an early stage· 
'reprise précoce' (early reoperation) for 'infection précoce' 
(early infection) Before the operation, however, he allows 
four to eight days for antibiotic treatment This should cause 
the acute signs of infection to disappear. During this 
preoperative period, the would is repeatedly relieved by 
puncturing, or a few sutures are removed. He has never 
observed these few days of postponement to lead to 
septicaemias or spread of the infection The antibiotics 
should restnet the infection so that at operation infected 
tissue can be removed as a whole with a margin of sound 
tissue. At operation, the scar is resected en bloc and the 
subsequent operation is time-consuming and gory and 
requires a good deal of patience and persistence (Letournel, 
1969). 
At operation, the femoral prosthesis may be 
temporarily removed to be reimplanted after sterilization 
(Wilson et al., 1973) After thorough debridement, primary 
closure of the wound may be performed, a drainage system 
being left in situ (Weber and Stuhmer, 1973, Wilson et al., 
1973; Muller M.E., 1976; Amstutz et a l , 1977). 
Eftekhar when gram-negative infection occurs leaves 
the entire wound open (Eftekhar, 1977). Others allow the 
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suprafascial soft parts to heal by second intention, or suture 
them after a few days (Wilson et al , 1973, Nolan étal ,1975, 
Fitzgerald et al, 1977) 
Amstutz advises, when drainage is used, to instill 125 
ml per hour and to change in- and outlet drains In case of 
insufficient flow, the drains are withdrawn after preliminary 
suction (Amstutz et al , 1977) 
Wilson reduces the duration of suction drainage as 
much as possible, to four to a maximum of 10 days He is 
afraid of superinfection (Wilson et al, 1973) 
Antibiotics should be administered intravenously for 
six to eight weeks and orally for three to six months 
(Muller Μ E , 1974, Salvati, 1976, Amstutz and Kass, 1977, 
Eftekhar, 1977, Hunter and Dandy, 1977b) Early, 
aggressive surgical treatment is reported by several authors 
to have given good results (Table 3 9) Reichelt and Riedl in 
15 early deep infections could leave the prosthesis in situ 
only four times, but they amve at the same conclusion early 
revision (Reichelt and Riedl, 1974) 
CONSERVATIVE 
antibiotics 
SURGICAL 
prosthesis 
IN SITU 
prosthesis 
REMOVAL 
REIMPLANTATION 'GIRDLESTONE' 
I no reimplantation 
ONE-STAGE 
without AB 
AB-cement 
syst AB+/-
AB cement 
TWO-STAGE 
short penod weeks 
(treatment) 
long period months 
(control healing) 
ACUTE DEEP INFECTIONS 
Author 
Letoumel '69 
Henke '73 
Muller '74 
Coventry '74 
Nolan '75 
Amstutz '77 
Total 
Total 
N 
11 
6 
5 
12 
6 
6 
43 
(100%) 
Healed 
7 
3 
4 
11 
6 
4 
35 
(81%) 
Table 3 9 Results of treatment of acute early postoperative deep 
infections of endoprostheses as reported by six authors 
3 6 3 Late deep infection 
In the treatment of late infection of the prosthesis, no 
distinction is made between latent and haematogenous 
infection of the prosthesis Occasionally, the late infection 
manifests itself during an exacerbation with acute signs and 
symptoms These acute late postoperative infections not 
rarely run a fatal course and require prompt treatment, as 
discussed in paragraph 3 6 2 The usual manifestation form 
of the late infection is less acute Highly divergent methods 
of treatment have been described The treatment may be 
conservative or surgical At operation, the prosthesis may be 
left in situ or removed, in which case reimplantation may be 
earned out immediately or later (Table 3 10) 
3 6 3 1 Conservative treatment 
If the patient's life expectation is limited, or surgery is 
refused, conservative treatment is indicated (Plaue and 
Stadtler, 1975) The aim of the treatment is then to relieve 
the symptoms and to prevent spread of the infection 
Relief of pain may be accomplished by the use of 
crutches If there is a sinus, it may be irrigated to keep the 
sinus tract open, but thorough bandaging is necessary to 
prevent superinfection Lxacerbation of the infection may 
be combated for a time with antibiotics However, 
antibiotics by themselves can never cure an infection (Plaue 
Table 3 10 Scheme of the various methods of treatment possible 
m an infected total hip prosthesis No reference is made to the 
degree of efficacy of the various techniques 
and Stadtler, 1975, Salvati, 1976, Hunter and Dandy, 
1977b) Some patients require a maintenance treatment 
with antibiotics for the rest of their lives 
Muller proposes to treat the fistulizmg, infected 
prosthesis with antibiotics for three to 12 months, both 
orally and locally through the sinus tract This often 
suppresses the inflammatory phenomena for one to two 
years, so that time is gained (Muller Μ E , 1974) Similarly, 
Hunter and Dandy recommend conservative treatment as 
long as the wound is dry and the pain, relieved by analgetics 
and antibiotics, remains bearable (Hunter and Dany, 
1977a) Eftekhar states that not every infected prosthesis 
demands immediate action (Eftekhar, 1977) 
An interesting study is that carried out by Lidgren et al 
(1977) m which 50 patients with infected hip prostheses 
were given antibiotics, and the effects were compared with 
periods during which the patients were not given antibiotics 
During the treatment, pain was alleviated and the BSR 
fell significantly Most sinuses persisted Radiological 
abnormalities were usually not progressive during the 
treatment However, in spite of protracted therapy, not a 
single patient was cured 
3 6 3 2 Surgical treatment 
At operation, all granulation and scar tissue should be 
removed In particular, the very thick neo-capsule should be 
excised There are three reasons for this thorough 
debridement the granulation and scar tissues harbour 
bacteria, the scar tissue is not well accessible to antibiotics 
because of bad vascularization and this inflexible tissue 
precludes obliteration of the dead space (Wilson et al, 1973) 
During the subsequent procedure, some leave the 
prosthesis in situ while others extract the prosthesis and the 
cement 
Hewitt states that during debridement the prosthesis may be 
left m situ and draws the comparison with infections around 
implants in vascular and neurosurgery Infections of 
implants are said to be curable if caused by bacteria of 
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low pathogenicity (coagulase-negative staphylococci, 
diphtheroids, Propionibacteria) It is then a condition that 
the antibiotic therapy should consist of preparations of low 
toxicity (penicillins, cephalosphonns), which sometimes 
have to be given as long as the patients live If the infection is 
caused by gram-negative organisms, removal of he implant 
is considered necessary The results of this treatment are not 
mentioned, however (Hewitt, 1977) 
Nolan only removes the prosthesis when it is loose (Nolan et 
al, 1975, Coventry et al, 1974) If the prosthesis is still 
firmly anchored, the infection is treated by debridement, 
closure of the wound and suction drainage Of the 11 
patients treated in this manner, three were cured, three died 
and m five, the prosthesis had to be extracted at a later stage 
Accordingly, in a later publication these authors conclude 
that in view of the disappointing results in a deep infection 
of the prosthesis, such prostheses should always be 
extracted (Fitzgerald et al, 1977) Hunter and Dandy made 
a retrospective study of 135 infected hip prostheses in 
Canada They concluded that repeated interventions (four 
operations on the average in their material) aimed at leaving 
the infected prosthesis m situ proved useless and destroyed 
the patients' morale (Hunter and Dandy, 1977a) 
if extraction of the prosthesis is decided upon, most authors 
recommend removal of all cement, as well, since residual 
cement precludes healing of the infection (Buchholz and 
Gartmann, 1972, Weber and Stuhmer, 1973, Fremont-
Smith, 1974, Muller Μ Ε , 1974, Flaue and Stadtler, 1975, 
Ganz and Meyer, 1976, Clegg, 1977, Eftekhar, 1977, Wilson 
et al, 1978, Thelen and Steinhauser, 1979) A few authors 
state that when cement rests are left behind, healing is 
nevertheless possible (Hunter and Dandy, 1977a, Ahlgren 
et al, 1980, Petty and Goldsmith, 1980) According to 
Hackenbroch, cement may be left in situ if absence of 
infection is certain This appears risky considering the fact 
that certainty regarding infection is sometimes only reached 
postoperatively, from cultures (Suezawa and Dietschi, 1977, 
Hackenbroch, 1979) 
Extracting the prosthesis and the cement is usually a 
laborious and timeconsuming procedure Most authors 
perform a trochanteric osteotomy 
Buchholz et al (1979) leave only a thin wall of bone of 
the greater trochanter Mallory (1978) avoids osteotomy by 
disinsertion of the abductor at the tip of the trochanter A 
good description of the technique of removing the cement is 
given by Stuhmer et al (1979) They designed special chisels 
to remove the cement Self-tapping extraction instruments 
have also been developed (Lindner, 1973, Dean Razzano, 
1977) Use is also sometimes made of strong, fast-rotating 
fraises (Harris and Oh, 1978, Turner, 1979) Some early 
experience of the use of laser to remove cement has been 
reported (Beacon et al, 1979) 
Use of a fibre light source facilitates work deep in the 
femoral shaft (Amstutz et al, 1976, Eftekhar, 1977) In 
order to be able to remove all the cement, it may be 
necessary to make a window in the femur This window as a 
rule measures one by three cm The corners should be 
drilled to avoid excessive concentrations of stress at acute 
angles The site of the window is important to avoid 
weakening with resulting fracture of the proximal femur 
Many authors point out the risk of fracture in case of a lateral 
window (Witt and Hackenbroch, 1976, Amstutz and Kass, 
1977, Buchholz et al, 1979, Stuhmer et al, 1979) The 
window should always be made ventrally or dorsally and, as 
Buchholz advises, not farther distally than the midle third of 
the stem of the prosthesis 
Clegg (1977) among 30 Girdlestone hips never saw a 
fracture if the window had been made laterally 
Hackenbroch mentions that the sawn-out window after 
extraction may be put back in (Hackenbroch, 1979) 
Buchholz advises against this, in view of the risk of 
sequestration (Buchholz and Gartmann, 1973) Some 
surgeons create a long ventral groove (Muller, 1974, 
Eftekhar, 1977) which would appear to render re­
implantation of a prosthesis practically impossible Only 
Buchholz still reports reimplantation with this technique 
(Buchholz and Gartmann, 1973) 
Henssge et al (1982) create an elongated ventrolateral 
window with the aid of pin holes ('geplannte ventro-
laterale Femurschaftdeckelung' = planned creation of a 
ventrolateral femoral shaft lid) which at reimplantations 
may be closed and fixed using cerclages 
In removal of the acetabular prosthesis, lumps of 
cement m the pelvis constitute the major problem These, 
also, should be removed In case of an infected hip 
prosthesis, they may lead to severe spread of the infection, 
into the pelvis or farther into the abdomen (Beck, 1977) 
A control X-ray is advised to check if all cement has 
been removed 
After extraction of the hip prosthesis, the decision 
whether or not to reimplant it has to be made Ifextraction is 
not followed by reimplantation, the result is a hip joint with 
absence of the femoral head and neck and usually of the 
capsule as well This situation is called 'Girdlestone' It is 
comparable to Girdlestone's primary operation in arthritis 
of the hip (Girdlestone, 1943) At operation it is attempted 
to make a good, smooth resection at the level of the 
intertrochanteric line some surgeons in addition remove 
the lateral acetabular rim (Muller Μ Ε , 1974, Clegg, 1977, 
Petty et al, 1980) (Fig 3 4) 
The stability after resection of the hip joint may be 
improved by distal displacement of the abductors to the 
lateral femur (Colonna, 1960, Eftekhar, 1977) Stability may 
also be achieved by leaving the femoral neck in situ after cup 
arthroplasty (Soren, 1960) In addition, a subtrochanteric, 
valgus-inducing osteotomy may provide stability by 
supporting the pelvis and lengthening the abductors (Witt 
and Hackenbroch, 1976) However, the osteotomy is 
inadvisable if the cortex is thin (Witt, 1977) 
After extraction of a prosthesis, most authors order six 
weeks' traction on the leg, and recommend protracted use of 
a crutch or walking stick during subsequent mobilization 
The 'Girdlestone' hip is stable to varying degrees and 
usually reasonably capable of weight-beanng As a rule, 
however, abductor weakness necessitates use of a crutch or 
walking stick (Clegg, 1977) The leg as a rule is shortened by 
four to eight centimeters, necessitating a shoe with a very 
thick sole and high heel 
In most cases, the function of the 'Girdlestone' hip 
improves during the first year after operation Ultimately, a 
state of increased exorotation usually persists (Clegg, 1977, 
Wilson et al, 1978, Ahlgren et al, 1980) The subjective 
results vary greatly Pain is mostly reported to be mild or 
absent, but this may be related to the preoperative situation 
(Haw and Gray, 1976, Clegg, 1977) 
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Figure 3.4 Representation of various possibilities in infection in 
the hip. 
a. solution as described by Girdlestone in arthritis of the hip 
(Girdlestone. 1943); 
b. removal of an infected total hip prosthesis through a long ventral 
groove. Osteotomy through the greater trochanter. Removal of the 
lateral acetabular edge (from Müller, 1974); 
c. removal of the infected prosthesis by means of a thin peel-shaped 
trochanteric osteotomy and a small ventral or dorsal femoral 
window at the level of the centre of the prosthesis. After nettoyage, 
reimplantation of a new prosthesis (from Buchholz et al., ΜΊΨ). 
Letournel after the extraction performs an arthro­
desis: the 'coaptation trochantero-iliaque' (trochantero-iliac 
coaptation), with the aid of external fixation material 
(Letournel, 1969). 
3.6.3.3. Reimplantation 
A prosthesis may be reimplanted at the same surgical 
session as the extraction (one-stage) or subsequently (two-
stage). If reimplantation is not performed immediately, the 
interval may be kept short, and is then often used to treat the 
infection (two to six weeks), or allowed to last longer, to 
await definite healing of the infection (six to twelve 
months). The subsequent reimplantation may be carried 
out with or without antibiotic-containing cement, and with 
or without systemic administration of antibiotics. 
Combinations result in a number of possibilities (Table 
3.10), which are briefly described with mention of the 
results (Fig. 3.5). 
/. Direct reimplantation 
a. Without antibiotics 
When at direct reimplantation, antibiotic prophylaxis is 
refrained from, it is usually omitted because the diagnosis of 
'infection' has not been made. Diagnostics, however, is 
often imperfect. Understandably, direct reimplantations 
performed in this manner lead to a large percentage of 
infections. This large proportion of infections, indeed, 
supports the view that many cases of loosening classified as 
aseptic actually involved an undiagnosed infection of the 
prosthesis (Hunter et al., 1977). The percentages of 
infection of reimplanted prostheses reported in the 
literature are large (Table 3.11): five out of 64 patients 
(Hackenbroch jr, 1979), 17 % (Dandy and Theodorou, 1975) 
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Author 
LP. Wilson'73 
2. Fremonl-Smith 74 
3. Wilson '74 
4. Dandy '75 
5. Ganz '76 
6. Beck '77 
7. Hunter '77b 
8. Wilson '78 
9. Hackenbroch '79 
10. Hunter et al. '79 
11. Hunter'79 
12. Polster '79 
13. Lindberg et al. 77a 
14. Carlsson '78 
15. Josefsson '80 
16. Buchholz '81 
17. К. Müller '81 
Total 
number 
17 
41 
19 
83 
10 
50 
30 
51 
64 
20 
140 
65 
109 
92 
21 
77 
68 
659 
25 
Follow 
up у г. 
1-4 
'/2-? 
2-5 
7 
1/4-3/4 
9 
?-5 
7 
7 
7 
V2-? 
«/2-? 
7 
V2-? 
1/2-? 
'/2-3'/2 
2-5 
Ví>-10 
2 
Infected 
% 
11.8% 
7.3% 
10 % 
17 % 
70 % 
36 % 
63.3% 
12 % 
7.8% 
20 % 
32 % 
39 % 
23.3% 
16 % 
19 % 
10 %(12%) 
24 % 
15 % 
28 % 
Remarks (indication, therapy) 
1+2 stage, long-term AB 
1 stage, long-term + high-dose AB 
1+2 stage, long-term AB 
not infected 
2 pat. AB-cement 
data missing 
all infected; no AB or AB-cement 
2 stage; no AB 
not infected 
infected 
not infected 
infected; AB or AB-cement 
100% after fourth reimplantation; different 
indications 
infected; 1-stage, AB-cement 
infected; 2-stage, AB-cement 
infected 1+2 stage, AB-cement 
infected; 1+2 stage, AB-cement 
infected; 1-slage, AB-cement 
infected; 21 pat. AB-cement 
Table 3.11 Review of literature data on proportions of infections after first reimplantations of endoprostheses. Abscence or presence of 
infection of the prosthesis, and the therapeutic procedure have been included where mentioned by the authors. 
b. With systemic antibiotics 
Direct reimplantation in infection, with supplementary 
treatment of the infection by means of postoperative 
systemic administration of antibiotics is described by 
authors from the Mayo Clinics and the Hospital for Special 
Surgery (Wilson M.R. et al., 1978; resp. Wilson P.D. et al., 
1973,1974; Wilson P.D., 1974; Salvati, 1976; Hughes et al., 
1979). The antibiotics have to be given in large doses, 
intravenously for the first few weeks and then orally for 
three to six months. 
Hughes et al describe 13 patients. In the group 
consisting of these 13 plus 13 other patients subjected to 
two-stage reimplantation, a recurrence rate of 15.4% was 
found. Earlier publications from the same clinic mentioned 
lower recurrence rates due to less strict criteria of infection 
(Hughes et al., 1979). Fremont-Smith (1974) among 41 
patients saw only three recurrences. The number of patients 
followed up for longer than two years amounted to only 11. 
с With antibiotic-containing cement 
Buchholz was the first to perform direct reimplantations 
under protection of an antibiotic mixed with the cement 
(see Chapter 4). During the first few years he did not 
combine this with systemic antibiotics (Buchholz et al., 
1981). However, good experiences of Swedish authors who 
in addition to antibiotic-containing cement administered 
antibiotics systematically for three to six months post­
operatively, convinced him of the value of this regimen 
(Buchholz, 1979a; Lindberg et al, 1977d; Lindberg, 1979b; 
Carlson et al., 1978), 
Up to the time of writing (mid-1982) no American 
literature was available on reimplantation with antibiotic-
containing cement. 
2. Postponed reimplantation 
If the infection is fulminant and caused by a virulent 
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Figure 3.5 After removal ofthe loose prosthesis, 
treatment of the infection when necessary (a). 
Subsequently, reimplantation or mobilization on 
a Girdlestone hip. In the latter case, shortening 
ofthe leg has to be accepted (b). 
to 32 % (Hunter et al., 1979). Polster and Blomer found that 
with repeated reoperations, the proportion of infections rose 
rapidly: 23.2 % infection after the first reoperation, 68 % after 
the second reoperation, 80% after the third and 100% after 
the fourth reoperation (Polster and Biomer, 1979). 
Slooff et al. removed 40 hip prostheses and 29 times 
performed immediate reimplantation: 11 of these 29 
prostheses subsequently were found to be infected. In six 
patients, the prosthesis soon had to be extracted. In the 
remaining five patients, healing was doubtful (Slooff et al., 
1976). Hunter and Dandy (1977) describe 31 re­
implantations after infection with bad results in 19. 
bacterium, certain authors refrain from direct re-
implantation (Ganz and Meyer, 1976; Hughes et al., 1979). 
Others after the extraction of the prosthesis always allow a 
shorter or longer interval to treat the infection or to check 
whether it is adequately under control (Michel and Spier, 
1979; Hovclius and Josefsson, 1979). 
Hughes et al (1979) reimplant the prosthesis after two 
to 11 weeks, but they conclude from their material that 
results improve with increasing duration of the interval. 
Amstutz agrees and proposes a minimal interval of three 
months if the causative agent is of low virulence, and a 
period of one to two years if a gram-negative bacterium is 
involved (Amstutz and Kass, 1977). 
M.R. Wilson et al. (1978) saw more recurrence of 
infections when reimplantation had been performed after 
less than six months. Among 51 patients they saw 12% 
recurrences of infection. However, they used no antibiotic-
containing cement, nor did they administer antibiotics 
systematically for long perios. 
The knee endoprosthesis at revisions causes more problems 
than the total hip prosthesis. After the first revision 
operation, cancellous bone is often completely absent in the 
distal femur and the proximal tibia, so that only a thin cortex 
remains (Tönnis and Handel, 1979). Consequently, revision 
is only feasible once or twice. 
In an acute deep infection of the prosthesis it may be 
attempted to save the knee prosthesis by early debridement, 
leaving the prosthesis in situ and instituting suction 
drainage. 
In the late deep infection, the prosthesis should be 
removed with all cement. Long ventral windows in femur 
and tibia are usually unavoidable in the hinge prostheses. 
Reimplantation after treatment of infection is reported only 
sporadically in the literature (Insali et al., 1979; Knutson et 
al., 1981; Wigren and Kolstad, 1981). Most of these cases 
involved a non-hinge prosthesis that is replaced by a hinge 
prosthesis if too much bone has been lost. In every case, 
however, it is necessary before reimplantation to ascertain 
whether an arthrodesis will still be possible if the loosening 
occurs again. If this is not the case, no reimplantation should 
be performed but arthrodesis should be carried out 
immediately (Tönnis and Händel, 1979). 
As a general rule, after extraction of a knee prosthesis with 
intra-medullary stem (hinge prosthesis, e.g. Guepar), an 
arthrodesis will have to follow. On the other hand, after 
extraction of a non-hinge prosthesis (e.g. Geomedic) 
reimplantation will be possible, usually with a hinge 
prosthesis (Knutson et al., 1981). 
For arthrodesis of the knee, use may be made of a medullary 
nail, a plate with screws, external fixation or a plaster cast 
(Brodersen et al., 1979; Lidgren et al., 1981). In case of 
infection, external fixation is to be preferred. 
Consolidation as a rule is difficult to achieve, owing in 
the first place to the extensive bone loss. Hagemann et al. 
(1978) observed a consolidation rate of 65 %, as againt 95 % 
after primary arthrodesis. In their opinion, it is especially a 
marked shortening that is associated with failure of the 
arthrodesis. 
Failure of an arthrodesis results in a fibrous ankylosis. 
This has to be supported by an orthesis, if necessary with 
ischial tuberosity loading. If this fibrous ankylosis cannot be 
rendered functional, or the infection cannot be controlled 
adequately, thigh amputation may become necessary 
(Blümlein et al., 1979). 
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Chapter 4. Antibiotic-containing cement 
4.1 Introduction 
Polymethyl methacrylate (PMMA, 'bone cement') consists 
of interlinked molecules of methyl methacrylate. At 
operation the polymer, a powder, is mixed with the liquid 
monomer. An activator is added to the latter. After mixing 
of the powder and the liquid, the polymers fuse. This 
polymerization is an exothermic reaction. 
The gentamicin-PMMA beads consist of this 
polymethyl methacrylate which has been mixed in the 
factory with gentamicin sulphate before its hardening (see 
Chapter 5.2). A discussion of the qualities of antibiotic-
containing cement will elucidate the possible applications 
and the mechanism of action of the gentamicin-PMMA 
beads. 
Buchholz attempted to reduce the incidence of infections of 
hip endoprostheses, especially by eliminating peroperative 
contamination as far as possible. To this purpose, he wore 
double gloves and applied a tissue-sparing surgical 
technique. In addition, however, he made extensive use of 
locally administered antibiotics: cloths soaked in antibiotics 
were sutured to the fascia and antibiotic-containing 
solutions were used for regular lavage of the wound 
(Buchholz and Gartmann, 1972). The fact that in spite of 
these measures, infections still occurred (approx. 3 % among 
1409 prostheses) Buchholz attributes in the first place to 
haematogenous infections (Buchholz and Gartmann, 1972; 
Buchholz, 1973a). The importance of bacteraemias as a 
cause of these haematogenous infections had been 
emphasized to him by Lodenkamper (Lodenkamper, 1969, 
1971,1974). 
In developing the antibiotic-containing cement, Buchholz 
used data obtained from Knappwost. The physical chemist 
Knappwost, working in Hamburg just as the surgeon, 
Buchholz and the bacteriologist, Lodenkämper, showed 
Buchholz how owing to diffusing processes sustained 
release of various substances from bone cement is possible. 
Like the residual monomerous component, CuS, for 
instance, is also released by diffusion from the cement 
(Buchholz, 1973b, Knappwost and Freitag, 1976; 
Knappwost and Gerlach, 1976). Buchholz mixed four heat-
stable powdered antibiotics with bone cement: penicillin G, 
erythromycin (heptogluconate), rolitetracycline and 
gentamicin sulphate. The powdered antibiotic was mixed 
with the powdered polymer followed by mixing and 
hardening-out with the monomer. In-vitro tests showed that 
these antibiotics, also, were released into a fluid by a 
diffusion process, with the exception of the tetracycline 
(Buchholz and Engelbrecht, 1970). 
These findings were confirmed by a study carried out 
in the same period by Hessert and Rückdeschel: tetra-
cycline was not released from bone cement, but gentamicin 
and TotocillinR (a combination preparation of ampicillin 
with dicloxacillin) were (Hessert and Rückdeschel, 1970, 
1973). These findings, and the fact that the mechanical 
qualities of the cement are affected only slightly by addition 
of the powdered antibiotics (Buchholz and Engelbrecht, 
1970) led to increasing use of antibiotic-containing cement. 
Since that time, additional research has been carried out in 
the laboratory, in animal experiments and during clinical 
use, in order to gain more insight into the qualities and 
possibilities of the various combinations of antibiotics and 
bone cement. 
4.2. In-vitro studies 
During in-vitro research, qualitative assays have been 
carried out to determine what antibiotics will be released 
from bone cement, and quantitative assays to determine 
when and at what concentrations these antibiotics diffuse 
from the bone cement. 
4.2.1. Qualitative assays 
A small block of antibiotic-containing cement is placed on 
an agar plate that has been inoculated with a bacterial strain 
sensitive to the antibiotic in question. After some time, the 
plate is inspected to see whether around the cement, an area 
of inhibited growth has formed in the culture that has 
developed. This occurs if the antibiotic has not been 
destroyed by the intensive polymerization heat of the 
cement, if it has not become bound to the cement and if it is 
released in an effective concentration to nearby bacteria 
sensitive to the antibiotic (Fig. 4.1). 
Figure 4.1 Example of qualitative in-vitro study of antibiotic-
containing cement. Diffusion of the antibiotic Jrom a cement cylinder 
causes an area of inhibition of bacteria on a culture medium. 
These tests show that most antibiotics diffuse sufficiently 
from the cement to cause an area of inhibited growth: 
penicillins, cephalosporins, aminoglycosides, fucidic acid, 
clinda- and lincomycin and streptomycin (Table 4.1). Λ few 
antibiotics show no or hardly any area of inhibition, probably 
due to insufficient heat stability. These are colistimethate 
and polymixin В (Chapman and Hadley, 1976), tetracycline 
(Buchholz and Engelbrecht, 1970) and chloramphenicol 
(if in Simplex®, Fischer et al., 1977). 
The polymerization temperature of the bone cement 
that is reached during hardening, depends on the thickness 
of the cement and on the preparation technique: in vivo, 
local, short-lasting temperatures of 60° to 100° are reached 
in the cement (Goebel and Ohnsorge, 1973; Huiskes, 1979), 
while during manufacture of gentamicin beads ad the 
factory, temperatures of 130° to 150° occur (Grieben, 
1981a). 
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Antibacterial activity of cement without addition of anti­
biotics is not probable Chapman et al (1976) observed 
some growth-inhibiting effect of Simplex1* cement on 
certain bacteria Staphylococcus aureus and Staphylococcus 
epidermidis Two-thirds of the number of bacteria mixed 
with the cement were killed by the polymerization heat or 
the toxic monomer Marks et al (1976) saw no inhibitory 
effect of PalacosR or Simplex" on Staphylococcus aureus, E 
coli or Pseudomonas aeruginosa. Hessert and Ruckdeschel 
(1970) observed no bacteriostatic effect of cement without 
antibiotic, either 
Some alternatives to antibiotics or to the cement have been 
studied, but this has not led to any clinical applications. It 
has been found, for instance, that various silver salts can also 
diffuse from the cement (Spadaro et al, 1979), just as CuS 
(Knappwost and Gerlach, 1976). Silver exerts an anti­
bacterial action by a mechanism that is not yet fully 
understood (Becker and Spadaro, 1978) CuS in the form of 
CuS04 exerts antibacterial action by interfering with the 
bacterial protein synthesis Release of antibiotics from other 
vehicles is also possible Gentamicin has occasionally been 
dissolved in an absorbable matrix for use in ophthalmology 
(Bloomfield et al., 1978) or for intravagmal or rectal 
implantation (Touitou et al., 1978) (see par 5 2) 
4 2 2 Quantitative assays 
The diffusion of water-soluble substances from bone 
cement is possible because water in molecular form is 
incorporated among the macromolecules of the polymethyl 
methacrylate the acrylate can incorporate two (Wahlig, 
1979, Knappwost and Gerlach, 1976) to five per cent (Levin 
et al, 1975) by weight of water The diffusion processes run 
the same course for all substances, such as for CuS, silver 
salts, NaCl or antibiotics The amount of the substance 
mixed with the cement that is released is proportional to 
- the surface of the cement (Wahlig et al, 1972a; 
Ruckdeschel et al, 1973, Holm and Vejlsgaard, 1976, 
Wroblewski, 1977; Schurman et al, 1978, Welch, 1978a; 
Hoff et al, 1981); 
- the concentration of the antibiotic in the cement (Wahlig 
et al, 1972, Ruckdeschel el al, 1973; Medcraft and 
Gardner, 1974; Marks et al., 1976, Welch, 1978a); 
- the amount of fluid around the cement (Wahlig et al., 
1972; Welch, 1978''), and accordingly, the frequency of 
replacement of the fluid around the cement, or the flow 
rate of the fluid around the cement 
For the quantitative in-vitro assays, small blocks of cement 
of known dimensions, usually cylinder-shaped, are sub­
merged for some time in a liquid (broth, plasma, serum, 
Author 
1. Buchholz et al '70 
2 Hessert et al '70 
3.Wahligetal '72a 
4. Wahlig and Hameister '73 
5. Wahlig and Dingeldcin '80 
6. Gartenmann '73 
7. Gartenmann '76 
8. Ruckdeschel et al. '73 
9 Sattel et al. '73 
10 Medcraft et al. '74 
11 Levin'75 
12 Chapman et al '76 
13 H o l m e t a l '76 
14 Marks et al. '76 
15. Nelson et al '76 
16 Rosenthal et al. '76 
17 Elson et al. '77" 
18 Fischer et al. '77 
19 Hill et al. '77 
20. Picknell et al. '77 
21. Wannskeet al '76 
22. Quinian et al. '78 
23. Schurman et al. '78 
24. Welch '78a 
25 Hoffetal . '81 
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Table 4 1 Review of literature data on m-vitro studies of various combinations of antibiotic-containing cement with antibiotics 
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phosphate buffer, NaCl), as a rule at 370C. After a fixed 
interval, the fluid is poured off and the cement cylinder is 
placed in a new liquid, sometimes after preliminary 
determination of the residual antibacterial activity of the 
cement block in a culture medium. The concentration of the 
antibiotic in the bathing fluid is determined (Fig. 4.2). The 
authors listed in Table 4.1 studied the diffusion of various 
antibiotics from different types of cement. Table 4.2 shows 
how much the several quantitative in-vitro assays differ 
Figure 4.2 Scheme of quantitative determination of release of 
antibiotics from a cement cylinder. From a cylinder of predetermined 
surface and weight, the antibiotic diffuses to an elution fluid. This 
elution fluid has a known volume and temperature, and is replaced 
at preset intervals. The experiment takes a number of weeks to a 
number of years (see also Table 4.2). 
from each other. The composition, amount and 
temperature of the elution fluid vary, and the same holds 
true of the frequency of replacement of the elution fluid, the 
duration of the experiment and the sizes of the cement 
cylinders. These differences render it impossible to compare 
the quantitative results of the various determinations with 
each other, but they do show the constant occurrence of the 
same diffusion process, in which the above-named factors 
play a part. 
During the first few hours, sometimes the first few days, a 
very high concentration of the antibiotic in the elution fluid 
is observed, but this decreases rapidly. Judgements of the 
length of time during which the antibiotic may be released 
from the cement vary greatly. It appears, however, that in 
this respect the dimensions of the test block of cement are of 
particular importance: Schurman et al. (1978) found that 
from a disc of cement of 100 \sm all the antibiotic had been 
diffused within one hour. From a thicker disc of 700 μπι, 
only 19 % had disappeared from the cement block after one 
hour. They found that from gentamicin-PalacosR twenty 
times as much antibiotic diffused during the first hour as 
during the second hour. One week later, the rate per hour 
had dropped to one-tenth of that of the second hour. 
Wahlig and Dingeldein (1980) found that gentamicin 
is released from PalacosR for a considerable length of time: 
even after five years, small constant amounts were still 
Author 
1. Buchholz et al. '70 
2. Bessert et al. '70 
3. Wahlig et al.'72a 
5. Wahlig et al. '80 
6. Gartenmann et al. '73 
7. Gartenmann '76 
8. Rückdeschel et al. '73 
9. Sattel et al. '73 
10. Medcraft et al. '74 
11. Levin'75 
12. Chapman et al. '76 
13. Holmetal.'76 
14. Marks et al. '76 
15. Nelson et al.'76 
16. Rosenthal et al. '76 
n.Elsonetal. '77a 
18. Fischer et al.'77 
19. Hill et al. '77 
20. Picknell et al. '77 
22. Quinian et al. '78 
23. Schurman et al. '78 
24. Welch '78a 
25. Hoffetal.'81 
Elutionfluid 
Type 
broth 
NaCl/phosph. 
buffer 
phosp.buffer 
posph.buffer 
NaCl/serum/ 
dextrose 
dextrose 
posph. buffer 
? 
plasma 
NaCl 
NaCl 
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plasma 
H2O 
culture medium 
peptone-HsO 
H2O 
NaCl 
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Vol. 
(ml) 
10 
2 
10-50 
20 
2 
7 
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25 
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10 
9 
— 
— 
1 
50 
? 
10 
10 
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9 
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H2O 
2 
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37 
37 
37 
37 
37 
7 
? 
7 
4-64 d.? 
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7 
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7 
33/37 24 h. 
37 
37 
35 
35 
35 
37 
? 
? 
37 
37 
37 
37 
37 
37 
37 
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Id. 
Id. 
Id. 
Id. 
1 d. 
1/10/14 d. 
4d. 
34 d. 
3-18 h. 
1 d. 
l - 7 d . 
1 h. - 7 d. 
2 - 7 d . 
2 - 7 d. 
l - 7 d . 
Last 
assay 
after: 
2-3 months 
24 h. 
70 weeks 
5 yrs 
7d. 
7d. 
63 d. 
48 weeks 
6 weeks 
60 d. 
8d. 
4 months 
45 d. 
45 d. 
8d. 
24 d. 
4-31 d. 
36 d. 
Id . 
187 d. 
3 weeks 
7d. 
175 d. 
65 d. 
9-13 weeks 
Cement cylinder 
0 Х Я 
(mm) 
var. 
5.5X3 
25X3-20 
25X10 
9 
7 
25X3-7 
div. 
14X7/20X3 
26X5 
7 
10X4X110 
12X? 
12 x? 
10X5 
Weight 
ω 
7 
0.082 
2.1-11 
5.9 
7 
7 
7 
5.32-60 
7 
7 
0.19 
1.8 
7 
7 
0.450 
20X20X5-10 ? 
7 
10X4 
7X7 
15X2 
? 
7 
6X12 
15X12 
? 
? 
1 
0.275 
7 
9 
9 
0.382 
0.254 
7 
Table 4.2 Review of the literature concerning different experimental protocols in in-vitro study of the release of antibiotics from cement 
cylinders. (See also Table 4.1.) 
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released. Cement cylinders measuring 25 mm χ 10 mm at 
the centre still contained the same concentration after five 
years as at the start of the determinations. Depending on 
cement dimensions, they found gentamicin releases from 
2.5 to 17.5 % after 20 to 22 weeks (Wahlig et al., 1972a); in a 
subsequent study, three to eight per cent after a few months 
(Wahlig and Dingeldein, 1980). 
Picknell for 11 difTerent antibiotics found release 
percentages varying from 2.3 to 11.0 % in the first 24 hours 
(Picknell et al., 1977). Welch and others found release rates 
from 22.7 to 26.3 % of the antibiotic in 20 to 22 weeks (Welch 
et al., 1978). 
Markedly different percentages are reported by 
Hessert and Riickdeschel (1970) and by Chapman et al. 
(1976) who recorded as much as 80% release of the 
antibiotic after one to two days. All authors listed in Tables 
4.1 and 4.2 confirm that the release of antibiotic from 
cement is a diffusion process during which the rapid initial 
release from the superficial cement layers is followed by a 
period during which the amount of antibiotic released per 
unit of time decreases gradually. In the most prolonged 
study of release (Wahlig et al., 1980), it was found that in 
vitro the releases per unit of time became constant, 
although the amounts were small. 
4.2.3. Antibiotic-bone cement combinations 
In researching the various combinations of antibiotic and 
cement. Wahlig studied the release of gentamicin from 
different types of cement. He constantly found that 
gentamicin and cafazedon* were released in larger amounts 
and for longer periods of time from PalacosR than from other 
types of cement (Wahlig et al., 1972a; Wahlig and Buchholz, 
1972; Wahlig, 1979; Wahlig and Dingeldein, 1980). 
Lividomycin (an aminoglycoside), lincomyein and 
Clindamycin were released adequately but in slightly 
smaller amounts. The diffusion was measured in 
microgrammes of antibiotic per ml of elution fluid per day 
and per cement cylinder. 
Sattel and Nabert-Bock (1973) also concluded that 
gentamicin diffused better from PalacosR-R than from 
CMW bone cementR and Simplex11, but they do not report 
their findings concerning the diffusion from SimplexR. 
Elson (Elson et al., 1977a) found that out of the four 
types of cement, PalacosR showed the best release of 
fucidin and gentamicin. Picknell (Picknell et al., 1977) 
found better diffusion of gentamicin from PalacosR than 
from SimplexR, but no difference between the two types of 
cement where release of other antibiotics (penicillins, 
cephaloridine, clindamycin, fusidic acid) was concerned. 
Hoff, just as Picknell, studied various penicillins and found a 
better diffusion from PalacosR than from SimplexR (Hoffet 
al., 1981). 
Marks and Nelson (Marks et al., 1976; Nelson and 
Marks, 1976) investigated the release from Simplex11 and 
PalacosR; several antibiotics, especially gentamicin, were 
diffused better from PalacosR. The supposed explanation is 
that PalacosR has larger pores than SimplexR. Holm and 
Vejlsgaard (1976) also saw better release of gentamicin from 
PalacosR than from other types of cement. 
Quinian and Mehigan (1978) found that fucidin is 
released to approximately the same extent from CMWR, 
Simplex11 and PalacosR. In vitro, release of gentamicin from 
CMW11 lasted longest, that from SimplexR shortest. 
If gentamicin is chosen as the antibiotic, combination 
with PalacosR is the best choice according to the majority of 
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investigations. If a different antibiotic is considered, it is less 
clear which type of cement has the best qualities. 
In studying different antibiotics. Wahlig and Dingeldein 
(1980) found that of 12 antibiotics, gentamicin and 
lividomycin diffused best from PalacosR. Fischer et al. 
(1977) combined the three types of cement with 14 different 
antibiotics and observed adequate release in all cases, 
except for the combination of chloramphenicol with 
Simplex1*. Levin (1975) studied six different antibiotics in 
SimplexR. Cefalotin proved to be released well, clindamycin 
less well. Gentamicin and erythromycin proved ineffective. 
Chapman et al. (1976) studied the diffusion from SimplexR 
of ten antibiotics and saw no differences between them. 
Welch (1978a) concluded that from Simplex8, gentamicin 
was released better than cefalotin. Nelson and Marks (1976) 
found that from SimplexR, oxacillin was released better than 
cefalotin and gentamicin. From PalacosR, on the other hand, 
the diffusion ofgentamicin was better (Marks et al., 1976b). 
Picknell et al. and Hoffet al. focused their attention on 
the heat-unstable beta-lactam antibiotics. In contra­
distinction to what other had expected, several types of 
penicilin were released well (Picknell et al., 1977; Hoffetal., 
1981). Hoff even observed that penicillin was released for a 
longer length of time from PalacosR than gentamicin. 
However, the amounts diffusing from the cement in that 
case are less active than gentamicin. This last finding by 
Hoff el al. reflects the core of the problem: whether it is 
rational on the basis of in-vitro studies to decide which 
antibiotic is released best and from which type of cement. 
That PalacosR releases several antibiotics well, and 
especially gentamicin, is confirmed by most investigations. 
However, comparison of the release rates of different anti­
biotics is based on investigations that are not comparable 
quantitatively, and is useless when concentrations of 
antibiotics are compared with one another. More important 
than the concentrations themselves is the biological activity 
of a particular concentration of a particular antibiotic. For 
instance, 2 [¡g per ml of antibiotic A may be much more 
active against Staphylococcus aureus than 6 \¡g per ml of 
Antibiotic B. This is why in-vivo studies are so important. 
4.3. In-vivo studies 
At investigations in vivo, the release of antibiotics from 
cement has been determinated by assay of levels of 
antibiotics in serum, urine, wound exudate and tissues of 
laboratory animals and humans. It appears that the findings 
obtained by in-vitro studies can be extrapolated to the in-
vivo situation only with the greatest caution (Marks et al., 
1976; Quinian and Mehigan, 1978). On the whole, it could 
be confirmed that antibiotics are released to the environ-
ment and that the rate of diffusion is maximal shortly after 
the implantation, but the release in vivo proved to persist 
longer than was to be expected on the basis of certain in-
vitro studies. 
In the wound exudate, gentamicin concentrations occur that 
build up in a similar manner as in the elution fluid in in-vitro 
studies. Koschmieder could aspirate wound exudate 
through a gentamicin-palacos window in a femur in nine 
dogs for three weeks. The amounts varied from 0.5 to 5 ml 
per day. The concentration ofgentamicin was determined 
by a micro-biological method and fell from 20.2 μg per ml on 
the first postoperative day, via 2.7 pg per ml (seventh 
* Refosporin® 
postoperative day), 1 0 pg per ml (14th postoperative day) to 
0 01 \ig per ml on the 21st postoperative day (Koschmieder 
et al., 1973). Wahlig et al were able to obtain wound 
exudate for nine days after implantation of gentamicin-
palacos cement in the femur in the dog. The concentrations 
of gentamicin varied greatly, from 1 02 to 54 0 pg per ml 
(Wahhg et al, 1972b; Wahlig and Buchholz, 1972; Wahlig 
and Hameister, 1973). Quiman and Mehigan (1978) 
irrigated through a cannula in the bone-cement interface 
and thus determined the release of antibiotic from the 
cement. They observed protracted release of antibiotic, but 
differences from in-vitro assays were considerable 
In man, a similar concentraten of antibiotic in the exudate is 
found, after implantation of a prosthesis, 8 to 64 pg per ml 
(Wahlig, 1979), 20 to 10 pg per ml during the first four 
postoperative days (Sattel and Nabert-Bock, 1973) or 27 \jg 
per ml to less than 1.0 pg per ml after seven days (Elson et al, 
1977'') Sattel and Nabert-Bock (1973), puncturing hip joints 
of 30 patients after implantation of an endoprosthesis with 
gentamicin-palacos, observed that the in-vivo wound 
exudate concentrations were influenced by the amount of 
cement that was in contact with the wound haematoma at 
the level of the cutting plane through the femoral neck 
Determinations between the sixth and the 264th 
postoperative days showed that after the 50th postoperative 
day the concentration in the punctate was always below 
0 2 pg per ml All values were constantly obtained by micro­
biological assay methods. 
The tissues surrounding implants of antibiotic-loaded 
cement show high levels of antibiotic in the haematoma and 
to diminishing degrees also in the connective tissue, 
cancellous bone and cortex Concentrations of gentamicin 
in tissue were determined in test animals by various 
authors· Wahhg et al (Wahlig et al, 1972ь; Wahlig and 
Buchholz, 1972,1973; Wahlig and Hameister, 1973; Wahlig, 
1979, Wahhg and Dingeldein, 1980), Schurman et al. 
(1978), Welch (1978b) and Wannske et al. (1976). 
In general, the concentration in tissues is in inverse 
proportion to their distance from the cement and to the 
length of time elapsed after operation. Tissues that have a 
more compact construction, show a lower concentration. 
Elson studied the penetration of gentamicin through the 
cortex of a cadaver femur It was found that gentamicin 
diffused well through the dead bone, especially if the 
cement used had been PalacosR (Elson et al, 1977) 
However, the diffusion probably took place through 
canaliculi, which are present in sclerotic bone but not 
necessarily in dead bone 
In vivo, good diffusion in the bone proved 
demonstrable in humans as well Assays by Wahlig and 
Buchholz (1973) and by Stohr et al. (1973) showed high 
levels in cancellous bone and cortex close to the cement, but 
a rapid decrease at one to two cm distance Four days to 69 
months postoperatively, it was found in 18 patients that the 
highest gentamicin level occurred in connective tissue close 
to the layer of cement (Wahlig and Dingeldein, 1980). Hoff 
et al demonstrated good diffusion of penicillin and 
gentamicin in the rabbit femur, extending into the 
outermost layer of the cortex (Hoff et al, 1981) 
Serum and unne concentrations of the antibiotic indicate how 
much of the antibiotic enters the blood circulation and how 
much is excreted Determinations of these concentrations 
are important because they afford insight into the 
pharmacokinetics m test animals and humans, and into 
possible toxic side effects 
In contradistinction to the locally high tissue levels, 
serum levels prove to be very low. All authors find for all 
types of cement and all antibiotics that a few hours after 
implantation a maximal serum level is reached, which as a 
rule falls to very low levels or even trace level within one day 
(Wahlig and Buchholz, 1972, 1973, Marks et al, 1976; 
Pickneil et al., 1977, Schurman et al, 1978, Welch, 1978b). 
In the serum of patients, the same pattern is observed 
(Wahhg and Hameister, 1973; Wahlig, 1979; Wahlig and 
Dingeldein, 1980, Elson et al, 1977a). 
Of gentamicin, 98% is excreted by the kidneys. 
Accordingly, determination of the renal excretion rate of 
gentamicin supplies an accurate indication of the amount of 
gentamicin released by the cement. 
After implantation of a hip prosthesis with gentamicin-
containmg cement, Wahlig and Buchholz (1972) observed 
gentamicin concentrations in the urine from 9 0 to 1 4 μg/ml 
during the first 12 postoperative hours Within six days, the 
level falls to below 1 μg/ml. A later paper reports low urinary 
concentrations which, however, remained measurable for 
several months (Wahlig and Dingeldein, 1980) However, 
not a single publication instead of the urine levels states the 
renal excretion rate of gentamicin The concentration of 
gentamicin in the urine samples, namely, depends greatly 
on the production of urine by the kidney. 
4.4. Experiments in animals 
Infections m test animals have been studied to determine 
whether antibiotic-loaded cement does indeed protect 
against infection by contamination or haematogenous 
infection. Elson implanted a cement plug with or without 
antibiotic into a rat tibia The wound was contaminated, or a 
haematogenous infection was brought about by intravenous 
administration of a bacterial suspension Gentamicin 
provided good protection against contamination by 
Staphylococcus aureus, Pseudomonas, Proteus and 
streptococci. The haematogenous infection was effectively 
prevented by gentamicm-containing PalacosR when the 
infection was brought about one half hour postoperatively. 
However, when the haematogenous infection was only 
brought about six weeks postoperatively, the difference 
between gentamicin-containing PalacosR and PalacosR 
without antibiotic was less (Elson et al., 1977b) Picknell et 
al. implanted amoxicillin-containing Simplex1* sub-
cutaneously in mice. A low blood level nevertheless 
protected against intraperitoneal infection with 
Staphylococcus aureus (Picknell et al., 1977). 
A hemi-arthroplasty mixed with gentamicin-PalacosR 
in rat knees was protected adequately against early post­
operative infection (Schurman et al, 1978) In the rat, per-
opcrative infection of subcutaneously implanted cement 
cylinders by E. coli, Pseudomonas and Staphylococcus 
aureus was prevented by antibiotic m the cement (Welch, 
1978b). Touw observed that bone cement without antibiotic 
reduced the resistance to infection of a medullary cavity m 
the guinea-pig femur. Antibiotic-containing cement 
(gentamicin-PalacosR or SimplexR-erythromycin + 
Colistine) reduced the risk of infection (Touw, 1980). This 
study, just as that by Welch, only shows that contamination 
at operation is counteracted 
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Blomgren made an extensive study in the rat of the long-
term protective effect of antibiotic-containing cement 
against haematogenous infection of endoprostheses 
(Blomgren, 1981). In addition he demonstrated that a 
prosthesis is susceptible to haematogenous infection 
(Blomgren and Lindgren, 1980b), and that the natural 
defence against infection is impaired by a prosthesis (1980J). 
This study shows that in vivo, owing to a falling gentamicin 
concentration, no protection against a late postoperative 
haematogenous infection (6 to 8 weeks postoperatively) is 
possible. This is spite of a residual antibacterial activity of 
the cement in vitro (Blomgren and Lindgren, 1981). 
4.5. Clinical results 
Among 1138 endoprostheses implanted in a little over four 
years with the aid of cement without added antibiotics, 
Buchholz and Engelbrecht (1970) observed 14 infections 
(1.2%). Subsequent publications show that with longer 
follow-up the infection rate gradually rises: 3% (Buchholz 
and Gartmann, 1972), 4.1% (Buchholz, 1973a) and 5% 
(Buchholz, 1979b) (Fig. 4.3). 
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Figure 4.3 Cumulative percentage of infection of 2028 total hips 
implanted without use of antibiotic-containing cement in the period 
1964-1968 (from Buchholz, 1979ь). The graph also shows the 
percentages of infection (*) as stated by Buchholz in successive 
publications (respectively, Buchholz and Gartmann, 1972; Buchholz, 
1973a+b and Buchholz, 1979ь). It is clear from the graph that the 
percentage of infections increases with longer folluw-up. 
Starting January 1969, antibiotics were added to the cement 
in Buchholz's clinic: in the first 272 patients, mostly 
penicillin but also streptomycin, kanamycin or chlor­
amphenicol. At that time there had not yet been any 
research of the properties of antibiotic-loaded cement 
(Buchholz, 1973a). 
In order to avoid side effects of the above-named four 
antibiotics, especially allergy, Buchholz subsequently 
switched to erythromycin. Addition of this antibiotic to the 
cement was followed by a decrease of the infection rate but 
also by a shift of the bacterial flora to the anaerobics 
(Buchholz, 1973b). Pseudomonas infections proved 
particularly stubborn. Therefore, from 1971, gentamicin 
was added to the bone cement at all implantations of hip 
prostheses. It was expected that this addition would result in 
long-term protection against infection of the prosthesis 
(Röttger et al, 1979). 
On the basis of a very large clinical material, Buchholz 
et al. illustrate the protective effect of addition of antibiotics 
to bone cement. To this purpose, the patients were divided 
into three groups, according to the type of cement used. 
Especially from 1972, there was a marked decrease of the 
infection rate, which was ascribed to the admixture of the 
gentamicin (Buchholz et al., 1979; Buchholz, 1979ь) (Fig. 
4.4). 
% infected hip prostheses 
cement with 
¡genlamicin 
Buchholz 1979 b 
Buchholz 1979 
Buchholz 1977 
Figure 4.4 The effect of addition of antibiotic to bone cement 
reflected by the percentages of infection of the total hip prosthesis 
reported per year after implantation by Buchholz. From 1968, 
various antibiotics were added, from 1971, gentamicin. This graph, 
just as Figure 4.3 shows that Buchholz regularly checks the results 
of his treatment and corrects the percentages of infection. These 
increase as the follow-up period grows longer (respectively, Buchholz 
et al., 1977; Buchholz et al., 1979; Buchholz, 1979ь). 
Wannske and Tscheme (1979) made a prospective study of 
the value of prophylactic application of antibiotic-loaded 
cement in 445 patients (476 hip prostheses). If gentamicin-
PalacosR was used, the infection rate amounted to 1.1%, 
without antibiotic-loaded cement to 5.9%. Follow-up 
ranged from 3.5 to 6 years. 
Elson (1979) observed that use of gentamicin-PalacosR 
reduced the rate of infection after implantation of a hip 
prosthesis from 2.7 to 0.8 %. This was not a prospective study 
and the follow-up had been short. 
Also in a non-prospective study, Thierse compares 
patients with standard cement (336 patients, 1970-1972) 
with patients in whom gentamicin-loaded cement had been 
used (331 patients, 1972-1973). The follow-up was four to 
five years. In the former group, there were 6.3 % early post­
operative infections and 4.1 % late postoperative infections. 
The group with antibiotic-loaded cement showed 0.6 % early 
and 0.6% late postoperative infections (Thierse, 1978). 
Pfarr and Burri made a prospective study of 800 
patients with a follow-up of two years. They alternatingly 
used cement with and without gentamicin and observed no 
infections in either group. They did find that the gentamicin-
cement group had more periarticular calcifications with a 
larger radiologic bone cement interface at the acetabulum 
and BSR's often in excess of 20 mm. The differences were 
not significant, however (Pfarr and Burri, 1979). 
Joscfsson in a prospective study of two groups of 
patients compared the prophylactic effect of the gentamicin-
loaded cement with the prophylactic effect of systemic 
antibiotics (one to 24 hours intravenously before operation 
and seven to 14 days orally after operation). During a follow-
up of one to two years, the gentamicin-cement group 
showed more superficial infections and fewer deep 
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infections. However, the percentage of non-infectious 
loosening was also significantly larger in the antibiotic 
group. These might have been undiagnosed deep infections 
(Josefsson, 1980; Josefsson et al., 1981). 
Knöringer used PalacosR to close cranial defects in 115 
patients. In this group, the infection rate was 6.1%. 
Infections occur particularly during treatment of frontobasal 
injuries with opening of the nasal sinuses. Use of 
gentamicin-PalacosR cement in 53 patients prevented the 
infection (Knöringer, 1979a, 1979b). The protective effect on 
cranioplasty after injury was also reported by Stula (1979). 
Knöringer and Weidenbach made use of this 
protective effect of the antibiotic-loaded cement in seven 
patients treated for osteomyelitis of the roof of the skull: 
immediately after removal of the sequestered bone, a 
cranioplasty was carried out with gentamicin-containing 
bone cement (Knöringer and Weidenbach, 1978). 
Once Buchholz had become convinced of the efficacy 
of the antibiotic-containing cement by the results of its 
extensive prophylactic application during primary 
implantation of endoprostheses, he started in 1969 to use it, 
increasingly, to treat infected prostheses. After removal of 
the prosthesis with cement, and after debridement, he 
immediately reimplanted a new prosthesis, using the anti-
biotic-containing cement. 
Earlier, in 1965, he had begun to mix his cement with 
erythromycin, Colistine, cefalotin, carbenicillin, chlor-
amphenicol or penicillin for these reoperations. From 1972, 
only gentamicin-PalacosR was used (Buchholz and 
Gartmann, 1972; Buchholz, 1973a). This enabled him to 
perform reimplantation with growing success in infections 
with virulent bacteria, such as Pseudomonas and 
cntcrococci. In ten publications, ever-larger numbers of 
patients are reported: from 140 in 1972 to 659 in 1981. 
Patient data are arranged in various ways in these papers, 
and the results reported are sometimes contradictory 
(Buchholz and Gartmann, 1972; Buchholz, 1973a, 1973ь, 
1973е; Buchholz and Siegel, 1973; Buchholz et al., 1977; 
Buchholz et al., 1979; Buchholz, 1979b; Röttger et al , 1979; 
Buchholz et al., 1981). 
However, all publications mention that since the use 
of gentamicin was introduced in 1972, reimplantation was 
successful in 73 to 85% of the cases. By repeating the 
exchange of the prosthesis in case of recurrence of the 
infection, naturally again with debridement, the success rate 
of treatment of infection increases to an average of 88 %. In a 
few patients, it was even necessary to reoperate five times; 
this raised the cure rate to 90% (Buchholz et al., 1981). The 
follow-up in these cases ranged from one to 114 months. 
K. H. Müller reports 25 reimplantations in 21 patients; 
gentamicin-PalacosR was used 19 times in this series. 
During a follow-up of 21 months, seven recurrences were 
seen; in four of these, a second reimplantation resulted in 
healing (Müller, 1981). 
Josefsson followed up 68 revised reimplanted prostheses for 
two to five years: 52 of these were free from infection and six 
more became so after a second revision (Josefsson, 1980; 
Carlsson et al., 1978, 1980). This Scandinavian team, who 
just as Buchholz have much experience of the use of 
antibiotic-containing cement, compared the results of 
immediate exchange with two-stage exchange. In 92 and 21 
patients, respectively, they observed cure rates of 84 and 
81 % (Table 3.11). However, 14 of these patients of the one-
stage group had only been followed up for less than six 
months (Lindberg et al., 1977). In a subsequent publication, 
the conclusion is reached that there was no significant differ-
ence between the results of the one-stage and of the two-
stage procedure (Carlsson et al., 1980). Lindberg et al. 
(1977) and Buchholz et al. (1981) are of the opinion that the 
two-stage procedure, which involves a temporary Girdle-
stone situation, offers no advantages. The Scandinavian 
authors in addition to the antibiotic in the cement also 
administer antibiotics systemically for six months after the 
operation. Buchholz regards this as an enrichment of the 
treatment (Buchholz, 1979a). 
Both the Scandinavian and the Hamburg authors saw 
the worst results in infections with gram-negative bacteria, 
especially Klebsiella and Pseudomonas, and in infections 
with anaerobic streptococci. Buchholz in cases of this nature 
attempts to prevent failure of the treatment by adding more 
gentamicin to the PalacosR cement. The commercially avail-
able RefobacineR contains 0.5 g gentamicin per 40 g 
PalacosR. Buchholz increases the dose to 3 g and, if 
necessary, depending on the causative agent determined 
preoperatively, adds other antibiotics: cefalotin, oxacillin, 
lincomycin and ampicillin (Buchholz et al., 1981). An 
adverse effect of this addition on the mechanical properties 
of the cement has to be expected, however. 
4.6. Conclusion 
The efficacy and value of antibiotic-containing bone cement 
have been demonstrated largely empirically by Buchholz. 
Its prophylactic use in primary implantation of prostheses 
is still a matter of debate, and it remains to be demonstrated 
adequately that its protective effect against contamination is 
superior to that of other measures such as Charnley's 'clean 
air' protection, or prophylactic systemic administration of 
antibiotics. The protection against haematogenous infection 
of a prosthesis in a late postoperative phase is doubted on 
the basis of experimental research and has been 
insufficiently proved by clinical studies. Its value at re-
implantation, if necessary one-stage, of an infected 
endoprosthesis has been demonstrated convincingly, on the 
other hand. In-vitro studies show that many antibiotics are 
released from various types of cement and that a diffusion 
process is always involved. 
In order to be used in bone cement, antibiotics have to 
fulfil a number of conditions (Wahlig and Buchholz, 1973; 
Welch, 1978a): 
1. Good solubility in water 
2. Heat stability (50 to 150oC) 
3. Protracted stability at 370C 
4. No fixation to cement molecules 
5. Small volume 
6. Little influence on mechanical properties of the 
cement. 
In addition, the antibiotic should possess the following 
microbiological qualities: 
7. Maximally broad spectrum 
8. Bactericidal action 
9. Activity at small doses (low MIC and MBC) 
10. Low primary resistance 
11. Low allergy and toxicity. 
In-vitro and in-vivo studies show that gentamicin fulfils the 
above requirements. Its use, particularly in PalacosR is a 
logical choice. 
Chapter 5. Gentamicin-PMMA beads 
5.1. Introduction 
The results of the use of antibiotic-containing cement in 
prosthetic surgery prompted a number of surgeons to apply 
the antibiotic-containing cement in the treatment of osteo-
myelitis. A favourable effect was expected of the 
combination of packing the cavity (see par. 2.6.4) and the 
release of an antibiotic. 
5. The many small spheres greatly increase the surface of 
the cement. This leads to release of more gentamicin per 
unit of time from the same amount of cement (see par. 
4.2) 
6. Since the cement hardens outside the body, no thermic 
damage to the patient's tissues is to be expected, and less 
toxic action of monomer. 
(Klemm, 1977) 
Vidal and Allieu used PMMA with antibiotic for massive 
packing of an osteomyelitic cavity in 17 patients. They 
report only one bad result. A sterilizing effect of the 
exothermic polymerization reaction was postulated (Vidal 
and Allieu, 1969). Jenny reports unsatisfactory results of the 
same technique and repeats the attempt after adding 
gentamicin to the cement, again with little success (Jenny et 
al., 1977; Jenny and Taglang, 1979). Voorhoeve and Stöhr 
describe 17 patients treated with an antibiotic-containing 
cement plug (Voorhoeve and Stöhr, 1973; Stöhr et al., 
1973). They observed five recurrences, mostly with low 
dosages of gentamicin. The literature contains no adequate 
survey of the late results of these methods of treatment. 
Publications on gentamicin-PMMA beads do explain, on 
the other hand, why packing the cavity with antibiotic-
containing cement was unsuccessful (Klemm, 1977, 1979; 
Jenny and Taglang, 1979): 
1. Drainage of secretion was prevented by the plug and the 
infection spread in the periphery. 
2. After decrease of the antibiotic concentrations, the 
cement plug continues to act as a foreign body. 
3. Removing of the cement plug is difficult and is 
accompanied by destruction of the bone. 
4. Packing the medullary cavity with a rigid cement plug 
transforms cortical into cancellous bone and disturbs the 
biomechanical relations, so that fractures occur. 
Klemm observed more frequent recurrence of the sinus 
with a sterile secretion. He regards this as a manifestation of 
a foreign-body reaction to the cement, and the infection that 
occurred along the cement cover as a retrograde infection 
(Klemm, 1977, 1979). 
These bad results of solid plugs in 1972 prompted 
Klemm to knead the cement into small spheres before 
introducing it into the wound. This gave better results than 
the solid cement plug. Later, the loose spheres were strung 
on a thread and from 1976, they were manufactured at the 
factory from PalacosR (firm of Kulzer, Bad Homburg) and 
gentamicin (Refobacin11, Merck, Darmstadt). When these 
were used clinically, the following advantages were noticed, 
especially by comparison with the solid cement plug: 
1. Retained possibility of drainage of the secretion 
2. Gradual filling of the space between beads by granulation 
tissue 
3. The beads are easy to remove because they are strung on 
a thread 
4. Packing with beads was shown by a tension-optical study 
not to affect the biomechanical properties of the bone 
5.2. The beads 
The gentamicin-PMMA beads as they are being factory-
made since 1976, are spherical with a diameter of 7 mm. 
They consist of methyl methacrylate-methylacrylate 
copolymer. One bead of 0.2 g contains 7.5 mg gentamicin 
sulphate (equivalent to 4.5 mg gentamicin base) and 20 mg 
zirconium dioxide (radiocontrast medium). In addition, the 
beads contain a little glycine and a residue of the catalyser, 
dibenzoyl peroxide (maximally 0.5 %). 
The beads are supplied loose (in sets of 10) or strung 
on a chromium-nickel multistranded thread: 10, 30 or 60 
beads to a chain*. The chains measure approx. 1 cm per 
bead (Wahlig et al., 1977, product information SeptopalR, 
Merck Darmstadt) (Fig. 5.1). 
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Figure 5.1 Gentamycin-PMMA beads. The beads are spherical 
with a diameter of 7 mm. Tbey are supplied singly, or strung on a 
metal wire, 10, 30 or 60 beads to a chain. 
Factory production of smaller beads has so far not proved 
possible. These smaller beads of 3 χ 5 mm, the socalled 
mini-chains have been hand-made by Asche and used, 
among other applications, in surgery of the hand (Asche et 
al., 1979). Not all antibiotics that are released in vitro from 
test blocks of cement are suitable for admixture to beads. 
During manufacture of beads at the factory, temperatures of 
120 to 150° are reached (Grieben, 198 Γ), so that heat-
stability becomes an even more important condition. 
There are no publications or reports concerning 
antibiotic-containing cement beads in other combinations 
The author is aware that beads strung on a thread should be called 
strings rather than chains. However, the latter word having gained 
currency in Anglo-Saxon literature, it has been used throughout this 
book. also, to avoid confusion. 
than gentamicin with PalacosR. On the other hand, anti­
biotics have been mixed in plaster beads (Mackey et al., 
1982): gentamicin, fucidine, cefazolin and lincomycin. 
These antibiotics are also released from plaster by diffusion 
to an aqueous environment. The plaster beads need not be 
removed and are said to contribute to osteoneogenesis in 
the cavity in the bone (Peltier and Jones, 1978) (see also 
Chapter 2.6.4). 
5.3. In-vitro research 
The gentamicin-PMMA beads, also, at in-vitro studies show 
a diffusion process with the release of gentamicin 
proceeding as an exponential function. Wahlig et al. in 
solutions of beads in a phosphate buffer observed a release 
of gentamicin that showed a half-life during the first 10 days 
of 3.3 days. During these first 10 days, a total of 1.92 mg 
gentamicin is released per bead to the surrounding elution 
fluid (10 beads in 10 ml). On the first day, 200 to 400 pg 
gentamicin is released per bead and per ml elution fluid 
(Wahlig et al, 1977). 
After replacement of the hand-made beads by factory-made 
beads, this even rose to 400 to 600 pg per 24 hours on the 
first day (Wahlig and Dingeldein, 1978; Wahlig et al., 1978; 
Wahlig, 1979,1980,1981). After 40 to 80 days, the release is 
diminished to 10 pg/bead/day/ml elution fluid. 
5.4. In-vivo research 
Pharmacokinetic properties and the activity of the 
gentamicin-PMMA beads have been studied in dogs 
(Wahlig et al, 1977, 1978; Wahlig and Dingeldein, 1978; 
Wahlig, 1979, 1980, 1981). Gentamicin-PMMA beads 
implanted in non-inflamed femurs in 12 healthy dogs show 
a release rate that is comparable to the findings obtained 
during in-vivo studies of antibiotic-containing cement in 
humans (par. 4.3.1). Two to four hours after the operation, a 
maximal serum concentration of gentamicin is determined 
that is low: 0.3 pg per ml. The concentrations in the игіпеате. 
maximal during approximately the first postoperative day 
(1.5 to 20 μ g per ml) but they depend on the urine flow. In 
the serum, gentamicin is no longer demonstrable after 12 
days, in the urine it only becomes non-demonstrable (by a 
microbiological method) after 115 days. Assays during 10 
days postoperatively show a urine concentration of 10 to 
18 ng per ml (Wahlig, 1980). 
Here, also, the tissues around the beads show a gentamicin 
concentration that depends on the distance to the beads and 
on the type of tissue. The highest concentration is found in 
the haematoma (104 to 212 pg per ml), the lowest in the 
cortex (0 to 20 pg per gram tissue, moist weight). Cancellous 
bone immediately beside the beads shows a higher 
concentration than that at a distance of 2 to 3 cm (see Table 
5.1). 
The exudate shows a concentration that reaches a peak 
after about four days and subsequently decreases linearly. 
Harle and Ritzerfeld determined the concentrations in five 
dogs. For nine days, all concentrations in the exudate were 
higher than 5 pg per ml and maximally 80 pg per ml, for 
amounts of exudate that ranged from 1.8 to 20.4 ml per day. 
A decrease of the volume of the secretion is accompanied by 
an increase of the concentration of the gentamicin in it. The 
product of volume per day and concentration in the 
secretion indicates the amount of gentamicin released per 
day into the secretion. According to Härle, this diminishes 
linearly. After 10 day^ the amount of gentamicin released 
per day has fallen to only 5 % of the original value (Härle and 
Ritzerfeld, 1979). 
Implanted beads Tissue type 
Retention 
Number time in 
17 
15 
13 
16 
18 
17 
14 
14 
19 
19 
7 
14 
28 
39 
30 
days 
3 
3 
7 
7 
14 
14 
28 
28 
42 
42 
63 
63 
116 
116 
116 
Haematomc 
m 
148 
112 
200 
212 
124 
104 
Connective 
ι tissue 
0) 
9.1 
7.5 
16.1 
7.7 
4.4 
4.4 
5.6 
5.4 
2.2 
Cortical 
Cancellous bone 
(2) 
17.8 
15.2 
24.0 
16.4 
8.2 
5.2 
2.9 
4.9 
8.4 
4.9 
0.4 
0.9 
5.1 
2.6 
1.1 
(3) 
14.5 
5.9 
2.1 
0.4 
0.34 
0.9 
0.2 
0 
1,0 
0.2 
0.8 
(4) 
3.6 
3.6 
4.0 
6.6 
0.6 
0.8 
0.4 
0.2 
0.2 
0.5 
0.2 
0 
0.7 
0.2 
0 
bone 
(5) 
6.8 
13.0 
20.1 
14.1 
1.8 
3.8 
1.6 
0.4 
0 
0 
0 
0 
0 
0 
0 
Table 5.1 Concentrations of gentamycin in the tissues around the 
beads: the haematoma or the granulation tissue (1), the cancellous 
bone at increasing distances (2, 3, 4) and the cortical bone adjacent 
to the beads (5). As the figures show, the concentration decreases 
with the passage of time and with increasing distance from the beads 
(from Wahlig et al., 1978). 
The possibilities of using gentamicin-PMMA beads were 
tested in 21 dogs with the aid of a femoral osteomyelitis 
provoked artificially by means of Staphylococcus aureus. 
Treatment of the inflammation five to seven weeks after 
infection, with debridement and implantation of 
gentamicin-PMMA beads resulted in rapid clinical 
improvement that was confirmed radiologically and 
scintigraphically. A control group without gentamicin-
PMMA beads still showed infection after a few months, 
even when the inserted foreign bodies had been removed 
(Wahlig et al, 1978; Wahlig, 1981). PMMA beads not 
containing gentamicin caused a more severe infection 
(Wahlig et al., 1977; Wahlig, 1981). 
5.5. Clinical research 
Clinical applications enabled assay of concentrations of the 
gentamicin in humans (Dingeldein and Wahlig, 1977; Jenny 
et al., 1977; Lidgren, 1977; Wahlig et al., 1978; Hedström et 
al., 1980). Here again, it is always found that the serum level 
of the gentamicin is low and peaks shortly after operation. In 
10 patients, with 80 to 180 beads, the peak always remained 
below 0.5 pg per ml (Wahlig et al, 1978; Wahlig, 1981). 
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After implantation of 14 to 90 beads in the soft tissues 
of seven patients, the serum level was even lower (Wahlig, 
1981)· The urine concentration of the gentamicin is maximal 
after two to three days; levels higher than 10 yg per ml have 
never been measured (Wahlig et al , 1978; Wahlig, 1981). 
Jenny after one to three months, with gentamicin-PMMA 
beads in situ still observed urine levels of 0 to 0.7 pg per ml 
(Jenny et al., 1977) (Fig. 5.2). 
loo geniamicin cone ug /m 
GENTAMICIN PMMA beads 
exudate 
20 days 
Figure 5.2 Schematic representation of the concentrations of the 
gentamicm (in \ig/ml) in the serum, the exudate and the urine. Data 
have been culled from the literature and confirmed by personal 
determinations (see Chapters 13 and 15). The gentamicm con-
centration is represented logarithmically, this graph, just as Table 
5.1 shows that after 10 to 15 days, the concentration of the gentamicin 
in the exudate has fallen below the minimal inhibitory concentrations 
of most bacteria. In other words, after this period no influence of 
of the gentamicin-PMMA beads on the healing of the infection is 
to be expected. 
The wound exudate here also showed a very high initial 
concentration shortly after operation, sometimes decreasing 
from the beginning, sometimes only decreasing after a peak 
on the second or third postoperative day. The maximal 
concentrations determined vary greatly. 
Wahlig et al. (1978) report a concentration of 345,6 pg 
per ml in a patient with 87 beads on the second to third post-
operative day, whereas Lidgren determined a maximal 
concentration of 17.0 pg per ml in a patient with 540 beads 
on the first postoperative day (Lidgren, 1977). 
The concentration in the wound exudate is influenced 
by the number of beads, the amount of exudate secreted per 
unit of time and the time elapsed since implantation, as 
observed during in-vitro studies (Chapter 4). In humans, 
and during use of gentamicin-PMMA beads, the influence 
of these variables on the gentamicin concentrations has not 
been determined with sufficient thoroughness. 
In nine patients, Wahlig was able to determine the 
gentamicin concentration in the tissues, 30 to 70 days after 
implantation. He observed a distribution of the 
concentration over the various tissues identical to that in 
test animals (Table 5.1) (Wahlig, 1979, 1981). 
5.6. Histological examination 
The reaction of the body to the gentamicin-PMMA beads 
has been tested in vitro by culturing fibroblasts from rabbit 
kidneys on gentamicin-PMMA and, as usual, on glass. This 
showed the tissue tolerance of gentamicin-PMMA to be 
very good (Wahlig et al., 1977,1981). In vivo the reaction has 
been assessed in tissue that could be removed some time 
after implantation from beside the gentamicin-PMMA 
beads. By this method, Walter found in 31 biopsies taken 
two weeks to 24 months after implantation that the 
gentamicin-PMMA beads often provoke a foreign-body 
reaction (Walter, 1977). 
Bonk and Frieden also saw a foreign-body reaction 
with giant cells in excision biopsies from 17 patients (Bonk 
and Frieden, 1979). Böhm and Hörster examined 147 
biopsies from 61 patients which implies that from a number 
of patients several biopsies were taken (Böhm and Hörster, 
1979). Just as Walther, they found good correlation of the 
clinical evolution of the inflammation and the histological 
picture. They observed that, from the histological point of 
view, the healing process after implantation of gentamicin-
PMMA beads does not proceed differently from that of 
osteomyelitis treated in other ways. However, the course 
was more rapid, with less inflammatory reaction. These 
authors, also, observed a foreign-body reaction which, 
however, did not influence the healing process. 
5.7. Application and technique 
The application, indications, contraindications and results of 
the treatment with gentamicin-PMMA beads have been 
explained at several symposia. Four review papers have 
been published (Contzen, 1977; Burri and Rüter, 1979; 
Smith, 1980; Van Rens and Kayser, 1981). Where in this 
chapter general remarks on gentamicin-PMMA beads are 
not accompanied by references to the literature, these may 
be found at various places in these review papers. 
The use of gentamicin-PMMA beads is always a part of 
a more comprehensive treatment of the infection. It is only a 
supplement to other, mostly surgical interventions (Klemm, 
1979, 1980''), especially nettoyage and stabilization. 
Nettoyage, in contradistinction to debridement, also 
comprises excision of non-osseous pathologically changed 
tissues (scars, sinuses, granulation tissue) and removal of 
sequestra and foreign bodies (osteosynthesis material, bone 
cement) (Nielsen, 1969). Inadequate nettoyage leads to 
recurrence of the infection. Gentamicin-PMMA beads, also, 
have disappointed surgeon who attached undue importance 
to them. History repeats itself: the introduction of 
antiseptics and antibiotics also let down those who believed 
that chronic infections would be relegated to the past (par. 
2.6). 
An exception to the rule of nettoyage is the early 
postoperative period in infection with osteosynthesis 
material in situ. Some authors prefer to wait until adequate 
consolidation is accomplished and leave the osteosynthesis 
material in situ (Burri, 1979; Müller, 1981; Vecsei and 
Barquet; 1981). Once there is consolidation, the plate may 
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Figure 5.3 Treatment of osteomyelitis of a tibia (a) always begins with nettoyage and, if necessary, sequestrectomy (b). Subsequently, 
stabilization, prefereably by external fixation, and implantation of the gentamicin-PMMA beads (c). After 14 days, the gentamicin-PMMA 
beads are removed and the cavity, if necessary, is packed with cancellous bone (d). 
be removed and the infection of the plate bed can be treated 
(Klemm, 1980"). 
Stabilization may also be achieved with removal of 
osteosynthesis material and in a defect pseudarthrosis, by 
making use of external fixation material, especially in 
diaphyseal regions (Klemm and Vecei, 1980), in which case 
the fixation nails have to be inserted outside of the infected 
area (Härle, 1979b) (Fig. 5.3). 
While performing nettoyage, it is constantly necessary 
to choose between two decidera ta: maximal radicality and 
maximal conservation of skeletal continuity. Information 
concerning the borderline of vitality of the bone may be 
obtained in several ways. Disulfine blueR (ICI) stains vital 
tissues green, while sequestra stand out in white. One hour 
prior to operation, 30 ml Disulfine blueR solution is injected 
intravenously in 10 minutes. This technique requires blood-
lessness ('Blutleere') of the extremity (Klemm, 1977; Jenny, 
1977; Hedström et al., 1980). 
Tetracycline is incorporated into vital bone. At 
operation, it is rendered visible by UV light. It has to be 
administered orally, 250 mg three times daily on three days 
during the week before the operation (Enneking, 1979). If 
no staining of the vital bone is used, the vitality of the bone 
may be recognized by the punctate bleedings, that are 
absent in sequestra (Müllerand Biebrach, 1979). The blood-
lessness of the extremity renders it easier to recognize the 
borderline of the vitality in the bone. To this purpose, it is 
advisable not to exsanguinate the extremity entirely by 
bandaging ('Blutsperre' as distinguished from 'Blutleere'). 
A special problem are the infections after 
intramedullary fixation. Efficient sequestrectomy of the 
lamellar sequestra is only possible by drilling out the 
medullary cavity to 1 mm beyond the dimensions of the nail 
(Klemm, 1978a; Lidgren and Törholm, 1980). 
Endoprostheses in case of infection should be 
removed completely: all components should be regarded as 
infected and every residual fragment of cement may cause a 
recurrence of the infection (see Chapter 4). 
During introduction of the gentamicin-PMMA beads it is 
necessary to insert as many beads as possible into the entire 
infected area, in order to achieve the highest gentamicin 
concentration possible in the entire infected region. In this 
connection it should be kept in mind that the capacity of the 
gentamicin to diffuse from the beads into the tissues is 
limited (see par. 5.3). Klemm dusts the wound with 
thrombin powder to bring about rapid organization of the 
haematoma, thereby preventing the loss by discharge of 
gentamicin-containing secretion (Klemm, 1980). Since 
1978, after removing a hip prosthesis, he packs the cavity 
with gauze to reduce the dead space and to prevent 
excessive blood loss (Klemm, 1980a, 1981a). 
The chains of beads should be implanted in such a way 
that removal remains possible: along a meandering course. 
The risk that chains catch on each other or on a bony edge 
should be avoided. For intramedullary introduction, e.g. 
after removal of an intramedullary nail, there exists a useful 
special insertion instrument (Fig. 5.4). 
A high local gentamicin concentration is achieved optimally 
by: 
1. Implantation of as many beads as possible; 
2. Closure of the skin, if necessary with transient use of 
synthetic skin (e.g. EpigardR, Parke-Davis); 
3. Draining sparingly: vacuum drainage should be carried 
out for a brief period only and soon be replaced by 
syphoning. 
Jenny considers watertight closure of the wound so 
important that he prefers an open cancellous bone graft if 
the wound cannot be closed (Jenny et al., 1977). Κ H. 
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Müller, on the other hand, regards retention of secretion as 
the main cause of recurrence and withdraws it continuously 
by means of reden or chest pump drainage. In his view, the 
loss of gentamicin does not cause failure of the treatment 
and he does not regard open treatment as contraindicated 
(Müller, 1978; Müller and Biebrach, 1979). 
Härle and Ritzerfeld on the basis of determination of 
concentrations in exudate advise against suction drainage 
(Härle and Ritzerfeld, 1979). 
Figure 5.4 Flexible metallic insertion implement of 50 cm length. 
With this tool, gentamicin-PMMA chains can be introduced into 
the medullary cavity through a small opening. 
The chains can be placed in the wound in such a way as to 
leave the last bead protruding from the skin. Allegedly, this 
renders it possible to remove the chains more easily and 
without anaesthesia. It is then necessary to remove the 
chains after 10 to 14 days. The gentamicin-PMMA bead 
chains, namely, become soon enveloped in a firm 
granulation tissue. This anchors the chains in place to a 
degree depending on their disposition (extended, rolled up) 
and on the type of surrounding tissue (soft parts, bone). 
Fixation might be prevented by daily removal of one or two 
beads, starting on about the seventh day after operation. If 
removal of the chains is postponed for longer than two to 
three weeks, surgery is required. 
Removal of the beads without anaesthesia and surgery 
is not generally recommended because it is said to be 
painful and difficult. 
Some authors do not leave the chains protruding from 
the skin and remove them at a second operation (Müller en 
Biebrach, 1979; Härle, 198lb). 
If surgical after-treatment is necessary, e.g. a cancellous 
bone graft or reimplantation of a prosthesis, the chains may 
be left in situ longer, for a few weeks or months. At reoper-
ation, it is then mostly necessary to excise them together 
with the granulation tissue. Extraction, for instance from a 
femoral shaft, is no longer possible at that stage. 
Figure 5.5 Gentamicin-PMMA beads used in the treatment of an 
infected total hip prosthesis and not subsquently removed. Owing 
to the movements in the Girdlestone hip, the metal wires break. 
The beads remain fixed in the scar tissue. 
No adverse effects are known of gentamicin-PMMA beads 
that have remained in situ permanently. Some patients 
refuse reoperation for removal of the chains. Then, if a 
Girdlestone situation exists, the metal wires are found to 
break (Vecsei, 1981b; Klemm, 1981b) (Fig. 5.5). It happens 
occasionally that the last bead slips offa chain, particularly 
in case of removal long after operation. The slight dis-
advantage of leaving such beads in situ should be weighed 
against the disadvantages of the frequently extensive 
intervention necessary to remove such ieft-behind beads. 
As a rule, this necessitates the use of an image intensifier 
(Fig. 5.6). 
Combating the inflammation does not require treatment for 
longer than seven to 10 days, since after this period the 
gentamicin levels have fallen greatly. 
Success of the treatment should be visible at that stage, 
revealed by rapid covering of genta beads with granulation 
tissue, rapid attenuation of local signs of infection and 
decrease of the BSR. 
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Figure 5.6 A bead has slipped off the end of a string introduced into the medullary cavity. The gentamicin bead has been left in situ because 
removal means a disproportionally major intervention. Beads left in situ have never been known to cause side effects, even after several years. 
Failure of the treatment is revealed first of all by absent 
growth of granulation tissue and persistent discharge from 
the wound. In that case, the treatment should be repeated 
by another nettoyage and insertion of new gentamicin-
PMMA beads. 
The result of the treatment cannot be determined by 
culturing after removal of the genta beads; owing to the high 
gentamicin concentration, the culture is usually sterile. 
Certain authors in addition to the local treatment with 
gentamicin-PMMA beads also administer antibiotics 
systemically (Thoma, 1978; Hedström et al., 1980; Weise 
and Weller, 1980; Härle, 1981a). Others regard this 
additional systemic stress as superfluous (Jenny and 
Taglang, 1980; Klemm, 1981a; Vecseiand Barquet, 1981). It 
is only on particular indications that they consider it 
desirable to add systemic antibiotics to the local gentamicin 
treatment. One reason for prophylactic administration is the 
fact that extensive covering soft parts, as at the thigh or hip, 
are always contaminated at operation. The gentamicin from 
beads, buried deep, cannot diffuse adequately in 
voluminous covering soft parts. Addition of systemic 
antibiotics for therapeutic purposes is indicated in case of 
pronounced spread of acute signs of infection in the soft 
parts, of weak resistance of the patient to infections and of 
sepsis. In Klemm's clinical material, additional systemic 
antibiotics were necessary on these indications in 15 % of the 
cases (Klemm, 1980a). 
5.8. Bacteriological aspects 
The main purpose of the local treatment with gentamicin-
PMMA beads is to reach very high local tissue levels not 
necessitating high serum levels. When this method of 
administration is used, it should be kept in mind that 
concepts such as 'resistance' and 'spectrum' are relative. 
Gentamicin is effective against a wide range of bacteria: 
both gram-positive and gram-negative and hence is called a 
broad-spectrum antibiotic. It acts by interfering with the 
protein synthesis of growing bacteria: it is bactericidal. With 
the usual dosage and parenteral administration, tissue 
concentrations of 1 to 4 pg per ml are reached. Bacteria with 
a MIC (minimum inhibitory concentration) higher than 4 
pg per ml are regarded as resistant (Walter and Heilmeyer, 
1975). The MBC (minimum bactericidal concentration) is 
for gentamicin, as a bactericidal antibiotic not much higher 
than the MIC. At a gentamicin concentration of 4 pg per ml, 
80 to 90% of the gram-negative bacteria are inhibited. 
Streptococci and anaerobics as a rule have a higher 
gentamicin MIC and then are called resistant. 
However, by raising the local gentamicin 
concentration, it becomes possible to destroy bacteria with a 
higher MIC as well. Determination of the MIC of a 
'resistant' bacterium will provide information whether it is 
possible to destroy such a bacterium by a higher 
concentration of gentamicin. Accordingly, with this method 
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of treatment, the term 'resistance' should be expressed 
quantitatively, by determination of the MIC (Kayser and 
Eberle, 1981). 
Dingeldein studied 64 bacteria from culturing material 
from osteomyelitis patients: 74% of the bacteria had MIC's 
lower or equal to 4 μ§ per ml (Dingeldein, 1979). Kayser 
investigated the sensitivity to gentamicin of 381 strains of 
enterococci and found that 98 % were inhibited by 50 pg per 
ml gentamicin. Other 'resistant' bacterial strains from osteo­
myelitis patients also usually had a relatively low MIC. A 
high degree of resistance is rare in his material. He 
concludes that infections caused by bacteria with MIC's up 
to 50 pg per ml can be treated with gentamicin-PMMA 
beads (Kayser and Eberle, 1981). 
Resistance to gentamicin is largely due to R-factors. These 
are resistance factors which as genes may occupy an extra-
chromosomal position in the bacterium. These R-factors 
may be transferred to the same or some other bacterial 
strain and play an important part particularly in hospital 
infections (Lode, 1979). With increasing use of gentamicin, 
growing resistance to it might be feared. However, 
Dingeldein in a three-year study of 544 patients in Klemm's 
clinic did not see any increase of the resistance to 
gentamicin; on the contrary, the resistance to gentamicin of 
certain bacterial strains even decreased (Dingeldein, 1981). 
As the release of gentamicin from the cement tapers 
off, gentamicin concentrations become low in the long run. 
She also investigated the effect of such low, subinhibitory 
concentrations of gentamicin on the development of 
resistance. The MIC's of the bacteria exposed to these low 
concentrations remained unchanged (Dingeldein, 1981). 
This confirmed earlier studies of certain other authors of the 
influence of subinhibitory concentrations of antibiotics 
(Lorian, 1978), but was contradictory to the findings of 
Gialdroni Grassi (1979). 
5.9. Indications and contra­
indications 
Klemm regards gentamicin-PMMA beads as indicated in 
bone infections and infections in the soft parts (Klemm, 
1980a). Several authors mention application in acute and 
chronic haematogenous osteomyelitis, acute and chronic 
post-traumatic osteomyelitis, infection pseudarthrosis, 
pinhole sinuses and empyema of the medullary cavity (in: 
Contzen, 1977; Burri and Rüter, 1979; Smith, 1980 and Van 
Rens and Kayser, 1981). 
Treatment of arthritis is also said to be possible 
provided it involves the shoulder or the knee (Klemm, 
1980e). Gentamicin-PMMA beads have a function in the 
treatment oí infected endoprostheses if reimplantation is not 
carried out directly (Walenkamp, 1981; Wilde, 1981). No 
literature is yet available concerning use of the beads in 
acute, early postoperative infection of a prosthesis. 
Technically, a prosthesis left in situ may render introduction 
of gentamicin-PMMA beads difficult for lack of space. In 
such cases, suction drainage is to be preferred. 
On a number of indications, use of the beads may be called 
prophylactic. By using them in open fractures, it is attempted 
to prevent post-traumatic osteomyelitis (Taglang, 1980; 
Vecsei and Barquet, 1981; Klemm, 198Γ). By covering an 
open cancellous bone graft with gentamicin-PMMA beads, 
this graft is protected from secondary infection and will be 
rapidly covered by protective granulation tissue (Schulte 
and Burri, 1979; Burri, 1979). 
Many applications in inflammations of soft parts are 
also of a prophylactic nature. Eberle concludes that use of 
gentamicin-PMMA beads at amputations of extremities for 
diabetic or arteriosclerotic gangrene with phlegmonous 
inflammation allows a more sparing amputation (Eberle, 
1978). Goudarzi reports good results of use of gentamicin-
PMMA beads in contaminated gunshot wounds (Goudarzi, 
1981). 
Hirsch and Güntert (1979) implanted gentamicin-
PMMA beads after pneumonectomy to prevent empyema 
of the residual cavity. 
Sachweh observed that implantation of gentamicin-
PMMA beads in the cavity after abdomino-perineal rectal 
amputation resulted in far better wound healing than use of 
a drainage system (Sachweh, 1979). Prophylactic use of 
gentamicin-PMMA beads after excision of coccygeal 
sinuses and in contaminated appendicectomy wounds also 
reduces the incidence of infections (Sachweh, 1981). 
Kampshoff reports good experiences in anorectal fistulae 
(Kampshoff, 1979). 
Wassner treated wound infections with the aid of 
gentamicin-PMMA beads in 133 patients, mostly with 
perforated appendicitis and empyema of the gallbladder 
(Wassner and Drognitz, 1978; Wassner, 1981). Senge et al. 
used gentamicin-PMMA beads in a paranephritic abscess 
and in a septic necrotic shrunken bladder (Senge et al., 
1978). Härle treated 80 patients with various soft-part 
infections of the locomotor apparatus (Härle, 1980,19810). 
Applications are possible in abscesses of all kinds and 
localizations: postoperative wound infections, mastitis, 
septic endometritis, etc. (Klemm, 1980b). 
Grieben in a collective study reports applications of 
gentamicin-PMMA beads in soft parts in 361 patients: 36 
times prophylactically, 84 times in postoperative infections 
and 241 tims in primary soft-part infections (Grieben, 1980, 
1981"). 
No clinical literature on abdominal intraperitoneal 
application has yet been published. Jonkisz et al. in an 
unstated number of rabbits implanted gentamicin-PMMA 
beads in the abdominal cavity. Rapid connective-tissue 
fixation developed around the beads, with a predominance 
of young fibroblasts. Gentamicin was demonstrable in the 
urine, proving that it was being released (Jonkisz et al., 
1980). However, this study of intraperitoneal implantations 
certainly does not justify any recommendations for clinical 
applications. 
On the contraindications, there is no unanimity. Most 
contraindications are not absolute, and are not endorsed by 
all authors. 
- Osteomyelitis of long standing with severe sclerosis is 
mentioned as an absolute contraindication to treatment 
with gentamicin-PMMA beads in Klemm's earliest 
publication (Klemm, 1977); later, the result is classified 
as poor (Klemm, 1979) and in more recent publications 
no more mention is made of the matter (Klemm, 1980a, 
1981). It may be important that in some of these patients 
he did not observe any reaction in the shape of 
granulation tissue while removing gentamicin-PMMA 
beads (Klemm, 1980b). 
Other authors also regard this form of osteomyelitis as 
the one most difficult to treat, with the least chance of 
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success (Jenny and Taglang, 1980). Other methods of 
treatment appear to hold out as little hope of success, 
however. 
- In the treatment of an acute infection with osteosynthesis 
material in situ, the spread of the inflammation may be 
arrested. The tips of screws, and the osteosynthesis 
material which after a few weeks is enveloped in 
connective tissue are inaccessible to the antibiotic. 
A chronic infection will certainly not heal without 
removal of this material (Klemm,' 1980a). One reason to 
leave the osteosynthesis material in situ may be to await 
consolidation, especially in places where application of 
external fixation is difficult. 
- Impossibility to close the wound is regarded by Jenny as 
a reason to choose some other method of treatment 
(Jenny et al., 1977). Once in a way, however, the wound is 
left open on purpose (Müller and Biebrach, 1979). 
- Resistance to gentamicin may be a cause of failure of the 
treatment and hence constitutes a contraindication. It is 
especially infection by Streptococcus faecalis that is said 
to be difficult to treat with gentamicin-PMMA beads 
(Klemm, 1981b). If a causative agent shows resistance, 
the MIC should be determined to find out whether treat-
ment with gentamicin-PMMA beads could be effective 
(see par. 5.7). 
- Allergy to one of the components of the gentamicin-
PMMA beads is not an absolute contraindication. Several 
patients with a positive gentamicin skin test have been 
treated by Buchholz and Elson with antibiotic-containing 
cement at reimplantation of a prosthesis. None of them 
developed a general allergic reaction (Elson, 1979). An 
allergic reaction to the chromium-nickel wire of the chain 
is reported in one patient (Grieben, 198Γ). Briefly, 
therefore, the risk of allergic reactions is slight and the 
treatment is simple because the strings can be removed 
immediately, certainly when they protrude from the skin. 
There is one case report of a myasthenia-like reaction 
with polyneuropathy in a patient treated with 
gentamicin-beads (Martens and Ansink, 1979). Neuro­
muscular block is a very rare side effect of amino­
glycosides, but the neuromuscular transmission is also 
affected by polymyxin derivatives, tetracyclines and 
lincomycin derivatives (Booy, 1980). 
In the patient described, the symptoms were noticed 2 г 
months after implantation of 24 beads, and they subsided 
after removal of the beads (Martens and Ansink, 1979). 
- The space required for the gentamicin-PMMA beads 
sometimes renders it technically impossible to implant 
them into certain joints (ankle, hip joint). Implantation of 
gentamicin-PMMA beads into small joints, e.g. in the 
hand, and into long bones with diameters less than 7 mm, 
mm, will also have to wait till mini-chains will be 
available. Nor is it possible to pack screw holes with 
gentamicin-PMMA beads after removal of the screws 
without widening them considerably. 
- In pregnant women, the risk of slight systemic exposure 
has to be balanced against the disadvantages of other 
methods of treatment. The local gentamicin treatment 
renders systemic antibiotics superfluous. If gentamicin-
PMMA beads would be more effective then other 
methods of treatment, that would constitute another 
argument against regarding pregnancy as a contra­
indication. The risk of a chronic recurrent inflammation 
then has to be weighed against the side effects of the 
gentamicin. The possible side effects of slight but 
protracted exposure to gentamicin are determined in this 
study in adults. The influence on a foetus, with a still 
immature kidney, remains an open question, however. In 
the immature kidney, glomerular filtration and tubular 
functions are still deficient (Neims, 1980). The relative 
sensitivity ofthe immature renal tubule to the toxic efTect 
of gentamicin is a matter of controversy (Macleod and 
Mahon, 1979). 
5.10. Gentamicin-PMMA beads 
versus irrigation systems 
The irrigation system, just as the gentamicin-PMMA beads 
is only one part of the treatment of an infection (see par. 
2.6.7). However, the irrigation system suffers from several 
important disadvantages. 
To function well it requires first-class nursing care, 
acommodation and technical facilities. Even Willeneggcr, 
the promotor of the irrigation system, considers simpler 
treatment systems desirable (Willenegger, 1979b). A 
retrospective comparison of gentamicin-PMMA beads and 
an irrigation system was carried out by Asche and Klemm in 
two groups of 38 patients (Asche and Klemm, 1977; Asche, 
1978) and by Kentner in 34 and 44 patients, respectively 
(Kentner, 1981), while prospective studies were carried 
out by Iledström et al. (1980) and by Lautenbach (1980). 
Other authors present arguments without substantiating 
them by figures. The following arguments are being used in 
favour ofthe premise that the gentamicin-PMMA beads are 
to be preferred to an irrigation-drainage system: 
- The patient is no longer chained to the bed and to the 
drains of the system. 
Primary closure of the wound as a rule gives a better 
cosmetic result. The period of bed rest and particularly 
also that of hospitalization is shortened. 
Temporary discharge with the beads in situ is possible. 
When the wound is closed, the patient need not be kept 
in isolation after a few days. 
- The nursing staff is burdened heavily when an irrigation-
drainage system is used. Drains, which are prone to clog 
and leak, necessitate intensive care. The necessity of 
isolating the patients also creates extra work for the 
nursing staff. 
Cleansing and dressing of the wound is necessary only 
incidentally during gentamicin-PMMA-bead treatment. 
- From the bacteriological point of view, drainage systems 
have severe drawbacks. Superinfection with gram-
negative pathogens, especially Pseudomonas, is 
notorious. 
The increasing use of gentamicin has not led to an 
increase of resistance to gentamicin, according to a study 
by Dingeldein (Dingeldein, 1981). Moreover, improved 
hygiene and less parenteral administration of antibiotics 
cause a reduction of the proportion of resistant bacterial 
strains. 
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- Financially, large amounts can be saved owing to 
π shortened hospitalization 
a less intensive nursing 
π reduced use of parenteral antibiotics and irrigation 
fluid 
ρ reduction of wound infections by prophylactic use 
Asche and Klemm (1977) on the basis of 38 patients 
calculated that hospital stay was reduced by approx 50 %. 
Patients treated with a drainage system required an 
average hospitalization of 60 days, those treated with 
gentamicin-PMMA beads an average of 32 days The 
costs involved averaged DM 15 000 and DM 7 000, 
respectively 
Kentner found that the mean duration of hospitalization 
was 130 days with a drainage system and 62 days with use 
of gentamicin-PMMA beads (Kentner, 1981). 
Sachweh concluded that after abdommo-penncal rectal 
amputations, the incidence of postoperative infections 
could be reduced by packing the presacral cavity with 
gentamicin-PMMA beads. The proportion of post­
operative infections that amounted to 69% with a 
drainage system was then reduced to 20%. This 
shortened the average duration of the hospital stay from 
44 to 21 days. A similar cost reduction by shortening 
hospitalization was accomplished by using gentamicm-
PMMA beads in the wound of an appendectomy when a 
phlegmonous or perforated appendix was involved. The 
cost reduction for these appendectomies according to 
him amounted to DM 1200 per patient (Sachweh, 1981) 
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Chapter 6. Gentamicin 
6.1. Introduction 
Gentamicin belongs to the group of the aminoglycosides. 
Aminoglycosides are oligosaccharide-like antibiotics 
that consist of amino sugars interconnected by a glycosidic 
link. In solution, the amino groups ensure the alkaline 
character of the compounds. 
The sulphates are highly soluble in water and stable at 
pH 6 to 8 (Lammers et al., 1968; Kagan, 1980). Gentamicin 
is closely related chemically to sisomicin, tobramycin and 
netilmicin. It is a fermentation product of Micromonospora 
purpurea. The commercially available gentamicin consists 
of three structural analogues: 40% gentamicin Q, 20% 
gentamicin C l a and 40% gentamicin C2 (Lode, 1979). 
6.2. Bacterial aspects 
The aminoglycosides are characterized by a rapid bacterial 
action. Aspects of their action in sensitive bacteria are 
binding to ribosomes in the cell and interference with the 
protein synthesis. This brings about non-sense proteins and 
morphological changes of the bacterial cytoplasmatic 
membrane. Loss of essential cytoplasmatic components 
causes cellular death (Jackson, 1977; Lode, 1979). 
In vitro there is a very broad spectrum of action. Most 
aerobic gram-negative bacteria are sensitive. The sensitivity 
to aminoglycosides of the gram-positive aerobic bacteria 
varies. Most strains of Streptococcus pneumoniae, 
Streptococcus pyogenes and Streptococcus faecalis 
(including the pcnicillinase-producing ones) are resistant. 
Anaerobic bacteria are not sensitive to aminoglycosides 
administered in the usual, parenteral way, Bacteroides 
being especially insensitive (Kagan, 1980). The activity of 
the aminoglycosides is influenced by, among other things, 
the ρ H and the cation concentration. 
When gentamicin is administered parenterally, tissue 
concentrations of approx. 1 to 2 pg per ml are reached. In 
general, bacteria with an MIC of less than 1 pg per ml are 
regarded as sensitive, those with an MIC of more than 4 pg 
per ml as resistant. The bactericidal concentration (MBC) is 
the same or slightly higher (Walter and Hameistcr, 1975; 
Lode, 1979). The nature of bacterial resistance to 
aminoglycosides varies: 
- intrinsic resistance: for instance the incapacity of an 
aminoglycoside to pass through the cell wall; 
- resistance due to mutation. The mutation in question is 
always a one-step mutation. This kind of resistance to 
gentamicin has been observed almost exclusively in the 
laboratory. It has no clinical significance (Wiedemann, 
1976); 
- enzymatic resistance (often plasmid-coded): in this case, 
a DNA ring (plasmid) is situated extrachromosomally in 
the cytoplasm. To this are attached genes (R factors) 
which cause the insensitivity. This plasmid can be trans­
ferred to another bacteria even of a different species 
(Wiedemann, 1976; Dingeldein, 1979). 
6.3. Pharmacokinetics 
Since resorption of gentamicin in the digestive tract is 
minimal, it is administered intramuscularly or 
intravenously. After intramuscular administration, 
gentamicin is resorbed fast from the muscles and the peak 
serum level is reached after 30 to 90 minutes (Jackson, 1977; 
Lode, 1979). 
The distribution in the body is best described by a two-
compartment model. We then distinguish a large central 
compartment and a small peripheral (deep) compartment. 
As a consequence, the scrum level plotted against time 
forms a biphasic curve with half-lives of two and 112 hours, 
respectively (Schentag et al., 1977, 1978a). The delayed 
release of gentamicin from the deep compartment causes a 
very protracted, although slight excretion with the urine. 
After 24 hours, 85 to 95 % of an injected dose of gentamicin 
has been excreted with the urine (Jackson, 1977). 
The central compartment has a distribution volume of 
0.15 to 0.301 per kg, not much larger than the volume of the 
extracellular water (Jackson, 1977; Lode, 1979). The deep 
compartment consists of tissues in which gentamicin is 
accumulated inlracellularly. Wahlig et al. demonstrated in 
dogs and mice that accumulation occurs predominantly in 
the renal cortex (Wahlig et al., 1974). Accumulation also 
occurs in the endolymph and perilymph of the internal ear 
(Federspil et al., 1976, 1977). 
In patients with normal kidneys, the non-renal 
excretion of aminoglycosides amounts to only 2.4% (Dettli, 
1976). Virtually all renal excretion probably takes place by 
glomerular filtration. The renal clearance of gentamicin is 
100 ml per minute, based on total plasma conentration. For 
a protein binding of 20%, the true renal clearance amounts 
to IOO/BO χ 100 = 125 ml per minute, which equals the 
creatinine clearance. The renal clearance of gentamicin is 
not correlated to urinary flow and pH, in other words there is 
no passive reabsorption. Possibly, a small proportion of the 
aminoglycosides is excreted actively by the tubuli. 
Gentamicin is reabsorbed actively in the proximal 
tubulus. This active reabsorption brings about a gentamicin 
concentration in the tubular cell that may be over 50 times 
higher than the serm level (Scherberich et al., 1980). This is 
probably accomplished by the system that actively 
reabsorbs aminoacids and protein residues. 
6.4. Side effects of gentamicin 
6.4.1. Hypersensitivity reactions 
Hypersentivitity reactions are possible particularly in the 
skin and in the haemopoietic system: exanthema, granulo­
cytopenia, anaemia, thrombocytopenia. The reactions are 
always reversible and are said to occur in 0.3% of patients 
treated parenterally (Sack et al., 1978). 
The cutaneous allergy occurs especially after local 
application and then is quite frequent. Pirilä et al. among 
1760 patients saw allergic skin reactions to local application 
of the aminoglycoside, neomycin, in 9.8% (Pirilä, 1967). 
Cross-sensitization occurs frequently with aminoglycosides. 
An allergic reaction after internal use of gentamicin, and in 
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the presence of an allergy to neomycin has not been 
described in the literature, however (Van Joost et al, 1981). 
6.4.2. Neuromuscular block 
Neuromuscular block is possible owing to influence on the 
release of acetylcholine (Nielsen and Elb, 1973; Booy, 
1980). However, owing to the wide safety margin of the 
neuromuscular transmission, the effect only manifests itself 
in patients with neuromuscular abnormalities, e.g. 
myasthenia gravis. Aminoglycosides also influence muscle-
relaxing agents (pancuronium, succinylcholine, NC45) as 
used in anaesthesia (Rutten et al., 1980). Only five cases of 
neuromuscular block due to gentamicin have been 
described, and all these occurred during simultaneous 
administration of other drugs that also affect the neuro-
muscular transmission (Martens and Ansink, 1979). 
6.4.3. Ototoxicity 
Ototoxicity probably results from accumulation of the 
aminoglycosides in the fluids of the internal ear. These 
fluids act as a deep compartment and the elimination from 
the peri- and endolymph is slower than that from the serum. 
The concentration in these fluids is directly proportional to 
the dose (Federspil et al , 1976). High concentrations of 
gentamicin cause destruction of the ciliary cells of the 
cochlea and of the vestibular labyrinth. This leads to loss of 
hearing acuity and disturbances of the equilibrium (Igarashi 
et al., 1971; Waitz et al., 1971; Webster et al., 1971 ; Jackson 
and Arcieri, 1971; Brummet et al., 1978; Akiyoshi, 1978; 
Carrière, 1980). Auditory sensitivity to high tones is affected 
first, that to lower tones later (Huizing, 1972). Disturbances 
of the equilibrium may be compensated, especially if they 
occur gradually. 
Ototoxic lesions are said to occur in 1 to 2 % of the 
patients (Jackson and Arcieri, 1971). With growing 
experience of the use of gentamicin, the frequency of side 
effects allegedly decreases (Sack, 1978b; Lode, 1979). 
However, when more sensitive tests and prospective studies 
are carried out, the frequencies are found to be higher 
(Jackson, 1977; Carrière, 1980). 
The possibility of recuperation of the hearing after 
damage due to gentamicin is very small, unless a very mild 
lesion is involved (Carrière, 1980). Risk factors are: 
- protracted higher concentrations (large surface below the 
serum level-time curve); 
- renal dysfunction; 
- use of ototoxic substances in the past; 
- simultaneous use of other ototoxic substances; 
- neonates are said to be more sensitive to ototoxicity; 
- high 'individual susceptibility'; 
(Bernard et al., 1979a, 1979b; Federspil et al., 1979; Lode, 
1979; Carrière, 1980). 
6.4.4. Nephrotoxicity 
Nephrotoxicity is caused by accumulation of gentamicin in 
the lysosomes of the proximal tubular cell. Autoradio-
graphic studies show that in the cell there is also some 
binding to mitochondria and to the nucleus. The 
accumulation of gentamicin in the lysosomes is believed to 
cause them to leak enzymes, leading to necrosis of the 
proximal tubular cell. Accordingly, nephrotoxicity 
manifests itself with loss into the urine of tubular epithelial 
cells and enzymes from these cells (Scherberich et al., 1980; 
Jerauld and Silverblatt, 1980) (Fig. 6.1). 
The glomerular filtration is affected by a direct toxic 
action on the glomerular endothelial cells or by a tubulo-
glomerular feedback via the renin-angiotensin II system 
(Schentag, 1979; Evans et al., 1979). 
Here again, with growing experience of the use of 
gentamicin, the nephrotoxicity during parenteral 
administration has decreased from 7.7% (1966 to 1967) to 
2.9 % (1970 to 1973) (Lode, 1979); these figures are based on 
the serum creatinine level or creatinine clearance as 
parameters. 
Whether nephrotoxicity will occur depends in the first 
place on the duration of the treatment and on the serum 
level. It is especially if the minimal serum level is higher 
than 2 pg per ml and the treatment is protracted that 
nephrotoxicity is to be expected (Dahlgren etal, 1980). The 
risk is increased in case of pre-existent damage to the 
proximal tubulus or reduced renal function (Sensi et al., 
1980). Combination with cefalosporins probably increases 
the nephrotoxicity (Mannion et al., 1981). 
Reiner observed in dogs that continuous 
administration of gentamicin by infusion significantly more 
Figure 6.1 The processing 
of aminoglycosides by the 
proximal tubular cells, mod-
ified from Scherberich et ai, 
1980. Uptake takes place 
possibly by active reabsorption (I), possibly also by active 
secretion (2) and perhaps 
also by endocytosis (3). The 
aminoglycosides are accum-
ulated in the lysosomes (4) 
which consequently increase 
in volume and form myeloid 
bodies (5). The lysosomes 
rupture, causing local destr-
uction of the ciliated cell 
membrane (6). The lysosomal 
contents, enzymes and rem-
nants of the membrane are 
excreted with the urine (7). 
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often had nephrotoxic effects than one single large daily 
dose. As the principal criterion of nephrotoxicity he 
regarded a decrease of the creatinine clearance (Reiner 
et al., 1978). 
6.5. Parameters for toxicity of 
gentamicin 
The ototoxicity necessitates control examinations of the 
hearing and of the organ of equilibrium. Hearing can be 
measured with adequate sensitivity and good 
reproducibility with the usual audiological methods. 
Damage due to gentamicin manifests itself first by loss of 
sensitivity to high tones (Huizing, 1972; Carrière, 1980). 
Confusion may result from loss of hearing in case of bad 
condition, which may be present postoperatively. In that 
case, however, the loss of hearing affects all frequencies 
(Carrière, 1980). 
Effects on the organ of equilibrium can be determined 
precisely by measuring nystagmus after stimulation of the 
organ of equilibrium (posturally or calorically) (Igarashi et 
al., 1971; Websteretal., 1971). 
The nephrotoxicity may be detected by determination of 
serum creatinine and creatinine clearance. This supplies 
information on the glomerular function. However, the 
serum creatinine level only rises when renal function has 
deteriorated considerably (approx. 75%) (Bricker et al., 
1960; Müllerand Seifert, 1975; Chiou and Hsu, 1975). Since 
aminoglycosides, and particularly also, gentamicin may 
damage the proximal tubular cell, determination of the 
influence on this cell is desirable. This may achieved by 
measurement in the urine of: 
1. cellular components of damages tubular cells 
2. enzymes from damaged tubular cells 
3. the functioning of the tubular cell. 
Sub J: Sack et al. measure the renal epithelial cells that are 
excreted into the urine after damage: REP in cells/minute 
(Sack and Freiesleben, 1975; Sack, 1976; Sack et al., 1976; 
Sack and Ziillich, 1978). 
Sub 2: The same authors determine the urinary con-
centrations of the enzymes, malate dehydrogenase, lactic 
dehydrogenase and glutamic oxalacetic transaminase. If the 
tubular cell is damaged, the excretion of these enzymes with 
the urine is increased. Other enzymes that may be 
determined are: alkaline phosphatase isoenzymes 
(Pfleiderer et al, 1980), ß-galactosidase, γ-glutamyl 
transferase and N-acetyl-ß-glucosamine (Schulte, 1976; 
Schentag, 1978; Giamarellou et al., 1979; Hïrokawa et al., 
1979; Keys et al., 1981). 
Mondorf et al. determine the enzyme, alanine amino-
peptidase (AAP) in 24-hour urine. This is an enzyme from 
the surface of the proximal tubular cell and probably part of 
the brush border membrane (Mondorf et al., 1978a, 1978", 
1979, 1980; Scherberich et al, 1980). 
They demonstrated that a raised excretion of AAP in 
the 24-hour urine may have many different causes: 
infections, use of cefalosporins or aminoglycosides, renal 
angiography and urography. 
Sub 3: ßs-microglobulin is a natural body protein that 
is present in all body fluids. It is the small polypeptide chain 
of the HLA antigens. It is synthetised by virtually all cells of 
the body. Being a low-molecular protein, it undergoes 
complete glomerular filtration. 99.9 % of it is reabsorbed in 
the proximal tubular cells and subsequently metabolised. 
Its normal serum level is 1 ± 0.2 pg per ml (Vree et al., 
198 Γ); ¡t may be raised by increased synthesis or decreased 
glomerular filtration. 
A raised serum level due to increased syntheses of ß2-
microglobulin is encountered in neoplasia, especially solid 
tumours and lymphoproliferative diseases and in 
hepatobiliary, immunological and haematological diseases 
(Takagi et al., 1980; Beorchia et al., 1981). With increasing 
age, the median value of the serum level is said to rise: after 
the age of 70 it is 2.30 Mg per ml (Merret et al., 1980). 
A rise of the serum level due to decreased GFR occurs, 
for instance, in case of rejection of a kidney graft (Roxe et al., 
1981), but also during use of aminoglycosides, so that the 
serum level of ß2-microglobulin is said to be useful as an 
early indication of disorders of the GFR (Valsamis et al., 
1970; Sethi et al., 1981). However, depression of the GFR in 
aminoglycoside toxicity is a late manifestation of the 
nephrotoxicity (Kaloyamides and Pastoriza-Munoz, 1980). 
The amount of ß2-microglobulin in the urine is 
normally very small. An increased renal excretion may be 
due to a raised serum concentration or to disturbance of the 
tubular reabsorption in hypofunction of the kidney (Evrin 
and Wibell, 1972; Wibell, 1974; Kult et al., 1974; Revillard, 
1979; Vree et al., 1981a). This increased excretion into the 
urine in disorders of the proximal tubular reabsorption 
makes it a parameter of this renal function (Fig. 11.1). 
Just as the excretion of renal epithelial cells and of the 
enzymes mentioned above, it is a non-specific parameter: 
tubular dysfunctions of various nature may cause a raised 
excretion of ß2-microglobulin with the urine (Peterson et al., 
1969; Hall and Vasiljevic, 1973; Shiroïshi et al., 1977; lesato 
et al., 1977). The excretion and clearance of ß2-micro-
globulin are also increased in a high urinary tract infection, 
but in cystitis they are normal (Schardyn et al., 1979). 
The non-specific character of ß2-microglobulin as a 
parameter of nephrotoxicity is also confirmed by the fact 
that its excretion is increased after operations and injuries 
(Wide and Thorén, 1972) (see also Chapter 11). However, it 
is a faster-reacting and more sensitive parameter than the 
others (AAP, enzymes, cylindruria, serum creatinine, 
creatinine clearance) (Schentag et al., 1978; Schentag et al., 
1979a). 
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Chapter 7. Definition of the problem 
In the use of gentamicin-PMMA beads, more than in other 
methods of treatment, the emphasis is on local treatment of 
the infection. This is a deviation from certain surgical and 
bacteriological starting points which too often have been 
accepted as axioma. 
The treatment involves the implantation for a few 
weeks, sometimes a few months, of an antibiotic that when 
used parenterally has only a narrow therapeutic margin. The 
side effects of systemically administered gentamicin are 
admittedly not frequent but if they occur, they are often 
irreversible. Extra guarantees of safety and certainty about 
the harmlessness are desirable when a potentially toxic 
substance is used in situations that are not potentially fatal. 
The use of a new method of treatment is adequately justified 
if its results are better than those of earlier methods. If the 
results are similar, factors other than the therapeutic results 
should also be taken into account. On the basis of the study 
of the literature described in the preceding chapters, the 
following questions may be asked in regard to the treatment 
of infections by means of chains of gentamicin-PMMA 
beads: 
1. Is their use in the treatment of infections successful? 
2. Is treatment of the infection by means of these chains of 
beads more successful than other methods of treatment? 
3. Arc there other aspects of the treatment of infections, 
apart from the cure rate, on the basis of which the use of 
gentamicin-PMMA beads is or is not to be preferred? If 
so, what are they? 
4. Do low serum levels of gentamicin affect the kidney, in 
other words, are nephrotoxic side effects to be expected? 
5. Are ototoxic side effects (audiologic or vestibular) to be 
feared during treatment with gentamicin-PMMA beads? 
These questions could be considered on the basis of the 
experience gained in the treatment of infections in 
orthopaedic patients. Accordingly, their consideration and 
answering is limited to use of gentamicin-PMMA beads in 
infections of the locomotor apparatus, predominantly in 
osteomyelitis and infected endoprostheses. 
Answers to questions 1,2 and 3 will be sought by studying 
the data of patients who have been treated with chains of 
gentamicin-PMMA beads. In addition, these data will be 
compared with data concerning the treatment and 
therapeutic results of a group of patients treated by methods 
other than gentamicin-PMMA beads. The prospective and 
retrospective studies are reported in Chapters 8 and 9. The 
comparative statistical analysis is reported in Chapter 10. 
Chapters 11, 12 and 13 will be concerned with finding an 
answer to question 4. 
For the investigation of the possible influence on the 
kidney of gentamicin during treatment with gentamicin-
PMMA beads, we have opted for a study by means of 02-
microglobulin assays in serum and urine since this is 
believed to be a more sensitive parameter than the others. 
However, in order to be able to answer question 4, 
three sub-problems have to be solved: 
a. Is ß2-microglobulin indeed a sensitive parameter of the 
effect of gentamicin on the proximal tubular cell? An 
attempt to obtain an answer to this question from an 
experiment with three test subjects is described in 
Chapter 11. 
b. Do factors other than gentamicin also influence the 
excretion of 02-microglobulin and are these factors 
relevant to this study? To find an answer to this question, 
measurements have been carried out in patients who 
have been subjected to operation but not to treatment 
with gentamicin; these arc described in Chapter 12. 
с Does a treatment with gentamicin-PMMA beads of 
approximately two weeks' duration influence the renal 
tubulus, and can this influence be demonstrated on the 
basis of the renal excretion of β 2-microglobulin? The 
investigation of this question is described in Chapter 13. 
Chapter 14 describes a study of the possible influence on the 
ear during treatment with gentamicin-PMMA beads 
(question 5), which included both audiometrical and 
vestibular examinations. 
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Chapters. Treatment of infections from 1962 to 1977, 
without use of gentamicin-PMMA beads 
8.1. Introduction 
The Department of Orthopaedics of the Sint Radboud 
Hospital (R.C. University) of Nijmegen has been in 
existence since the autumn of 1961*. It treats patients from 
the immediate environment, but an important proportion 
are referred from outside the region. The latter group of 
patients as a rule has been treated for some considerable 
time by other orthopaedic surgeons or general surgeons, 
and many are referred because of complications risen 
during the treatment, not rarely an infection. 
The treatment of infections of the locomotor apparatus is 
administered, just as all other therapy, by teams and where 
necessary in consultation with other disciplines. The 
Department of Orthopaedics had no facilities for isolated 
nursing or nursing in an infection unit: patients with an 
infection are treated in the department itself. There, the 
only form of isolation available was single rooms. 
Operations are performed in operating rooms reserved for 
Orthopaedics. 
8.2. Treatment of infection from 
1962 to 1977 
The treatment of infections of the locomotor apparatus was 
carried out without a fixed protocol, but may be described 
roughly. To this purpose, the patients are subdivided into 
three categories: those with osteomyelitis, infected endo-
prostheses and infections of soft parts. 
8.2.1. Osteomyelitis 
Haematogenous osteomyelitis was rarely submitted for 
treatment in the acute phase but usually only when 
extensive destruction was already present or a chronic stage 
had been reached. When treatment was possible at an early 
stage, decompression of the focus of haematogenous osteo-
myelitis was performed with debridement and, if necessary, 
sequestrectomy. Until 1977, a local irrigation-drainage 
system was introduced if possible and parenteral and oral 
antibiotics were given for long periods of time. 
Early postoperative infections in patients with 
fractures or after elective surgery were treated by 
nettoyage, large doses of antibiotics and a closed irrigation 
system or open drainage of the focus of infection. Stable 
osteosynthesis material was either left in situ or, if possible, 
replaced by external fixation. 
Chronic osteomyelitis was treated by debridement 
and, if necessary, sequestrectomy, with removal of osteo-
synthesis material and of any other foreign bodies. The 
operation was performed without vital staining and usually 
without exsanguination. In most cases, an irrigation system 
was introduced and antibiotics were given. Cancellous bone 
grafting was carried out in cases with large defects or pseud-
arthrosis, sometimes primarily but mostly after the infection 
•Heads: 1961 to 1969: Prof. Dr. G.M. San Giorgi 
1969 to 1972: Prof. Dr G. Chapchal 
1972 - present: Prof. Dr Th.J.G. van Rens 
had been treated first. Any muscle and skin grafting 
required was performed after healing of the infection. 
8.2.2. Infection of endoprostheses 
The treatment of a painful, loose endoprosthesis consisted 
in removal of the prosthesis. Up to 1977, it was attempted to 
difierentiate between aseptic and septic loosening with the 
aid of clinical signs of infection (general, local), of laboratory 
tests (BSR, if necessary leukocyte differentiation),and of the 
roentgenographic and scintigraphic findings. 
The surgeon's peroperative assessment also played a 
part and occasionally, a gram preparation was made 
peroperatively. The culture findings of material collected 
peroperatively were received a few days after the operation. 
As a rule, material for one (aerobic) culture was collected. 
If it was concluded from the pre- and peroperative 
findings that no infection was present, reimplantation was 
performed at the revision operation (one-stage 
reimplantation). The culture findings, therefore, could not 
influence this decision. 
If infection was diagnosed, an irrigation system was 
introduced after removal of the prosthesis with all cement, 
and traction was exerted by means of a tuberosity wire. 
Irrigation-drainage treatment was administered as 
described in par. 8.3. 
Reimplantation of a prosthesis was sometimes 
performed after treatment of the infection (two-stage re-
implantation), i.e. a few weeks after removal of the infected 
prosthesis. In most cases, however, the patient was first 
mobilized on the Girdlestone hip and an interval of six to 12 
months under out-patient control was allowed to find out 
whether the inflammation would recur and whether the 
patient still wanted to be considered for reimplantation. 
8.2.3. Inflammation of soft parts 
Infection of soft parts were treated in the classical surgical 
manner. Infected haematomas were drained and evacuated; 
abscesses were incised and drained; sinuses were explored 
and excised with their source. 
Infections of soft parts were usually accompanied by 
osteomyelitis or infection of an endoprosthesis. In such 
cases, the treatment of the osteomyelitis or of the infection 
of the endoprosthesis was given priority. 
8.3. The irrigation-drainage system 
The irrigation-drainage system constitutes the principal 
alternative to gentamicin-PMMA beads in the treatment of 
infections. Since until 1977 it was an important part of the 
treatment, the application of this system during that period 
is described below. Some technical changes were 
introduced with the passage of years, progressively more 
emphasis being placed on prevention of ascending 
infections via the drainage system. 
The irrigation fluid used was Ringer's solution with 
addition of 10 mg Polymyxin-B-SulphateR and 10 ml 
NebacetineR per 500 ml. Under the influence of gravity, the 
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irrigation fluid entered the wound through a ramified 
infusion system, mostly through two drains. It drained off 
through a similar ramified system, with usually slightly 
wider drains, into a closed bag around which a chest pump 
provided a negative pressure of approx. 25 cm H2O (Fig. 
8.1 ). The drains were anchored by suturing them to the skin, 
and the in- and outlet openings were tended and treated 
with betadine ointment once a day. In principle, all patients 
received antibiotics parenterally or orally, guided by the 
result of the peroperative culture. Three times a week, 
culture material was collected from the outflow drains. 
Before this material was collected, flushing was carried out 
for half an hour with 500 ml Ringer's solution. When three 
cultures in succession remained sterile, the irrigation-
drainage was terminated. Other reasons for discontinuing 
the irrigation-drainage were frequent clogging of the drains 
and leakage. In principle, irrigation-drainage was never 
carried our for longer than six weeks. Even if the cultures 
remained positive, the drainage system was removed after 
this period. 
Figure 8.1 Suction drainage system as used in the department of 
Orthopaedics of the Sint Radboud Hospital of Nijmegen. Propelled by 
gravity, an irrigation fluid flows into the wound through a ramifying 
system. Outflow is through thicker drains which join and lead the 
irrigation fluid into a closed bag. This bag is enclosed in a glass bottle 
in which a chest pump maintains a negative pressure. This creates a 
controllable suction force on the outflow side of the drainage system, 
permitting the system to remain closed. 
8.4. The follow-up 
In order to evaluate the results of the treatment of infections 
from 1962 to 1977, data were collected on all patients who 
during that period had been treated for an infection without 
use of gentamicin-PMMA beads. Patients who belonged to 
this category but in addition had received treatment with 
gentamicin-PMMA beads after 1977, have been classified in 
the group described in Chapter 9. 
8.4.1. Method 
The aim was to obtain as complete a picture as possible of all 
patients subjected to operation. To this purpose, the names 
of all patients who might have been treated for an infection, 
were collected from the administration of the operation 
room. Examination of the case reports revealed that 198 
patients had been treated for osteomyelitis, a possibly 
infected prosthesis or an inflammation of soft parts. From 
every file, the data were collected and after coding stored in 
the computer. These data, arranged by patient and by 
operation, are listed in table 8.0. For every operation, all data 
were coded separately. 
The course of the healing, the presence or absence of 
recurrences and the ultimate result were evaluated by 
interpretation of the notes in the patients' case reports. 
8.4.2. Material 
In slightly over 15 years, 198 patients were treated, one of 
them bilaterally. These patients' data (sex, origin, 
localization) are listed in Table 8.1 and Fig. 8.2, 
The diagnoses were classified into four main groups: 
osteomyelitis, infected endoprosthesis, infection of soft 
tissues and 'non-infected' (Table 8.2). The last-mentioned 
category comprises the patients in whom treatment for 
infection had been instituted on the basis of the clinical 
picture but in whom the cultures, after removal of the 
painful and sometimes loose prosthesis proved sterile. Also, 
these patient's files did not contain enough hard evidence 
(clinical examination, laboratory, roentgen, scan) of the 
presence of an infection. As proof of infection of an 
endoprosthesis were regarded the presence of a sinus or 
abscess, BSR values repeatedly higher than 30 mm in the 
first hour (and not due to some other cause) and positive 
culture of material removed at operation. 
Radiological abnormalities were not a condition. 
Scans, when made, were always positive but this did not in 
itself constitute proof of infection. 
Isolated infections of soft parts did occur but most of 
these infections were associated with osteomyelitis or 
infection of the endoprosthesis (Table 8.2). 
All four main diagnostic categories were divided into 
sub-groups (see Table 8.3). If a patient's diagnosis was 
changed in the course of the treatment, the patient was 
categorized on the basis of the diagnosis made at the start of 
the treatment. 
In the 198 patients with the 199 localizations treated, 345 
operations were carried out. Table 8.3 in addition to the 
number of infections treated shows how many operations 
were required for each diagnostic category. 
The figures shown do not include any o/ceMreatments, 
such as cancellous bone grafts, reimplantation and 
arthrodeses. 
At every operation, several treatments were 
performed. 
These treatments are listed in Table 8.4 which shows 
in what percentage of the 345 operations the treatment in 
question was carried out. The table also shows what after-
treatments have been performed in these patients. These 
after-treatments were carried out not to combat infection 
but to create a better useful extremity. These after-
treatments have not been included in Tables 8.3 and 8.4 
because the operations listed in these tables were 
performed to combat the infection. Tables 8.5 and 8.6 
provide information on the causative agents encountered in 
the patients. Four mixed infections, all the causative agents 
found are listed separately. The percentage listed indicates 
in how many per cent of the 345 operations the micro-
organism was cultured. The proportions of mono- and 
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PER ΡΑΉΕΝΤ 
/. General patient number 
group number 
date of birth 
sex 
origin: own/referred 
result: healed/not healed, amputation/uncertain, deceased, unknown 
at follow-up: BSR tendency to decrease? 
sinus absent? 
recent culture sterile? 
2 Dates 
3. Diagnosis 
4. Treatment 
date accident or elective operation 
date first manifestation of infection 
dates operations 1 to 6 inclusive 
dates recurrences 1 to 5 inclusive 
date healed (recurrence-free) 
date last examination or follow-up examination 
main diagnosis 
subdiagnosis 
localization: 
left/right 
osteomyelitis: 
endoprosthesis 
soft tissues: 
PER OPERATION 
osteomyelitis/infection of prosthesis/infection of soft tissues/not infected 
nos. 1 and 2 
cause: haematogenous/injury/fracture ± operation/± complicated/ 
elective operation 
type: infected pseudarthrosis/pinhole sinus/decubitus/arthrodesis 
fixation: int.fix./ext.fix./intramedullary fix./others 
stable/unstable 
type: total hip/double cup/head-neck/Girdlestone/Guepar/Geomedic/knee 
arthrodesis/others 
type: abscess/postoperative haematoma/sinus/others 
systemic antibiotics 
debridement 
sequestrectomy 
abscess drainage 
extraction of endoprosthesis 
removal of cement rest 
removal of fix. mat. 
stabilization 
sub irrigation system 
duration in weeks 
superinfection after x weeks 
leaking drains 
clogged drains 
reoperation drains 
reason of termination 
sub genta beads 
number of beads 
duration in situ 
extraction technique 
5. After-treatment cancellous bone graft 
arthrodesis 
reimplantation of prosthesis 
Girdles tone 
6. Causative agent 
genta beads 
other local antibiotic 
irrigation system with antibiotic 
irrigation system without antibiotic 
cancellous bone graft open 
cancellous bone graft closed 
tamponade 
muscle/periosteum/skin graft 
amputation 
other 
Table 8.0 Data of every patient and of every operation of a patient that have been recorded and studied. 
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mixed infections in the several main diagnostic categories 
are also shown. In calculating the percentage, the 'non-
infected group' was left out of account. Finally, the table 
shows what proportion of the cultures was negative in spite 
of the presence of an infection. 
There were several reasons why no causative agent 
could be mentioned (Table 8.5). Sometimes the data failed 
to make clear which of the bacteria encountered had 
actually caused the inflammation (12%). Also, data were 
sometimes unreliable or incomplete (19%). Cultures were 
sometmes sterile when antibiotics were used (1 %). Finally, 
sterile cultures were seen while clinically the infection was 
certain (11%). 
The evolution of the disease is reconstructed with the aid of a 
time scale that shows the main dates (Table 8.7). These 
dates show how long a sub-clinical or manifest 
inflammation was present, and what were the durations of 
the periods of treatment, postoperative healing, freedom 
from recurrence and follow-up. For the main diagnostic 
categories, these periods are listed in Table 8.9, in which the 
figures refer to the numbers of months. The median age in 
years at the time of the first operation is shown in Table 8.8. 
The duration of stay in hospital and in the nursing home is 
shown in Table 8.10 for each main diagnostic category. The 
figures refer to the duration of hospital and nursing-home 
stay in months, added per patient for all operations together. 
8.5. Results 
With a median follow-up of three years after the last 
operation, 72% of the patients were free from recurrences 
during a median period of 28 months (see for results Table 
8.11, for the distribution of the follow-up periods, Table 
8.9). Excluding, for the calculation, the results of patients in 
the category 'non-infected endoprostheses', since we are 
concerned here with the treatment of infections, we find a 
proportion of 76% patients free from recurrence. Failure of 
the treatment is recorded for 14%, which includes the 
patients subjected to an amputation. Healing was uncertain 
in 10% of the patients. The largest proportion of freedom 
from recurrence was obtained in patients with infection of 
an endoprosthesis (83 %), the smallest proportion in patients 
with osteomyelitis (72 %). 
As mentioned above, during the period with which this 
study was concerned (1962-1977), these 198 patients have 
been subjected to 345 operations for treatment of an 
infection. In addition, 61 o/ter-treatments have been 
necessary. 38 % of the patients required more than one 
operation for the treatment of the inflammation (Table 
8.12). Treatment of the infection was relatively difficult 
particularly in patients with an infected pseudarthrosis, an 
infected knee prosthesis or osteomyelitis (Table 8.3). 
Infected pseudarthrosis required slightly over three 
operations on the average, the other two diagnostic 
categories an average of two operations. 
Patients in whom an infected endoprosthesis was 
treated constituted a special group. Table 8.13 shows how 
the treatment proceeded in 34 patients with a deep infection 
of a total hip prosthesis. Six times, a treatment was 
instituted without removing the prosthesis in toto. In all 
these cases, the treatment failed and the prosthesis had to 
be removed at a later stage. When in-toto removal of the 
prosthesis had been performed immediately (28 patients), 
reimplantation was successful in 12 out of 14 cases. 
Unfortunately, the records did not show whether antibiotic-
containing cement had been used in all cases. Ultimately, 
the treatment of the infections of 34 total hip prostheses 
resulted in a Girdlcstone or arthrodesis 19 times, and in 
successful reimplantation 15 times. 
Table 8.9 presents a survey of the durations of the total 
courses of the disease. Of the 199 localizations treated, the 
data are included to the extent they are known. The 
numbers of unknown localizations can be found by 
subtracting the figure listed under 'total' from 199. For 
instance, of 44 localizations treated the duration of the sub-
clinical infections was unknown (199-155). The durations 
are rounded off downwards to whole months. As a result, for 
instance, the median duration of surgical treatment (c) is 
always 0 months. The table also clearly shows, for instance 
for this duration of surgical treatment, the difference 
between mean duration and median duration. This 
difference is sometimes considerable, because in calculating 
the mean durations the extreme values have been included. 
Influence of these extreme values on the median duration is 
much less. Examination of the data shown in Table 8.9 
prompts a number of remarks: 
- Patients with osteomyelitis as a rule already show the 
symptoms shortly after the operation or the accident. The 
median duration of this period: the subclinical infection: 
is one month. The median duration of the interval before 
operation (a + b) is 14 months. The mean durations of 
these periods differ even more owing to a few extremely 
long periods of manifest infection (b) in cases of haema-
togenous osteomyelitis. 
- In patients with an infected endoprosthesis, the infection 
is diagnosed after a mean period of nine months (period 
a). 
On the average, the operation is carried out eight to 10 
months later. 
- In the main diagnostic category with aseptic loosening 
of the prostheses, the onset of the symptoms on the 
average follows 21 months after implantation of the 
prosthesis (median period 14 months, period a). Here, 
also, operation was also performed approximately nine 
months later. Median age is highest in this group of 
patients (Table 8.8). 
Table 8.10 shows the durations of the stays in hospital and in 
the nursing home, rounded off downwards to whole 
months, that were necessary for the treatment of the 199 
localizations in the 198 patients: hospital months, nursing-
home months and total. The figures represent the totals per 
patient of all admissions required for all treatments listed in 
Tables 8.3 and 8.4. We find that the median duration of 
intramural care is longest for infected endoprostheses, viz. 
not less than one year. 
For osteomyelitis patients this amounts to six months, 
for soft-part infections to three months and for non-infected, 
revised prostheses, to 11 months. Where the long duration 
of treatment after revision of an articular prosthesis is 
concerned, it makes little difference whether a septic or an 
aseptic loosening was involved. In the septic cases the 
period spent in hospital is relatively longer than that spent in 
the nursing home. 
8.6. Discussion 
Within the restrictions characteristic of a retrospective 
study, examination of the medical files of these 198 patients 
nevertheless affords good insight, particularly in the 
evolution of the condition in these patients. The most 
interesting data are those that concern patients with osteo-
myelitis or with an infected endoprosthesis. 
The restrictions of this study imply that no information 
could be obtained apart from that which had been recorded 
in the medical files. Accordingly, maximal attention has 
been paid to the socalled 'hard data': dates, ages, operation 
protocols, culture results, laboratory lists, etc. Even when 
only a medical file is studied, the subjective notes in the case 
history often clearly reveal the manifestation of a 
recurrence, and its moment of onset. Even so, the results in 
the follow-up still have to be classified as uncertain in 10 % of 
the cases. 
Author 
1. Harris '60 
2. Blockey + McAllister '70 
3. Blockey + McAllister '72 
4. Molían + Piggot '77 
5. Petersen et al. '80 
6. Gillespie + Mayo '81 
7. Baer '31 
8. Kulowski '31 
9. Prigge '46 
10. Rowling '59 
11. Horwitz '73 
12. Shannon et al. '73 
13. Brunei + Berteaux '75 
14. Grace + Bryson '50 
15. Winter '51 
16. Axhausen '61 
17. Axhausen '65 
18. Hurley et al. '66 
19. Rowling '70 
20. Organ '71 
21. Paus '71 
22. Hedström '74 
23. Becker et al. '78 
24. Schuman + Wheeler '78 
Ν 
45 
113 
38 
93 
73 
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Healed Follow-up Treatment 
25. Burri + Henkmeyer '71 
26. Burri '73 
27. Roy Camille et al. '76 
28. Lortat et al. '77 
29. Miné et al. '79 
30. Piganiol '79 
31. Burri '79 
32. Sudman '79 
33. Dombrowski + Dunn '65 
34. Dilmaghani '69 
35. Anderson + Hom '70 
36. Kelly et al. '70 
37. Taylor + Mandsley '70 
38. Lawyer + Eyring '72 
39. Clawson et al. '73 
40. Hagen '74 
41. Kelly et al. '75 
42. Boda '79 
43. Burri '79 
44. Geneste et al. '79 
45 
56(61) 
11 
27 
20 
29 
16 
50 
36 
14(15) 
46 
25 
200 
46 
41 
68 
33 
79 
13 
22 
24 
75 
40 
35 
112 
12 
12 
97 
62 
186 
103(125) 
121 
115 
71% 
81% 
89% 
81% 
93% 
80% 
89 
130(154) 
61(64) 
58 
40 
68 
54(58) 
45% 
76% 
94% 
83% 
83% 
68% 
85% 
69% 
93% 
82% 
82% 
50% 
86% 
63% 
80% 
90% 
80% 
57% 
92% 
95% 
70% 
61% 
80% 
91% 
92% 
92% 
77% 
87% 
68% 
80% 
57% 
54% 
68% 
92% 
74% 
74% 
80% 
33% 
89% 
94% 
l-8yr 
> 14mn 
3 mn-12yr 
1-l lyr 
4-33yr 
l -2yr 
9-19mn 
> 7,/2 mn 
3 mn-7l/4yr 
2-З 2УТ 
5-22 yr 
1 -10 yr 
1-5 yr 
7 mn 
6 yr 
4% yr 
9 mn-33/4 yr 
4-33 mn 
3-36 mn 
l - 6 y r 
l - 2 0 y r 
ІУгуг 
4 mn - 2 yr 
1-20 yr 
9 mn - 3 yr 
'/2 - 5 yr 
2-8 yr 
2-8 yr 
2-8 yr 
/2-З 2УТ 
> 2 y r 
V2 - 5 yr 
3 mn-10 yr 
5yr 
> 2 y r 
l - 2 0 y r 
> 16 mn 
acute haem.osteom.: 
surgical + AB 
treatment 
maggots 
'Orr' method 
muscle graft 
muscle, skin graft 
saucerisation 
saucerisation + skin graft 
muscle graft, AB 
local AB -solution 
AB -bloodplug 
AB -plug 
AB -plug 
local AB perfusion 
AB. 
regional AB perfusion 
AB 
AB long-term treatment 
Silver ions 
AB 
cancellous bone graft 
cancellous bone graft 
'Papineau' 
'Papineau' 
'Papineau' 
'Papineau' 
cancellous bone graft 
cancellous bone graft 
suction drainage 
suction drainage 
Orr + suction drainage 
saucerisation + suction drainage 
saucerisation + bone graft 
suction drainage 
suction drainage 
suction drainage 
suction drainage 
suction drainage 
suction drainage 
suction drainage 
suction drainage 
suction drainage 
Table 8.15 Review of the literature on results of treatment of various types of osteomyelitis. Cure rates, and in some cases thefollow-up, have 
been calculated where necessary. 
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In regard to the interventions carried out at the operations, 
a distinction should be made between a number of 
interventions that were performed nearly always, and a 
number of interventions from among which subsequently a 
choice had to be made The first intervention then consisted 
of debridement, sequestrectomy, abscess drainage and/or 
removal of fixation material or prosthesis (Table 8 4). Sub­
sequently, an irrigation system with antibiotics was used 
frequently (24%) and antibiotics were administered 
systematically in most cases (70 %). Packing of cavities was 
carried out occasionally (16%). cancellous bone grafting, 
packing with tampons, skin or muscle grafting 
An irrigation-drainage system was used 87 times in these 
198 patients, and another 14 times in the patients described 
in Chapter 9. The data concerning these 101 applications of 
irrigation-drainage systems are shown in Table 8.14 
Although in principle a duration of six weeks was aimed at, 
most irrigation systems prove to have functioned for no 
longer than two to three weeks. In a substantial proportion, 
problems with the drains necessitate discontinuation. 
Cultunng of the material collected three times a week 
revealed a superinfection in 27 patients, mostly after two 
weeks. Twenty-one times, the irrigation had to be 
discontinued in spite of a positive culture Only 57 of the 101 
irrigation-drainage systems were removed after the culture 
had become negative 
These findings corroborate the trend in the literature 
to reduce the total duration of the irrigation-drainage system 
DATA ON PATIENTS 
Total number of patients 198 
Sex Number % 
men men 110 56 
women 88 44 
origin Number % 
own 66 33 
referred 129 65 
unknown 3 2 
Total number of localizations- 199 
Localization Number % 
left-sided 95 48 
right-sided 97 49 
central 6 3 
unknown 1 0,5 
Table 8 1 Data on patients from the follow-up of the period 1962-
to one to a maximum of three weeks (Willenegger, 1970, 
1973, 1979'i; Willenegger et al, 1970; Polster and Samimi, 
1979; Burn and ν d Werken, 1981) Fear of superinfections 
proved not unfounded in our patients, either, and problems 
with the drains also occurred frequently. 
The results of the treatment of osteomyelitis (72 % free from 
recurrence during a median follow-up of 33 months) is 
comparable to the, admittedly widely divergent, results of 
the authors listed in Table 8 15. Most authors approach a 
cure rate of about 80 %, some one of over 90 %. 
It should be noted, however, that often it is not made 
clear precisely what is meant by 'follow-up' Most authors 
appear to mean the period from the last operation to the 
follow-up examination (period d + e in Table 8.9) Greater 
importance attaches to the penod of freedom from 
recurrence (period e in Table 8.9) In our material, the mean 
follow-up after treatment of the osteomyelitis amounted to 
43 months. However, the period free from recurrence was 
35 months- a difference of eight months, on the average. 
The result of the treatment of infected endoprostheses (83 % 
free from recurrence during a median follow-up of 37 
months) may be compared with the results of 
reimplantations as reported by various authors and 
summarized in Table 3 11 However, our results should 
preferably be compared only with those reported in the nine 
publications, in which it is established with certainty that it 
was indeed infected endoprostheses that had been treated. 
DATA ON PATIENTS 
Total number of patients: 90 
Sex 
men 
women 
Ongm 
own 
referred 
Number 
46 
44 
Number 
49 
41 
% 
51 
59 
% 
54 
46 
Total number of localizations: 93 
Localization Number % 
left-sided 47 51 
nght-sided 45 48 
central 1 1 
Table 9 1 Data on patients from the study of the penod 1977-1981 
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DATA ON TREATED LOCALIZATIONS CLASSIFIED 
BY DIAGNOSIS 
DATA ON TREATED LOCALIZATIONS CLASSIFIED 
BY DIAGNOSIS 
Diagnosis Number % With infection of Diagnosis 
Osteomyelitis 
infection of endoprosthesis 
infection of soft tissues 
not infected 
Total 
39 
41 
34 
9 
199 
58 
21 
17 
S 
100 
sofl tissues 
88 (of 115 = 
15 (of 41 = 
• 77%) 
37%) 
Table 8.2 Number of localizations treated during the period from 
1962 to 1977, classified according to the mam diagnosis. Soft-tissue 
infections occurred not only isolatedly (34) but also m some other 
main diagnostic group (103). 
osteomyelitis 
infection of endoprosthesis 
infection of soft tissues 
not infected 
Total 
Number % With infection of 
loft Пччие 
31 (of 39 = 79%) 
13 (of 41 = 32%) 
39 
41 
4 
9 
42 
44 
4 
10 
93 100 
Table 9 2 Number of localizations treated during the period from 
1977 to 1981, classified according to the mam diagnosis. Soft tissue 
infections occurred not only isolatedly (4) but also in other mam 
diagnostic groups (44). 
Diagnosis 
OSTEOMYELmS haematogeen 
posttraumatic 
postoperative 
decubitus 
miscellaneous 
Of the 115 osteomyelitis 
infected pseudarthrosis 
pin-hole sinus 
INFECTED ENDOPROSTHESES 
total hip 
double cup 
head-neck 
Girdlestone 
Guepar 
Geomedic 
knee arthrodesis 
various prostheses 
INFECTION OF SOFT TISSUES 
abscess 
postop. haematoma 
sinus 
miscellaneous 
NOT INFECTED hip prostheses 
knee prostheses 
miscellaneous 
TOTAL 
Number 
Loc. Oper. 
32 
51 
26 
1 
5 
115 
loc: 
16 
8 
34 
0 
2 
1 
1 
3 
0 
0 
41 
13 
7 
11 
3 
34 
9 
0 
0 
9 
199 
70 
ПО 
49 
1 
9 
239 
56 
10 
47 
0 
2 
1 
2 
5 
0 
0 
57 
16 
9 
12 
3 
40 
9 
0 
0 
9 
345 
OSTEOMYELmS 
INFECTED 
Diagnosis 
haematogenous 
posttraumatic 
postoperative 
decubitus 
miscellaneous 
Of the 39 osteomyelitis 
infected pseudarthrosis 
pin-hole iinus 
ENDOPROSTHESES 
total hip 
double cup 
head-neck 
Girdlestone 
Guepar 
Geomedic 
knee arthrodesis 
various prostheses 
INFECTION OF SOFT TISSUES 
NOT INFECTED 
abscess 
postop. haematoma 
sinus 
miscellaneous 
hip prostheses 
knee prostheses 
miscellaneous 
TOTAL 
Number 
Loc. Oper. 
2 
23 
13 
1 
0 
39 
loc: 
7 
5 
25 
2 
1 
3 
5 
1 
3 
1 
41 
1 
2 
1 
0 
4 
7 
1 
1 
9 
93 
4 
37 
26 
2 
0 
69 
11 
5 
35 
4 
1 
3 
11 
2 
8 
1 
65 
1 
2 
1 
0 
4 
7 
1 
1 
9 
147 
Table 8 3 Localizations treated during the period 1962 to 1977, 
classified according to mam diagnostic groups and diagnostic sub­
groups. The table lists the numbers of localizations and the numbers 
of operations required for those localizations. These figures are 
presented separately for the infected pseudarthroses and the pinhole 
Table 9.3 Localizations treated during the period ¡977 to 1981 
classified by mam diagnostic groups and diagnostic sub-groups. The 
table lists the numbers of localizations and the number of operations 
required for those localizations. The data concerning the infected 
pseudarthroses and the pinhole sinuses are presented separately. 
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Treatments 
systemic antibacterial treatment 
systemic prophylactic treatment 
debridement 
sequestrectomy 
removal of cement rest 
abscess drainage 
prosthesis removed in toto 
prosthesis removed in part 
fixation material removed 
stabilization 
gentamicin-PMMA beads 
other local antibiotic 
irrigation system with antibiotic 
irrigation system without antibiotic 
cancellous bone grafting open 
cancellous bone grafting closed 
tamponade 
muscle/skin/periosteal graft 
amputation 
other 
After-treatments 
cancellous bone grafting 
arthrodesis 
reimplantation 
Girdlestone 
Number 
243 
1 
232 
99 
0 
75 
51 
3 
70 
30 
0 
29 
84 
3 
4 
26 
12 
12 
8 
10 
8 
6 
26 
21 
% 
70 
0,3 
67 
29 
0 
22 
15 
0,9 
20 
9 
0 
8 
24 
0,9 
1 
8 
4 
4 
2 
3 
2 
2 
8 
6 
Treatments 
systemic antibacterial treatment 
systemic antibacterial prophylactic 
debridement 
sequestrectomy 
removal of cement rest 
abscess drainage 
prosthesis removed in toto 
prosthesis removed in part 
fixation material removed 
stabilization 
gentamicin-PMMA beads 
other local antibiotic 
irrigation system with antibiotic 
irrigation system without antibiotic 
cancellous bone grafting open 
cancellous bone grafting closed 
tamponade 
muscle/skin/periosteal graft 
amputation 
other 
After-treatments 
cancellous bone grafting 
arthrodesis 
reimplantation 
Girdlestone 
Number 
42 
27 
83 
45 
10 
20 
43 
1 
20 
5 
116 
1 
14 
0 
1 
1 
1 
1 
1 
2 
19 
7 
19 
33 
% 
29 
18 
57 
31 
7 
14 
30 
0,7 
14 
3 
79 
0,7 
10 
0 
0,7 
0,7 
0,7 
0,7 
0,7 
1 
13 
5 
13 
22 
Table 8.4 Review of the treatments performed at the 345 operations 
during the period from 1962 to 1977 The percentages indicate how 
often the (after-)treatment was carried out at the 345 operations: 
345 = 100 %. As a rule, several treatments were carried out at one 
operation 
Table 9 4 Review of the treatments performed at the 147 operations 
during the period from 1977 to 1981. The percentages indicate how 
often the (after-)treatment was carried out at the 147 operations: 147 
= /00% As a rule, several treatments were carried out at one 
operation. 
Causative agent 
Staphylococcus aureus pen.-resistant 
Staphylococcus aureus pen.-sensitive 
Staphylococcus albus 
Pseudomonas aeruginosa 
Proteus (nn.) 
Proteus mirabilis 
Proteus vulgaris 
Esch. coli 
enterobacteriaceae (nn.) 
Enterobacter 
Klebsiella 
anaerobic bact. (nn.) 
Bacteroides fragilis 
anaerobic gram+ cocci 
other anaerobic bact. 
other causative agents, or 
determination of agent not possible 
sterile 
sterile during use of antibiotic 
unreliable or incomplete 
Number 
106 
43 
33 
30 
7 
9 
4 
6 
3 
2 
2 
0 
0 
1 
0 
42 
39 
4 
67 
% 
31 
13 
10 
9 
2 
3 
1 
2 
0,9 
0,6 
0,6 
0 
0 
0,3 
0 
12 
11 
1 
19 
Causative agent 
Staphylococcus aureus pen.-resistant 
Staphylococcus aureus pen.-sensitive 
Staphylococcus albus 
Pseudomonas aeruginosa 
Proteus (nn.) 
Proteus mirabilis 
Proteus vulgaris 
Esch. coli 
enterobacteriaceae (nn.) 
Enterobacter 
Klebsiella 
anaerobic bact. (nn.) 
Bacteroides fragilis 
anaerobic gram+ cocci 
other anaerobic bact. 
other causative agents, or 
determination of agent not possible 
sterile 
sterile during use of antibiotic 
unreliable or incomplete 
Nu 
51 
13 
27 
15 
3 
1 
0 
4 
10 
3 
0 
3 
1 
5 
3 
25 
12 
12 
2 
% 
35 
9 
18 
10 
2 
0,7 
0 
3 
7 
2 
0 
2 
0,7 
3 
2 
17 
8 
8 
1 
Table 8 5 Review of the causative agents cultured at the 345 
operations of the period rom 1962 to 1977. This figure includes the 
operations of endoprostheses which subsequently proved to be non-
¡nfected. The percentages show m how many per cent of the 345 
operations, the bacterium m question was encountered m a mixed or 
mono-culture: 100 % = 345. 
Table 9 5 Review of the causative agents cultured during the period 
from 1977 to 1981 at 147 operations (including the operationsfor the 
non-infected prostheses) The percentages show in how many per cent 
of the ¡47 operations the bacterium in question was encountered m a 
mixed or mono-culture. 100 % = 147. 
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Main diagnosis Mono 
% 
Mixed Neg. Total 
osteomyelitis 58 
infection of endoprostheses 58 
infection of soft tissues 50 
not infected 
% 
17 
9 
8 
% 
2 6 
3 3 
4 2 
Total 55 14 3 1 
% Number 
100 239 
100 57 
100 40 
9 
100 
Table 8 6 Distribution of the mono- and mixed cultures and sterile 
cultures of the period 1962 to 1977 classified on the basis of the main 
diagnosis. 
Main diagnosis Mono Mixed Neg. Total 
osteomyelitis 
infection of endoprostheses 62 
infection of soft tissues 
n o t infected 
% 
55 
;se  62 
100 
-
% 
35 
20 
0 
-
% 
10 
18 
0 
-
% Number 
100 69 
100 65 
100 4 
9 
345 Total 56 25 19 100 147 
Table 9 6 Distribution of the mono-and mixed-cultures and sterile 
cultures of the period 1977 to 1981 classified on the basis of the main 
diagnosis. 
В 
3 
—ι— 
5 
— t — 
1 date of injury or elective operation 
2 date of first manifestation of the inflammation 
3 dates of operations 1 to X inclusive 
4 date declared 'cured' (recurrence-free) 
5 date of last examination or follow-up examination 
A period of sub-clinical infection 
В period of manifest infection 
С period of surgical treatment 
D period of postoperative healing 
E period of postoperative freedom from recurrence 
A + B duration of anamnesis 
B + C + D total duration of the infection 
C + D total duration of treatment of the infection 
D + E follow-up period 
Table 8 7 / 9 7 Time scale of the case history. Markings indicate the mam dates (1 to 5 inclusive), and the mam penods (A to E inclusive) 
In the course ofpenod С of the surgical treatment, one or more operations have been earned out, some of them followed by a recunence 
Diagnosis 
osteomyelitis 
infection of prosthesis 
infection of soft tissues 
not infected 
Total 
Median age 
32 
6 5 , 5 
30 
70 
40 
Diagnosis 
osteomyelitis 
infection of prosthesis 
infection of soft tissues 
not infected 
Total 
Median age 
31 
65 
42 
60 
55 
Table 8 8 Median ages of the patients at the time of their first 
operations, expensed in years. These patients have been treated 
dunng the period 1962 to 1977. 
Table 9 8 Median ages of the patients at the time of their first 
operations, expressed m years. These patients have been treated 
during the period 1977 to 1981 
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REVIEW OF DURATIONS O F P E R J O D S I N T H E C A S E HISTORIES 1962-1977 
Period 
a. subclin. inf. 
b. manifest inf. 
с surgical 
treatment 
d. postoperative 
healing 
e. recurrence-
free 
a+b anamnesis 
b+c+d total infection 
c+d treatment of 
infection 
d+e follow-up 
Osteomyel. 
(115) 
N Mean Med. 
85 6 1 
109 52 11 
113 19 0 
87 7 2 
89 35 24 
85 41 14 
81 62 30 
87 29 9 
87 43 33 
Inf. prosth. 
(41) 
N Mean Med. 
38 9 5 
37 8 6 
40 4 0 
32 2 2 
31 42 38 
37 19 18 
29 15 12 
31 6 2 
32 43 37 
Inf. soft 
tissues (34) 
N Mean Med. 
26 2 1 
34 10 2 
34 3 0 
27 1 1 
27 54 37 
26 11 4 
27 7 4 
27 3 1 
27 56 37 
Not inf. 
(9) 
N Mean Med. 
6 
6 
9 
2 
2 
6 
1 
2 
2 
21 
8 
0 
3 
17 
30 
7 
3 
21 
14 
8 
0 
3 
17 
24 
7 
3 
21 
Total 
(199) 
N Mean Med. 
155 
186 
196 
148 
149 
154 
138 
147 
148 
7 1 
34 7 
12 0 
5 2 
40 28 
30 13 
41 16 
19 3 
45 36 
Table 8 9 Survey of the durations of periods of the case histories of 198 patients with 199 treated localizations, from the penod 1962 to 1977. 
The lengths of time have always been rounded off downwards to whole months. The table shows what numbers of durations were known and 
what were the mean and median values. 
SURVEY O F T H E D U R A T I O N S O F I N T R A M U R A L CARE 1962-1977 
stay in hospital 
stay in nursing home 
total duration 
intramural care 
Osteomyel. 
(US) 
N Mean Med. 
114 
108 
110 
9 
4 
13 
6 
0 
Inf. prosth. 
(41) 
N Mean Med. 
39 
37 
37 
7 
8 
15 
6 
6 
12 
Inf. soft 
tissues (34) 
N Mean Med. 
33 
33 
33 
5 
0 
3 
0 
Not inf. 
(9) 
N Mean Med. 
2 3 9 
9 
11 11 
Total 
(119) 
N Mean Med. 
195 
187 
189 12 
Table 8 10 Survey of the total duration of intramural care of the patients classified by diagnostic category. The lengths of time have been 
rounded off downwards to whole months. The total duration of intramural care is subdivided into periods of hospitalization and periods in the 
nursing home. 
RESULTS OF T R E A T M E N T RESULTS OF TREATMENT 
Result 
cured 
not cured 
amputation 
uncertain 
deceased 
no infection 
Total 
Total 
N 
144 
19 
8 
19 
0 
9 
199 
Infection 
ecxlusrvely 
% 
72 
10 | 
4 ƒ 
10 Ì 
of 
5 
100 
% 
76 
14 
10 
100 
Osteom. Prosth. 
% 
72 
18 
10 
100 
% 
83 
7 
10 
100 
Sofi 
tissues 
% 
79 
9 
12 
100 
Table 8 11 Results of the treatments of the penod 1962 to 1977. 
The durations of the follow-up (mean and median) are listed in 
Table 8.9, which also shows the recurrence-free periods. 
Result Total 
N 
cured 75 
not cured 4 
ampu ta t i on 1 
uncer ta in 2 
deceased 2 
no infection 9 
Total 93 
Infection 
exclusively 
% 
81 
4 \ 
1 / 
ì) 
10 
100 
% 
89 
6 
5 
100 
Osteom. 
% 
92 
5 
3 
100 
Prosth. 
% 
85 
7 
7 
100 
Sofi 
tissues 
% 
100 
0 
0 
100 
T a b l e 9.11 Results of the treatments of the penod ¡977 to 1981. 
The durations of the follow up (mean and median) are listed m 
Table 9.9, which also shows the recunence-free penods. 
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REVIEW OF DURATIONS OF PERIODS IN THE CASE HISTORIES 1977-1981 
Period 
a. subclin. inf. 
b. manifest inf. 
с surgical 
treatment 
d. postoperative 
healing 
e. recurrence-
free 
a+b anamnesis 
b+c+d total infection 
c+d treatment of 
infection 
d+e follow-up 
Osteomyel. 
(39) 
N Mean Med. 
35 13 2 
38 19 5 
38 10 0 
36 1 1 
37 14 12 
35 34 12 
35 31 15 
36 11 3 
36 16 14 
Inf. prosth. 
(41) 
N Mean Med. 
41 22 5 
41 17 18 
40 3 0 
36 0 0 
37 15 12 
41 39 30 
36 23 22 
36 4 0 
36 16 12 
Inf. sofi 
tissues (4) 
N Mean Med. 
4 0 0 
4 1 0 
4 0 0 
4 4 1 
3 14 13 
4 1 1 
4 5 3 
4 4 1 
3 15 14 
ΛΌ/ inf. 
(9) 
N Mean Med. 
8 23 
8 7 
9 0 
8 0 
8 11 
8 31 
7 8 
8 0 
8 11 
8 
6 
0 
0 
10 
14 
7 
0 
10 
Total 
(93) 
N Mean Med. 
88 
91 
91 
84 
85 
88 
82 
84 
94 
17 2 
17 7 
6 0 
1 0 
14 12 
35 21 
24 14 
7 1 
16 13 
Table 9.9 Survey of the durations of periods of the case histories of 90 patients with 93 treated localizations, from the period 1977 to 198 J. The 
lengths of time have always been rounded off downwards to whole months. The table shows what numbers of durations were known and what 
were the mean and median values. 
SURVEY OF THE DURATIONS OF INTRAMURAL CARE 1977 -1981 
stay in hospital 
stay in nursing home 
total duration 
intramural care 
Osteomyel. 
(39) 
N Mean Med. 
38 
37 
38 
5 
0 
Inf. prosth. 
(41) 
N Mean Med. 
40 
38 
39 15 
5 
6 
11 
Inf. soft 
tissues (4) 
N Mean Med. 
4 
4 
Not inf. 
(9) 
N Mean Med. 
Total 
(119) 
N Mean Med. 
91 
88 
90 11 
Table 9.10 Survey of the total duration of intramural care of the patients classified by diagnostic category. The lengths of time have been 
rounded off downwards to whole months. The total duration of intramural care is subdivided into periods of hospitalization and periods in the 
nursing home. 
NUMBER OF OPERATIONS REQUIRED 
Number of operations Number of localizations 
per localization treated 
1 123 
2 29 
3 16 
4 12 
5 6 
6 3 
Total 199 
% 
62 
15 
8 
6 
3 
2 
100 
Table 8.12 Number of operations that were required for the 
treatment of the infections of one localization in the period 1962 to 
1977. 
NUMBER OF OPERATIONS REQUIRED 
Number of localizations Number of operations 
per localization treated 
1 
2 
3 
4 
5 
Total 
58 
20 
12 
2 
1 
93 
62 
22 
13 
2 
1 
ÏÖÖ 
Table 9 12 Number of operations that were required for the 
treatment of the infections of one localization m the period 1977 to 
1981. 
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,extr. in toto 28-
deep infection total hip 34^ extr. in part 2 
-not extr. 4 
-14 reimplantation 2 extr. at later stage; 
1 Girdlestone 
1 arthrodesis 
-14 Girdlestone 
6 extr. at later stage ; 
-3 reimplantations 
-3 Girdlestone 
Table 8.13 Review of the progress of the treatment of 34 deep infections afa total hip prosthesis treated during the period 1962 to 1977. 
deep infection total hip 24 : 
-10 reimplantation-
•14 Girdlestone 
1 reimplantation followed by Girdlestone at later stage 
Table 9.13 Review of the progress of the treatment of 24 deep infections of a total hip prosthesis treated during the period 1977 to 1981. 
LOOSENING OF 
ENDOPROSTHESIS 
Aseptic 
OSTEOMYELITIS SOFT TISSUE 
INFECTION 
Figure 8.2 Distribution of the localizations that have been treated in 198 patients (199 localizations). These are subdivided into infected and 
non-infected endoprostheses (left) and osteomyelitis or infection of soft tissues (right). The number of soft-tissue infections also includes 
infections of soft tissues in an osteomyelitis or infected endoprosthesis, usually abscesses or sinuses. 
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IRRIGATION SYSTEM GENTAMICIN-PMMA-BEADS 
total number of irrigation systems used: 101 
of which with antibiotics: 98 
without antibiotics: 3 
duration in situ of irrigation system in weeks: 0 week: 1 
superinfectio after: 1 week: 
2 weeks: 
3 weeks: 
4 weeks: 
unknown: 
8 
12 
6 
1 J 
9 
27 
1 week: 12 
2 weeks: 37 
3 weeks: 29 
4 weeks: 11 
^5 weeks: 10 
? weeks: 1 
leaking drains: 39 
clogged drains: 31 
reoperation: 4 
no remarks: 27 
none: 65 
TERMINATION irrigation system 
with a positive culture: 21 
because of failing system: 19 
after a negative culture: 57 
unknown: 4 
Table 8.14 Review of the data concerning the suction drainage 
treatments performed during the period 1962 to 1981. Eighty-seven 
treatments were carried out before 1977, 14 treatments during the 
period after 1977. The data presented comprise the duration of the 
treatment, the reason of termination, the recorded drain problems and 
the superinfections. 
LOOSENING OF 
ENDOPROSTHESIS 
Aseptic 
total number of times implanted at operation: 116 
removed manually without anaesthesia: 7 
not removed (deceased): 2 
removed at a second operation: 107 
Numbers of beads implanted Duration in situ in weeks 
5-30 : 27 
45-60 : 19 
75-90 : 24 
100-150: 25 
180-360: 20 
0-1 week : 2 
1-2 weeks: 20 
2-3 weeks: 69 
3-4 weeks: 16 
â4 weeks: 6 
unknown: 1 
Table 9.14 Review of the treatments with gentamicin-PMMA beads 
during the period after 1977. Data presented comprise the techniques 
of removal, the numbers of beads inserted and how long they were left 
in situ. 
OSTEOMYELITIS SOFT TISSUE INFECTION 
Figure 9.1 Distribution of the localizations that were treated in 90 patients (93 localizations). These have been subdivided into infected c.q. 
non-infected endoprostheses (left) and osteomyelitis or soft-tissue infection (right). The numbers of infections of soft tissues include the infections 
of soft tissues in osteomyelitis or infected endoprostheses, which were mostly abscesses or sinuses. 
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Chapter 9. Treatment after 1977 of 90 patients 
with gentamicin-PMMA beads 
9.1. Introduction 
At the Department of Orthopaedics of the Sint Radboud 
Hospital (R.C. University) of Nijmegen, gentamicin-
PMMA beads have been used in the treatment of infections 
since 1977. During the first IV2 years, the gentamicin-
PMMA beads were used side by side with the suction 
drainage system, from 1979 suction drainage was no longer 
used in the treatment of infections. 
For patients with osteomyelitis, infected endoprostheses 
and infections of soft parts in whom gentamicin-PMMA 
beads were used, the surgical procedure did not differ 
significantly from that described in Chapter 8. Complete 
debridement remains essential, and the same holds true of 
complete removal of bone cement in infected 
endoprostheses. Infections of soft parts have only been 
treated with gentamicin-PMMA beads in an early 
postoperative phase or in case of pronounced extension of 
the infection. 
Greater uniformity of the treatment was possible than prior 
to 1977, and in particular, more attention could be given to a 
complete, correct bacteriological diagnosis, owing to the 
prospective nature of this part of the investigation. 
9.2. Use of gentamicin-PMMA 
beads 
Following nettoyage of the focus of infection, chains of 
gentamicin-PMMA beads are implanted in the residual 
cavity, care being taken to place beads wherever in the 
entire region infection is assumed to exist. 
As experience grew with the passage of time, 
emphasis was progressively placed on complete packing of 
the entire infected cavity, using as many beads as possible. 
This was done to achieve a maximal concentration of 
gentamicin in the entire wound. 
Wounds are drained by suction for a few hours, and 
subsequently by syphoning. In larger cavities, good 
compression with a pressure bandage is important to limit 
the volume of the haematoma, thereby keeping the local 
gentamicin concentration high. It is especially after removal 
of total hip prostheses that very large haematomas with 
considerable blood loss may occur. If at all possible, the 
wound is closed. However, an open wound does not in itself 
constitute a contraindication to the treatment. In that case, a 
dry bandage is applied. While replacing bandages, strict 
asepsis is observed, and patients with open wounds are 
isolated, to prevent development of resistant bacteria in the 
hospital. Sealing the wound with plastic foil proved 
ineffective. The foil always came unstuck and the moist 
environment caused pronounced maceration of the skin. A 
few attempts to seal wound defects with synthetic skin 
(EpigardR, Parke-Davis; ColdexR, Temca) gave good results. 
Removal of chains protruding from the skin was carried 
out without anaesthesia in the first few patients. This 
method of removal proved laborious, often painful and 
sometimes impossible without severing adhesions in the 
subcutaneous layer or fascial sheath. After a few such 
experiences, the chains were placed in the wound in their 
entirety, and removed under anaesthesia. It is only in the 
case of an open treatment or of favourable local 
circumstances and a cooperative patient that occasionally, 
the chains are still removed without anaesthesia. 
If at surgical removal doubt arises whether the 
infection is cured, another nettoyage may be performed and 
gentamicin-PMMA beads implanted a second time. 
However, there are only few reliable criteria by which to 
judge healing. The impression has been gained that an all-
or-nothing reaction must be postulated: in case of failure of 
the treatment, hardly any granulation tissue develops and a 
purulent secretion persists. 
If the treatment is successful, a markedly proliferating 
granulation tissue develops after as little as a few days, and 
pus is absent. In case of open treatment, the gentamicin-
PMMA beads are then covered rapidly by granulation 
tissue. 
This assessment is more difficult to make in the 
treatment of infections of endoprostheses, especially hip 
prostheses. In the usually large cavity left by the removed 
prosthesis, a haematoma forms which undergoes 
liquefaction and assumes a light-brown colour. The 
granulation tissue remains mucous for a long time and at 
removal of the beads after two or three weeks is still soft, 
with a reddish-brown colour. It is only after three to six 
weeks that the granulation tissue grows firmer and becomes 
organised, and by then, the connective tissue firmly encases 
the beads even in large cavities. 
It was only in the few earliest cases of the group of 
patients described here that the beads were left in situ for 
long periods, of up to eight weeks. In these cases this was 
done because it was expected that at a second operation the 
entire wound would have to be explored, for instance for 
cancellous bone grafting or reimplantation of a prosthesis. 
Subsequently, the gentamicin-PMMA beads were always 
left in situ for periods of approximately two weeks, even 
when a cancellous bone grafting was performed 
immediately. Removal of these gentamicin-PMMA beads, 
two weeks after the first operation, was combined 
increasingly often with immediate reimplantation of a new 
prosthesis, without waiting for six months to one year as 
used to be the custom. 
9.3. Therapeutic complications 
In the course of the use of gentamicin-PMMA beads, the 
following complications proved to be more or less specific of 
this method of treatment: 
1. In large cavities, a large haematoma may develop, 
especially after removal of a hip prosthesis. The 
haematoma may be combated by application of a 
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pressure bandage or by simultaneous implantation of 
gauzes (Klemm, 198Γ). The latter method has not been 
used by us. 
2. The last gentamicin-PMMA bead may slip off the chain; 
this usually occurs when the chains are removed too late. 
In one patient, the removal was delayed because of a 
myocardial infarction In another patient, a bead slipped 
off during intramedullary introduction of two chains with 
the insertion implement Whether a bead has slipped off, 
as sometimes happens during removal, may be checked 
by inspecting the end of the chain. 
3 Cutaneous necrosis may develop after attempts to close 
the skin hermetically in spite of tightness In one woman, 
a gentamicin-PMMA bead was placed in the sub­
cutaneous tissue on the tibia, following which the 
pressure caused necrosis of the overlying skin. 
4 No allergic reactions to the gentamicin-PMMA beads 
have been observed by us 
5 Renal dysfunction during the treatment occurred in two 
patients In neither case was it caused by the treatment 
with gentamicin-PMMA beads In the first patient, sepsis 
had been present prior to the first operation and this had 
led to a disorder of renal function In the second case, the 
renal dysfunction developed in the course of the 
treatment with gentamicin-PMMA beads However, 
thorough examination failed to reveal any connection 
with the treatment; the findings suggested that the renal 
dysfunction was due to a pcnartcntis nodosa These two 
patients are described in Chapter 15, stating the 
frequently determined serum gentamicm levels 
6. Two patients have died. In both, severe sepsis constituted 
the indication for operation. In one, a woman, severe 
cardiac decompensation and renal dysfunction 
developed (see above). The other patient suffered from 
hepatic dysfunction as well and briefly after operation a 
septic shock occurred which could not be attributed to 
the gentamicin-PMMA treatment. 
9.4. The study 
9.4.1, Introduction 
The study of the clinical efficacy of gentamicin-PMMA 
beads has a prospective character, unlike the study of the 
patients described in Chapter 8 From mid-1977, the 
treatments were followed personally by the author. The 
treatments were performed as uniformly as possible, by the 
method described in par. 9 2. Growing insight prompted a 
few adjustments of the treatment, which are described in 
the same paragraph. 
The patients' medical files have been analysed in the 
same way as for the retrospective study of the patients 
described in Chapter 8 (Table 8 0) Patients whose 
treatment had already been completed were invited for the 
follow-up examination or, occasionally, interviewed by 
telephone 
9 4 2. Material 
From July 1977 up to and including April 1981, 90 patients 
were treated with gentamicin-PMMA beads, three of them 
in two different localizations. Table 9.1 lists these patients' 
data (sex, origin) (Table 9 1). 
These 90 patients were divided into four main groups 
on the basis of the diagnosis (as in par. 8 4 2). There were 
four infections of soft parts not associated with osteomyelitis 
or an infected endoprosthesis In addition, a large number of 
soft-part infections (mostly sinuses) did occur in 
combination with osteomyelitis or an infected 
endoprosthesis (Table 9.2 and Fig. 91). Each main 
diagnostic category has been divided into sub-groups as 
shown in Table 9.3. In these 90 patients, 93 localizations 
were treated by 147 operations. In addition to these 147 
operations, all of them performed for an existing or 
postulated infection, a number of a/ter-treatments were 
carried out. The numbers of operations required for 
treatment of the infection are also shown in Table 9 3, 
classified by main diagnostic groups and diagnostic sub­
groups. 
At each of the 147 operations, several interventions were 
carried out. These interventions are listed in Table 9 4, with 
the percentages of the total of 147 operations at which they 
were carried out The numbers of after treatments are listed 
in the same table This table shows that gentamicin-PMMA 
beads were implanted at 116 of the 147 operations Most of 
the 31 operations at which no beads were implanted, were 
carried out prior to subsequent implantation of gentamicin-
PMMA beads. These operations without gentamicin-
PMMA beads have nevertheless been included in the 
coding, in order to gain a complete insight into the case 
histories. 
Table 9 5 lists the causative agents cultured at the 147 
operations The several bacteria encountered in mixed 
infections have been listed separately The number of 
anaerobic causative agents is larger than in Table 8 5 
because from tnid-1977, anaerobic cultures were always 
included. The larger proportion of sterile cultures when 
antibiotics were used (8 % as gainst 1 %) is explained by the 
fact that culture material was collected at removal of the 
gentamicin-PMMA beads. Even in case of an unsuccessful 
treatment with gentamicin-PMMA beads, the culture is 
nevertheless often negative, possibly owing to the locally 
high concentration of antibiotic. 
The fact that the proportion of unreliable or 
incomplete data was much smaller than in the retrospective 
study (1 % as against 19%) is explained by the prospective 
character of this part of the study The numbers of mono-
and mixed infections are shown separately in Table 9 6 
Table 9 8 shows the median age in years at the time of the 
first operation 
Table 9 9 surveys the durations of the various periods in the 
evolution of the disease in the 90 patients in whom 93 
localizations were treated. The durations have been 
rounded off downwards to whole months. They have been 
distilled from the case histories according to the scheme 
shown in table 9.7 Just as Table 8 9, Table 9 9 states what 
phases of the evolution were known and what were the 
mean and median durations for the main diagnostic 
category in question 
Table 9 10 gives a survey of the duration of intramural care 
of the patients, subdivided by diagnostic groups. This 
duration has been calculated per patient by adding up the 
durations of the various stays, in the hospital and in the 
nursing home, which are listed separately. 
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9.5. Results 9.6. Discussion 
The results of the treatment with gentamicin-PMMA beads 
in 90 patients, three of them treated for two different 
localizations, are shown in Table 9.11. These figures have 
been corrected by omitting the results of the treatment in 
the nine patients in whom no infection could be 
demonstrated: the patients with a painful loose prosthesis in 
whom infection could be excluded on the basis of the 
peroperative cultures. Of the remaining patients, after a 
median follow-up of 13 months, 89% proved free from 
recurrence for a median period of 12 months. The cure rate 
in the osteomyelitis group (92 %) was higher than that of 
the group with infected endoprostheses (85%). All four 
patients with an infection of soft parts were cured. 
In 44% of the infections, more than one treatment was 
necessary (Table 9.12). When a treatment failed, this was 
always found to be due to inadequate debridement. If 
nettoyage and sequestrectomy had been over-cautious or a 
cement rest was left in situ, reoperation was always 
necessary. The results of the treatment of infected total hip 
prostheses are shown in Table 9.13. In the group of 24 
patients in whom a total hip prosthesis was removed, 
immediate reimplantation was carried out ten times. One of 
these reimplantations was performed after removal of just a 
loose femoral component of the total prosthesis. This 
second exchange of the femoral component proved once 
more unsuccessful, and a Girdlestone resection was carried 
out (patient 4 in Chapter 15). In nine patients, reimplanta­
tion with use of antibiotic-loaded cement was successful. 
In the patients with an infected endoprosthesis of the 
knee, arthrodesis of the knee was carried out after removal 
of the prosthesis and treatment of the infection. 
Consolidation was not always easy to achieve, especially in 
patients with Guepar prostheses. Also, in two of these 
patients the infection could not be controlled, and in one of 
these, a thigh amputation was ultimately necessary and 
revealed the presence of cement up to high in the femur. 
In considering the data in this chapter, it should be kept in 
mind that out of the 147 operations performed on the 90 
patients, 31 were carried out without use of gentamicin-
PMMA beads. In 21 cases, the subsequent operations were 
carried out with implantation of gentamicin-PMMA beads. 
These operations have been included in the coding in order 
to obtain a complete survey of the case history. Ten times, 
after earlier use of gentamicin-PMMA beads was followed 
by a recurrence, a different method of treatment, without 
beads, was opted for. In two patients, the method of 
treatment was even changed twice: alternatingly, 
gentamicin-PMMA beads and suction drainage. 
In other words, the results as shown in Table 9.11 
are not to be attributed exclusively to treatment with 
gentamicin-PMMA beads, A detailed analysis of the effect 
of one type of operation is presented in Chapter 10. 
The prospective nature of this part of the study may affect 
the results. Observance of a protocol for the treatment of 
infections guarantees increased attention for the treatment 
of infections. This is confirmed by a smaller number of 
unusual culture results and a larger number of anaerobic 
causative agents detected, compared with the study of the 
period prior to 1977. 
Table 9.5, listing the causative agents encountered shows a 
persistently important part of Staphylococcus aureus (see 
also Table 8.5 and Tables 2.1 and 3.9). There has been no 
major shift in the range of causative agents of the infection 
compared with the period prior to mid-1977. In particular, 
the group of Pseudomonas and Proteus shows no 
pronounced increase. On the other hand, a decrease can be 
observed of the proportion of penicillin-sensitive strains of 
Staphylococcus aureus. Further, there is a slight increase of 
Staphylococcus albus and enterobacteriaceae. The higher 
frequency with which anaerobic bacteria were 
demonstrated in our material (over 7%), should be 
attributed to the systematic anaerobic culturing from mid-
1977. 
The fact that thorough culturing, including anaerobic and 
multiple culturing, provides more data and frequently 
surprises as well is illustrated by Fig. 9.2. Among the 58 
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Figure 9.2 Results of cultures of material collected peroperatively at removal of infected total hip prostheses during 
the period 1962 to 1981; contradictory culture results were obtained in 10 patients. If material for only one culture had 
been collected, the erroneous conclusion of absence of infection would have been drawn in nine of these 10 cases. 
St.alb.: Staphylococcus albus; st.aur.: Staphylococcus aureus; kleb.: Klebsiella; an.st.; anaerobic rod;pr.a.: Propioni­
bacterium acnes; o: sterile culture. 
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cases of infected total hip prostheses described in Chapters 
8 and 9, there were ten in which different culture results 
were obtained from the different localizations. The 
combination of sterile cultures and Staphylococcus albus 
was seen frequently, and also that of Klebsiella and 
anaerobic bacteria. It is clear that if only material for a single 
culture had been collected, the erroneous conclusion that 
no infection was present, might have been drawn in nine of 
these ten cases. In these ten patients, there was other 
evidence suggestive of an infection, as well, so that 
contamination as the cause of a positive culture side by side 
with sterile cultures can be excluded. 
Table 9.14 lists the data of the 116 treatments with 
gentamicin-PMMA beads. Removal of the beads without 
anaesthesia was carried out only seven times. Mostly the 
beads were left in situ for two to three weeks. 
Table 9.15 allows a comparison of the results of our 
treatment with the results as reported in the literature. 
Author 
In Contzen 1977: 
Klemm '77 
Übelhör et al. '77 
Jenny '77 
Vecsei '77 
Winkelman et al. '77 
in Burri + Rüter 1979: 
Klemm '79 
Müller et al. '79 
Vecsei '79 
Schulte et al. '79 
Lambiris et al. '79 
Jenny et al. '79 
Probst et al. '79 
W 
69 
78 
40 
18 
20 
147 
171 
75 
40 
88 
134 
205 
in v. Rens + Kayser 1981: 
Klemm '81 
Groóte et al. '81 
Vecsei '81 
Härleetal. '81 
Weise et al. '81 
Jenny et al. '81 
Eberle '81 
in several journals: 
Ackermann '80 
Asche '78 
Goudarzi '81 
Graeber '80 
Härle '78 
Hedström et al. '80 
Jenny 
Kantor '78 
Mehdi et al. '80 
Vecsei et al. '81 
101 
27 
44 
118 
44 
47 
34 
60 
31 
68 
31 
38 
40 
12 
296 
35 
24 
48 
51 
60 
25 
Follow-up Prim. + Sec. 
-4 years 
- 2 years 
- 1 years 
VA - 2 years 
-10 months 
3 -6 years 
1 - 3 years 
l-4 ,/2 years 
V2-2V2 years 
1 year 
11/2 _ 41/2 years 
'/з-4 years 
3 years 
3 years 
2-З years 
1 - 6 years 
'/2 - 3 '/2 years 
1 VA years 
9-45 months 
10-40 months 
8-34 months 
1 - ? years 
2-28 months 
З 2 years 
3-24 months 
3-24 months 
2-5V2 years 
? 
9-39 months 
? - 2 years 
1-36 months 
1 years 
3-5 years 
healed 
67% 
79% 
85% 
67% 
70% 
86% 
85% 
92% 
80% 
80% 
70% 
89% 
86% 
82% 
73% 
96% 
82% 
55% 
71% 
63% 
58% 
75% 
65% 
82% 
82% 
64% 
79% 
94% 
92% 
73% 
80% 
92% 
88% 
Recid. 
14% 
6% 
8% 
10% 
6% 
7% 
Doubtful 
28% 
4,5% 
(after second revision 
0% 
5% 
6% 
8% 
11% 
8% 
2% 
20% 
5% 
5% 
3% 
8% 
2% 
Not 
healed 
19% 
21% 
15% 
5% 
30% 
7,5% 
15% 
3% 
20% 
8% 
20% 
11% 
8% 
11% 
27% 
4% 
100%) 
45% 
24% 
27% 
32% 
35% 
18% 
10% 
25% 
21% 
6% 
23% 
8% 
12% 
Indications ' ' 
osteomyelitis 
osteosynth. inf. 
osteomyelitis 
osteomyelitis 
17 osteomyelitis, 
3 total hip 
Osteom., prosth. ST 
osteom., prosth. 
osteomyelitis 
osteom., prosth. ST 
osteom., prosth. ST 
osteom., soft tiss. 
osteomyelitis 
osteom., stable 
osteom., unstable 
osteom., prosth. 
osteomyelitis 
haemat. osteomyelitis 
osteom. soft tiss. 
local osteitis 
chron. osteomyelitis 
inf. pseudarthr. 
ostemyehtis, arthritis 
many indications 
hand inf. 
osteomyelitis 
inf. pseudarthrosis 
osteomyelitis 
osteomyelitis 
osteomyelitis, arthritis 
many indications 
osteomyelitis 
osteomyelitis 
osteomyelitis 
Table 9.15 Review of the literature on the results of the treatment of osteomyelitis with gentamicin-PMMA beads; where necessary, 
percentages have been calculated. 1) ST: soft tissue infection) 
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9.7. Comparison of the results of the 
treatments with suction drainage and 
with gentamicin-PMMA beads 
A prospective comparison of the two methods of treatment 
of infection has been carried out in our patients in 1977 and 
1978. In these years, two groups of patients (with osteo­
myelitis or with an infected total hip prosthesis) were 
divided at random into two groups, of which one was treated 
with gentamicin-PMMA beads and the other with suction 
drainage. In all, 27 patients were treated in IVfe years. The 
therapeutic results of treatment with gentamicin-PMMA 
beads seemed better (Table 9.16). However, statistical 
analysis showed that there was no significant difference 
between the two treatment groups in regard to the 
proportions of cured and non-cured patients (Fisher exact 
test, ρ = 0.50). The number of patients proved too small to 
allow a statistically significant conclusion. 
Since the results were not demonstrably worse, either, 
it was decided, on the basis of the 'clinical' impression, 
always to use gentamicin-PMMA beads from 1979. This 
decision was largely based on the many practical advantage 
of this treatment: patients' comfort, nurses' workload and 
bacteriological superiority. 
% of t h e -
infect ions 
100-1 
8 0 -
6 0 -
Д 0 -
2 0 -
190 infections 
conventional 
treatment 
. ·.—· healed 
-· not healed 
uncertain 
a 
3 4 5 6 
N. o p e r a t i o n s / pat ient 
Results 1977-1978 
prim, cured 
sec. cured 
not cured 
not certain 
Total 
Suction drainage 
N 
7 
6 
1 
14 
% 
50 
43 
7 
100 
Gentamicin-PMMA 
beads 
N % 
8 61 
1 8 
3 23 
1 8 
13 100 
Table 9.16 Comparison of the results of a prospective study of 
treatment with suction drainage or with gentamicin-PMMA beads, 
with at-random allotment of treatments. There is no statistically 
significant difference (Fisher exact text, ρ = 0.50). 
Since further prospective comparison of the two methods of 
treatment was no longer possible, the results were 
compared with the retrospectively studied group described 
in Chapter 8. The diagnostic distribution of this group was 
similar to that of the group of patients who Λαί/been treated 
with gentamicin-PMMA beads. The earlier group had been 
treated in the same clinical department by a team of 
orthopaedic surgeons which, in spite of some coming and 
going, nevertheless displayed a high degree of continuity 
and uniformity of treatment. In spite of the difference 
between the two groups of patients where moment of 
treatment and investigation technique are concerned, there 
is a good deal of similarity. 
Comparison of the cure rates in the two groups leads to the 
conclusion that 'cure' was on the whole achieved more often 
in the group treated after 1977: 89% as against 76% in the 
group treated prior to 1977. This difference is more 
pronounced if only the osteomyelitis cases are considered: 
92% and 72%, respectively (see Tables 9.11 and 8.11). 
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Figure 9.3 Results of the treatment of infections. The curves show 
the results at the maximal number of the operation performed per 
patient. Fig. A shows the results of patients treated by conventional 
methods m the period 1962 to 1977. Fig. В shows the results of 
treatment with gentamicin-PMMA beads during the period 1977 to 
1981. The results of treatments of non-infected endoprostheses have, 
of course, been discounted. After for instance 3 operations (or ¡ess!) 
with the use of the gentamicin-PMMA beads more infections are 
healed than in the case of a convential treatment. 
Another way of comparing the two methods of treatment is 
by graphic plotting of the maximal number of operations 
which the patient had undergone in the department against 
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the number of infections cured by thai number of 
operations (Fig. 9.3). We then find that in patients treated 
with gentamicin-PMMA beads (84 infections) the cure rate 
of 89 % was achieved after a maximum of three operations in 
one patient. In the 190 infections treated by a different 
method, a success rate of 76 % required a larger number of 
operations. This difference between the two treatment 
groups in the number of operations required to achieve the 
ultimate result is even larger if we include the operations 
that had been performed elsewhere. In the group of patients 
treated with gentamicin-PMMA beads, namely, the 
proportion of referred patients amounts to 46 %, as against 
65% in the other group (see Tables 8.1 and 9.1). 
That cure is obtained faster with the gentamicin-PMMA-
bead treatment is also confirmed by the different durations 
of the 'periods of post-operative healing', which (according 
to the medical files) was less than one month with the 
gentamicin-PMMA beads (Table 9.9) as against two months 
with other methods of treatment (Table 8.9). 
Comparing results of two methods of treatment, as done 
here, is a precarious business. It should be kept in mind that 
'cured' means '(still) free from recurrence'. It is only 
incompletely possible to take into account differences in 
indication, age structure, sex, follouw-up, etc. To account for 
these factors, statistical analyses have to be carried out. 
These statistical calculations are presented in Chapter 10. 
For this purpose, use has been made of the analysis of the 
case history and of the findings at operation as stored in the 
computer (Tables 8.0 and 8.7). 
Apart from the results of treatments, we also have to 
consider the discomfort to the patient caused by these 
treatments. Accordingly, in Chapters 8 and 9, we have 
discussed the numbers of operations that are required, and 
any additional treatment that may be necessary, such as 
systemic antibiotics. The number of complications, 
including superinfection via the irrigation system, also plays 
a part in this comparison. This comparison, in as far as 
relevant, has already been described in Chapters 8 and 9. To 
facilitate the figures concerning the two groups of patients, 
the tables have been drawn up uniformly and are presented 
side by side. 
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Chapter 10. Comparative statistical analysis of treatment 
with suction drainage and with 
gentamicin-PMMA beads 
10.1. Introduction 
When a new method of treatment is being used, and 
ultimately a choice will have to be made between it and 
existing methods that have already proven their value, 
comparison of the therapeutic results is the main element. 
Other aspects of the treatment, such as technique, costs, 
patient stress and nursing workload, are important but 
secondary: the final result is paramount. When results are 
compared in a non-statistical manner, as done in Chapter 9, 
the possible influence of a number of factors such as age 
distribution, differences in diagnosis, duration of follow-up 
infection of soft parts 
not infected 
TOTAL NUMBER OF OPERATIONS 1962-1981 
__ _ osteomyelitis 
430] infected prosthesis 
Intermediate operations: 194 
incomplete data : 19 
4Final operations: 236 
incomplete data: 15 
deceased : 2 
amputation : 9 
analysed intermediate operations: analysed final operations: 
175 210 
genta beads 25 
irrigation system 36 
Others' 114 
genta beads 67 
irrigation system 51 
'others' 92 
Recurrence function (par. 10.4 + 5) Duration of healing function (par 10.4 + 6) 
chance of T> 0 duration of Τ chance of G = 0 
(par. 10.5.2) (par. 10.5.3) (par. 10.6.2) 
duration of G 
(par. 10.6.3) 
Table 10.1 Review of the operations analysed statistically in 
Chapter ¡0, indicating the distribution of operations of various types, 
and the paragraphs in which these operations are discussed. 
Main 
diagnosis 
osteomyelitis 
infected 
prosthesis 
infection of 
soft tissues 
not infected 
Total 
Number of localizations with 
1, 2, 3, 4, 5 or 6 operations 
1 
77 
52 
34 
18 
181 
2 
33 
24 
2 
0 
59 
3 
23 
3 
2 
0 
28 
4 
12 
2 
0 
0 
14 
5 
6 
1 
0 
0 
7 
Numbers of 
localizations 
6 
3 154 
0 82 
0 38 
0 18 
3 292 
Table 10.2 Review of the total number of localizations treated, 
numbers of operations performed and the mam diagnoses. 
etc. cannot be included in the analysis. Comparison of the 
two groups of patients requires the application of statistical 
methods in which the differences between the groups of 
patients are taken into account. 
10.2. Material 
Only those operations have been used in the statistical 
analysis in which the main diagnosis was osteomyelitis or 
infected endoprosthesis and concerning which all data could 
be collected that were necessary for an explanatory analysis 
of the surgical results. Table 10.1 and 10.2 presents a survey 
of the total number of localizations treated (bilateral in four 
patients) that have been included in the material. 
Subdivisions have been made on the basis of the number of 
operations performed per localization and on the basis of 
the main diagnosis. The total number of infections treated 
amounts to 274; in addition, 18 non-infected endo-
prostheses have been treated. In 236 localizations (81%), 
the main diagnosis was either osteomyelitis or infected 
82 
prosthesis. The total number of operations performed in 
these cases is 430 (see also Tables 8.3 and 9.3). 
The 430 operations are divided into two groups (see 
table 10.1): 
a. 'Intermediate operations': these operations were followed 
by other operations because of a recurrence of the in-
flammation. 
b. 'Final operations': these operations were not followed by 
others. Accordingly, they are either the last operation of a 
series of treatments, or, in the case of patients whose first 
operation they were, their only operation. 
The intermediate operations numbered 194, the final 
operations 236. 
At two final operations, the patients died and at nine 
final operations, amputation proved necessary; these 11 
final operations have not been taken into account. 
Therefore, the numbers of intermediate operations 
and final operations in principle to be considered for 
statistical analysis are 194 and 225, respectively. 
However, the data required for statistical analysis were 
not always present in the medical files. For 6% of the 
intermediate operations, the duration of the period free 
from recurrence is unknown. The duration of the post-
operative healing period c.q. follow-up period is unknown 
for 4% of the final operations. For 175 intermediate 
operations and 210 final operations, we know not only the 
duration of the period free from recurrence and of the post-
operative healing period, but also all values of a number of 
background variables. It was decided to base the analysis on 
175 of the 194 intermediate operations (90 %) and 210 of the 
225 final operations (93%) (Table 10.1). 
Of the intermediate operations, none of the 
gentamicin-PMMA-bead operations had to be excluded for 
lack of data; 10% of the intermediate operations with 
suction drainage and 12 % of those treated by other methods 
had to be excluded for this reason. Of the final operations, 
the percentages for the three methods of treatment 
(gentamicin-PMMA beads, suction drainage and 'other' 
treatments) that had to be excluded amounted to 1 %, 6% 
and 11 %, respectively. 
For this reason, in interpreting the results of the 
explanatory and comparative analyses in the paragraphs 
below, the possibility should be taken into account that 
owing to selective dropping-out of the suction drainage 
operations and 'other' treatments, the picture that emerges 
is slightly distorted. This distortion has to be attributed to 
the fact that the operations with gentamicin-PMMA beads 
were studied prospectively, and the other methods of 
treatment retrospectively. 
10.3. Statistical methods 
For this study, methods are applied that are used to study 
the survival time data. In many studies of the duration of 
survival, the cardinal element is the duration of the interval 
between a marking point and the occurrence of a particular 
critical event. In the present study, such a marking point is 
the moment of operation, while the critical event is the 
presence of a recurrence after an intermediary operation or 
the statement that the infection was cured at a final 
operation. 
The function most often used to describe durations of 
survival is the survival function S(t); this is defined as: the 
probability to survive at least for a perod of time t. In the 
context of this investigation, the concepts 'survival time' 
and 'survival function' have to be adjusted to the critical 
events as defined for intermediate operations and final 
operations, respectively. The following definitions arc used 
to describe durations of recurrence and durations of post-
operative healing in 'survival time' terminology. 
For intermediate operations: survival time is: the duration 
of the period free from recurrence 
For final operations: surival time is: the duration of post-
operative healing. 
So, the meaning of'survival time' in regard to intermediate 
operations and final operations is different and to some 
extent even contradictory. Also, in the analysis of final 
operations, we face the problem of the incomplete follow-
up, i.e. for a number of operations, the moment at which the 
infection can be declared cured falls outside the follow-up 
period. All that is known about these operations is that the 
duration of postoperative healing exceeds the observation 
period. This eventuality is called a censored observation. 
Accordingly, in the statistical analysis of the final 
operations, this problem of incomplete follow-up has to be 
taken into consideration. In this connection it should be 
postulated, however, that the censoring takes place 
according to a mechanism that is independent of the 
mechanism that determines the duration of postoperative 
healing. 
In describing and comparing the therapeutic results of 
gentamicin-PMMA-bead treatments, suction-drainage 
treatments and treatments by other methods, use is made of 
'recurrence functions' and 'healing time functions'. The 
definitions of these functions correspond to the definitions 
of survival functions in studies of survival times: 
R(t) = recurrence function at intermediate operations 
= probability of a recurrence-free period of at least t 
months 
G(t) = healing time function at final operations 
= probability of a duration of healing of at least t 
months. 
In addition to a description and comparison of surgical 
results with the aid of recurrence functions and duration of 
healing functions, regression models are applied for a 
comparative analysis of the three surgical techniques. As 
mentioned above, in comparing methods of treatment it is 
important also to take into account background variables 
that-in a statistical sense-may influence the surgical 
result1). The regression models applied in the paragraphs 
below meet this purpose. 
10.4. First review of therapeutic 
results of intermediate operations and 
final operations 
For the description of the surgical results, the recurrence-
free periods at intermediate operations and the duration of 
postoperative healing at final operations are subdivided into 
intervals. We have opted for a subdivision based on the 
following moments: 
moment of operation (0), immediately after operation 
) The statistical analysis does not refer to causal relationship 83 
Tdble 10 3 RECURRENCE-FRF F PERIODS AT Γ5 INTERMEDIATE OPbRATTIONS SUBDIVIDED INTO 
GENTAMICIN-PMMA BEAD TRLATMLNT, IRRIGATION SYSTEM AND OTHER' OPERATIONS 
Interval ' ' 
(months) 
Type of operation 
Number of patients without 
recurrence at beginning of interval 
Genta Irrig Others Total 
Recurrence function R(t) 
Cumulative pere without 
recurrence at end interval2) 
Genta Irrig Others Total 
0-0+ 
0+-30 
3 0 - 6 0 
6 0 - 1 2 0 
120-240 
24 0-60 0 
600 
25 
6 
6 
3 
2 
0 
36 
14 
11 
7 
1 
1 
0 
114 
52 
36 
24 
13 
6 
5 
175 
72 
53 
34 
16 
7 
5 
24 
24 
12 
8 
0 
39 
31 
19 
3 
3 
0 
46 
32 
21 
11 
5 
4 
0 
41 
30 
19 
9 
4 
3 
0 
i)0 = moment of operation Q+ = immediately after the operation 2) = end point of interval not included 
(0+) and 3 0, 6 0, 12 0, 24 0 and 60 0 months, respectively, 
after operation 
The recurrence functions R(t) and the duration of 
healing functions G(t) corresponding to the three types of 
operdtion-gentamicin-PMMA beads, suction drainage and 
'other methods'-are compared with the aid of the Lee-
Desu statistic (SPSS computer package) In the comparative 
analysis of the duration of healing functions G(t), the 
incomplete follow-up of operations is taken into account 
The distorting influence of a possible difference in back­
ground variables on this comparison is studied in 
paragraphs 10 5 and 10 6 
FUNCTION OF RELAPSE R(t) 
Gentamicm-PMMA-Beads (25) 
Suction-drainage (36) 
Other treatments (114) 
24 6 0 
m n t h 
Figure 10 1 Graphic representation of thefiinction of relapse R(t) of 
the three types of treatment of an infection gentamian-PMMA beads 
(25 operations), suction drainage (36 operations) and 'other' 
treatments (114 operations) Plotted on the Y-axis is the probability of 
a recurrence-free period of at least t months The time t m months is 
plotted on the X-axis (0 = moment of operation 0+ = immediately 
after the operation At moment t, the probability that after this 
moment t the relapse will occur, amounts to Y% 
10 4 1 Intermediate operations 
Table 10 3 presents a survey of the recurrence-free penods 
with gentamicin-PMMA beads, suction drainage and other 
operations The recurrence functions R(t) of these three 
surgical techniques are represented graphically in Fig 10 1 
This figure shows at time t after operation (X-axis) the 
probability (Y-axis) that the recurrence will take place after 
time t (this recurrence will take place because it is an 
intermediate operation) 
No clearly significant differences between the three 
recurrence functions is found (p = 0 23) However, there is 
some evidence to suggest that after gentamicin-PMMA-
bead operations the interval before a recurrence will be 
shorter, this by comparison with 'other' operations (p = 
0 10) We find for gentamicin-PMMA-bead operations that 
if Ά recurrence takes place (in 25 of the 102 operations), this 
recurrence is observed immediately following the operation 
in 76% (19 of the 25 recurrences) However, when no 
recurrence takes place immediately after the operation, it 
takes three months before a recurrence is observed After 
'other operations', 54% show immediate recurrence For 
suction drainage operations this proportion amounts to 
61% 
10 4 2 Final operations 
Table 10 4 shows a survey of the durations of postoperative 
healing The duration of healing function G(t) of 
gentamicin-PMMA beads, suction drainage and other 
operations, are represented in Fig 10 2 The therapeutic 
results of the three types of operation are clearly different 
(P < ю^) 
At paired comparison, also, the functions G(t) prove to 
differ significantly from each other (genta-suction ρ < 10"4, 
genta-others ρ < IO"*, suction-others ρ = 0 05) At 'final' 
operations with gentamicin-PMMA beads, 52% is 
immediately declared cured Subsequently, the number of 
patients that is 'cured' is larger during the entire case history, 
with extrapolation where necessary 
For 'other' operations, the median duration of healing is 
three months and with the suction drainage operations, it 
even takes over four months after the final operation before 
50 % of the patients (operations) are declared cured 
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Table 10 4 POSTOPERATIVE HEALING TIME AT 210 FINAL OPERATIONS SUBDIVIDED INTO GENTA-
MICIN-PMMA BEAD TREATMENT, IRRIGATION SYSTEM AND OTHER' OPERATIONS 
Interval· > 
(months) 
Type of operation Healing function G(t) 
Number of patients not yet cured 
at beginning of interval2) 
Cumulative percentage not yet cured 
at end interval ^  
Genta Irrig Others Total Genta Irng 
1) 0 = moment of operation 0+ = immediately after the operation 
2) ( ) = numbers of operations with a censured duration of heating during the interval in question 
3) end point not included 
Others Total 
0-0+ 
0+-30 
3 0 - 6 0 
60-120 
120-240 
24 0-60 0 
60 0 
67 
32 
13(2) 
4 
2(1) 
KD 
0 
51 
48(2) 
28(2) 
19(1) 
16(3) 
10(4) 
3(2) 
92 
78(4) 
40 
29(2) 
23(5) 
12(6) 
3(2) 
210 
158(6) 
81(4) 
52(3) 
41(9) 
23(11) 
6(4) 
48 
19 
8 
4 
4 
4 
94 
58 
43 
38 
30 
19 
9 
85 
47 
34 
29 
21 
14 
7 
75 
41 
28 
23 
18 
12 
6 
FUNCTION OF HEALING-TIME G(t) 
1 Gentamicin- PMMA-Beads (67) 
2 Suction-drainage(51) 
Ч
Ч ^ 3 Other treatments (92) 
4 \ 
24 6 0 
m n t h 
Figure 10 2 Graphic representation of the function of healing time 
G(t) with the same types of treatment as in Fig 10 1 but now for 67,51 
and 92 operations, respectively Plotted on the Y-axis is the 
probability m per cent of a duration of healing of at least t months, 
plotted on the X-axis is the time t m months At moment t, the 
probability that a patient will be declared cured аист this timet is Y% 
10 4 3 Conclusion 
There is some evidence to suggest that at intermediate 
operations the interval before a recurrence, if any, is shorter 
if gentamicin-PMMA-bead treatment is applied At the final 
operations, it is then evident that the patient is declared 
healed sooner and more often In this connection, the differ­
ence m follow-up has been taken into account However, 
this comparison still fails to take into account the differences 
in background variables such as age at the time of the 
operation, sex and diagnosis To what extent possible 
diflerences m background variables influence the results 
obtained here is studied in the next two paragraphs 
10.5. Analysis of intermediate 
operations 
10.5 1 Definition of the problem and variables 
At the analysis of the intermediate operations, there are two 
questions to be answered 
a What vanablc(s) influence(s) the probability of 
occurence of a period free from recurrence after the 
operation9*) 
b If a recurrence-free period takes place, what variables 
then contribute to an explanation of the duration ofthat 
period9 
The variables that were considered to be of possible 
importance for these questions and which therefor have 
been included in this analysis are 
1 age at the time of the operation 
2 sex 
3 diagnosis 
4 duration of the manifest inflammation 
5 in regard to the anamnesis is it the first operation of the 
(own) patient or is it a patient who has been operated 
before, sometimes several limes (own or referred)9 
6 the type of (surgical) treatment 
In order to find answers to questions a and b, logistic and 
multiple linear regression analyses have been carried out 
The interpretation of the results of these analyses depends 
on the definitions of the variables m question These 
variables are defined below A distinction is made between 
*) Induente is used in a statistical sense, ι e 
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variables to be explained (dependent variables) and 
explanatory (independent) variables: 
- variable to be explained: 
Τ = duration of recurrence-free period of an intermediate 
operation in months 
- explanatory variables: 
Zi = age at the time of the operation in years 
г
г
 = sex (0 = man, 1 = woman) 
Z3 = diagnosis (0 = osteomyelitis, 1 = infected endo­
prosthesis) 
Z4 = elog (d + 1), in which d = duration of the manifest 
inflammation in months*) 
Z5 = 0 = own patient and first operation, z5 = 1 = others. 
To study the results of operations with gentamicin-PMMA 
beads and irrigation systems, use has been made of socalled 
'dummy variables' (ze, Z7). This pair of variables describes 
the classification of the operations in three types as follows: 
Zé = 1 z7 = 0 : gentamicin-PMMA beads 
Zé = 0 Z7 = 1 : irrigation system 
z6 = 0 z7 = 0 : others. 
In addition, analyses have been carried out to study the 
influence of the variables Z] to z5 inclusive on the result. For 
these analyses, only data concerning operations with 
gentamicin-PMMA beads and irrigation systems have been 
used. 
10.5.2. Explanatory variables of the probability of a 
recurrence-free period after an intermediate operation 
10.5.2.1. Method 
In the linear logistic regression model, the chance of a 
recurrence-free period is explained from the values of 
variables Z\ to z7 inclusive. The probability of a recurrence-
free period (P(T > 0), is expressed as a function of variables 
z1 to Z7 inclusive by: 
exp (p0 + Σ = PjZj) 
P ( T > 0 ) = '—^ 
1 + exp (β0 + Σ_ PjZj) 
j - 1 
The meaning of the regression coefficients β! to ß7 inclusive 
in the model may in general be described as follows: 
ßj = 0: the corresponding variable Zj exerts no influence on 
the probability of occurence of a recurrence-free 
period. 
ßj = positive: the higher the value of the corresponding 
explanatory variable Zj, the higher the probability of 
a recurrence-free period. 
ßj = negative: the higher the value of z,, the less this 
probability. 
For instance, if the dichotomous variable z3 has a negative 
regression coefficient ß3; this means that the chance of a 
recurrence-free period after an intermediate operation is 
less for the diagnosis 'prosthesis' as compared with the 
diagnosis 'osteomyelitis' (for equal values of the other 
variables included in the model). 
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10.5.2.2. Results 
For the analysis, only those intermediate operations (175) 
have been used for which the values of all explanatory 
variables are known. The mean values of these variables are 
listed in Table 10.5. 
The percentages of the intermediate operations 
followed by a recurrence-free period are 24% for 'genta-
bead-operations, 39% for 'irrigation system' operations and 
46% for 'other' operations (see also Table 10.3 and par. 
10.4.1). If a possible influence of variables z, to z5 inclusive is 
discounted, no clearly significant difference between these 
three operations is demonstrable. At most we can say that 
there is an indication of a difference in probability of 
occurrence of a recurrence-free period (Chi-square test for a 
(3 χ 2) table, ρ = 0.13). 
A logistic regression analysis with simultaneous use of 
variables Z! to z
s
 inclusive and the surgical method of treat­
ment yields the following: A significant 'overall' influence of 
these seven explanatory variables is not demonstrable 
(Ho : ßi = ßj = . . . = β? = β? = 0, likelihood ratio test, 
ρ = 0.22). 
However, an investigation of the influence of the 
individual explanatory variables on the probability of a 
recurrence-free period in which the values of the other 
explanatory variables are taken into account, yields an 
indication that at operations with gentamicin-PMMA beads 
the probability of a recurrence-free period is less than with 
'other' operations (β6 = -1.02, ρ = 0.05). In this respect, no 
significant differences are found between irrigation-system 
operations and 'other' operations and between irrigation-
system operations and gentamicin-PMMA-bead operations 
(p = 0.38 and ρ = 0.27, respectively). 
The joint influence of the explanatory variables Z| to Z5 
inclusive on the chance of a recurrence-free period (H0 = ßi 
= Рг = . . . = ßs = 0) has been studied for each of the three 
groups of operation types separately (genta beads, irrigation 
system, others). No significant influence is demonstrable 
(logistic regression analyses: ρ = 0.69, ρ = 0.30, ρ = 0.22). 
10.5.2.3. Conclusion 
There is some evidence to suggest that /fatter an operation a 
recurrence develops, the probability of a recurrence-free 
period after a treatment with gentamicin-PMMA beads is 
relatively small as compared with suction drainage system 
or other treatment. In this comparison, the influence of the 
other explanatory variables on the result has been taken 
into account. 
The explanation of the above-mentioned statistical 
findings may be sought in difference between the three 
types of treatment (genta beads, irrigation system, others) 
and possibly also in differences in the set-up of the study 
(genta beads and no genta beads, respectively 
predominantly prospective and retrospective). 
In treatments with gentamicin-PMMA beads it 
usually became clear during the approximately two weeks 
of the treatment whether or not the infection was 'under 
control'. If it was not, another treatment was instituted 
immediately: recurrence-free periods occur less often 
because more often, presence of a recurrence was presumed 
immediately after the operation. 
*) The duration of the manifest inflammation (d) showed a highly skew 
distribution In order to obtain a more symmetrical distribution with 
fewer extreme values, a logarithmic transformation has been applied. 
elog (d + 1) 
Table 10.5 EXPLANATORY VARIABLES CONCERNING THE CHANCE OF A RECURRENCE-FREE PERIOD 
РСГ>0) AT INTERMEDIATE OPERATIONS (LOGISTIC REGRESSION ANALYSIS) 
Explanatory variables (mean or pere.) 
Type of operation 
gentamicin-PMMA beads 
suction drainage system 
'others' 
Total 
V 
25 
36 
114 
175 
P(T>0) 
% 
24 
39 
46 
41 
z, z2 
Age (year) Woman (%) 
44 
43 
37 
39 
44 
42 
41 
42 
Z3 
Prosthesis (%) 
48 
25 
14 
21 
* (d)" 
Manif. (mean) 
2.0 ( 6) 
2.4 (10) 
2.4 (10) 
2.4 (10) 
25 
First op. (%) 
32 
22 
19 
22 
INFLUENCE EXPLANATORY VARIABLES 
Explanatory variable 
age 
sex 
diagnosis 
manifest duration 
1st operation 
gentamicin operatior 
suction drainage op. 
zi 
Z2 
23 
Z4 
zs 
IZ6 
Z7 
Regression 
coefficient 
P, 
p2 
Рз 
P4 
Ps 
Pe 
P7 
Estimate 
0.01 
-0.38 
-0.25 
0.09 
-0.52 
-1.02 
-0.35 
Value of ρ 
0.23 
0.26 
0.66 
0.44 
0.20 
0.05* 
0.38 
1) d = duration of the manifest inflammation in months 
24 = <7og (d + 1) 
* significarli 
With other methods of treatment, it is usually much less 
clear whether or not there is response to the therapy: the 
diagnosis of 'recurrence' is made later. One possible 
explanation is that the use of systemic antibiotics (in 70 %, as 
against 29% with genta-bead operations) masks a 
recurrence for a greater length of time. 
This higher degree of certainty in the treatment 
combined with a fixed two-week schedule is one of the 
advantages of the gentamicin-PMMA-bead treatment, as 
others have emphasized as well (Müller, 1978b). 
10.5.3. Explanatory variables for the duration of a 
recurrence-free period after an intermediate operation 
10.5.3.1. Method 
In the multiple linear regression model, the duration of a 
recurrence-free period Τ that has occurred (T > 0) is defind 
as a linear combination of variables Z! to Z7 inclusive: 
Τ = p0 + β,ζ, + p2z2 + ... + p7z7 ( T > 0 ) . 
The meaning of the regression coefficients β; Q = 1 to 7 
inclusive) can be described as follows: 
If Pj has a value of zero, the corresponding variable z, exerts 
no influence on the duration of a recurrence-free period that 
has occurred. A positive (negative) regression coefficient ßj 
indicates that the mean duration Τ grows longer (shorter) 
the more the value of the corresponding explanatory 
variable z, increases. 
10.5.3.2. Results 
After a total of 72 intermediate operations (41 % of the 175, 
see Table 10.3),a recurrence-free period T > 0 was recorded. 
The distribution of these intermediate operations over the 
three types of operation (gentamicin-PMMA beads, 
irrigation system and others) was 6,14 and 52, respectively. 
With the last-mentioned two types of operation, a few 
extremely long recurrence-free periods occurred. Table 10.6 
EXTREME LENGTHS OF THE DURATION OF RECURRENCE-FREE PERIODS (1>0) OBSERVED 
AFTER INTERMEDIATE OPERATIONS 
Table 10.6 
Patient no. 
2146 
2146 
2146 
2026 
2147 
2123 
2067 
( 
Τ 
Months 
379 
30 
49 
72 
69 
68 
62 
Operation 
others 
others 
irrigation 
others 
others 
others 
others 
Zi 
Age 
10 yr 
46 yr 
49 yr 
13 yr 
6 yr 
29 yr 
27 yr 
Explanatory variables 
z2 
Sex 
M 
M 
M 
M 
F 
F 
F 
Z3 
Diagnosis 
osteom. 
Osteom. 
osteom. 
osteom. 
osteom. 
osteom. 
osteom. 
ΖΑ(Ψ» 
Mean duration 
manifest infection 
1.8 ( 5) 
6.1 (437) 
6.2 (468) 
3.6 ( 35) 
2.9 ( 18) 
5.0 (147) 
1.1 ( 2) 
= duration of the manifest inflammation in months ζ
Λ
 =
 elog (d + J) 
25 
First operation 
+ own patient 
no 
no 
no 
no 
no 
no 
no 
Vd 
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presents a survey of these extreme values. The diagnosis 
was osteomyelitis in all cases, and haematogenous osteo­
myelitis in five of the seven operations. One patient (nr 
2146) underwent three 'intermediate operations' followed 
by very long recurrence-free periods. The seven extreme 
cases, listed in Table 10.6, have been discounted in the 
analysis below. 
Table 10.7 REVIEW OF DURATIONS OF 
RECURRENCE-FREE PERIODS Τ (MONTHS) AFTER 
EXCLUSION OF EXTREME VALUES 
Type of operation N S.D. Tm 
gentamicin-PMMA beads 6 9.2 
suction drainage 13 5.2 
'other' 46 5.5 
6.5 
3.2 
4.3 
3 19 
1 11 
1 16 
Total 65 5.8 4.4 1 19 
If the values of the explanatory variables Z\ to Z5 inclusive 
are not taken into account, a direct comparison of the mean 
T-values (T
m e a n
 = 9.2, 5.2 or 5.5 months, see Table 10.7) 
reveals no clearly significant difference (analysis of variance 
one-way classification Fg2 = 2.06, ρ = 0.14). 
Table 10.8 presents a survey of the values of variables Ζχ to 7
Ί 
inclusive, and the estimated regression coefficients ßj (j = 1, 
, 7) with the corresponding levels of significance 
(results of tests of the seven H0-hypotheses ßj = 0,j = 1, 
, 7). There is some evidence to suggest that the 
explanatory variables exert some (slight) influence on the 
duration of the recurrence-free period (H0-hypotheses β, = 
β2 = . . . = β7 = 0, F
757 = 1.88, ρ = 0.09). 
In particular, some influence is demonstrable of the 
variables sex (¿2), manifest duration (Z4) and genta beads 
(zg The mean duration of the recurrence-free period Τ 
(Τ > 0) appears to be slightly prolonged in: female patients, 
a long manifest duration of the inflammation and genta-
bead operations. 
However, the practical importance of the explanatory 
variables is small (multiple correlation coefficient R2 = 0.19, 
residual S.D. = 4.2 months). There are some indications of a 
difference in duration of the recurrence-free period between 
the gentamicin-PMMA-bead operations and the irrigation-
system operations (H0 : β6 = P7,p = 0.13). With gentamicin-
PMMA beads, the mean duration tends to be longer (9.2 
months). However, as mentioned above, after 'other' and 
'irrigation-system' operations, a few extremely long 
recurrence-free periods were observed. 
10.5.3.3. Conclusion 
There are some indications that-after discounting the 
extreme cases-the duration of the recurrence-free period is 
longer in female patients, in cases with a long duration of the 
Table 10.8 EXPLANATORY VARIABLES CONCERNING THE DURATION OF RECURRENCE-FREE PERIODS 
(TX» OBSERVED AFTER INTERMEDIATE OPERATIONS (MULTIPLE LINEAR ANALYSIS). THE FIGURES 
STATED REFER TO A MEAN VALUE OR A PERCENTAGE 
Type of operation 
gentamicin-PMMA beads 
suction drainage system 
'other' 
Explanatory variables (mean or pere.) 
N 
6 
13 
46 
Tmean 
(months) 
9.2 
5.2 
5.5 
Zl 
Age (yrs) 
39 
39 
44 
Z2 
Woman % 
50 
31 
35 
За 
Prosthesis % 
50 
15 
20 
Z4(d)" 
Manifest 
duration 
(mean) 
2.2(8) 
2.4(10) 
2.4(10) 
¿5 
1st 
% 
17 
38 
26 
operation 
Total 65 5.8 42 35 22 2.4(10) 28 
INFLUENCE OF EXPLANATORY VARIABLES 
Explanatory variables 
age 
sex 
diagnosis 
manif.duration 
1st operation 
genta beads 
irrigation system 
Zi 
z2 
Z3 
z4 
Z5 
Z6 
Z7 
Regression 
coefficient 
Pi 
P2 
Рз 
P4 
Ps 
Pe 
P7 
Estimate 
РУ 
-0.002 
2.05 
1.43 
0.73 
-0.42 
3.09 
-0.29 
Value 
of P 
0.96 
0.08 (*) 
0.38 
0.05 (*) 
0.74 
0.11 (*) 
0.83 
" d = duration of the manifest inflammation in months 
z4 =
 elog (d + 1) 
* significant 
manifest inflammation and after genta-bead operations. 
However, the influence of these three explanatory variables 
is of little importance for the prognosis of the duration of the 
recurrence-free period. A possible influence of the sex 
cannot be explained adequately. 
Nor is it simple to explain the influence of a long 
duration of the manifest inflammation. The assumption was 
that an infection of long duration would be difficult to treat 
and consequently would lead to bad results, in other words, 
faster recurrence. In regard to the duration of the 
recurrence, the inverse may apply, however. 
The longer interval between genta-bead operations 
and recurrences is in agreement with the finding that the 
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probability of a recurrence-free period is smaller and the 
recurrence more often develops immediately. When 
gentamicin-PMMA beads are used, namely, a subsequent 
treatment is more readily decided upon immediately, and 
the decision to wait and see whether a recurrence will take 
place is made less often. This more active policy during the 
actual treatment period leads to a longer average 
recurrence-free period whenever a recurrence has not been 
diagnosed immediatey postoperatively (see also par. 
10.5.2.3). 
10.6. Analysis of final operations 
10.6.1. Definition of the problems, variables and models 
This analysis is concerned with the surgical results of those 
operations that were not followed by any more operations 
during the follow-up period stated. In other words, the 
analysis concerns the 'first and only' operation (of a patient 
of our own department) or a 'last' operation. The question 
here is: what variables influence the duration of 
postoperative healing (G)? The following classification is 
used: 
G = 0 : patient has been declared cured immediately after 
operation and is free from recurrence during the 
follow-up period; 
G = g : patient has been declared cured g months after the 
final operation (in the course of the follow-up 
period); 
G > g : patient has not yet been declared cured during the 
follow-up period of g months (censored 
observation). 
The set of explanatory variables for the duration of post­
operative healing comprises the same variables as used for 
the explanation of the duration of the recurrence-free 
period (the variables ζ
λ
 to Z5 inclusive and the dummy 
variables z^  and z1, see par. 10.5). 
Just as in par. 10.5, the main question is divided into two 
subquestions: 
a. what variables influence the probability of immediate 
cure (p(G = 0))? 
b. what variables contribute to an explanation of the 
duration of postoperative healing if the patient is not 
cured immediately? 
To answer question a, logistic regression analyses have been 
carried out once more (see also par. 10.5.2). To answer 
question b, use has been made of the 'proportional hazards 
model' of Cox. In this model, 'hazard rate' function λ (t) 
occupies a central position (theory of the analysis of survival 
time data). In the present study, the following meaning is 
ascribed to λ (t): λ (t) At = the chance that a patient who has 
not yet been declared cured t months after operation will yet 
be classified as such during the subsequent period At. 
In the proportional hazards (PH) model, λ (t) is defined 
as a function of a number of explanatory variables. In the 
present study, these are the variables Zj to z7 inclusive: 
(defined in par. 10.5.1) 
λ (t) = λο (t). exp (β,Ζ! + β ^ 4- + β ^ ) . 
The term 'proportional hazards model' derives from the 
assumption that of two groups, both of them individually 
homogeneous as regards the explanatory variables, it holds 
true that the proportion of the hazard functions is constant 
for all values of t. In our present case, for instance, the 
following equations apply: 
λ (t/genta)
 = eß6 a n d λ (t/genta) = ep6-ß7 
λ (t/other) λ (t/irrigation) 
The meaning of the regression coefficients fy(j = 1 to 7 
inclusive) in the PH-model follows from the model function 
and from the above-mentioned relations between hazard 
functions of the different groups. Should, for instance. β6>0, 
it follows that λ (t/'genta') >λ (t/'other') and this means that 
with genta-bead operations in general, the duration of post­
operative healing would be shorter than with 'other' 
operations. 
For a comparison of operations with genta beads and 
with drainage systems, the sign of (ß6-ß7) is of importance. 
A positive (negative) sign constitutes an indication of a 
shorter (longer) duration of postoperative healing after 
genta-bead operations compared with operations with use 
of a suction-drainage system. As regards the meaning of the 
regression coefficients β,ίΓ = 1, , 5), we can read 
immediately from the equation for λ (t) that β,ζ,^ (β,ζ,^) 
exerts a favourable (unfavourable) influence on the 
duration of postoperative healing. 
10.6.2. Results of logistic regression analysis 
Only those final operations have been used for the analysis 
of which the values of all explanatory variables (Z| to ζ
Ί 
inclusive) are known: 210 operations. 
A review of the values of these variables is shown in 
Table 10.9. The percentages of the final operations at which 
the patients were immediately declared cured, are clearly 
different for the three types of operation (chisquare test, 
(3 χ 2) table, ρ < 10^). In the group of gentamicin bead 
operations, 52% of the patients were declared cured 
immediately after the 'final' operation. This proportion is 
considerably larger than those seen after the 'final' 
operations with irrigation systems or other methods of 
treatment (6% and 15%, respectively). 
In the comparison of the three types of operation, the 
possible influences of the explanatory variables z, to Z5 
inclusive should also be considered. To this purpose, the 
following logistic regression model has been used: 
7 
exp(ßo + I = 1β
Λ
) 
P(G = 0) = L -7 
1 + exp (ßo + Σ ßjZj) 
j = 1 
A positive (negative) sign of the regression coefficient ßj 
indicates influence of the variable in question, z, (j = 1, 
...., 7). 
The general rule is once more that with a positive 
regression coefficient, the higher the value of the 
corresponding explanatory variable, the higher the 
probability of cure immediately after the operation. In case 
of a negative regression coefficient, this chance grows 
smaller and ßj = 0 means that no influence of the variable in 
question is demonstrable. 
The results of the logistic regression analysis are listed 
in Table 10.9 and show clearly that the diagnosis 
(osteomyelitis or prosthesis), the manifest duration and the 
Table 10 9 E X P L A N A T O R Y VARIABLES C O N C E R N I N G T H E C H A N C E O F C U R E I M M E D I A T E L Y A F T E R 
T H E L A S T O P E R A T I O N ( P G = 0 ) 
Type of operation N 
gcntamicin-PMMA beads 67 
suction drainage system 51 
'other' 92 
Total 210 25 
Explanatory variables (mean or pere) 
P(G=0) zi 
% 
52 
6 
15 
ZI 
Age (yrs) 
48 
48 
42 
Z2 
Woman % 
48 
47 
40 
Z3 
Prosthesis % 
48 
41 
23 
z*(d)" 
Manifest 
duration 
(mean) 
2 6(12) 
2 9(17) 
3 0(19) 
Z5 
First 
operation 
% 
25 
10 
18 
45 44 35 2 9(17) 19 
I N F L U E N C E O F E X P L A N A T O R Y V A R I A B L E S 
Explanatory variables 
age z, 
sex Z2 
diagnosis Za 
mani f durat ion Z4 
first operation Z5 
genta beads Ze 
irrigation system z7 
Regression 
coefficient 
P. 
P2 
Рэ 
P4 
Ps 
Pe 
P7 
Estimate value 
P/ o/p 
-0 0006 
0 536 
1523 
0 331 
-0 015 
1693 
-1481 
0 65 
0 20 
0 005 (*) 
0 03 (*) 
0 95 
0 000 (*) 
0 02 (*) 
'' d = duration of the manifest inflammation in months 
Z4 = elog (d + I) 
(*) significant 
type of surgical treatment, influence the chance of an 
immediate cure (P(G = O)) Accordingly, the hypothesis 
that the type of operation and variables z\ to z
s
 inclusive do 
not contribute to an explanation of cure immediately after 
the operation is clearly rejected 
(HQ β, = P 2 = = ß 7 = ß7 = O , p < 1 0 3 ) 
The differences in percentages of the three types of 
operation (52 %, 6 %, 15 %) at which the patients proved to be 
cured immediately after the treatment, apparently should 
not be attributed to differences in the background variables 
Z] to Z5 inclusive In particular, these differences in 
percentages cannot be explained by differences in diagnosis 
(osteomyelitis or infected prosthesis) and in manifest 
duration of the infection The fact that these two variables 
influence the chance of a 'direct cure', is illustrated by the 
data listed in Table 10 10 
At the 67 gentamicin-PMMA-bead oprations, 52% 
were immediately declared cured In regard to this number, 
a differentiation should be made on the basis of diagnosis 
and duration of manifest infection There are clear 
indications that at operations with use of gentamicin-
PMMA beads the probability of a direct cure is greater if the 
diagnosis had read 'infected prosthesis' and the duration of 
the manifest infection has been relatively long (longer than 
12 months) 
At operation with irrigation systems or 'other' 
methods of treatment only three and 14 patients, respective-
Table 1010 THE CHANCE OF DIRECT CURE (P[G 
=0]) IN RELATION TO THE DIAGNOSIS AND THE 
MANIFEST DURATION OF THE INFLAMMATION 
WITH GENTAMICIN-PMMA BEAD OPERATIONS 
Numbers and percentages of operations after which patients 
were immediately declared cured 
Manifest duration 
0-12 months 12-24 months > 24 months Total 
diagnosis N(%) N (%) 
prosthesis 13 (54) 7 (86) 
osteo-
myelitis 16 (38) 8 (13) 
total 29 (45) 15 (47) 
12 (75) 32(69) 
11 (55) 35(37) 
23 (65) 67(52) 
ly, were immediately declared cured These numbers of 
operations are too small to show the correlation with the 
diagnosis and the manifest duration in tabular form 
A more detailed study has been made of the relationship 
between diagnosis and the manifest duration of the 
inflammation, respectively, and the duration of healing 
function of the gentamicm-PMMA-bead operations (see 
par 10 2, Fig 10 2) For this purpose, the manifest durations 
have been divided into those lasting one year or longer and 
those lasting less than one year, with this subdivision, no 
significant influence on the duration of healing function 
G(t) is demonstrable (Gchan test, ρ = 0 26) However, the 
duration of healing functions of the operations for infected 
endoprostheses and osteomyelitis are clearly different 
(Gehan test, ρ = 0 009), these functions are shown in 
Fig 10 3 and Table 10 11 Of these, Fig 10 3 indicates the 
probability (Y%) at time t that the patient will be declared 
cured after time t It is emphasized that these curves 
represent observed data, 1 e no adjustment is made for 
differences m background variables 
10 6 3 Results proportional hazards model 
At 158 of the 210 final operations, the patient has not 
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Table 10.11 DURATIONS OF POSTOPERATIVE HEALING AFTER 67 GENTAMICIN-PMMA BEAD TREAT-
MENT OPERATIONS, SUBDIVIDED ACCORDING TO THE DIAGNOSES OF PROSTHESIS AND OSTEO-
MYELITIS 
Interval·* Operations Healing function G(t) 
(months) Number of patients not yet cured at beginning of interval2'1 Cumulative percentage not yet cured at end 
of interval3* 
Prosthesis Osteom. Total Prosthesis Osteom. Total 
0-0+ 
0+-3.0 
3.0-6.0 
6.0-12.0 
12.0-24.0 
24.0-60.0 
32 
10 
3 
2 
KD 
35 
22 
10(2) 
2 
1 
KD 
67 
32 
13(2) 
4 
2(1) 
KD 
31 
9 
6 
3 
3 
63 
29 
10 
5 
5 
5 
48 
19 
8 
4 
4 
4 
11
 0 - moment of operation 0+ = immediately after the operation 
21
 ( ) = number of operations with a censured duration of healing during the interval in question 
31
 end point not included 
Table 10.12 EXPLANATORY VARIABLES CONCERNING THE POSTOPERATIVE DURATION OF HEALING 
G(G > O)0. THE FIGURES REFER TO A MEAN OR A PERCENTAGE 
Type of operation 
Explanatory variables (mean or pere.) 
N cens. G or F mean zi Z2 Z3 Z4 (dp 
% (months) Age (yrs) Woman % Prosthe-Mean manifest first operation 
sis (%) duration % 
gentamicin-PMMA beads 32 12 3.9 42 44 
suction drainage 48 29 13.7 46 46 
'other' 78 24 11.7 41 33 
Total 158 23 10.7 43 39 
31 
38 
19 
2.3(9) 
2.9(17) 
3.0(19) 
27 2.8(15) 
28 
10 
15 
16 
INFLUENCE EXPLANATORY VARIABLES 
PH-MODEL 
Explanatory variable 
age z, 
sex Zs 
diagnosis z3 
manifest duration Z4 
1st operation z5 
genta beads z6 
suction drainage 
system Z7 
Regression 
coefficient 
Pi 
ß2 
ßa 
ß4 
ßs 
ße 
ß7 
Estimate Value 
Й/ 
-0.008 
0.03 
0.13 
-0.13 
-0.29 
0.39 
-0.16 
of ρ 
0.16 
0.89 
0.66 
0.12 
0.27 
0.09(*) 
0.48 
TRE 
% 
1 0 0 
8 0 
11
 In the censuring of the duration of postoperative heating G, the 
duration of the follow-up period F has been used for the 
calculation of 'mean' in the column 'G or F. 
2
' d = duration of the manifest inflammation in months 
z4 = 'log (d + 1) 
(*)•' significant 
Figure 10.3 Graphic representation of the function of healing time 
G(t) in a treatment with gentamicin-PMMA beads of osteomyelitis 
(35 operations) or an infected endoprosthesis (32 operations). Just 
as in Fig. 10.2, at moment t, the probability that the patient will be 
declared cured after the time is Y%. 
FUNCTION OF HEALING-TIME G(t) IN 
ATMENT WITH GENTAMICIN-PMMA-BEADS 
6 0 · 
4 0 -
2 0 -
osteomyelitis (35) 
— 1 г 
24 60 
mnth 
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immediately been declared cured (Table 10 9 ) These 
operations have been analysed by means of the proportional 
hazard (PH) model In this model, censored observations 
are taken into account After 36 operations (23 % of 158), the 
patient has not been declared cured during the follow-up 
penod The mean value of the duration of healing (G) or 
follow-up penod (F) at a censored observation was 11 
months This mean value, therefore, constitutes an 
underestimation of the actual mean duration of healing A 
review of the frequencies of censured observations per type 
of operation is given in Table 10 12 This table also describes 
the influence of the explanatory variables on the duration of 
postoperative healing 
The H0-hypothesis that variables Z\ to Ζη inclusive do 
not contribute to an explanation of the duration of 
postoperative healing (G) is rejected (H0 ßi = Рг = β? = 
0, ρ = 0 04) The type of operation is the principal 
explanatory variable for G 
There exists a clear indication that the duration of 
postoperative healing after final operations with genta-
micm-PMMA beads is shorter than after 'other' operations 
β = 0 39, ρ = 0 09) No signiiicant ditterence is 
demonstrable between operations with suction drainage 
and 'other' operations (β-, = -0 16, ρ = 0 48) 
A distinct difference is observed between the suction-
drainage system and the treatment with gcntamicin-PMMA 
beads (p < 0 05, normal approximation) Some weak 
indications are found of a possible influence of the age and 
the manifest duration ot the inflammation on the duration 
of postoperative healing As expected, advanced age and a 
long manifest duration of the inflammation seem not 
contributory to a short duration of postoperative healing if 
the patient cannot be declared cured immediately after an 
operation 
10 6 4 Conclusion 
After operations with use of the gentamicin-PMMA beads, 
the duration ot postoperative healing is distinctly shorter, 
and the frequency of immediate cure higher than after 
operations with use of an irrigation system or other 
methods In this comparison, incomplete follow-up and 
differences in background variables (age at the time of the 
operation, sex, diagnosis, duration of the manifest 
inflammation and the patient's anamnesis) have been taken 
into account However, since in this analysis there has been 
a selective dropping-out of irrigation-system and 'other' 
operations (6% and 11%, respectively), the results of the 
comparison may be distorted 
The healing time functions of gentamicin-PMMA 
bead operations for the diagnoses of infected 
endoprosthesis and osteomyelitis, respectively,are different 
(overall comparison, without adjustment for differences in 
background variables) The duration of postoperative 
healing is shorter for the diagnosis of infected endo­
prosthesis There are indications of an influence of the 
manifest duration of the inflammation on the duration of 
postoperative healing 
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Chapter 11, The renal excretion rate of ß2-microglobulin 
as a parameter of the effect of gentamicin 
on the renal tubulus in test subjects 
11,1 Introduction 
ßa-Microglobulin is a natural body protein with a molecular 
weight of 11,800 dalton. 
After glomerular filtration 99.9 % of it is reabsorbed in 
the proximal tubular cell where subsequently it is metaboli-
zed completely. No reabsorption to the plasma occurs. Out 
of the 340 mg that are filtered per day, only 370 pg (0.1 %) is 
excreted with the urine (Schardijn et al., 1979). If the urine 
has a pH value lower than 6.5, a pseudohydrolysis takes 
place as the result of which the concentration of ßs-micro-
globulin in acid urine decreases (Evrin and Wibell, 1972; 
Wibell, 1974). This hydrolysis appears to be caused by a 
natural body component that is activated by the low pH 
(Hiesche, 1981). An increase of the excretion of ß2-micro-
globulin may be brought about by increased production, 
and consequently, increased supply of ßs-microglobulin 
while the glomerular filtration rate (GFR) remains 
unchanged. If the supply of ß2-microglobulin and the 
glomerular filtration remain unchanged, an increased 
urinary excretion of ß2-microglobulin may result from a 
diminished reabsorption in the proximal tubulus. Accord-
ingly, determination of ßs-microglobulin in the urine may 
afford insight into the function of the proximal tubular cell 
(Fermin et al., 1974; Wibell, 1974; Schardijn et al, 1979; 
Uthmann et al, 1981) (Fig. 11.1). 
During treatment with gentamicin, the renal excretion of ßs-
microglobulin rises (Schentag et al , 1978). 
Determination of ß2-microglobulin in the urine 
renders it possible for the nephrotoxicity that may be 
caused by aminoglycosides to be demonstrated sooner and 
more sensitively than by other methods such as 
determination of enzymes, demonstration of cylindruria or 
ultimately also the determination of the serum creatinine 
level (Schentag et al , 1979a). The plasma creatinine level, 
namely, is influenced only after a reduction of renal function 
to 30% of the normal level (Bricker et al , 1960). 
The nephrotoxicity which may occur during treatment with 
gentamicin changes the function of the kidney and 
consequently, the renal excretion of gentamicin and 
synthesis 
serum cone. 
UF.R. 
tubular reabsorbtlon 
urinary excretion 
normal 
synthesis 
normal 
serum cone. 
normal 
aF.R. 
impaired 
I tubular reabsorbtlon 
Increased 
urinary excretion 
Figure 11.1 ^-microglobulin after synthesis in the body cells and release into the blood circulation is filtered completey in the renal 
glomerulus. In the proximal tubulus, it is reabsorbed and a small proportion is excreted with the urine (a). If the tubular reabsorption of the ßs-
microglobulin is decreased and the supply remains unchanged, the excretion with the urine increases (b). (See also Eg. 12.8). 
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endogenous substances such as ß2-microglobulin. The renal 
clearances of these substances constitute the most direct 
parameters of the glomerular and tubular functions, more 
direct than determination of serum or urine levels. 
A direct measurement of the renal function is a 
continuous determination of the renal clearances of 
creatinine, ßs-microglobulin and enzymes that may be 
released due to damage to tubular cells. The best way to 
accomplish this is by determination of the clearance of a 
specific substance in all spontaneously voided volumes of 
urine, the collection times of the volumes being kept as 
short as possible. 
The renal clearance (ml/min) is the ratio of the renal 
excretion rate and the plasma concentration of a substance. 
The renal clearance constant varies in the course of the 
24-hour period and depends on a number of factors such as 
the urinary pH, urine flow, GFR and interaction in tubular 
transport. The degree of deterioration of the renal clearance 
is dependent for every individual substance on the partial 
influences of the mechanisms of the secretion. 
The purpose of this experiment was to determine to 
what extent the renal excretion and clearance of creatinine 
and of ß2-microglobulin change under the influence of 
gentamicin, and to gain at least some degree of insight into 
the mechanism of the changes of the renal clearance and of 
the excretion of ß2-microglobulin observed in the course of 
gentamicin treatment. 
11.2 Material and methods 
11.2.L The test subjects 
Three healthy male test subjects (26, 33, 36 years) were 
subjected to a total of five experiments (Table 11.1). Every 
experiment lasted three days. During these three days, the 
urine was kept alkaline (pH 7.5 - 8.5) by ingestion of approx. 
10 g sodium bicarbonate daily. The first day served as the 
blank period, to record the excretion rate of ß2-micro-
globulin. On the second day, gentamicin was administered 
intravenously in doses of 20, 60, 80 or 120 mg. In two 
experiments, a second dose was given: in test subject H.D., 
the injection of 20 mg was repeated after four hours, in test 
subject G.W., the injection of 60 mg was repeated after four 
hours. Test subject G.W. underwent three experiments: 
one injection of 80 mg, two injections of 60 mg and one 
injection of 120 mg. The intervals between the three 
experiments in this test subject were one year and six 
months, respectively. Throughout the experiments, the 
subjects used no alcohol, nor any drugs apart from the 
bicarbonate. 
11.2.2. Blood samples 
The blood samples were collected by intravenous puncture. 
Subject M/F Age Height Weight Gentamicin I. V. 
P.E. m 36 1.79 m 72 kg 80 mg 
H.D. m 26 1,92 m 80 kg 2 Χ 20 mg 
G.W. m 33 1.93 m 90 kg 80 mg 
2 X 60 mg 
120 mg 
Table 11.1 Data concerning the test subjects and the dosage of 
gentamicin in the experiments (five in all). 
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During a period of approx. 10 hours after the injection, 
blood samples were taken frequently. To this purpose, an 
intravenous catheter (Abbocath® nr 16) was introduced into 
the left cephalic vein. A three-way cock enabled the test 
subject to collect samples himself using one hand (see Fig. 
11.2). 
Figure 11.2 Intravenous catheter in the lefl forearm which with the 
aid of a threeway valve renders possible frequent collection of blood 
samples by the test subject himself. 
The collection of undiluted venous blood necessitated 
the removal of the contents of the intravenous catheter and 
of the three-way cock (approx. 1 '/2 ml). After the collection 
of the blood, physiological saline with heparin was injected 
into the catheter to prevent theformation of thrombi in the 
system. Each blood sample had a volume of approx. 2 ml. 
On the'first (blank) day, two or three samples were taken. 
After the injection of gentamicin into the right-sided 
median cubital vein, blood samples were collected every 15 
minutes for three hours and thereafter, every 30 minutes for 
five hours. Subsequently, some five to eight blood samples 
more were taken until the 36th hour after the injection of 
gentamicin. 
11.2.3. Urine samples 
Throughout the experiments, all amounts of urine were 
collected after spontaneous micturition, their volumes were 
measured and one sample of approx. 8 ml per voiding was 
kept. After the injection of gentamicin, urine samples were 
collected at the same intervals as the blood samples. 
Moderate water loading, of approx. 500 ml water per hour 
during the first few hours after the injection ensured 
production of enough urine to allow frequent, spontaneous 
micturition. During the experiment, the urinary pH was 
checked by means of a Copenhagen radiometer (PMH61). 
11.2.4. Determinations 
In all samples of blood and urine, in this study of test 
subjects totalling approx. 350 samples, the concentrations of 
creatinine and of ß2-microglobulin were determined. From 
the moment the gentamicin was injected, the gentamicin 
level as determined as well. The creatinine level was 
determined by an automated Jaffé method. The 
concentration of ßs-microglobulin was determined by radio-
immunoassay (Phadebas® ß2-microtcst: made available by 
Pharmacia, Zoetermeer, the Netherlands, and Uppsala, 
Sweden). The gentamicin concentration was determined by 
radioimmunoassay (made available by Merck, Amsterdam, 
the Netherlands, and Darmstadt, GFR). All analyses were 
carried out by the ABL Central Medical Laboratory of 
Assen, the Netherlands. 
For every portion of urine, the clearances were calculated 
for ßs-microglobulin, creatinine and gentamicin according 
to the equation: 
renal clearance = renal excretion rate 
plasma concentration 
or Cr 
dQ/dt (ml/min), 
in which Q and Ca are exposed in μg (gentamicin), μηιοί 
(creatinine) and ng ^-microglobulin), respectively. 
11.3 Results 
In Figs 11.3 to 11.6 inclusive the plasma levels of gentamicin 
(G) and the renal excretion rate of gentamicin (G), 
creatinine (creat.) and ß2-microglobulin фг-М) are plotted 
against the time. The period from -25 to 0 h o u r s c o n s t i t u t e s 
the blank period (day 1); this shows the m e a n r e n a l 
excretion rate of the volunteer. 
At t = 0 hours, an intravenous injection of g e n t a m i c i n 
was administered: of 20, 60, 80 or 120 m g (Figs 11.3, 11.4, 
11.5 and 11.6, respectively). At t = 4 h o u r s , te s t s u b j e c t s 
H.D. and G.W. were given second injections of g e n t a m i c i n , 
of 20 and 60 mg, respectively (Figs 11.3 a n d 11.4). 
In the figures, the immediate renal excret ion of g e n t a m i c i n 
with the urine is visible; this excretion runs paral le l t o t h e 
falling plasma level. After 35 hours,93.3 to 100 % of t h e d o s e 
of gentamicin injected has been excreted. 
The plasma level of gentamicin shows a b i p h a s i c 
course, as visible most clearly in Figs 11.4, 11.6 a n d 11.7. 
During the first phase, the distribution of g e n t a m i c i n o v e r 
the body is superimposed on the renal excre t ion. Fig. 11.7 
shows that this phase runs an oscillating course . T h e p l a s m a 
levels of creatinine and ß2-microglobulin, w h i c h a re n o t 
shown, remained constant throughout all the e x p e r i m e n t s 
(Table 11.2). Since the renal excretion rate a n d p l a s m a level 
of creatinine dit not change, the renal clearance of c r e a t i n i n e 
also remained constant during this expe r imen t . 
The renal excretion rate of ß2-microglobulin r e s p o n d s to t h e 
gentamicin injection with a rise. This rise, which is vis ible in 
all the experiments shown, proves d o s e - d e p e n d e n t (Fig. 
11.8) and disappeared again within a few hour s . A s e c o n d 
injection after four hours possibly results in a rise t h a t 
slightly exceeds the rise seen after the first inject ion (Figs 
11.3 and 11.4). 
"q plasma cone, ug/ml 
Figure 11.3 Plasma concentration-time curve of gentamicin (G) and the renal excretion rate-time curves of gentamicin (G), ^¡i-microglobulin 
($-M) and creatinine (creat.) in a test subject after two intravenous injections of'20 mggentamian. Gentamicin does not perceptibly influence the 
renai excretion rate of ^ •¡-microglobulin. 
95 
1 0 0 0 
1 0 0 
1 0 
p l a s m a cone ug/ml 
r e n a l excr. rate 
Subj G W 2 ж 6 0 mg Gentamicin iv 
^ 
^Ί·ϊΛ^'-'
Γ
- r 
ТЦ 2 h 
ι—
r
~L_ 
» 
· « •. 
' ¡creai umolxm 
" " " " G ug/mm 
95 7% 
•4.G V/2Lh 
Ι ­
ΣΟ 
π— 
30 h -г
-
-2 0 
T " 
-10 
Τ 
10 
Fig. 11.4 Plasma concentration-time curve ofgentamian (G) and the renal excretion rate-time curves ofgentamicin (G), $2-microblobulin 
($2-M) and creatinine (creat.) in a test subject after two intravenous injections ofóOmggentamicin. There is a slight possibility of influence of 
gentamicme on the renal excretion rate offii-microglubulm, the reaction being slightly stronger after the second dose. 
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Figure 11.5 Plasma concentrat­
ion-time curve ofgentamicin (G) 
and the renal excretion rate-time 
curve ofgentamicin (G), ^-micro­
globulin ($2-M) and creatinine 
(creat.) in a test subject after a 
single intravenous injection of 
80 mg gentamicin. The renal 
excretion rate of$2-microglobulin 
is distinctly influenced by the 
gentamicin injection. 
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Figure 11.6 Plasma concentrat-
ion-time curve ofgentamicin (G) 
and the renal excretion rate-time 
curves of gentamicin (G), ß2-
microglobulin фг-М) and crea­
tinine (creai) in a test subject 
afiera single intravenous injection 
of 120 mg gentamicin. The rise of 
the renal excretion rate offa-
microglobulin is more pronounced 
than after injection of a smaller 
dose ofgentamicin. 
Figure 11.7 Detail of Fig. 11.6. 
showing the first 14 hours after 
injection of 120 mg gentamicin. 
After 14 hours, 100% of the gent­
amicin injected has been excreted 
with the urine. The plasma con­
centration-time curve of gent­
amicin shows a biphasic, oscillat­
ing course. 
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Figure 11.8 Renal excretion rate of ^-microglobulin plotted 
against the time after the injection. The maximal excretion rate of 
^-microglobulin depends on the dose ofgentamicin that is injected at 
time t = 0. The normal range of the renal excretion rate of ^ -micro­
globulin is shaded (100 ± 60 ng/minute). Starting at a dose ofapprox. 
70 mg gentamicin, the rate of excretion of$2-microglobulin rises above 
the normal value. Normalization is accomplished after approx. 7 
hours. 
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Subj. dose Ph 
P.E. blank 7.27±0. 
80 mg 7.72±ö. 
H.D. blank 8.78±0. 
2X20 mg 8.73±0. 
G.W. blank 6.26±0. 
80 mg 7.67±0. 
G.W. blank 7.50+0. 
2X60 mg 7.60±0. 
G.W. blank 7.62+0. 
120 mg 7.95+0. 
Flow 
ml/min 
32 1.63±0.84 
30 1.96+0.51 
97 1.35±0.39 
58 2.59±1.89 
56 0.95+0.73 
77 4.98±4.27 
23 1.04±0.36 
30 4.55+3.55 
93 3.84+2.52 
25 6.37±2.84 
Plasma 
conc. 
β2-Λ/ 
\ig/ml 
1.335±0.11 
1.16 ±0.19 
1.40 ±0.10 
1.66 ±0.21 
1.42 ±0.10 
±0.14 
±0.12 
±0.19 
±0.21 
1.31 
1.33 
1.51 
1.27 
1.32 ±0.22 
Plasma 
conc, 
creat. 
\imolA 
85.2 ±1.1 
86.40±6.14 
101 ±9.85 
94.1 ±8.11 
84.60±5.20 
84.24±5.52 
108 ±5.29 
99.8 ±8.13 
89.00±8.00 
89.30±5.84 
Cl. β2-Λ/ 
ml/min 
Cl. creat. 
ml/min 
Genta % 
Uh Excr. 
h. gentam. 
Cl. gentam. 
ml/min. 
0.047±0.011 145.63±28.40 - -
0.281±0.315 143.73±27.16 2 h 92.2% 82.88+29.01 
0.049±0.010 117.20±15.89 - -
0.044±0.014 119.57±26.00 2 h 93.3% 117.26±34.33 
0.070±0.0028 162.30±25.09 - -
variable 148.88±12.98 2 h 94.5% 84.3Ш1.55 
0.050±0.0078 107.74± 7.10 - -
0.077±0.0033 118.66±14.20 2 h 95.7% 71.21±21.30 
0.111±0.075 94.65±19.10 - -
variable 109.17±31.64 2 h 100 % 103.11±28.68 
Table 11.2 Kinetic parameters ofgentamicin, creatinine and ^-microglobulin. Data obtained in five experiments and three test subjects. The 
values obtained during the blank period and those obtained during the period after the gentamian injection are shown separately. 
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Figure 11.9 Correlation between 
the renal excretion rate ofgenta­
micin and the renal excretion rate 
of $2-microglobulin, based on 
determinations in three test sub­jects andseven injections ofgenta­
micin. It appears that there are 
two processes involved, or there is 
an exponential relationship. 
Figs 11.9 and 11.10 represent the relationship between 
the renal excretion rates of ß2-microglobulin and of 
gentamicin (both expressed in pg/mia). In Fig. 11.9, an 
exponential relationship appears to be present. When the 
renal excretion rate of gentamicin is plotted against the 
logarithm of the excretion rate of ß2-microglobulin, a linear 
relationship is indeed found. In Fig. 11.10, just as in Fig. 
11.8, the range of the normal value is shown: 100 ng/min 
± 60 ng/min. It is only when the renal excretion rate of 
gentamicin rises above approx. 150 ng/min, that the renal 
excretion rate of ß2-microglobulin increases to above the 
normal value. This dose-dependent effect of the rise of the 
excretion rate of ß2-microglobulin is also represented in Fig. 
11.8. Here, after an injection of 60 mg gentamicin, an 
excretion rate of ß2-microglobulin is reached that exceeds 
the normal value only minimally. 
After injection of 80 and 120 mg, a more pronounced 
effect is visible. The normal value of the renal excretion rate 
of ß2-microglobulin (100 ±60 ng/min) was calculated from 
the blank periods: the period before the injection of 
gentamicin and the period after normalization of the 
excretion of ßz-microglobulin (with the urinary pH 
alkaline). 
Fig. 11.11 shows that the renal clearance ofgentamicin 
is independent of the urine flow, provided this flow is 
adequate, over approx. 1 ml/min. 
11.4 Discussion 
Approaching the kinetics of ß2-microglobulin as a drug or 
foreign substance, by means of the renal clearance concept 
is a fairly new procedure. By regarding the natural body 
compound, ß2-microglobulin as a drug and by approaching 
it pharmacokinetically, we obtain more data than are 
supplied by the usual measurements of concentrations in 
serum or urine, a fortiori if for the urine assay, the 24-hour 
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Figure 11 10 The renal excretion rate of gentamicm plotted against 
the logarithm of the renal excretion rate of ^-microglobulin The 
interrelationship is linear At a renal excretion rate of gentamicm m 
excess ofapprox 150 \ig/minute, the renal excretion rate offa-micro-
globulm rises above the normal value of 100 ± 60 ng/minute, based on 
determinations in three test subjects given seven injections of 
gentamicm 
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Figure 1111 The renal clearance of gentamicm plotted against the 
unne flow in one test subject after injection of 80 or of 120 mg 
gentamicm At a flow rate m excess ofl mg/mmute, the gentamicm 
clearance is independent of the unne flow (see also Fig IS 3) 
urine is used Since the greater portion of ß2-microglobulin 
is reabsorbed and catabohzed in the proximal tubular cell, 
that which can be calculated by determination of ßz-micro-
globulm in the unne is never the actual clearance, but an 
apparent clearance, seeing that the reabsorbed amount of 
ß2-microglobulin cannot be determined (Vree et al, 1981). 
Alkalinization of the urine to raise the pH above 7 5 is 
useless if done afierthe voiding Hydrolysis, namely, occurs 
already m the pre-urine and in the bladder Accordingly, the 
correct method is to administer an alkalizing substance, e g 
sodium bicarbonate to the subject Bicarbonate has the 
additional advantage of not influencing the reabsorption of 
gentamicm (Senekjian et al , 1981) 
Determination of the renal excretion of ß2-micro-
globulin in the manner described above proves to be a 
sensitive and immediately responding parameter of the 
influence of gentamicm on the proximal tubulus Also, the 
effect proves to be dependent on the dose of the gentamicm 
In addition, the renal excretion rates of ß2-microglobulin 
and gentamicm are directly proportional This 
proportionality can be subdivided into two processes, as 
shown in Fig 11 9, or it can be regarded as an exponential 
function (e-power) as shown in Fig 11.10 
The uptake of aminoglycosides in the proximal tubular cell 
is preceded by a binding to receptors on the brush border 
membrane of these cells This is followed by uptake into the 
tubular cell by pinocytosis Subsequently, apical vesicles 
fuse in the cell with the lysosomes (Kaloyamdes and 
Pastonza-Munoz, 1980, De Broe et al, 1981) (Fig 6 1) 
Mogensen and Soiling found that reabsorption of 
protein in the proximal cell could be inhibited by ammo 
acids Lysine in particular could inhibit the reabsorption of 
albumin, of free light immunoglobulin chains and also of 
ßs-microglobulin (Mogensen and Sailing, 1977). They 
attribute this inhibition to competition of substances with a 
free positive amino or guamdino group on the protein 
molecule that wants to form a bond with a negative group on 
the surface of the tubular cell 
Whelton and others observed that large doses of 
amino acids exerted an inhibitory influence on the 
reabsorption of gentamicm (Whelton et al, 1978) 
Just et al found that gentamicm and polypeptides are 
absorbed in the same way in the proximal tubulus binding 
to the surface of the tubular cell (the brush border) is 
followed by pinocytosis and lysosomal sequestration in the 
tubular cell There is competition for the binding to the 
brush border membrane in which the number of amino 
groups per molecule proved to be a particularly important 
element (Just et al., 1977, Just and Habermann, 1977) 
11.5 Conclusion 
Competitive inhibition might also be the explanation of the 
interaction of gentamicm and ß2-microglobulin 
Gentamicin and ß2-microglobulin might compete for the 
binding sites on the brush border membrane of the 
proximal tubular cell, since both substances contain amino 
acid groups The competition between gentamicm and ß2-
microglobulin manifests itself in an increased renal 
excretion of ßs-microglobulin as long as gentamicm is 
present in the pre-urine in a sufficient amount This explains 
whv the influence of gentamicm is of short duration, and 
dose-dependent Similarly, the increased excretion rate of 
ß2-microglobulin is a means of judging the amount of 
gentamicm that is reabsorbed in the proximal tubular cell 
Since nephrotoxicity of gentamicm is related to 
reabsorption and subsequent accumulation of gentamicm 
in the tubular cell, the renal excretion rate of ß2-micro-
globulm might constitute a useful parameter for the 
determination of this influence of gentamicm on the kidney 
Chapter 12. The effect of an operation on the renal 
excretion rate of ß2-microglobulin in patients 
12.1 Introduction 
ßs-Microglobulin is produced by nearly all cells in the 
human body. Lymphocytes and tumour cells produce much 
ßs-microglobulin. If the GFR (glomerular filtration rate) 
remains unchanged, a rising serum level of ßs-micro-
globulm is always due to an increased synthesis. This 
phenomenon occurs in patients with tumours, with 
leukaemia and with chronic diseases such as rheumatoid 
arthritis, SLE and Crohn's disease (Revillard, 1979). Wide 
and Thoren observed an increased clearance of ßj-micro-
globulin after operations or injuries The same influence is 
exerted on insulin, albumin and luteinizing hormone (LH). 
Just as ß2-microglobulin, these substances undergo 
complete glomerular filtration, and the major portion is 
reabsorbed in the proximal tubulus. For one to three days 
after an operation, these substances show an increased 
urinary clearance while the creatinine clearance remains 
unchanged (Wide and Thoren, 1972). 
Davey determined the renal excretion of ßs-micro-
globulin and alanine aminopeptidase (AAP) in patients 
after an operation or injury with infections, or with 
hypotension after an infarction. He also studied the 
influence of a treatment with aminoglycosides He used 24-
hour urine samples over periods of five days. He observed 
that the excretion of ß2-microglobulin was maximal within 
four days after the operation or the injury, or the onset ot the 
hypotension or the infection, while that of AAP was 
maximal after five to six days The excretion of ß2-
microglobulin returned to normal faster than that of the 
AAP 
With his measuring techniques, there appeared to be 
insufficient difference between patients and a control group 
where the excretion of b2-microglobulin was concerned 
(Davey, 1979). 
In Chapter 11, the importance was emphasized of a study of 
the effect of gentamicin on renal function if low serum levels 
are present constantly for long periods of time. 
The growing use of gentamicin-PMMA beads in the 
treatment by orthopaedic surgery of bone infections 
Patient M/F Age Height Weight Operation 
1 Sj. f 23 1.75 m 54 kg ant. spondylodesis 
Ls-Si 
2. К m 25 1.71 m 64 kg ant. spondylodesis 
Ls-Si 
3. Bo. m 39 1.89 m 94 kg ant spondylodesis 
L4-L5-S1 
4 P-B. f 53 1 61 m 73 kg release median 
nerve 
Table 12 1 Data concerning the four patients and the operations 
performed on them 
rendered it desirable to study the influence of gentamicin on 
the kidney after implantation of gentamicin-PMMA beads. 
Chapter 11 describes the influence of gentamicin on the 
proximal tubulus as determined with the aid of ß2-
microglobulin However, use of the clearance or renal 
excretion rate of ß2-microglobulin to study the influence of 
gentamicin during and after an operation, requires thorough 
familiarity with the intrinsic effect of the operation on these 
parameters 
The studies described below were intended to gain 
insight into the changes of the clearance and the renal 
excretion of ß2-microglobulin during and after an operation. 
12.2 Material and method 
12 2 1 Patients and their operations 
Of four patients, each was subjected to one operation Data 
on the patients and the type of operations are shown in 
Table 12 1 Samples of blood and urine were collected for 
three days. The patients were willing to take sodium 
bicarbonate, approx 10 g daily. During the operation, 
acidification of the urine was prevented by moderate 
hyperventilation, and as long as oral nutrition was not 
possible, 125 ml bicarbonate 4 2% were administered via 
the infusion system every six hours. 
Patients 1, 2 and 3 were subjected because of a 
discopathy to anterior spondylodesis in the lumbar spine 
between the vertebral bodies of L5 and SI Patient 3 also 
underwent a spondylodesis between the bodies of L4 and 
L5. In patient 4, release of the right-sided median nerve was 
performed because of a carpal tunnel syndrome. 
For anterior lumbar spondylodesis, the L5-S1 disc is exposed 
extrapentoneally by means of an incision to the left of the 
median line The disc is situated at the level of the 
bifurcation of the aorta and the vena cava The L4-L5 disc is 
reached by preparing the aorta and inferior vena cava to the 
right of the spinal column, usually after ligation of one or 
several venous rami The disc is excised and the covering 
plates of the two adjoining vertebral bodies are chiselled 
away, resulting in a square defect. Two corticocancellous 
grafts, taken from the iliac crest, are wedged into the defect 
Nearly all the blood loss during the operation occurs from 
the period of chiselling away the covering plates and taking 
the grafts from the iliac crest. Most of the blood loss is from 
the cancellous bone Sometimes, there may be considerable 
blood loss from the venous plexus of the spinal canal, as 
well Once the grafts are wedged in, further blood loss is 
slight. In patients 1,2 and 3 this operation took approx. four 
to five hours in all, and the peroperative blood loss varied 
from 1200 to 1800 ml (Table 13.5). All three operations were 
carried out under general anesthesia, with supplementary 
epidural anaesthesia (marcain, level L1-L2) in patient 3 
The release of the median nerve in patient 4 was performed 
under Bier's anaesthesia the arm was exsanguinated by 
bandaging and injected intravenously with 50 ml of a 
100 
marcain solution The exsangumation improves the view of 
the operation field and avoids blood loss A volar incision 
was then made over the wrist, after which the transverse 
carpal ligament could be identified and severed The 
duration of the operation of patient 4 was 15 minutes 
Postoperatively, the patients were kept under 
observation in the recovery room for two to three hours and 
then returned to the wards The drugs administered to the 
four patients as premedication or during and after the 
operation are listed in Table 12 2 
Medication 
Nocturnal medication (oral) 
diazepam 
nitrazepam 
Premedication (im) 
diazepam 
dropendol 
fentanyl + dropendol (ml) 
mcomorphme 
pintramide 
Peroperative (ι ν) 
atropine 
bupivacaine (ml) 
calcium gluconate 
diazepam 
dropendol 
fentanyl 
furosemide 
gallamme 
metarammol 
mcomorphme 
pancuromum 
pintramide 
prothipendyl 
succmyl choline 
thiopental 
Inhalation 
diethyl ether 
N2O2/O2 
halothane 
Infusion (ml) 
glucose 3 3 %/NaCl 0 25 % sol 
Haemaccel 3 5 % solution 
NaCl 0 9% solution 
Na-bicarbonate 4 2 % solution 
Ringer's solution 
whole blood 
packed cells 
Per- and postoperative (iv) 
ampicillm 4 dd 
flucloxacillin 4 dd 
/ Sj 
10 
5 
10 
10 
2 
10 
2 Kl 
5 
10 
5 
15 
3 Bo 4 P-B 
10 
5 
10 
10 
2 
1/4 
20** 
500 
20 
0,35 0,20 
7,5 
15 
9 
4 
5 
130 
250 
X 
X 
1500 
500 
625 
100 
2500 
1000 
1000 
1000 
5 
6 
21,5 
5 
500 
X 
X 
X 
1000 
500 
100 
2500 
500 
1000 
Э/4 
7 
9 
100 
900 
X 
X 
2000 
1000 
2000 
1000 
1000 
500 
10 
5 
10 
5 
50" 
100 
500 
* 0 25% Bier's anaesthesia ** Epidural anaesthesia 
Doses of all drugs stated m mg, unless otherwise stated 
Table 12 2 Data concerning the drugs, anaesthetic gases and 
infusion fluids that have been administered to the patients before, 
during and after the operation 
12,2.2 Blood and urine samples 
For three days, of every urination, the volume and the 
moment of voiding were recorded and a sample was kept In 
the course of the operations of patients 1,2 and 3 an amount 
of unne could be collected every half hour, because a 
unnary catheter is introduced for this operation 
Postoperatively, the interval between collection of urine 
samples was increased gradually to four hours 
Urine of patient 4 was only obtained by spontaneous 
mictuntion Blood was collected by venipuncture, three to 
four times both on the day before and on the day after the 
operation Peroperatively, and in the recovery room, blood 
could be collected via an intra-artenal line, inserted for the 
anaesthesia In the absence of an intra-artenal line, blood 
was collected by means of a three-way cock system 
connected to the infusion 
Blood and urine were kept in a refngerator (40C) for 
some time, and then, after pipetting off the serum, stored in 
a freezer (-250C) until the time of laboratory assay 
12 2 3 Determinations 
The concentrations of ßs-microglobulm and creatinine were 
determined in approx 250 samples of blood and urine 
(Pharmacia, Sweden, ABL b ν , Assen, the Netherlands) 
12.3 Results 
In Figs 12 1 to 12 4 inclusive, the renal excretion rates of 
creatinine (pmol/min), ß2-microglobulin (ng/min) and the 
urine flow (ml/min) are plotted against the time In Figs 
12 1,12 2 and 12 4, the plasma levels of creatinine (μπιοΐ/ΐ) 
and ßs-microglobuhn (ng/ml) are also plotted 
The plasma levels of creatinine and ßs-microglobuhn 
are not affected by the operation Fluctuation within the 
limits of normal can be observed during the periods of 
frequent sample-collecting (during operation and in the 
recovery room) (Table 12 3) 
The variability of the urine flow is physiological, and 
also visible during the preoperative 'blank' period 
A noticeable element here is a pronounced decrease of 
the unne flow in patients 1 and 4, occurring early in the 
morning, just before the operation The same decrease is 
observed in patient 2, shortly before the beginning of the 
anaesthesia, and in patient 3, of longer duration, for several 
hours during the operation The decrease of the urine flow 
was associated with a decrease of the renal excretion of 
creatinine and ß2-microglobulin Normalization of'the flow 
is associated with a relative, short-lasting polyuria, probably 
a sort of compensation effect This can be observed in 
patients 1 and 4 but not in patients 2 and 3 
The renal excretion rate of creatinine is not affected by 
the operation in patients 1,2 and 3 In patient 4, there is a 
bnef increase of the renal excretion Especially in patients 1, 
2 and 3 the renal excretion rate of ß2-microglobulin shows a 
pronounced rise after normalization of the unne flow dunng 
the operation In a very short time, a maximum is reached 
that is always more than 15,000 ng/min and in patient 3 
even almost reached 100,000 ng/min 
A normalization of this renal excretion rate of ß2-
microglobulin occurs in patient 1 in 40 hours, with a 'half-
life' of four hours In patients 2 and 3, the decrease is much 
less fast and appears to run a biphasic course 
The renal excretion rates of ß2-microglobulin and 
creatinine in patient 4 parallelled the urine flow from the 
time of the operation 
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Figure 12 1 Plasma concentration-time curve 
of $2-mtcroglobuhn ($2-M) and creatinine 
(creai ), the renal excretion rate-time curves of 
^-microglobulin and creatinine and the 
variations of the urine flow with the passage of 
time in patient 1 (Sj) At time t = 0, an anterior 
spondylodesis L5-S1 was performed 
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Figure 12 2 Plasma concentration-time curve 
of ^-microglobulin (fii-M) and creatinine 
(creat), the renal excretion rate-time curves 
of ^¡-microglobulin and creatinine and the 
variations of the urine flow with the passage 
of time in patient 2 (K) At time t = 0, an 
anterior spondylodesis L5-S1 was performed 
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Subj. 
1. 
2. 
3. 
4. 
S,j 
К. 
Во. 
P-B. 
Blank 
or 
surgery 
blank 
surgery 
blank 
surgery 
blank 
surgery 
blank 
surgery 
pH 
6.97±0.77 
6.8710.53 
8.06±0.65 
7.22+1.22 
7.90±0.70 
5.54+0.48 
8.69±0.66 
7.75±0.93 
Flow 
ml/min 
0.87±0.56 
1.97±1.43 
1.08+0.83 
1.58±1.10 
2.62+2.75 
0.95±0.53 
1.17zfc0.51 
1.49+1.99 
Plasma corte. 
ßs-A/ \3g/ml 
1.32+0.11 
1.3O±0.28 
1.87±0.12 
1.76±0.24 
1.40±0.082 
1.43±0.18 
1.64+0.13 
1.67+0.13 
Plasma corte. 
creai. \smol/L 
66.2 ± 7.3 
69.3 ± 4.8 
88.67± 9.56 
84.40± 7.74 
123.25±29.76 
110.25±15.41 
75.00± 4.64 
69.40± 7.42 
C/. p2-M 
ml/mm 
0.039±0.016 
variable 
0.055+0.040 
6.145±4.716 
0.101±0.075 
variable 
0.029±0.007 
0.063+0.051 
Cl. creat. 
ml/min 
68.70±14.28 
65.90±32.10 
84.13±29.58 
92.75±46.08 
96.38±36.46 
97.00+56.63 
41.94±14.68 
95.37±73.60 
Table 12 3 Kinetic parameters ofßz-microglobulm and creatinine in four patients who underwent an operation. The data are subdivided into 
those obtained m the course of the blank period and those obtained since the operation. 
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Figure 12 3 Renal excretion rate-time curve of 
^-microglobulin and creatinine, and the variations 
of the urine flow with the passage of time in patient 
3 (Bo). At time t = 0, an anterior spondylodesis 
was carried out at levels L4-5 and L5-S1. The 
plasma levels of creatinine and ^-microglobulin 
are not shown, but were constant (Table 12.3). 
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There is a direct proportionality between the renal excretion 
rates and clearances of creatinine and ßa-microglobuhn in 
patient 4 (Fig. 12.5). Both clearances show a similar 
correlation with the urine flow (Fig. 12.6). In these figures, 
the urine flow on the day of the operation varied between 
almost 0 and almost 6 ml/mm. 
103 
plasma cone. 
renal «xcr. rat· 
100 /^microglobulin ng/min 
plasma creatinine umol/L 
creatinine umol/min 
*—щ ·—plasma fl2 M ug/mt 
urine How ml/min 
¡,0 h 
Кг ^microglobul in ml/min-
015 
010 
0 05 
• blank 
© surgery 
y=0.00067 + 0 00057 
r=0 99 
/1 subj P-B 
0 50 100 
- 1 — 
150 200 
—ι— 
250 
Kr creatinine ml/min 
Figure 12.5 Correlation of the clearances offo-microglobulm and 
of creatinine in patient 4. The fluctuating urine flow brought about 
a variable creatinine clearance. The renal clearances of creatinine 
and ßi-microglobulin shows a linear interrelationship. It is indicated 
when the samples are collected: during operation or m the blank 
period. 
Figure 12.4 The plasma concentration-time 
curves of ^-microglobulin ($2-M) and crea-
tinine, the renal excretion-time curves of β2-
microglobulin and creatinine and the variations 
of the urine flow with the passage of time in 
patient 4 (P-B). At time t = 0, a decompression 
of the carpal tunnel was carried out. 
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Figure 12.6 Correlation of the renal 
clearances of creatinine and of ^ -micro­
globulin, respectively, with the urine flow 
in patient 4 (P-B). The flow varied from 
0 to almost 6 ml/minute. The clearances 
of creatinine and ^-microglobulin are 
influenced by the urine flow. Just as in 
Fig. 12.5, this figure indicates what 
samples were collected at operation. 
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Figure 12.7 Correlation of the renai clearances of creatinine andofßi-microglobulin, respectively, with the urine flow in patient 1 (Sj). The figure shows at what stage of the treatment the samples have been collected. Furosemide exerts influence on the creatinine clearance but not on 
the clearance of ^-microglobulin. 
For patient 1 (Sj), the correlation of the clearances of 
creatinine and ß2-microglobulin and the urine flow are 
shown in Fig. 12.7. The stages at which the samples have 
been collected are shown. The relationship between the 
creatinine clearance and the urine flow is clearly influenced 
by Lasix®: while the creatinine clearance remains constant, 
the urine flow increases. The clearance of ß2-microglobulin 
shows no correlation with the urine flow during the first 
hour of the operation, nor in the three samples of urine 
collected at operation. Then follows a period of pronounced 
rise of the excretion of ß2-microglobulin, during the stay in 
the recovery room. This correlation with the flow was not 
present at operation, nor after return to the ward. 
Furosemid does not affect the renal excretion rate of 
ßs-microglobulin. 
12.4 Discussion 
The operation exerts a distinct influence on the renal 
excretion rate and the apparent renal clearance of ß2-micro-
globulin. 
12.4.1. Influence of the urine flow 
At the operation of patient 4 (P-B), brief and not very 
traumatic, there is a decrease of the apparent renal 
clearance, probably resulting from a decrease of the urine 
flow and running parallel to the change of the creatinine 
clearance. 
It is a known fact that whether renal function is normal 
or disturbed, the renal creatinine clearance depends not 
only on the diet, body surface, activity, sex and age b u t also 
on the urine flow (Vree et al., 1981b). 
The same holds true of the gentamicin clearance in 
renal dysfunction (Walenkamp and Vree, 1981). T h e 
decrease of the urine flow in the hours just before opera t ion 
may be a normal diurnal fluctuation, possibly enhanced by 
dehydration because the patient had to be kept fasting for 
the operation. 
12.4.2. Influence of the surgical t rauma 
In patients 1, 2 and 3, also, the decrease of the ur ine flow was 
accompanied by a decrease of the renal excret ion of ß2-
microglobulin. The marked rise of this excretion could here 
not be attributed solely to an increase of the ur ine flow, 
however, although of course the latter played its part. 
Λη important observation is that the plasma level of β2-
microglobulin is not increased by the operat ion. Tissue 
damage at operation might lead to a depletion of ß2-micro-
globulin from the damaged cells. The fact that never the less , 
the plasma level of ß2-microglobulin does not rise after an 
operation (Table 12.3) might be explained by the comple te 
and direct filtration of ß2-microglobulin in the g lomerulus . 
In that case, the rise of the renal excretion rate of p2-micro-
globulin might be caused by a limited capacity of the 
proximal tubulus to reabsorb ß2-microglobulin. 
Another explanation of the raised renal excret ion of 
ßz-microglobulin is that when tissue is damaged , subs tances 
other than ß2-microglobulin are released which 
competitively inhibit the reabsorption of ß2-microglobulin. 
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Presumably, these substances are aminoacids or 
compounds with aminoacid groups. 
In that case, the observed effect of the operation is 
analogous to the influence of gentamicin since this 
antibiotic, also, causes a raised renal excretion of ß2-micro-
globulin. Gentamicin, also, enters into competition for the 
binding to the brush border membrane and consequently 
for the adsorption by pinocytosis (Just et al., 1977; Just and 
H a b e r m a n n , 1977; Mogenson and Solling, 1977; Whelton 
et al., 1978; De Broe, 1982). 
Fur thermore , the temporarily decreased reabsorption 
of p2-microglobulin in the proximal tubulus might be 
caused by a transient relative ischaemia of the kidney due 
to the operation. This effect might be brought about by the 
administration of drugs and by loss of blood. However, the 
frequent checks of the blood pressure and pulse rate during 
the operations never revealed a decrease of blood pressure 
or pulse rate as a manifestation of underfilling of the 
vascular system. For patients 1 and 2 (Sj and K), the blood 
loss, duration of the operation and type of operation, as well 
as the maximal renal excretion of ß2-microglobulin were 
identical. However, in patient 1 the return to normal values 
was faster. In patient 3, the operation involved two levels of 
the spinal column, so that it lasted longer and blood loss was 
larger. The maximal renal excretion rate of ß2-micro-
globulin in this patient amounted to almost 100,000 ng/min, 
very much more than in patients 1 and 2. Within the 
measur ing period, hardly any decrease of the renal 
excretion rate occurred. 
In patient 4, who underwent a short-lasting operation 
with only slight trauma, the renal excretion rate of ß2-
microglobulin showed hardly any increase. 
12.5 Conclusion 
The renal excretion rate of ß2-microglobulin is raised by an 
operation. There appears to exist a correlation between the 
severity of the surgical trauma and the maximal renal 
excretion rate of ß2-microglobulin. This raised renal 
excretion rate and the raised apparent ß2-microglobulm 
clearance may be due to an increased supply of ß2-micro-
globulin from the damaged cells, or to competition of ß2-
microglobulin with some other-unspecified-substance with 
amino acid groups. A limited absorption mechanism in the 
brash border of the proximal tubular cell leads to this 
competition, or to an excessive supply of ß2-microglobulm 
to be reabsorbed and consequently to a raised renal 
excretion rate of ß2-microglobulin (Fig. 12.8). 
The fact that Davcy (1979) observed too little difference in 
renal excretion rates of ß2-microglobulm between patients 
and a control group becomes understandable if we realise 
that when measurements are carried out only in 24-hour 
portions of urine, all minor fluctuations in excretion rates of 
ß2-microblobulin are missed. Good insight into the effect on 
this excretion rate exerted by gentamicin (Chapter 11), by 
an operation (this chapter) or by gentamicin-PMMA beads 
(Chapter 13), can only be gained by studying the clearance 
in frequently collected samples. 
a 
synthesis 
serum cone. 
G.F.R. 
tubular reabsorbtkxi 
urinary excretion 
increased synthesis 
or release 
normal 
or increased 
serum cone. 
normal 
G.F.R. 
normal 
but limited 
tubular reabsorbtion 
increased 
urinary excretion 
Figure 12.8 An increased renal excretion offo-microglobulin results from the fact that the capacity of the proximal tubulus to reabsorb the 
increased supply of ^ -microglobulin is limited (b). The increased supply results from an increased synthesis or from an increased release from 
the body cells and its complete glomerularfdtration. The above constitutes a posible explanation of the increased renal excretion of ^-micro-
globulin after an operation (see also Fig. 11.1). The normal situation is shown in a. 
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Chapter 13. The influence of gentamicin and of the 
operation on the function of the proximal 
tubular cell of patients with implanted 
gentamicin-PMMA beads 
13.1 Introduction 
The value of ß2-microglobuIin as a sensitive parameter of 
effect on the function of the proximal tubulus had to be 
investigated first, in order to render it possible to study the 
question whether treatment with gentamicin-PMMA beads 
might have a transient or permanent influence on renal 
function (Chapters 11 and 12). 
So far it has been maintained that a toxic side effect of 
treatment with gentamicin-PMMA beads is improbable 
because the plasma gentamicin levels are virtually always 
below the level of demonstrability (Dingeldein and Wahlig, 
1977; Wahlig et al., 1978; Wahlig, 1979, 1981). 
Bergmann and Dingeldein carried out experiments in 
animals and found no influence of gentamicin-PMMA 
beads on, among other factors, serum creatinine and the 
serum urea level (Bergmann and Dingeldein, 1978). No 
more direct measurement of the influence of gentamicin-
PMMA beads on the kidney has been carried out. 
Extensive use of gentamicin in the form of gentamicin-
PMMA beads on 'non-vital' indications justifies a more 
thorough study of the influence of gentamicin on the kidney 
during treatment with these gentamicin-PMMA beads, 
which treatment is sometimes protracted. It is especially in 
at-risk patients such as young children, the elderly, patients 
with renal dysfunction and patients treated with other 
possibly nephrotoxic drugs, that more certainty is to be 
desired than has been obtained from studies in otherwise 
healthy laboratory animals or humans as performed by the 
above-named authors. 
The nephrotoxicity of gentamicin has been studied 
mostly during intermittent administration of this drug. The 
effects of continuous administration of gentamicin have 
been studied only sporadically. 
Reiner et al. (1978) subjected dogs for ten successive 
days to a continuous infusion or one large daily dose of 
gentamicin. Continuous infusion brought about a greater 
decrease of renal function as measured with the aid of the 
creatinine clearance. 
Serum creatinine is an insensitive and very late-
responding parameter of nephrotoxic effects of 
aminoglycosides. A rise of the serum gentamicin level, also, 
is far too late a warning to permit timely adjustment of the 
treatment (Schentag et al., 1979a); when it occurs, namely, 
the glomerular filtration is already diminished. 
As mentioned before (Chapter 11), the renal excretion 
of ßs-microglobulin responds very sensitively even to a 
single injection of gentamicin. Also, the reaction is dose-
dependent. The effect, a rise of the renal excretion rate of ß2-
microglobulin, is limited to one to two hours after the 
intravenous injection. The influence of the operation on the 
renal excretion rate has also been described: in addition to 
the influence of the urine flow on the renal excretion rate of 
ß2-microglobulin, of creatinine and of gentamicin, the 
operation itself also affects the excretion of ßz-
microglobulin (Chapter 12). 
Patient M/F Age Height Weight Diagnosis 
28 
25 
33 
21 
67 
1.67 m 
1.86 m 
1.86 m 
1.94 m 
1.68 m 
88 kg 
76 kg 
82 kg 
68 kg 
57 kg 
osteomyelitis tibia 
osteomyelitis femur 
osteomyelitis tibia 
osteomyelitis femur 
painful total hip 
loosening 
Table 13.1 Data concerning five patients in whom gentamicin-
PMMA beads were implanted, stating the diagnoses. 
13.2 Material and method 
13.2.1. Patients and operations 
Five patients underwent a total often operations. The data 
on these patients are shown in Table 13.1: sex, age, height 
and weight and indication for operation. Patient 5 (AL-B) 
suffered from a recurrent posttraumatic osteomyelitis with 
formation of infiltrates in the covering soft tissues of the 
distal left tibia. Patient 6 (Ta) had a recurrence of an 
infection of the distal left femur, of traumatic origin. Patient 
7 (vdB) had a recurrent posttraumatic osteomyelitis of the 
entire right tibia dating from a complicated removal of an 
intramedullary nail. Patient 8 (Go) had a postoperative 
infection after a supracondylar osteotomy in the left femur. 
The osteotomy had been performed to correct an abnormal 
posture in an area where an osteomyelitis had been treated 
previously. Patient 9 (dG) suffered from a painful loose total 
hip prosthesis on the right. 
Each patient underwent two operations. In all cases, the first 
operation involved nettoyage of the inflammation followed 
by implantation of gentamicin-PMMA beads. In patient 7, 
the nettoyage comprised intramedullary drilling-out of the 
entire tibia. In patient 8, a condylar plate and eight screws 
were removed and in patient 9, a total hip prosthesis with 
bone cement was taken out. In these five patients, 48 to 360 
gentamicin-PMMA beads were implanted into the bone 
and as a rule, a few beads were placed in the soft tissues as 
well. In patients 8 and 9, most of the gentamicin-PMMA 
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Medication 
Nocturnal medication (oral) 
diazepam 
nitrazepam 
vinylbital 
Premedication (i.m.) 
diazepam 
dropendol 
nicomorphine 
pmtramide 
prothipendyl 
Peroperative (i.v.) 
diazepam 
dropendol 
fentanyl 
gallamine 
pancuronium 
pintramide 
succinylcholine 
thiopental 
Inhalation 
N2O2/O2 
halothane 
Epidural (ml) 
bupivacain 0.5 % + adrenalin 
mepivacain 2 % + adrenalin 
Infusion (ml) 
glucose 3.3 %/NaCl 0.25% 
Haemaccel 3.5 % sol. 
NaC10.9%sol. 
Na-bicarbonate 4.2 % 
Ringer's sol. 
whole blood 
packed cells 
Per- and postoperative (i.v.) 
cefalotin 4 dd 
Patient 5 
Al-B 
OKI 
5 
10 
5 
15 
7,5 
15 
4 
37,5 
100 
550 
X 
500 
OK2 
150 
10 
5 
10 
0.25 
16 
4 
100 
475 
X 
X 
1000 
Patient 6 
Ta. 
OKI 
10 
5 
2V2 
15 
10 
100 
20 
20 
1000 
300 
500 
500 
OK2 
5 
10 
5 
15 
0,05 
500 
18 
400 
450 
100 
Patient 7 
vdB. 
OKI 
10 
5 
10 
5 
11 VA 
IV2 
100 
15 
17 
500 
500 
500 
1000 
OK2 
10 
5 
10 
2'/2 
15 
5 
18 
500 
500 
Patient 8 
Go. 
OKI 
10 
5 
15 
20 
10 
5 
0,3 
20 
2 
100 
750 
X 
X 
1500 
400 
OK2 
10 
5 
10 
15 
20 
0,1 
20 
100 
400 
X 
X 
1000 
Patient 9 
dG. 
OKI 
5 
2 
22,5 
20 
4 
15 
75 
400 
X 
X 
1500 
500 
450 
200 
1000 
1500 
OK2 
5 
2 
5 
20 
4 
20 
75 
400 
X 
X 
1500 
500 
500 
500 
1000 
1500 
1000 
doses of all drugs stated in mg, unless otherwise stated 
Table 13 2 Data concerning the drugs, anaesthetic gases and mfusionfluids that were administered to five patients before, during and after the 
operation Each patient underwent two operations 
beads were imbedded m soft tissues At the second 
operations, after nine to 14 days, the gentamicin-PMMA 
beads were removed and in patient 9, a new total hip 
prosthesis was reimplanted as well 
In none of these patients had the orienting 
preoperative blood testing revealed any abnormalities of 
renal or hepatic function. There were no concurrent 
diseases, apart from status after cataract operation in patient 
9. The durations, and the peroperative blood losses of the 
various operations are listed in Table 13.5. In Table 13.2, the 
drugs administered on the day before operation, or during 
and directly after the operation are listed in alphabetical 
order Patients 7 (vdB) and 9 (dG) on the day of the 
operation were given 4 χ 1 g cefalotin at six-hour intervals. 
Epidural anaesthesia (marcain and/or scandicain) was 
administered to patients 6 (Ta) and 7 (vdB). 
Since the measurements had to be earned out during the 
entire penod of treatment, all patients had to take sodium 
bicarbonate throughout the treatment to maintain alkalinity 
of the unne 
Patient 5 (Al-B) took five tablets of 0 5 g every three 
hours but was unable to keep this up from approx the 
eighth day after operation, because of vague symptoms 
attributed to the bicarbonate. Therefore, the other patients 
took one tablet every hour, plus four to five tablets of 0.5 g at 
night before going to sleep. A few days after the first 
operation, dosage was changed to one tablet every other 
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hour pH checks showed whether the urine remained 
sufficiently alkaline On this regimen, there were no 
complaints and the urine remained sufficiently alkaline 
(pH > 7 5) No attempts were made to reduce the dosage of 
sodium bicarbonate further 
During the operationsjust as in the patients described 
in Chapter 12, it was attempted to maintain moderate 
hyperventilation and if postoperatively nothing could be 
taken orally, 125 ml sodium bicarbonate 4 2% in physio-
logical saline was administered every six hours 
13 2 2 Blood and unne samples 
In all, approx 215 samples of blood and 485 of urine were 
collected from these five patients Collection and storage 
procedures were the same as described in Chapters 11 and 
12 During and shortly after operation, blood samples could 
be collected frequently, every 30 minutes, usually from the 
infusion system The urine samples were always obtained 
by spontaneous voiding, except in patient 9 (dG) during the 
first operation because at that time he was wearing a bladder 
catheter The penod of the measurements lasted from one 
day before the first operation to three or four days after the 
second operation, in all 350 to 450 hours m each patient 
13 2 3 Determinations 
In all samples of blood and urine, the concentrations of 
creatinine and ßs-microglobuhn were determined, and from 
the first operation (OK-1) the gentamicin concentration, 
also The determinations were earned out as desenbed 
previously (Chapters 11 and 12) 
Furthermore, in the unne samples of all patients the 
concentration of alanine aminopeptidase (AAP) was 
determined This enzyme was determined by an Emit 
method which had a lower limit of demonstrability of 6 
mU/ml 
The renal excretion rates of ßs-microglobulm, gentamicin, 
creatinine and AAP were calculated, and expressed m 
ng/min, pg/min, pmol/min and mU/min, respectively 
13.3 Results 
Figs 13 1 to 13 5 inclusive show the renal excretion rate-
time profiles of ßs-microglobulm and gentamicin Fig 13 5 
also shows the renal excretion rate-time profiles of 
creatinine and alaninine aminopeptidase and the plasma 
levels of gentamicin and ßs-microglobuhn with the passage 
of time The moments of operation are always indicated by 
OK-1 and OK-2 
The renal excretion rate of ^-microglobulin shows a 
preoperative decrease in nearly all patients This decrease 
corresponds to a decrease of the unne flow In patient 5, the 
unne flow decreased, not before but dunng the OK-2 
operation At the first operation (OK-1), all patients show a 
marked nse of the renal excretion of ßs-microglobuhn The 
excretion peaks reached vary in patient 5 (Al-B) approx 
1500 ng/min, in patient 6 even 110,000 ng/min In patients 
5 (Al-B) and 9 (dG), this peak value was only reached after 
about two days 
Normalization of this raised excretion rate occurs 
within 50 to 100 hours m patients 5 to 8 inclusive In patient 
9 (dG), on the other hand, the renal excretion rate remained 
constant at the peak level of 60,000 ng/min for almost 200 
hours, to fall below the upper limit of normal during the 
next 150 hours, just before the second operation is 
scheduled This decrease in this patient occurs in two 
phases, each with a 'tW of 15 hours In the other patients, 
the renal excretion once normalized showed a fluctuation 
within the normal range of 100 ± 60 ng/mm 
It was only in patient 5 (Al-B) that from the eighth 
FigureB 1 Renal excretion rate-time curve of 
gentamicin and ^-microglobulin in patient 5 
(Al-B) In this patient, 48 gentamicm-PMMA 
beads were implanted in the distal tibia after 
debridement of a local focus of osteomyelitis 
(OK-1) The beads were removed after 12 days 
(OK 2) Owing to insufficient alkahmzation of 
the unne, the excretion rate of ^ -microglobulin 
varies markedly between t = 200 and t = 320 
hours even to less than the normal value The 
implanted gentamicm-PMMA beads cause a 
fairly constant renal excretion rate of gent-
amicin, of approx 4 yg/mmute 
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Figure 13.2 Renal excretion rate-time curves 
ofgentamicin and ^-microglobulin in patient 
6 (Ta). ^-Microglobulin shows a marked rise 
of the renal excretion rate as the consequence 
ofOK-1 but not as the consequence of OK-2. 
The constant excretion rate of gentamicm 
amounts to approx. 3 pg/mmute. In this 
patient, 90 gentamicm-PMMA beads were 
implanted. 
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postoperative day the excretion of ß2-microglobulin showed 
a highly irngular pattern with decreases that sometimes 
dipped far below the normal values. This pronounced 
fluctuation corresponds to the periods during which the 
patient took the bicarbonate very irregularly and 
insufficiently, so that the pH of the urine fell too low and 
hydrolysis of the ß?-microg]obuJin became possible. 
The second operation (OK-2) causes no rise of the 
excretion of ß2-microglobulin in patient 5 to 8 inclusive. The 
renal excretion did show a rise in patient 9 (dG). This second 
operation involved only a minor trauma in patients 5 to 8 
inclusive, since it consisted exclusively in removal of the 
gentamicin-PMMA beads. In patient 9, however, not only 
were the gcntamicin-PMMA beads removed but a new total 
hip prosthesis was also implanted. In patients 6 to 9 
inclusive, it was attempted at these second operations to 
administer identical anaesthesias, just as at OK-1. Patients 6 
(Ta) and 7 (vdB) were subjected to epidural anaesthesia at 
OK-1 and at OK-2. 
Figure 13.3 Renal excretion rate-time curves of gentamicin and 
^-microglobulin in patient 7 (vdB). Drilling out the medullary 
cavity of the tibia caused a very marked rise of the renal excretion 
rate of ^-microglobulin, many times higher than occurs after less 
drastic interventions, as shown m Figs. 13.1 and 13.2. Implantatton 
of 49 gentamicm-PMMA beads results in a renal excretion rate of 
gentamicme of approx. 4 pg/mmute. The removal of the gentamicin 
(OK-2) was not followed by a reaction of the renal excretion rate 
of ^-microglobulin. 
110 
Figure 13.4 Renal excretion rate-time curves 
ofgentamicin and ^-microglobulin inpatient 8 
(Go). Ninety gentamicin-PMMA beads were 
implanted along the femur and beneath the 
m. vastus lateralis (OK-1). Removal of the 
beads did cause some rise of the ^-micro­
globulin in this patient. The excretion rate of mo 
gentamicin in the course of the treatment 
remained fairly constant in this patient, as well, 
at approx. 10 \ig/minute. 
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The renal excretion rate of gentamicin remained constant 
throughout the treatment with gentamicin-PMMA beads 
(Table 13.3). In patient 5 (Al-B) there was a brief rise after 
the implantation, to a maximum of 10 pg/min, but a fall 
occurred within two days. Patient 9 (dG) showed a maximal 
excretion of gentamicin of 120 pg/min after approx. 48 
hours. In this patient, the excretion ofgentamicin fell after 
approx. five days to a plateau level of approx. 40 pg/min. In 
the other three patients, the excretion of gentamicin 
remained constant throughout, with plateau levels of 
approx. 3 pg/min (just as in patient 5) or of 10 pg/min 
(patient 8). After the bead treatment, of 9 to 14 days' 
duration, approx. 20 to 30% of the total amount of 
gentamicin implanted had been excreted. In patient 9, 
however, this proportion amounted to 69.6 %. In this patient 
(dG), the effect of implantation of a hip prosthesis with the 
aid of gentamicin-containing cement at OK-2, was 
demonstrable in the plasma and urine: a rapid rise, to 1.3 
Subj. N beads 
5. Al-B. 
6. Та. 
7. vdB. 
8. Go. 
9. dG. 
blank 
48 b. 
blank 
90 b. 
blank 
49 b. 
blank 
90 b. 
blank 
360 b. 
Genta pH 
mg 
8.22±0.69 
216mg 5.37±0.38 
7.40±0.66 
405mg 7.48+0.68 
7.88±0.61 
220,5mg 7.89±0.55 
8.15+2.86 
405mg 8.00±0.61 
7.83±0.54 
1620mg 7.59±0.97 
Flow 
ml/min. 
1.06±0.84 
0.32±0.057 
2.05±1.35 
2.18±1.43 
1.36±0.77 
2.50±1.69 
1.09±0.48 
2.36±].79 
1.87+1.95 
2.02±2.05 
Plasma créât 
\imol/L 
81.17± 3.49 
73.48± 7.23 
96.40± 7.25 
89.84± 8.66 
96.20+23.05 
85.88+11.19 
78.20± 6.72 
73.35± 5.01 
89.00+ 4.00 
73.00+ 6.97 
Plasma-
βζΛ/ \ig/ml 
1.72±0.25 
1.58±0.30 
1.10±0.133 
1.49±0.28 
1.58±0.49 
1.03±0.15 
1.34±0.17 
1.17±0.14 
1.20±0.10 
1.22±0.25 
Cl.-creat. 
ml/min 
55.15±27.23 
67.94+11.76 
163.30+73.30 
]41.44±38.93 
60.69±10.82 
102.29±33.4 
68.00±23.38 
88.00+20.63 
62.00±29.04 
78.70+33.91 
CI.-frM. 
ml/min 
0.049±0.024 
variable 
0.082±0.033 
variable 
0.031±0.007 
variable 
0.049±0.013 
0.079±0.097 
0.062±0.013 
variable 
Subj. N beads 
5. Al-B. 
6. Ta. 
7. vdB. 
8. Go. 
9. dG. 
blank 
48 b. 
blank 
90 b. 
blank 
49 b. 
blank 
90 b. 
blank 
360 b. 
Genia 
mg 
excr. β2Μ 
ng/min. 
Excr. genta Excr. genta 
\ig/min. % 
103.3 ± 12.61 
216mg variable (>1000) 
114.51± 44.63 
405mg 115.33± 33.21 
42.98± 9.26 
220,5mg variable 
65.4 ± 18.07 
405mg 110.4 ± 27.3 
75.0 + 16.1 
1620mg 44700 ±19520 95.6 ±53.1 69.6 
5.30± 2.37 37.3 
3.84± 1.12 19.66 
4.11± 1.49 29.8 
11.80± 2.62 36.3 
Table 13.3 Kinetic parameters of gentamicin, 
^-microglobulin and creatinine in the five 
patients in whom gentamicin-РММЛ beads were 
implanted. The data are subdivided in those that 
were obtained during the blank period and those 
obtained after the first or the second operation. 
Ill 
100000 
10000 
1000 
100 
450 h 
Figure 13 5 Patient 9 (dG) This figure shows the plasma concentration-time curves ofgentamwin and ^-microglobulin ($2-Af), and the renal 
excretion rate-time curves of ^-microglobulin, gentamicm-creatimne and alanine ammopeptidase At time t = 0, a total hip prosthesis is 
removed and 360 gentamicm-PMMA beads are implanted (OK-1) At the time of the removal of the gentamian-PMMA beads (OK-2), a new 
total hip prosthesis is implanted, with the aid ofgentamicin-contaming bone cement In this patient, the plasma-gentamian concentration was 
constantly measurable throughout the treatment (as a rule below 1 \ig/ml) and the rate of urinary excretion ofgentamian was relatively high 
Ibis was also the only patient in whom the rate of excretion of alanine ammopeptidase was measurable. This excretion rate rises slightly in the 
course of the treatment The renal excretion rate of ^-microglobulin in this patient, just as m patient 7 (Fig 13.3) rises to very high values. 
pg/ml and 96 μg/mln was followed by a rapid decrease. 
The serum level ofgentamian in patients 5 to 8 inclusive 
always remained below the detection limit (RIA method. 
0.15 pg/ml), apart from a few determinations immediately 
after implantation. Given a renal clearance of 100 ml/min, it 
can be calculated from the renal excretion rate that the 
serum level ol gentamicin amounted to 0.03 pg/ml when 48 
to 90 gentamicin-PMMA beads were in situ. In patient 9 
(dG), 360 gentamicin-PMMA beads were implanted, and 
the renal clearance for gentamicin was 88 ± 37 ml/min and 
that for creatinine, 79 ± 43 ml/min. The serum level in this 
67-year-old patient remained above the detection limit 
throughout the treatment, and reached a peak of 1 8 pg/ml 
and a plateau value of 0 4 pg/ml. 
These plasma concentrations of gentamicin are in 
accordance with values found in another patient in whom 
also 360 gentamicin-PMMA beads were implanted after 
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removal of a hip prosthesis. In this patient for approx. 10 
days we observed a serum level of 0.6 pg/ml (see Chapter 
15, patient 3). 
The plasma level ofty-microglobulin was not affected by the 
operation in any of the patients, and remained constant in 
all patients throughout the treatment with gentamicin-
PMMA beads (Table 13.3). It was only in patient 9 that a 
very slight rise of the plasma level was observed in the 
course of the measuring period of over 400 hours. 
13.4 Discussion 
In general, the nephro- and ototoxicity in the treatment with 
aminoglycosides is regarded as a dose-related problem 
(Barza and Lauermann, 1978). Dahlgren observed no 
nephrotoxic side effects in patients when the minimal value 
of the serum gentamicin level during intermittent 
administration was lower than 2 pg/ml. As the criterion for 
nephrotoxicity he regarded a rise of the serum creatinine 
level (Dahlgren et al., 1975). 
Others regard a rise of the minimal gentamicin level as 
an indication of developing nephrotoxicity. This rise is a 
manifestation of this nephrotoxicity, rather than a cause of it 
(Holm et al., 1979). 
After a single injection of radioactively labelled 
gentamin it is found that uptake of gentamicin occurs 
exclusively in the proximal tubulus. In this part of the 
tubulus, the uptake into the tubular cell increases in the 
farther distal tracts; a correlation appears to exist with the 
concentration gradient of the urine (Morin et al , 1979, 
1980). In the cell, gentamicin is concentrated in the 
lysosomes (Morin et al., 1979,1980; De Broe et al., 1981). 
However, when gentamicin is administered for longer 
periods of time, it is found that after an initial uptake in the 
lysosomes only, after seven days the gentamicin is 
distributed over all subcellular fractions (Kohlhepp et al, 
1979). 
Although the effect on lysosomes (Morin et al., 1979, 
1980) and on brush border enzymes such as AAP (Mondorf 
et al., 1978a) has an incompletely understood relationship 
with the nephrotoxicity, it is nevertheless regarded as an 
early and valuable indication of a toxic effect on the kidney 
during treatment with aminoglycosides. ß2-microglobulin is 
a sensitive parameter which responds faster than, for 
instance, AAP (Schentag et al., 1979a, Sethi et al., 1981). 
Studies in volunteers have shown that assay of ß2-
microglobulin provides a reproducible and sensitive 
parameter for the dose-dependent effect of gentamicin on 
the proximal tubulus (Chapter 11). Since the effect of the 
operation on the renal excretion of ß2-microglobulin is 
known (Chapter 12), the ßz-microglobulin might be used to 
investigate the influence of the very slight but continuous 
presence of gentamicin in the kidney after implantation of 
gentamicin-PMMA beads (this chapter). 
As mentioned in the paragraph above, during treatment of 
patients with entamicin-PMMA beads, the serum level of 
gentamicin is very low, and as a rule below the detection 
limit. Personal findings in eight patents (patients 5 to 9 
inclusive and patients 1 and 2, described in Chapter 15) are 
in agreement with literature data on this topic (Dingeldein 
and Wahlig, 1977; Jenny et al., 1977; Wahlig et al., 1978; 
Wahlig, 1979, 1981). 
The urinary concentration of gentamicin is of little importance 
since it is affected strongly by the urine flow. All th 
literature on the gentamicin-PMMA beads state that this 
urinary concentration remains low, mostly lower than 10 
pg/ml (Jenny et al., 1977; Wahlig, 1981). However, in a 
patient described elsewhere, in whom 360 gentamicin-
PMMA beads were implanted, urinary gentamicin levels 
above 20 pg/ml were found until the 10th day (see Chapter 
15, patient 3). In patient 9, the maximal urinary 
concentration even rose to as much as 200 Mg/ml, 12 hours 
after implantation of the beads. 
As regards the renal excretion rate of gentamicin after 
implantation of gentamicin-PMMA beads, values ranging 
from 4 to 12 pg/ml were observed after implantation in four 
patients of 48 to 90 gentamicin-PMMA beads in the bone 
and soft tissues (Table 13.3). However, in patient 9, after 
implantation of 360 gentamicin-PMMA beads, this rate 
amounted to approx. 95 pg/min. These observations do not 
permit any simple conclusions concerning the influence of 
the types of tissue around the gentamicin-PMMA beads on 
the amount of gentamicin excreted by the kidneys. 
In patient 8, the gentamicin-PMMA beads were 
localized along the femur, covered by the m. vastus lateralis. 
In patient 9, the 360 gentamicin-PMMA beads were 
situated partly in the proximal femur, partly at the site of the 
removed hip joint, surrounded by the periarticular 
musculature (Fig. 13.6). In the other three patients, the 
gentamicin-PMMA beads were situated mostly in more or 
less sclerotic bone. 
After removal of the gentamicin-PMM beads, the 
remaining gentamicin (present in the wound and in the 
kidney) is excreted slowly with the urine. After nine to 14 
days' treatment with gentamicin-PMMA beads, 20 to 40 % 
of the total amount of gentamicin implanted had been 
excreted in patients 5 to 8 inclusive. In patient 9,70% had 
been excreted. It is this total proportion of gentamicin that is 
excreted, rather than the value of the renal excretion rate of 
gentamicin that constitutes a manifestation of the capacity 
of the tissues around the gentamicin-PMMA beads to 
collect gentamicin from the beads via the wound, to 
distribute it in the body and subsequently to excrete it 
through the kidneys (Table 13.3). 
Some impression of the pharmacokinetic properties of 
gentamicin from gentamicin-PMMA beads may be gained 
by postulating that the amount of gentamicin that is 
released from the beads via the wound into the blood 
circulation and into the rest of the body equals the amount 
of gentamicin that is excreted by the kidneys. This holds 
true during the period in which the renal excretion rate 
remains at a plateau level (see Figs. 13.1 to 13.5 inclusive). 
This implies the assumption that the amount of 
gentamicin lost by drainage of the wound is nil. In regard to 
patients 5 to 8 inclusive, this assumption was correct: the 
wound was hermetically closed. In patient 9, approx. 200 ml 
exudate was lost through the wound drains on the first 
postoperative day. On the assumption that there is no extra-
renal excretion of gentamicin and that where gentamicin is 
concerned, the body may be regarded as a single 
compartment or distribution space, it may be stated that the 
supply of gentamicin equals its elimination. As an equation: 
D.Kç = C.Kf in which D is the total amount of gentamicin 
that is excreted during the treatment, KQ is the diffusion 
constant from the beads via the wound to the body, С is the 
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a b 
Figure 13.6 X-ray films of patient 9 (dG): after extraction of the total hip prosthesis with the bone cement, 360 gentamicin-PMMA beads are 
implanted (a). Two weeks later, the gentamicin-PMMA beads are extracted and a new total hip prosthesis is reimplanled immediately (b). 
Example of a shortened two-stage reimplantation as the treatment of an infected total hip prosthesis. 
plasma level of the gentamicin and Y^ is the renal clearance 
of gentamicin, Then, 
ν _ С X K,. K o - - ^ - renal excretion rate dose 
If the plasma level С of gentamicin is not known (in patients 
5 to 8 inclusive), it is calculated from the renal excretion rate 
and the gentamicin clearance (postulating that the 
gentamicin clearance equals the creatinine clearance): 
^ renal excretion rate 
gentamicin clearance 
From the diffusion constant Ко (expressed in 1/hr), a 'half-
life' of gentamicine can be calculated (expressed in days). 
This 'half-life' is the length of time required for 50% of the 
amount of gentamicin to be released from the beads via the 
wound to the body and to reach the kidney for excretion. 
The 'half-life' follows from: 
t'/2 = = Inj = 0,693 
Ко KQ 
The half-life values for release of gentamicin from 
gentamicin-PMMA beads in vivo are shown in Table 13.4. 
These values differ considerably from the in-vitro values 
calculated by Wahlig: 3.3 days (Wahlig, 1979). This 
difference has a simple explanation in the entirely different 
circumstances, the main ones of which are the difference in 
the bathing fluid and the replacement of this fluid. There 
does appear, now, to exist an influence of the localization of 
the beads and of its environment: in patient 6 (t1/2 = 10 
days), three chains were lying rolled up in the medullary 
cavity of the femur. In patient 8 (t V2 = 6.0 days), three chains 
were lying in the soft tissues along the femur, covered by 
muscle tissue. 
The renal excretion rate offo-microglobulin is influenced by 
the operation but is not influenced by the continuous 
presence of gentamicin. If the slight but protracted and 
continuous excretion of gentamicin by the kidney were to 
exert an adverse effect on the kidney, it might be expected 
that the excretion rate of ß2-microglobulin would rise 
gradually, especially with prolongation of the treatment 
with gentamicin to 10 to 14 days. This expectation is based 
on the reasoning that a continuous presence of gentamicin 
in the tubulus may bring about a continuous uptake and 
consequently, a toxic action in the cell. In the excretion of 
gentamicin, namely, there is a slow phase of over 100 hours 
(Schentag et al., 1977, 1978a). 
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Patient N beads Mg. genta In tissue Way of implantation Duration of therapy T,h beads 
5. Al-B. 
6. Ta. 
7. vd B. 
8. Go. 
9. dG. 
48 b 
90 b 
49 b 
90b 
360 b 
216 mg 
405 mg 
220,5 mg 
405 mg 
1620 mg 
bone 
bone 
bone 
soft tissue 
bone + soft tissue 
in heaps 
in heaps 
stretched 
stretched 
in heaps 
14 d 
14 d 
10 d 
9 d 
14 d 
7,3 d 
10 d 
7,7 d 
6,0 d 
5,7 d 
Table 13.4 Data concerning the numbers of gentamicin-PMMA beads, their position and the duration of the treatment in five patients. The 
table also shows the calculated half-life required for uptake from the wound and excretion with the urine. 
However, the amount of gentamicin that is constantly 
present in the tubulus during treatment with gentamicin-
PMMA beads does not demonstrably influence the rate of 
excretion of ß2-microglobulin. In all cases, the excretion rate 
falls to normal levels after a shorter (patients 6,7 and 8) or 
longer (patients 5 and 9) interval. A transient effect of the 
gentamicin in the early phase of the treatment with 
gentamicin-PMMA beads, shortly after implantation when 
the renal excretion of gentamicin is maximal, cannot be 
excluded because the effect of the operation is super-
imposed upon it. However, the influence of gentamicin on 
the renal excretion of ß2-microglobulin becomes 
demonstrable only when the rate of excretion of gentamicin 
reaches 150 pg/min (Chapter 11), a level never reached. 
The effect of the operation on the renal excretion of ßz-micro-
globulin (Chapter 12) has been confirmed once more at 
these ten operations and may now be defined more 
precisely. 
At these 10 operations, also, the extent of the rise of 
the renal excretion of ßs-microglobulin depends on the 
severity of the operation. The maximal value of this renal 
excretion rate is determined not so much by the duration of 
the operation or the blood loss involved but by the trauma 
sustained by the patient's tissues. Drilling out a tibia 
(patient 7, vdB) or removing a hip prosthesis with bone 
cement (patient 9, dG) are major, severely traumatizing 
operations, comparable to an anterior spondylodesis at two 
levels (patient 3, Bo). It should be noted that the operation 
of patient 7 lasted less long and led to less loss of blood than 
the operations of these other two patients (Table 13.5). 
Removal of gentamicin-PMMA beads from the lower 
leg is a minor operation involving very little trauma (patients 
5 and 7). Removal of beads from along the femur, from 
beneath the m. vastus lateralis, is somewhat more 
traumatizing and the removal of gentamicin-PMMA beads 
from the hip is the most traumatizing of all second 
operations (OK-2), a fortiori when it is combined with 
implantation of a new hip prosthesis. 
Exact quantification of the degree of tissue trauma at an 
operation is not possible. However, when it was estimated 
by five orthopaedic surgeons, there was a remarkable 
degree of agreement (Table 13.5). 
This factor, to be called the 'clinical trauma score'can 
be plotted in a graph against the maximal excretion of ßs-
microglobulin. This means combining exact objective data 
with subjective clinical assessments, but a relationship 
nevertheless emerges. The peak level of the excretion rate 
of ß2-microglobulin increases rapidly once the clinical 
trauma score reaches a certain liminal value, approximately 
at 50%. For this purpose, the trauma score of the most 
Patient 
1. Sj. 
2. K. 
3. Bo. 
4. P-B 
5. Al-B. 
6. Ta 
7. vd B. 
8. Go. 
9. dG. 
Blood loss 
1200 cc 
1300 cc 
1800 cc 
Occ 
150 cc 
10 cc 
600 cc 
20 cc 
200 cc 
20 cc 
400 cc 
75 cc 
1000 cc 
1700 cc 
Operation 
time 
4 h 
4 h 
5 h 
15' 
1.15' 
15' 
1.30' 
30' 
2.30' 
30' 
1.30' 
30' 
2.30' 
3 h 
1. 
65 
65 
80 
5 
45 
10 
60 
10 
100 
15 
40 
30 
80 
60 
Clinical trauma score 
2. 
60 
60 
85 
20 
30 
10 
40 
10 
100 
15 
30 
30 
80 
65 
5. 
65 
65 
80 
10 
30 
10 
50 
10 
100 
15 
50 
30 
90 
70 
4. 
60 
60 
100 
10 
30 
10 
40 
10 
80 
15 
50 
30 
95 
75 
'<%> 
5. 
70 
70 
100 
15 
25 
10 
75 
10 
65 
15 
65 
30 
95 
80 
6. 
80 
80 
100 
20 
20 
10 
30 
10 
75 
15 
30 
30 
80 
65 
Mean tr. score 
(%) 
67+7 
67±7 
91±10 
13±6 
30+8 
10±0 
49+16 
10±0 
87±15 
15±0 
44±14 
30+0 
87±8 
70±8 
Max. excr. 
fa-microglob. 
51,000 ng/min 
36,888 ng/min 
99,500 ng/min 
255 ng/min 
1,500 ng/min 
100 ng/min 
50,000 ng/min 
100 ng/min 
110,000 ng/min 
100 ng/min 
1,700 ng/min 
360 ng/min 
76,000 ng/min 
25,000 ng/min 
Table 13.5 Data concerning the blood loss and operation time of 14 operations in nine patients. These are the patients described in Chapters 
12 and 13. The table lists the clinical trauma scores as estimated by six orthopaedic surgeons. It also shows the maximal renal excretion rate of 
^-microglobulin of the patient ¡n question at that operation (see also Fig. 13.7). 
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m αχ renal excr rate /З^-М ug/min — renal excr rate AAP ml)/mm 
τ 1 1 
0 20 ¿0 60 80 100 
trauma score 
Figure 13 7 Maximal renal excretion rate of fa-mwroglobulm 
plotted against the clinical trauma score of 14 operations in nine 
patients A score of 100 corresponds to the clinical trauma score of the 
most traumatizing of these ¡4 operations m these nine patients Once 
a trauma score ofapprox 50 percent is exceeded, the renal excretion 
rate of ^-microglobulin rises markedly 
traumatizing of all the operations performed in these 
patients was put at 100% (Fig 13 7) 
Alanine amtnopepttdase (AAP) was not demonstrable in the 
unnes of patients 5 to 8 inclusive In patient 9, on the other 
hand, the AAP level could be determined, even prior to the 
first operation Its excretion in this patient was not affected 
by either the first or the second operation In the course of 
the gentdmicin treatment, the renal excretion rate of AAP 
rose slightly, proportionally to a nse of the creatinine 
excretion (Fig 13 8) The excretion rate of AAP appears to 
be correlated with renal function in renal dysfunction, the 
excretion rates of ß2-microglobulin as well as of AAP are 
increased 
Figure 13 9 The renal clearances of gentamian and creatinine 
plotted against each other in patient 9 (dG) There is an increasing 
correlation with decreasing renal function, represented by the 
divergent dotted lines 
Τ 
1 2 3 4 
renal excr. rate creatinine u mo I/mm 
Figure 13 8 The renal excretion rate of alanine amtnopepttdase 
plotted against the renal excretion rate of creatinine inpatient 9 (dG) 
There is a linear relationship 
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genlamicin ·—· 
subj dG creaiinine o—o 
o 
urine (low ml/min 
Figure 13 10 The renal clearances of creatinine and gentamian 
plotted against the unneflow m panent 9 (dG) The two clearances 
each show their own correlation with the unneflow. 
The clearance of gentamian and creatinine m patient 9 is 
plotted in Fig. 13.9. The clearances of the two substances are 
directly proportional, but the correlation grows less 
pronounced as the clearance of the two compounds 
increases, the correlation is more pronounced when renal 
function is decreased. This correlation between the 
clearances of gentamicin and creatinine is a known 
phenomenon (Detth, 1976; Lode, 1979) and has been 
described earlier in a woman with very severe renal 
dysfunction during treatment with gentamicm-PMMA 
beads (Walenkamp and Vree, 1981; Chapter 15, patient 1) 
In patient 9, a correlation of the clearances ot 
creatinine and gentamicin with the unne flow could also be 
demonstrated (Fig. 13.10). This correlation, also, has been 
described elsewhere (Vree et al., 1981b), and it has been 
demonstrated in the patient mentioned above with very 
slight urine flow, from 0.1 to 0.2 ml/min (Walenkamp and 
Vree, 1981; Chapter 15, patient 1). 
13.5 Conclusion 
Investigation of the influence of gentamicin and of an 
operation on the renal excretion rate of ß2-microglobulin 
during treatment with gentamicin-PMMA beads shows the 
known effect of an operation. Data collected at four earlier 
operations have been confirmed once more by the 10 
operations on these five patients. An operation causes a 
pronounced rise of the renal excretion rate of ß2-
microglobulm if the traumatic effect of the operation 
exceeds a critical limit The treatment with gentamicin 
c uses no measurable influence on the reabsorption of ß2-
microglobulin m the proximal tubular cell the renal 
excretion rate of ß2-microglobulin, namely, is not 
perceptibly raised by gentamicin. From this we conclude 
that at any rate this reabsorption mechanism in the 
proximal tubulus is not adversely affected by the treatment 
with gentamicin-PMMA beads 
The glomerular filtration, as revealed by the creatinine 
clearance and the corresponding filtration of ß2-micro-
globulin proved not to be affected by the gentamicin 
treatment, either. On the basis of this finding, also, we 
consider the conclusion justified that gentamicin-PMMA 
beads were not nephrotoxic in the patients we have studied. 
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Chapter 14. Study of patients treated with gentamicin-
PMMA beads for ototoxic side effects 
14.1 Introduction 
Gentamicin may bring about loss of hearing and 
disturbances of the equilibrium (see par. 6.4.3). Some 
relevant factors are the total dose of gentamicin per kg body 
weight, earlier use of ototoxic drugs and the renal function 
(Igarashi et al., 1971; Jackson and Arcieri, 1971; Fee et al., 
1978). 
The loss of hearing comprises in the first place a loss of 
high tones, while the disturbance of the balance manifests 
itself with dizziness and nausea (Lode, 1979; Carrière, 
1980). Allegedly, when ototoxicity is present, the balance is 
affected in two-thirds and the hearing in one-third of the 
cases (Jackson and Arcieri, 1971). It is believed that in most 
studies, too little attention is paid to the vestibular function 
(Bailey, 1981), possibly because subjective symptoms often 
fail to occur, owing to compensation, mostly by visual and 
proprioceptive functions. According to some, the 
ototoxicity, unlike the nephrotoxicity, is irreversible (Waitz, 
1971; Carrière, 1980). 
It is known from the literature on ototoxic side effects that 
the toxic effect of aminoglycosides is due to a disturbance of 
the integrity of the ciliated cells. It is therefore an obvious 
assumption that in vestibular toxicity, the function of the 
ciliated cells is also involved. 
The function of the cochlear ciliated cells can be 
examined simply and accurately by means of a tone 
threshold audiogram. 
Of the vestibular neuroepithelium, only the horizontal 
semi-circular duct is accessible to examination in clinical 
practice. Flow of endolymph inside this canal constitutes the 
physiological stimulus for the ciliated cells situated in the 
ampullar crest. The endolymph can be made to flow either 
by rotary stimulation or by caloric stimulation. In the latter 
case, a convection current in the endolymph is induced by 
changing the local temperature (by irrigation of the external 
acoustic meatus). Caloric stimulation was opted for because 
unlike rotatory stimulation it is suitable for application in 
bedridden patients. 
14.2 Material and method 
14.2.1. The patients 
The measurements were carried out in the same patients in 
whom the renal functions were measured (patients 5 to 9 
inclusive of Chapter 13). 
No vestibular examination could be carried out in 
patients 5 (Α-B) and 7 (vdB). 
Prior to the operation, all patients were examined by 
an ORL specialist. There were no abnormalities of ear, nose 
or throat. If necessary, cerumen was removed before the 
audiometrie examination was carried out. 
14.2.2. Cochlear examination 
In all five patients, hearing acuity was determined one day 
before the first operation (blank test), two or three days after 
the first operation and one day before removal of the 
gentamicin-PMMA beads (the eighth to 13th day post­
operatively). The measurement was performed by means of 
a tone audiogram (Peelers audiometer, type AP6). The air 
conduction threshold was determined in all cases. Bone 
conduction was investigated only if it was necessary for 
audiometrie reasons. An additional audiogram was made if 
in the meantime patients complained of tinnitus or if the 
tone threshold deteriorated. 
14.2.3. Vestibular examination 
The equilibrium was examined in three patients: one day 
before the operation (blank) and one day before removal of 
the gentamicin-PMMA beads. The vestibular examination 
is based on the vestibulo-ocular reflex (VOR). Every 
(apparent) rotatory movement of the head evokes a 
compensatory ocular movement, intended to stabilize the 
image of the environment on the retina. The principal 
parameter of the VOR is the angular velocity of the slow 
phase of the nystagmic movement, which is found by 
computerized analysis of the electronystagmogram (ENG) 
(Huygen, 1979). 
At every vestibular examination, it was first checked in 
various positions of the patient whether spontaneous 
nystagmus was present and whether the reflex movements 
of the eyes were intact. Before every irrigation of the 
external meatus, a calibration signal was recorded: 
alternatingly with the glance aimed 10° to the right and 10° 
to the left. 
With the head in 30° anteflexion, which places the 
horizontal semi-circular duct in a vertical position, the 
external meatus was irrigated for 20 seconds with water of 
30° or of 44° С (Nijhuis and Huygen, 1980). 
Both ears were irrigated with cold as well as with warm 
water, at five-minute intervals. The nystagmus was recorded 
in complete darkness, with the eyes open. 
After every irrigation, the average velocity 
(degrees/second) of the slow phase of a number of 
nystagmic movements was determined during the 
culmination phase (single response value). The total 
response per labyrinth (total response value) is then the sum 
of the single response values for cold and warm irrigation of 
that ear. 
The caloric sensitivity, always expressed as the velocity 
of the slow nystagmic phase in degrees per second, may be 
defined for each labyrinth separately (total response value 
per labyrinth) or for both labyrinths together (total response 
value per subject). 
The fluctuations of the caloric sensitivity were 
calculated by means of the equation: 
R - A £— -X100% B + A 
in which A is the preoperative caloric sensitivity and В the 
postoperative sensitivity. Equations of this type are 
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habitually used in caloñe studies, in which A and В in that 
case represent the simultaneous total response value per 
labyrinth. In practice, differences in caloric sensitivity are 
regarded as significant if they exceed approx. 20 %. 
14.2.4. Ototoxicity criteria 
In the literature on ototoxicity, various quantitative entena 
are used for both vestibular and cochlear toxicity We shall 
return to this m the discussion. 
14.3 Results 
The results of the audiometrie tests are shown in Table 14 1 
and those of the vestibular measurements in Table 14.2. 
The findings obtained in the individual patients are 
discussed below 
In patient 5 (Al-B), examination revealed no ORL 
abnormalities The preoperative audiograms were normal 
and no significant changes of the tone threshold occurred 
after operation. 
The preoperative vestibular examination showed no 
abnormalities. Postoperative repetition of the vestibular 
examination was not possible in this patient. 
Patient 6 (Ta) showed no abnormalities at ORL exam­
ination. A slight subjective hypacusis disappeared after 
removal of inspissated cerumen from both external 
meatuses. 
The preoperative audiograms revealed a mild perceptive loss 
for high tones on the left (4 and 8 keps). 
After operation, the tone threshold showed no 
significant changes. 
Per labyrinth 
Right Lefl 
Patient 6 (Та) ргеор. (A) 
postop. (B) 
32 
25 
31 
29 
change* 
* Calculated according to the equation. 
+4% -4% 
B-A 
Per subject 
63 
54 
Patient 8 (Go) 
Patient 9 (dG) 
change* 
ргеор. (A) 
postop. (B) 
change* 
ргеор. (A) 
postop. (B) 
-12% 
49 
45 
-4% 
51 
55 
- 3 % 
48 
46 
-2% 
62 
57 
-8% 
97 
91 
-3% 
113 
112 
-0% 
B+A У.100% 
Table 14 2 Results of the vestibular examination by means of 
electronystagmography ¡n three patients before and after the treat-
ment with gentamicm-PMMA beads 
Patient 5 (Al-B) 
preop 
postop. I 
postop. II 
Patient 6 (Та) 
preop 
postop. I 
postop. II 
Patient 7 (vdB) 
preop 
postop. I 
postop. * 
postop. II 
Patient 8 (Go) 
preop. 
postop. I 
postop II 
Patient 9 (dG) 
preop. 
postop I 
postop. II 
postop. ** 
0,25 
15 
15 
10 
15 
15 
10 
15 
10 
10 
5 
5 
10 
10 
10 
15 
25 
20 
0,5 
10 
10 
10 
15 
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f . higher than ¡20, 'dropped out' 
* : extra determination because of tinnitus 
** extra determination because of deterioration, two weeks after OK-2 
Table 14 1 The results of audiometrie examination of five patients before, during and after treatment with gentamicm-PMMA beads. 
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The preoperative vestibular examination showed no 
abnormalities. Postoperatively, the vestibular labyrinth 
showed slightly less caloric irritability than before operation 
(total 8% less, 12% on the right and 3% on the left). 
Patient 7 (vdB) preoperatively had no ORL abnormalities 
either. This patient had a history of several episodes of otitis 
media on the right, and there was mild subjective hypacusis 
in that ear. 
Preoperative audiometry revealed no abnormalities 
on the left but on the right there was a marked perceptive 
loss of high tones (at 4 and especially at 8 kcps). This loss 
may have been due to acoustic trauma although in his 
case the right-left asymmetry was difficult to explain. 
Postoperatively, no significant changes of the tone threshold 
were observed, and this also holds true of an interim 
determination performed because of complaints of tinnitus. 
No vestibular examinations were performed in this patient. 
In patient 8 (Go) there were no ORL abnormalities. 
The preoperative audiogram showed a considerable 
elevation of the tone threshold, amounting to approx. 30 dB 
at 4 kcps for the left ear, for which there was no anamnestic 
explanation. 
Postoperatively, there were no significant changes of 
the tone threshold on the left. On the right there was only a 
slight change at 8 kcps while postoperatively, values of 15 
and 10 dB were found instead of the preoperative 0 dB. 
The vestibular examination preoperatively showed no 
abnormalities and postoperatively, the response was 
virtually unchanged. 
Patient 9 (dG) at ORL examination showed no 
abnormalities of ear, nose or throat. Ophthalmologically, 
there was bilateral status post cataract operation and bad 
central vision after retinal haemorrhages. The preoperative 
audiogram revealed considerable presbyacusis: a perceptive 
loss for high tones at advanced age. 
The first postoperative audiogram (I) revealed 
deteriorations of 15 and 20 dB at 2 and 4 kcps, respectively, 
on the right while at 8 kcps the threshold was unchanged. 
The second postoperative audiogram (II) revealed a 
systematic deterioration of 10 to 15 dB over the low-tone 
range in both ears, whereas on the right, the high tones now 
showed a slight improvement of the tone threshold. A 
follow-up audiogram (III) showed bilateral improvement of 
the threshold for low tones. The improvement of the loss of 
high tones had already been observed at the second post­
operative determination, although this was performed at a 
time when the gentamicin treatment had reached its 
maximal duration (13 days). 
At vestibular examination before operation, a normal 
response was observed which postoperatively remained 
unchanged. 
14.4 Discussion 
Impairment of the hearing and balance is said to occur in 
10 % of the patients and to be symptomatic in 2 % (Barza and 
Laucrmann, 1978). Allegedly, sensitive test methods and 
prospective studies reveal three to five times that incidence 
(Jackson, 1977). Unfortunately, most studies did not 
include vestibular examination. The ototoxicity of 
gentamicin is said to be vestibular in two'thirds and cochlear 
in one-third of the cases (Jackson and Arcieri, 1971). 
According to Lode (1979), adverse effects on hearing and 
equilibrium occur only after protracted treatment and high 
dosage. However, at this time it is not yet possible to identify 
maximal or minimal thresholds at which ototoxicity occurs 
(Barza and Lauermann, 1978). It is probably the reason why 
the vague concept of 'individual sensitivity' has been 
introduced for ototoxicity. In spite of meticulous posology, 
there are always a few patients who sustain ototoxic damage 
(Sack et al., 1978b). Most authors recommend control tests 
of the renal function during treatment with gentamicin 
because ototoxicity occurs more often in renal dysfunction 
(Jackson, 1977; Barza and Lauermann, 1978; Bailey, 1981). 
Control of the hearing by means of audiometry is also 
recommended. However obvious its desirability, a pre-
treatment audiogram to determine the initial value is not 
always made. This is sometimes understandable, in view of 
the patients' bad condition, since parenteral gentamicin 
treatment is mostly given for severe infections. However, in 
audiological practice, it has become clear that severe illness 
need not preclude audiometrie examinations. Since 
audiometry is Άpsychophysical determination, deterioration 
of the general condition in severe illness or after major 
surgery does affect the findings. Bad general condition 
raises the tone threshold for all frequences, whereas 
gentamicin toxicity affects the registration of the high tones 
alone (Carrière, 1980; Winkel et al., 1978). 
The sense of balance may be difficult to investigate in 
severely ill patients. The caloric test, however, is usually 
feasible in bedridden patients. 
The existing uncertainty about the threshold of the 
serum gentamicin level at which ototoxicity occurs, 
enhances the desirability of investigation of possible 
otological side effects during treatment with gentamicin-
PMMA beads. Since such an investigation implies that the 
serum gentamicin levels have to be known, this study has 
been restricted to the five patients described in Chapter 13. 
Audiometrie examination could be carried out in all five 
patients. In four of the five patients, the preoperative 
audiograms showed abnormalities, and these were 
pronounced in patient 7 (vdB). In the course of the 
treatment, there were no significant changes of the tone 
threshold in four patients. In this respect it should be noted 
that in audiometry, the measuring inaccuracy is approx. 5 to 
10 dB. In patient 9 (dG), the tone threshold was raised for a 
number of frequencies. Winkel et al. (1978) regard 10 dB as 
the limit for cochlear toxicity. In view of the inaccuracy of 
the determination, we consider this a rather strict standard. 
Others use different criteria, e.g. Fee et al. (1978, at least 20 
dB) and Tjemström et al. (1973,30 dB). If such criteria are 
applied, the slight shift of the tone threshold observed in our 
patients cannot be attributed to ototoxicity (Table 14.1). 
Vestibular examination could be performed in only three 
patients, owing to circumstances. These examinations 
revealed no important abnormalities. Patient 6 (Ta) was the 
only one in whom a slight difference to the disadvantage of 
the right labyrinth was observed: 12 % calculated according 
to the equation in par. 14.2.3. Calculation according to Fee 
et al. (1978) shows that this corresponds to a decrease of 
22% which is still far below the threshold of 33% which 
these authors apply as the criterion of vestibular toxicity in a 
similar study of caloric responses during treatment with 
gentamicin. The criterium for vestibular toxicity applied by 
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Tjernström et al. (1973) in our opinion is hardly usable. 
These authors' criterion is 'reduced caloric irritability' which 
amounts to complete non-irritability during irrigation with 
water of 30 or 40oC. 
Although no distinct safety margin for the ototoxicity 
during treatment with gentamicin can be deduced from the 
literature, the serum gentamicin levels in these studies have 
always been considerably higher than those in our patients. 
We determined a serum gentamicin level that amounted to 
approx. 0.03 pg/ml (Chapter 13). 
Although the group of our own patients in whom this 
study was carried out was too small to justify statistical 
conclusions, we may nevertheless say that the findings in 
regard to possible adverse eflects on hearing or balance 
were reassuring. 
14.5 Conclusion 
In spite of the above, certain patients have to be regarded as 
being at risk where ototoxicity is concerned. These are in the 
first place: 
- patients with renal dysfunction 
- patients who have been treated with an aminoglycoside 
before 
- patients subjected to simultaneous parenteral treatment 
with aminoglycosides. 
Such at-risk patients should be regularly examined for 
ototoxicity during every treatment with an aminoglycoside. 
Unlike an adverse effect on the balance, namely, bilateral 
impairment of the hearing cannot be compensated. 
Patients without an increased risk do not require such 
control examinations during treatment with gentamicin-
PMMA beads. 
Examination for ototoxicity is best performed by 
means of audiometry alone. It is a simple, reliable 
determination that is easy to perform, at any rate by 
qualified personnel. 
Finally, it should be kept in mind that even in the socalled 
at-risk patients, deterioration of the hearing will probably 
only become demonstrable when the gentamicin in the 
wound has had ample time lo do its work. Therefore, if 
audiometrie abnormalities are observed, the treatment with 
the gentamicin-PMMA beads may be discontinued. 
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Chapter 15. Case histories 
The ten case histories recorded below serve to illustrate 
what possibilities exist and what problems arise in the 
treatment of infections with gentamicin-PMMA beads. 
In the first three patients, we were able to collect several 
samples of serum, urine and/or wound exudate. In each of 
these three patients, an unforeseen situation was involved, 
in which as many samples as possible were collected which, 
however, could not be processed as the samples in Chapter 
13 were. The first two patients were treated with 
gentamicin-PMMA beads in the presence of severe renal 
dysfunction. In the third patient, just as in patient nr 9 of 
Chapter 13 (dG), 360 beads were implanted. 
1. Patient R.W., female, bom 1907 
1955 Implantation of a Judet prosthesis in 
both hips with bilateral trochanteric 
osteotomy and fixation on both sides 
with a metal nail (Fig. 15.1a). 
1964-1965 On the right, the prosthesis was 
removed because of painful acetabular 
protrusion, following which a sub-
trochanteric femoral osteotomy was 
carried out. Postoperatively, an infection 
developed which healed after removal of 
the osteosynthesis material. 
Figure 15.1 
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Figure 15.2 The plastma concentration of gentamicin, the renal excretion rate of creatinine and gentamicin, and the concentration of 
gentamicin in the wound exudate plotted against the time m a patient who postoperatively developed severe renal dysfunction. The figure shows 
the moments at which the patient was dialysed (days 6 and 9). In spite of severe renal dysfunction and inadequate haemodialysis, the 
concentration of the gentamicin remains constant at a level of3 to 4 \ig/ml (also due to 2 χ 80 mg gentamicin i.V.). 
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Figure 15.3 The renal clearance of gentamicin plotted against the unneßow (a) and against the renal clearance of creatinine (b). The renal 
clearance of gentamicin is linearly dependent on the urine flow if the latter amounts to less than approx. 1 ml/minute (see also Fig. 11.11). 
There is a linear interdependence of the clearances of gentamicin and creatinine. 
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Figure 15.4 
1965-1966 On the left, the prosthesis had to be 
removed because of a deep, fistulizing 
inflammation. Subsequently, the 
patient was mobilized with two Girdle-
stone hips (Fig. 15.lb). 
March 1980 After 14 years' freedom of symptoms, 
pain developed in the left hip, with fever 
and later, sepsis. An abscess in the left 
hip was evacuated, the metal nail was 
removed and 150 gentamicin-PMMA 
beads were implanted (Fig. 15.Г). 
Progressive renal failure (1 ml/min) 
necessitated dialysis. Progressive 
circulatory insufficiency led to death 
from cardiac decompensation ten days 
after the operation. 
From the first postoperative day, serum, urine and wound 
exudate could be examined in this case. We found that in 
spite of severe renal dysfunction, the serum gentamicin 
level reached a plateau at approx. 3 Mg/ml, or 2 pg/ml after 
dialysis. The level of this plateau was determined not only 
by gentamicin-PMMA beads but also by two intravenous 
injections of 80 mg gentamicin administered before 
operation (Fig. 15.2). 
With this method of administration of gentamicin, 
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Figure 15.5 Plasma concentration-time curve 
of gentamicin, ^-microglobulin and creatinine 
in a woman with severe renal dysfunction. This 
patient was treated with implantation offirst 75, 
than 45 and subsequently 30 gentamicin-
PMMA beads. In spite of a renal creatinine 
clearance ofapprox. 4 to approx. 7 ml/mmute, 
the gentamicin level of the plasma decreased 
gradually in the course of this treatment to 
below the level ofdemonstrability (0.15 \¡g/ml). 
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also, the low renal clearance of gentamicin and creatinine 
and the small urine flow showed an interrelationship, 
represented in Fig. 15.3d+b. This patient has been reported 
earlier (Walenkamp and Vree, 1981). 
2. Patient J.-V., female, bom 1905 
1974 
1975 
T 
5 
"Γ­
ΙΟ 
" Τ
-
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1976 
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1981 
plasma cone. ^ M ug/ml 
Figure 15.6 The plasma concentrations of creatinine and ßs-
microglobulin, respectively, plotted against each other during the 
treatment with gentamicm-PMMA beads in patient J-V. During the 
period of deteriorated renal function, there is a linear interrelation-
ship. The blank values derive from data of test subjects and patients 
described in Chapters 11, 12 and 13. 
A Shiers prosthesis was implanted in the 
right knee because of gonarthrosis (Fig. 
15.4a). 
Because of painful loosening, the 
prosthesis was removed with its cement 
after which arthrodesis of the right knee 
was performed by means of external 
fixation. An infected pseudarthrosis 
developed. 
After removal of some remaining 
cement, re-arthrodesis was performed 
by means of external fixation (Fig. 
15.4b). Consolidation and good wound 
healing ensued. 
In an accident, the patient sustained a 
fracture through the arthrodesis of the 
right knee. This was treated by external 
fixation (Fig. 15.4e). 
Consolidation remained insufficient in 
spite of electrostimulation. 
Rearthrodesis was carried out with a 
long intramedullary nail and cancellous 
bone grafting (Fig. 15.4d). Postoperative 
wound infection occurred. After abscess 
drainage, implantation of 75 
gentamicin-PMMA beads. Because of 
insufficient healing, the beads were 
removed and replaced by 45 new ones. 
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Another exchange was carried out two 
weeks later, then combined with 
sequestrectomy (30 gentamicin-PMMA 
beads) (Fig. 15.4e). Once again the 
infection failed to heal: the intra-
medullary nail had to be removed. After 
sequestrectomy, an irrigation system 
was introduced. The system did not 
function well and was withdrawn after 
10 days. The wound healed by second 
intention and six months later, spontan-
eous abscess development was seen in 
the right hip,as well. This,also healed by 
second intention. 
During the first treatment with gentamicin-PMMA beads, 
the patient had been temporarily discharged. After 
readmission for the second operation, renal function was 
found to have deteriorated (serum creatinine 408 mol/1, 
serum urea level 18.3 mol/1. In view of the renal 
dysfunction, plasma samples were collected frequently from 
the second operation, for four weeks. During this penod, the 
renal creatinine clearance rose from approx. 4 to approx. 17 
ml/min. As Fig. 15.5 shows, the serum creatinine level and 
the serum ß2-microglobulin excretion rate increased slightly 
during these four weeks. In spite of repeated reimplantation 
of gentamicin-PMMA beads, the serum gentamicm level 
within three weeks fell to below the detection limit (RIA 
method 0.15 pg/ml). 
In this case the raised plasma creatinine and ßs-micro-
globulin levels were directly proportional (Fig. 15.6). Renal 
failure was due to a necrotizing vasculitis, possibly the 
consequence of periarteritis nodosa. This diagnosis was 
based on a cutaneous and a renal biopsy. The renal failure 
was treated with cyclophosphamide, on which renal 
function improved Follow-up examination eight months 
later showed consolidation of the arthrodesis; signs of 
infection had by then been absent for two months. 
3. Patient K.-B., female, bom 1916 
1975 Bilateral implantation of total hip 
prostheses because of coxarthrosis. 
Postoperatively, a wound infection 
developed in the left hip; it was treated 
by six weeks' oral administration of anti-
biotics. In spite of this, the hip remained 
painful for four years and the BSR 
remained raised (Fig. 15.7a+b). 
January 1980 An infiltrate in the left thigh was treated 
with antibiotics by the family doctor. An 
abscess developd 
March 1980 Removal of the hip prosthesis on the left 
with all cement because of a deep 
infection. 360 Gentamicin-PMMA 
beads were implanted, instead of the 
more usual 120-250 beads (Fig. 15 T). 
The beads were removed after two 
weeks. This patient will probably not be 
considered for reimplantation. She was 
free from s y m p t o m s after mobil izat ion 
on the Gird les tone hip. 
After a follow-up of 1 '/2 years , there 
were no signs of infection (Fig. 15.7d). 
In view of the large n u m b e r of gen t amic in -PMMA beads 
implanted, the gen tamicm levels of s e rum, ur ine a n d w o u n d 
exudate were de te rmined . The findings are listed in Table 
15.1 and represented graphically in Fig. 15.8. This pa t ien t 
has been described previously (Walenkamp , 1981). 
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Figure 15 8 The concentrations of gentamicm in serum, urine and 
wound exudate plotted against the time after implantation of 360 
gentamiun-PMMA beads in a hip joint (see Table 15.1). 
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4. Patient P.J., male, b o m 1925 
Table 15 1 The gentamicm concentrations m serum, unne and 
wound exudate m a woman aged 64 years On day 0, 360 gentamicin-
PMMA beads were implanted The serum concentration was 
measured by the RIA technique, the concentrations in unne and 
wound exudate by means of the agar diffusion method (see Fig 15 8) 
March 1971 
October 1971 
March 1973 
Total hip prosthesis on the right because 
of necrosis of the femoral head after a 
fracture of the femoral neck (Fig. 15.9d). 
A revision was carried out because of a 
loose head-neck prosthesis. This com­
ponent was reimplanted (Fig. 15.9b). 
Material collected at operation on 
culture proved to contain 
Staphylococcus albus which was 
considered to have contaminated the 
wound at operation. Postoperatively, 
signs of loosening gradually reappeared, 
combined with pain (Fig. 15.9°). 
Revision because of loose acetabular 
prosthesis. The entire prosthesis was 
removed with the cement, and a total 
hip prosthesis with a long femoral stem 
was implanted with the aid of con-
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ventional c e m e n t (Fig. 15.9d). The per-
operat ive cul ture once again revealed 
Staphylococcus albus. Ampicillin and 
l incomycin were administered for two 
weeks. 
January 1974 The right knee was painful. The BSR 
was normal. The hip scan showed no 
abnormalities. 
May 1974 Sinus in the right hip from which 
Staphylococcus aureus could be 
cultured. The patient retused a third 
revision. 
April 1979 Reoperation was performed after all: 
extraction of the hip prosthesis with all 
cement. All along the femur there were 
countless sinuses. Deep culture: 
Staphylococcus aureus. 360 Genta-
micin-PMMA beads were implanted 
and left in situ for two weeks; no 
additional systemic antibiotics were 
given (Fig. 15.9e). A third reimplan-
tation was refrained from. The patient 
was mobilized on a Girdlestone hip. 
Two and a half years later, the patient 
was free from symptoms and showed no 
signs of infection (Fig. 15.9f). 
5. Patient E.H., female, bom 1923 
1953 
May 1979 
September 1979 
January 1980 
August 1980 
Plastic correction of the left acetabulum 
because of congenital dysplasia of the 
hip. The patient developed cox-
arthrosis (Fig. 15.10a). 
Total hip prosthesis on the left. 
Pain in the left hip. 
Reimplantation after removal of a loose 
acetabular prosthesis. After operation, 
the left hip remained painful (Fig. 
15.10"). 
The loose total hip prosthesis and all the 
cement were removed. The per-
operative culture showed Staphylo-
coccus albus. 210 Gentamicin-PMMA 
beads were implanted. The pain 
persisted after operation. At revision, 
three weeks later, a cement rest was 
found to be the cause of the persistent 
infection. After its removal, 240 
gentamicin-PMMA beads were 
implanted (Fig. 15.10c). These were 
removed after two weeks, and at this 
same operation, a total hip prosthesis 
was reimplanted (Alio pro cup and 
Müller 'Geradschaft' = straight-stem 
prosthesis). One year later, the patient 
was free from symptoms and from signs 
of infection (Fig. 15.10d). 
6. Patient O.W., female, bom 1932 
January 1979 Bilateral Guepar prostheses because of 
rheumatoid arthritis. 
March 1979 Four weeks after implantation of the 
prostheses, a right-sided wound abscess 
had to be incised. Culture: Staphylo-
coccus albus. Treatment: flucloxacillin 
and lincomycin orally for three months. 
The wound healed by second intention 
but the knee remained painful (Fig. 
15.11a+b). 
August 1980 The prosthesis had to be removed and a 
ventral window was made in the tibia. 
180 Gentamicin-PMMA beads were im-
planted (Fig. 15.1Γ). Three weeks later, 
the beads were removed and still 
Figure 15.10 с d 
another abscess, along the femur, was 
found. At this time, 120 gentamicin-
PMMA beads were implanted (Fig. 
15.1 ld). 
Their removal had to be postponed for 
two months, because of a myocardial 
infarction. Removal proved difficult and 
one bead slipped off the chain and 
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remained in situ. Subsequently, an 
arthrodesis of the knee was performed 
with implantation of autologous and 
homologous cancellous bone. External 
fixation was applied (Fig. 15.11e). 
Postoperatively, a pin tract inflammation 
developed, which healed by second 
intention after removal of the external 
fixation material. Consolidation was 
complete and one year after the last 
operation, the patient was free from 
signs of inflammation (Fig. 15.15f). 
7. Patient T. W., male, bom 1962 
imber 1980 Fever and violent pain developed in the 
left distal forearm. The family doctor 
administered antibiotics but the pain 
proved more intense and spread over 
the forearm. Radiological examination 
January 1981 
haematogeous osteomyelitis (Fig. 15.12 
b). 
Nettoyage with removal of a 
sequestrum, 25 cm long, out of the 
involucrum of the radius. There was 
purulent arthritis of the wrist joint; 
puncture of the elbow joint revealed 
sterile hydrops. 90 Gentamicin-PMMA 
beads were implanted and left in situ for 
two weeks during which large doses of 
antibiotics were given (Fig. 15.12c). The 
gentamicin-PMMA beads were 
Figure 15.11 (Com.) 
'no abnormalities' (Fig. 15.12'1 and Fig. 
2.6b). After approx. 10 days, surgical 
decompression of the left forearm was 
carried out, with drainage down into the 
deep tissues, ventrally and dorsally. The 
patient was treated on the diagnosis of 
compartment syndrome. Necrotic tissue 
had to be removed on several occasions. 
A second X-ray, made late in December 
1980, revealed extensive lesions in the 
entire left radius, compatible with Figure 15.12 
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Figure 15.12 (Coni.) 
removed after two weeks and intensive 
after-treatment was administered with 
physiotherapy and a dynamic splint for 
the fingers and wrist. 
Complete restoration of function of 
elbow and fingers could be achieved. 
The wrist remained in a slightly 
dislocated position which impaired its 
function. In the X-ray film, the radius 
showed reossification within the 
involucrum (Fig. 14.12d+e). 
Ten months after the treatment, the 
patient was free from signs of infection. 
The wrist gave slight trouble during 
heavy labour. The pronation-supination 
movement was possible over an arc of 
70° (Fig. 14.12r). 
8. Patient P. C, male, bom 1957 
June 1976 Due to a motorcycle accident the patient 
sustained a number of fractures, 
including a complicated tibial fracture 
on the left (Fig. 15.13a). It was treated by 
external fixation. Figure 15.13 
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Figure 15.13 (Coni) 
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1976-1977 In view of delayed union, a cancellous 
bone graft was performed. Osteo­
myelitis developed. Sequestrectomy 
and oral antibiotics did not result in 
healing (Fig. 15.13b + c). 
February 1978 Nettoyage was performed with 
evacuation of pus from the medullary 
cavity. After sequestrectomy, 60 genta-
micin-PMMA beads were implanted 
(Fig. 15.13d). The beads were removed 
eight weeks later. In view of the 
presence of a generalized acne 
pustulosa, no cancellous bone grafting 
was carried out. 
January 1979 Triple arthrodesis was carried out of the 
left bony tarsus for correction of talipes 
equinovarus. Postoperatevely, undis­
turbed wound healing (Fig. 15.13e). 
October 1981 At follow-up examination, the patient 
was free from symptoms or signs of 
crural infection. 
9. Patient v. d. В., male, bom 1948 
1969 
1975 
In a car accident the patient among 
other lesions sustained a comminuted, 
uncomplicated crural fracture on the 
right. Fixation was carried out with a 
medullary nail (Fig. 15.14a). 
Removal of the medullary nail created 
considerable technical problems. It was 
only possible after splitting of the tibia 
over its entire length (Fig. 15.14b). 
Postoperatively, an osteomyelitis 
developed which necessitated several 
sequestrectomies in succession (Fig. 
15.14 )^. Pain in the lower leg persisted, 
with occasional febrile episodes and 
progressive functional impairment. X-
ray films showed sclerosis spreading 
over a large portion of the tibial cortex; 
the planigram revealed several small 
sequestra (Fig. I5.14d). 
Computed tomography was carried out 
to determine the thickness of the cortex 
over the entire circumference and the 
entire length of the tibia (Fig. 15.14е). 
Figure 15.14 
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September 1981 Through a window, proximally-lateral 
and distally-medial, the entire tibia was 
drilled out to a diameter of 13 mm. The 
operation was carried out in an 
exsanguinated shield, with cefalotin 
prophylaxis for 24 hours. Using the 
special insertion instrument, 49 
gentamicin-PMMA beads were 
introduced into the medullary cavity. 
The skin was closed, and the 
gentamicin-PMMA beads were 
removed two weeks later. The per-
operative culture was sterile at that 
moment. 
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Immediately after the drilling-out of the 
tibia, the patient was free from pain. Six 
months after the operation, the patient 
was still free from symptoms and from 
signs of infection (Fig. 14.14f). 
10. Patient J. Z., female, bom 1963 
This patient has a spina bifida at the level of LI with severe 
lordoscoliosis (lordosis of 123°, convex left-sided 
thoracolumbar scoliosis of 70°). 
This patient was subjected to several osteotomies of 
the legs and operations on the spine (Fig. 15.15a). 
April 1975 
September 1975 
January 1979 
September 1979 
October 1979 
January 1980 
Decubitus developed in the left buttock, 
owing to imbalance leading to excessive 
pressure. 
Exploration of a sinus going down to the 
ischium. An exostosis was removed; the 
wound was closed with a rotation skin 
flap. 
Recurrence of the decubitus. 
Osteomyelitis of the ischial tuberosity 
with a fracture through the superior 
ramus of the pubis (Fig. 15.15b). 
Sequestrectomy of the ischium was 
performed with implantation of 60 
gentamicin-PMMA beads, the wound 
being left open. The wound continued 
to produce exudate, with hardly any 
formation of granulation tissue (Fig. 
15.15°). The genta beads were removed 
through the open wound without 
anaesthesia (Fig. 15.15d). A connection 
between the sinus and the hip joint 
could be demonstrated. 
Resection of the head and neck of the 
left hip and of part of the ischium was 
carried out. 180 Gentamicin-PMMA 
beads were implanted and the wound 
was closed. The beads were removed by 
a reoperation two weeks later (Fig. 
15.15e). 
Eighteen months later, the 
patient was free from 
symptoms and showed no 
signs of infection (Fig. 
15.15f). 
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Chapter 16. Conclusions 
In Chapter 7, five questions were formulated, based on a 
study of the literature. Their answers follow from the clinical 
study in which the results of the various methods of 
treatment of infections of bones and soft tissues in patients 
were investigated (Chapters 8, 9 and 10). Other answers 
were obtained from the pharmacokinetic and toxicological 
studies which were concerned not only with the renal 
excretion of gentamicin but also with the influence of 
gentamicin on renal function and on the organs of hearing 
and balance (Chapters 11-14). 
These investigations provide the following answers to 
the questions asked earlier. 
1. Is the use of gentamicin-PMMA beads in the treatment 
of infections successful? 
Treatment of infections was followed by cure in 89 % of the 
cases after a median follow-up of 13 months. In 39 
treatments of osteomyelitis, the cure rate was 92 % and the 
treatment of 41 infected endoprostheses resulted in healing 
in 85 %. Four infections of soft tissues, all healed. 
In answering this question it should be kept in mind 
that 'healing' is relative. The conclusions concerning the 
therapeutic result drawn at the time of discontinuation of 
the study require further corroboration by long-term follow-
up of these patients. 
2. Is the treatment of the infection by means of these chains 
of beads more successful than other methods of treat­
ment? 
This question ought to be answered in the affirmative on the 
basis of comparison of the cure rates in the group of patients 
whose treatment was completed prior to 1977 (without use 
of gentamicin-PMMA beads) and the group whose 
treatment was administered wholly or in part after 1977 
(with use of gentamicin-РММЛ beads). In the second group 
of patients, the cure rate after treatment of an infection was 
89% as against 76% in the first group. 
In order to minimize the influence of the follow-up and 
of the various background variables, a statistical analysis has 
been carried out. With utilization of survival time studies, 
case histories of patients with osteomyelitis or infected 
endoprostheses have been analysed. It was found that when 
gentamicin-PMMA beads had been used in the treatment, 
the cure rate after operation was higher at any moment of 
the case history than when suction drainage or 'other' 
methods of treatment had been used. In this comparison, 
differences in follow-up were taken into account. The higher 
cure rate after use of gentamicin-PMMA beads proved not 
to be attributable to the background variables. 
However, this conclusion, also, should be interpreted 
with due reservations. The conclusion, namely, is based on 
comparison of data collected from a prospective study with 
data collected from a retrospective study. 
In spite of the statistical analysis in which as many 
variables as possible were taken into account, such a 
comparative study is less conclusive than a wholly pro­
spective study with allotment at random would have been. 
3. Are there other aspects of treatment of infections, apart 
from the cure rate, on the basis of which the use of genta­
micin-PMMA beads is or is not to be preferred? If so, 
what are they? 
We find that one important advantage of the use of 
gentamicin-PMMA beads, which is also confirmed by 
statistical analysis, is clearer and faster insight into the 
effects of the treatment. After the operation, it is sooner 
clear whether a relapse occurs and if the patient after an 
operation is not immediately declared cured, the 
postoperative period required to accomplish healing is 
significantly shorter. Thus, the beads provide not only a 
clearer but also a shorter treatment. The two factors are 
particularly also of subjective benefit to the patient who not 
rarely has had a chronic inflammation. 
Another advantage to the patient is that less systemic 
antibiotherapy is required. Moreover, when an irrigation 
system was used, leaking and clogged drains occurred in 30 
to 40 % of the cases, and superinfection in 27 %. The patients 
treated with gentamicin-PMMA beads were spared these 
difficulties. Also, patients treated with gentamicin-PMMA 
beads appreciated the freedom of movement of the 
extremity and the primarily closed, dry wound; this held 
especially true of patients previously subjected to suction 
drainage treatment. 
The number of operations necessary for the treatment 
of an infection before cure was achieved was also smaller 
when gentamicin-PMMA beads were used. 
4. Do low serum levels if gentamicin affect the kidney, in 
other words, are nephrotoxic side effects to be expected? 
In order to answer this question, three sub-problems were 
solved: 
a. ßs-microglobulin was found to be a sensitive parameter 
for the influence of gentamicin on the proximal tubular 
cell if the ß2-microglobulin was determined in small 
fractions during its renal excretion. The reabsorption of 
ßa-microglobulin in the proximal tubular cell is 
influenced dose-depently by gentamicin, probably 
through competition between ß2-microglobulin and gen-
tamicin in the brush border membrane of the tubular cell. 
b. The rate of excretion of ßs-microglobulin is increased not 
only by gentamicin but also by surgical trauma. Sim-
ilarly to the dose-dependent relationship with genta-
micin, more severe surgical trauma is found to cause 
larger rise of the maximal ß2-microglobuIin excretion. 
с The low serum levels of gentamicin that occur during 
treatment with gentamicin-PMMA beads cause no rise of 
the renal excretion rate of ß2-microglobulin during that 
treatment. From this it is concluded that tubular function 
is not affected. The glomerular filtration function of the 
kidney is found not to be decreased during the treatment, 
either. On the basis of our study of these patients and of 
the literature, nephrotoxic side effects may be regarded 
as improbable. 
5. Are ototoxic side effects (audiologic or vestibular) to be 
feared during treatment with gentamicin-PMMA beads? 
It may be stated on the basis of our orienting investigation 
that it is highly improbable that the treatment with 
gentamicin-PMMA beads will cause deterioration of the 
hearing or of the equilibrium. 
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Chapter 17. Summary 
17.1 Introduction 
The problem of infection in orthopaedic surgery deserves 
special attention because its consequences are so serious A 
growing number of skeletal infections is being caused by a 
growing number of endoprostheses implanted and 
increasing use of osteosynthesis material In the treatment 
of these infections, the possibility of implanting gentamicin-
PMMA beads has been available since 1976, as a 
supplement to the classical surgical measures In the 
wound, these beads release a relatively large amount of 
gentamicin which exerts a local bactericidal action 
This study begins with a survey of the literature on the 
problem of osteomyelitis and the infected endoprosthesis 
The properties of the antibiotic-containing cement, of 
gentamicin and of the gentamicin-PMMA beads are 
described A report is then presented of a clinical 
investigation, in two parts a retrospective study of the 
results of treatments before use of gentamicin-PMMA 
beads and a prospective study of the results of treatment of 
infection with gentamicin-PMMA beads A statistical 
analysis of the clinical data collected was carried out to 
compare the types of treatment 
The third part of this study is concerned with the 
possible nephrotoxic and ototoxic side effects of the 
gentamicin-PMMA beads 
Literature 
17.2 Osteomyelitis 
The pathological and clinical pictures of endogenous and 
exogenous osteomyelitis are concisely described The 
diagnosis is discussed with special reference to its bacteri-
ological elements correct collection of culturmg material 
and adequate interpretation of culturmg results are 
essential It appeared suitable to combine the introduction 
of this new method of treatment of osteomyelitis with a 
survey of the history of that treatment, illustrating what 
elements of the new method of treatment had already been 
tried As late as the 19th century, the treatment of osteo-
myelitis was symptomatic Still, the generally accepted 
management consisted in sequestrectomy, drainage and 
rest Around the turn of the last century, antiseptics were 
used and from World War II, antibiotics Again and again, 
surgeons who expected that the infections would be cured 
by application of non-surgical measures exclusively, were 
disappointed By themselves, antiseptics and antibiotics 
never brought about cure In the course of the 20th century, 
it was found that in addition to stabilization of the infected 
area, it was especially the prevention of cavitation that was 
essential for the treatment of osteomyelitis 
The gentamicin-PMMA beads combine the 
advantages of packing of the cavities with the advantages of 
local antibiotic therapy In this respect, the 'novelty' of the 
gentamicin-PMMA beads is relative 
17.3 Infected endoprostheses 
In the endoprosthesis, the bone-cement interface is a source 
of many problems With the passage of years after 
implantation of the prosthesis, loosening occurs in a 
growing number of patients To the present day, part of 
these loosenings arc erroneously regarded as a purely 
mechanical problem actually, a low-grade infection is often 
involved 
Therefore, after the discussion of the symptomatology 
of the acute, latent and haematogenous infection of the 
endoprosthesis, the diagnosis is discussed in greater detail 
The BSR is a very important parameter, especially if it is 
determined frequently In acute or in fulminating 
exacerbation of the latent infection of the prosthesis, 
making the diagnosis is usually not difficult In the latent 
low-grade infection, the diagnosis is a problem, however So 
far, no single method of clinical examination exists that 
allows reliable distinction between the aseptic loosening 
and the loosening due to a low-grade infection of the 
prosthesis Such latent infections can only be diagnosed by 
means of peroperative collection of multiple samples for 
culturmg, preferably from the tissue, and in every case some 
of these should be placed in an anaerobic transportation 
medium 
Treatment of an acute infection of a prosthesis is most suc-
cessful if extensive nettoyage is carried out at an arly stage 
and protracted antibiotic therapy is administered This 
applies to the acute superficial but particularly also to the 
acute deep infection oí a prosthesis 
Only occasionally can a latent low-grade infection be 
treated by conservative means Definite healing can only be 
achieved by removal of the entire prosthesis with all the 
cement Then, the choice has to be made between 
reimplanting a prosthesis or leaving it out (Girdlestone, 
arthrodesis) If reimplantation is decided upon, the best 
results according to the literature are obtained with anti-
biotic-containing cement The reimplantation can be 
performed at the same surgical session as the extraction and 
nettoyage 'one-stage reimplantation' If a shorter or longer 
interval is allowed before reimplantation, we speak of a 
'twostage' procedure This interval may be used to treat the 
infection This may be done with the aid of the gentamicin-
PMMA beads For a brief period (10 to 14 days), the beads 
may contribute to the treatment of the infection by a local, 
very highly active bactericidal treatment with gentamicin 
17.4 Antibiotic-containing cement 
The development of the antibiotic-containing cement was 
initially wholly empmcal Buchholz mixed bone cement 
with antibiotics to reduce the incidence of infection of the 
prosthesis Various studies of several combinations of 
antibiotics and types of cement showed that the release of 
antibiotic is proportional, among other things, to the surface 
of the cement and the concentration of the antibiotics in the 
cement The bathing fluid, also, influences the amount of 
antibiotic diffusing from the cement The process involved 
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is always diffusion, and therefore an aqueous environment 
is required. 
Some antibiotics are unsuitable to be mixed in bone 
cement because they are not heat-stable or water-soluble. 
Where the clinical applicability is concerned, it is important 
how much of the antibiotic is released per unit of time and 
particularly also whether the bacteriologically active 
concentration is reached. If (for bacteriological reasons) 
gentamicin is chosen, the best cement to mix it with is 
palacos. 
Experiments in animals have shown that antibiotic-
containing cement should be expected to be active mostly 
during and shortly after the operation. Activity for longer 
than approx. six weeks after the operation could not be 
proved conclusively. During clinical use, therefore, a 
protective effect is only to be expected peroperatively 
(against contamination) and fora brief postoperative period 
(against haematogenous infection). This is illustrated 
sufficiently by the good results after the use at one-stage 
reimplantation following removal of infected 
endoprostheses. 
17.5 Gentamicin-PMMA beads 
As the surface of antibiotic-containing cement increases, 
relatively more antibiotic is released into the environment. 
Owing to the large surface of the gentamicin-PMMA beads, 
the gentamicin concentration around the beads is very high. 
In between the beads, wound secretion remains possible. In 
spite of a very high local concentration of gentamicin in the 
wound secretion, the serum level remains very low, 
although continuous. 
Since the gentamicin levels in the wound may rise to 
many times the minimal inhibitory concentration (MIC) or 
the minimal bactericidal concentration (MBC) of the 
causative agents, it is necessary to exactly quantify the 
'resistance' of a micro-organism by determining the MIC. 
The release of the gentamicin from the beads and its 
activities have been demonstrated in vitro and in vivo. In 
clinical use, the practical advantages to the patient and the 
nursing staff are considerable, especially by comparison 
with treatment with an irrigation system. From the 
bacteriological and economic points of view, also, the beads 
offer advantages. 
Published reports concern not only use in skeletal 
infections, but also in infections of soft tissues. 
Absolute contraindications have been mentioned, but 
not all authors concur. However, there exist certain relative 
contraindications that render it necessary to weigh the 
advantages of the use of the beads against the disadvantages 
of some other method of treatment. Allegedly, the principal 
contraindication is pregnancy. However, in case of infection 
the possible adverse effects (on the foetus) of gentamicin-
PMMA beads have to be weighed against the drawbacks of 
another treatment. 
Other relative contraindications are: resistant bacteria, 
renal dysfunction, gentamicin allergy, an open wound, 
sclerotic bone and osteosynthesis material in situ. Still, in all 
these cases use of gentamicin-PMMA beads is possible if 
certain precautions are taken. 
17.6 Gentamicin 
The aminoglycoside, gentamicin, is a bactericidal, broad-
spectrum antibiotic. Its excretion from the body takes place 
virtually exclusively through the kidney. In the kidney, all 
the gentamicin is filtered in the glomerulus and a small 
portion is reabsorbed in the proximal tubulus. The ciliated 
cells in the proximal tubulus, just as the ciliated cells in the 
organs of hearing and equilibrium, constitute a 'deep 
compartment' in which the gentamicin concentration rises 
markedly due to accumulation, and from which the release 
of gentamicin is retarded. The nephrotoxicity and the 
ototoxicity are due to transient or permanent damage to 
these ciliated cells. In the kidney, damage to the proximal 
tubular cell leads to increased depletion of several 
substances. One of these is ß2-microglobulin. Ototoxic 
lesions manifest themselves with a raised tone threshold 
and with disorders of the equilibrium. 
17.7 Definition of the problem 
The study of the literature and experiences with practical 
use have prompted the following questions, answers to 
which have been sought: 
1. What are the results of the treatment of infections with 
the aid of gentamicin-PMMA beads? 
2. Is this treatment of the infections more successful than 
other methods of treatment used earlier? 
3. Are there other aspects of the treatment of infections, 
apart from the cure rate, on the basis of which the use of 
gentamicin-PMMA beads is or is not to be preferred? 
4. Are nephrotoxic side effects to be expected from the 
continuous presence for 10 to 14 days of a low serum 
concentration and from the continuous renal excretion of 
gentamicin? 
5. Does treatment with genlamicin-PMMA-bead chains 
cause ototoxic side effects? 
Clinical study 
17.8 The treatment without 
gentamicin-PMMA beads 
Between 1962 and 1977, 199 localizations in 198 patients 
were treated. In none of these treatments were gentamicin-
PMMA beads used. The treatments are studied retro-
spectively. 
The diagnoses were divided into four main groups: 
- 115 cases of osteomyelitis 
- 41 infected endoprostheses 
- 34 infections of soft tissues 
9 endoprostheses which in retrospect proved not to 
have been infected. 
In all, 345 operations were carried out. Nettoyage was 
performed practically always, with sequestrectomy and 
when necessary, removal of an endoprosthesis. Seventy per 
cent of the operations were combined with systemic 
antibiotic treatment. At 87 of the 345 operations, an 
irrigation system was introduced as well. 
After a follow-up with a median duration of three 
years, 76% of the patients proved to have been free from 
recurrence of infection for periods of a median duration of 
28 months. These figures do not include the patients in 
whom the endoprosthesis in retrospect proved not to have 
been infected. 
Between 1962 and 1977,34 total hip prostheses were 
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treated for infections. Successful reimplantation was 
possible in 14 patients; after one reimplantation the result 
was uncertain. In 18 patients, the treatment terminated in a 
Girdlestone operation, in one patient in an arthrodesis. 
Incomplete removal of the prosthesis always (six patients) 
resulted in a recurrence of the inflammation. 
A review of the 87 treatments with an irrigation system 
combined with the 14 irrigation system treatments 
described in Chapter 9, shows that during these 101 
treatments most irrigation systems were removed after two 
or three weeks, often because of problems involving leaking 
and clogged drains. A superinfection occurred in 27 
patients. 
17.9 Treatment with gentamicin-
PMMA beads 
Between 1977 and April 1981 inclusive, 90 patients were 
treated with gentamicin-PMMA beads for 93 localizations: 
- 39 cases of osteomyelitis 
- 41 infected endoprostheses 
- 4 infections of soft tissues 
- 9 endoprostheses which on retrospect proved not to 
have been infected. 
In all, 147 operations were carried out. This figure includes 
those operations that were performed before the 
introduction of gentamicin-PMMA beads, in order to gain 
complete insight into the case histories of the patients. 
At 116 operations, gentamicin-PMMA beads were 
implanted. The use of systemic antibiotics in the treatment 
of the infection was limited to 29 % of the 147 operations (in 
16% of the 116 gentamicin-PMMA-bead operations). 
After a follow-up of a median duration of 13 months, 
89% of the patients proved to have been free from 
recurrence for periods of a median duration of 12 months. 
Twenty-four patients were treated for a deep infection 
of a total hip prosthesis, which treatment ultimately resulted 
in nine successfully reimplanted prostheses and 15 
Girdlestone hips. 
A first rough comparison of the two groups of patients, 
without statistical analysis and without exact classification 
of the types of operation shows that it is especially in 
patients with osteomyelitis that 'healing' can be 
accomplished more often with than without gentamicin-
PMMA beads (92% and 72%, respectively, free from 
recurrence). Where gentamicin-PMMA beads were used, 
the patients' case histories show a smaller number of 
operations required to accomplish the healing. 
17.10 Statistical analyses of the treat-
ments of infections 
A statistical analysis was made of those operations that were 
performed for osteomyelitis or for an infected 
endoprosthesis. In this connection, a distinction was made 
between operations that were followed by at least one other 
operation because of a recurrence of the inflammation 
(intermediate operations) and operations that were the last 
ones in the case history (final operations). In addition, the 
operations were classified according to the type of 
treatment: gentamicin-PMMA beads, suction drainage and 
'other' operations. 
The analysis of the intermediate operations shows that the 
probability of a recurrence-free period after an operation 
with gentamicin-PMMA beads is less than after an 
operation at which neither gentamicin-PMMA beads nor an 
irrigation system was used. If a recurrence-free period 
occurs, there are indications that the duration of the 
recurrence free period is longer in women, in cases with long 
duration of manifest inflammation and after gentamicin-
PMMA bead operations. The fact that after intermediate 
operations with use of gentamicin-PMMA beads a 
recurrence either develops immediately or takes a longer 
time to develop, is explained by the more active policy in 
treatment with gentamicin-PMMA beads: at removal of the 
beads either reoperation is decided upon immediately 
because the lack of success of treatment is clear, or the 
treatment appears successful, in which case a recurrence is 
found to take a longer time to develop. This clearness may 
be attributable to the less frequent use of systemic anti-
biotics. 
Of the final operations it may be stated that if 
gentamicin-PMMA beads are used, the duration of the 
postoperative period until the patient is healed is distinctly 
shorter than if suction drainage or some other method of 
treatment is used. This conclusion takes into account the 
incomplete follow-up and differences in variables. The post-
operative healing time is shorter in infected endoprostheses 
than after treatment of an osteomyelitis. 
Also, advanced age and a long manifest duration of the 
inflammation are not contributory to a brief postoperative 
healing time (if the patient is not declared cured 
immediately after an operation). If gentamicin-PMMA 
beads are used, the probability that the patient may be 
regarded as cured immediately after the operation is better 
than after treatment with an irrigation system, particularly 
in the treatment of an infected endoprosthesis. This holds 
especially true in cases with long duration of the manifest 
inflammation. 
In general it may be stated that if gentamicin-PMMA 
beads are used for the treatment, the cure rate after 
operation is always higher than among patients treated by 
other methods (irrigation system or 'other' treatments). For 
this conclusion the difference in follow-up is taken into 
account. On more detailed analysis, this difference in cure 
rates is not attributable to background variables. 
Pharmacokinetic and toxicological 
study 
17.11 The effect of gentamicin on 
the renal excretion of ß2-microglobulin 
ßs-Microglobulin is a highly sensitive parameter of 
influences on the proximal tubulus of the kidney. The 
intention was to use this parameter for a study of the 
possible renal side effects of treatment with gentamicin-
PMMA beads. To this purpose, the measuring method with 
the aid of ß2-microglobulin had to be elaborated and 
refined. 
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For this reason, a study was made first of the efTect of 
various doses of gcntamicin on the renal clearance of ß2-
microglobulin, during five experiments on three volunteers 
A dose of 20, 60, 80 or 120 mg was administered intra-
venously, cither once or twice A dose-dependent influence 
of gentamicin on the reabsorption of ß2-microglobulin in the 
proximal tubular cell could be demonstrated This may be 
explained by competition of ß2-microglobulin and 
gentamicin for reabsorption in the brush border membrane 
of the tubular cell In the healthy volunteers, the normal 
value of the renal excretion of ß2-microglobulin was found 
to amount to 100 ± 60 ng/min It was only when the renal 
excretion of gentamicin rose above 150 μg/mln, that an 
increased renal excretion of ß2-microglobulin became 
demonstrable 
17.12 The effect of an operation on 
the renal excretion rate of ß2-micro-
globulin 
The effect of an operation on the renal excretion rate of ßa-
microglobulin was studied in four patients (three cases of 
anterior spondylodesis, one of carpal tunnel release) The 
first finding obtained was a dependence on flow the renal 
clearances of both ß2-microglobulin and creatinine decrease 
when the urine flow grows less In addition, the surgical 
trauma brings about a marked to very marked increase of 
the renal excretion rate of ß2-microglobulin This effect was 
confirmed once more at ten operations in the five patients 
described in Chapter 13 
The value of the maximal renal excretion of ß2-micro-
globulin appeared to be correlated with the seventy of the 
trauma When the operations were compared with the aid of 
a socalled 'clinical trauma score' it was found that when the 
trauma score rose to above approx 50 %, the renal excretion 
rate of ß2-microglobulin increased greatly We measured 
one maximal value of 110,000 pg/min 
The increase of the excretion of ß2-microglobulin 
under the influence of a trauma may be attributable to 
increased depletion from injured tissues This presupposes a 
limited capacity of the proximal tubulus to reabsorb ß2-
microglobulin Another possibility is that the trauma 
releases other substances which in the proximal tubulus 
enter into competition for the limited tubular reabsorption 
In that case these substances released by the trauma ought, 
just as gentamicin, to contain one or several ammo groups 
17.13 The effect of treatment with 
gentamicin-PMMA beads on the renal 
excretion of ß2-microglobulin 
The renal excretion rate of ß2-microglobulin has been 
studied in five patients throughout their treatment After 
the ten operations to which these five patients were 
subjected, the effect of the trauma on the renal excretion of 
ß2-microglobulin was observed as described in Chapter 12 
After the 10 operations on these five patients, it was found 
once more that the severity of the trauma determined the 
maximal value of the renal excretion of ß2-microglobulm 
The treatment with gentamicin, of 10 to 14 days' 
duration, caused no measurable effect on the excretion ol 
ß2-microglobulin, apart from the above-mentioned effect of 
the trauma This prompts the conclusion that there was no 
measurable influence of the continuous excretion of 
gentamicin on the function of the proximal tubulus The 
glomerular filtration during the treatment was not 
demonstrably influenced by the gentamicin, either 
This pharmacokinetic study confirmed in all five patients 
that the gentamicin-PMMA beads constitute a genuine 
sustained release system throughout the treatment, a 
constant release was recorded The serum level in all cases 
remained below 1 pg/ml,and the concentration in urine was 
usually less than 10 pg/ml The renal excretion rate of 
gentamicin ranged from 4 to 12 pg/min after implantation of 
48 to 90 gentamicin-PMMA beads 
An approximation of the half-life of gentamicin in vivo 
indicates the length of time required for 50% of the amount 
of gentamicin to be released by the beads through the 
wound into the body and to be excreted by the kidney This 
half-hie was found to amount to 6 to 10 days, in contra-
distinction to the known half-life m vitro which is 3 3 days 
Possibly, the half-life m vivo is influenced by the position of 
the beads and by the types of tissue surrounding them 
17.14 The effect of a treatment with 
gentamicin-PMMA beads on the 
hearing and on the organ of 
equilibrium 
In five patients, tone-threshold audiography was carried out 
before and during the treatment In three ol them, a 
nystagmographic examination could be carried out before 
and during the treatment 
Neither the audiometrie nor the vestibular studies 
revealed any sign of ototoxicity 
In spite of the reassuring results obtained in this 
orienting investigation, it is advisable that patients with a 
higher ototoxicity risk should be examined regularly for 
adverse effects on the hearing Bilateral auditory damage, 
namely, in contradistinction to an adverse efTect on the 
equilibrium, cannot be compensated The best method of 
controlling patients for ototoxicity is by audiometry alone 
Patients without an extra risk require no control 
examination during treatment with gentamicin-PMMA 
beads 
17.15 Case histories 
The case histories of ten patients are described to illustrate 
the problems that arise in the treatment of bone infections 
in general, and the role of the treatment with gentamicin-
PMMA beads m the evolution of the disease This 
treatment was always only one part of a Irequently 
protracted management 
In three patients gentamicin levels were determined in 
serum, urine and/or exudate These determinations, unlike 
those described in Chapter 13, were not intended for the 
calculation of clearances In the first two patients, the serum 
gentamicin levels were determined during long periods of 
renal insufficiency Both patients in spite of very 
pronounced renal dysfunction had only low serum 
gentamicin levels 
The patients with infected endoprostheses illustrate 
how the course of the disease may be unnecessarily 
141 
prolonged when an infection of a prosthesis is not diagnosed 
correctly or if it is treated inadequately. This contrasts 
sharply with the briefness-confirmed by statistical 
analysis-of the period required to suppress infections, even 
infections of long standing. 
From among the patients with osteomyelitis, a choice 
has been made of the various types of osteomyelitis: 
haematogenous osteomyelitis, post-traumatic osteomyelitis 
and one osteomyelitis resulting from decubitus. 
17.16 Epilogue 
Skeletal infections are still a serious problem and are often 
difficult to cure. They are often badly crippling and because 
of their chronic character they frequently bring about great 
mental stress as well. The treatment of infected 
endoprostheses, and particularly also of osteomyelitis, is 
often difficult and takes a long time. We believe on the basis 
of our investigation that in several important respects, this 
treatment may be improved by using antibiotic-containing 
cement, especially in the form of gentamicin-PMMA beads. 
The results of treatment with gentamicin-PMMA beads are 
equivalent and possibly even superior to those of other 
methods of treatment, such as suction drainage. The 
management of the patient also differs considerably from 
that with other methods of treatment. The patient is treated 
for a fixed period of two weeks. If an immediate favourable 
effect on the inflammation fails to occur, this period may be 
repeated one or more times. With gentamicin-PMMA 
beads, namely, it sooner becomes clear whether the 
treatment is successful. If it is successful, relapses occur 
later, if at all. Also, the local treatment is more comfortable 
to the patient since it takes place with the wound closed, 
with the possibility of adequate mobilization and as a rule 
without systemic administration of antibiotics. 
The perusal of 288 case histories and of the literature also 
leads to conclusions of a more general nature. 
A correct bacteriological diagnosis constitutes the key 
to the treatment of osteomyelitis and infected endo-
prostheses. Only too often, endoprostheses with loosening 
due to a low-grade infection are treated as a purely 
mechanical problem. As a result, the problem is solved only 
temporarily and cure is relayed and rendered more difficult. 
Great importance attaches to more thorough and efficient 
preoperative diagnostics, including better distinction 
between septic and aseptic loosening. Lack of diagnostic 
certainty is particularly embarrassing when at revision of a 
painful prosthesis one component is found to be loose while 
the other is still anchored firmly. 
Treatment of osteomyelitis is mostly a step by step 
procedure. Occasionally, a single step suffices to cure the 
patient, but often several longer and shorter steps are 
necessary. Keeping this fact in mind will have a beneficial 
effect and prevent discouragement when a relapse occurs. 
Complete nettoyage and elimination of the causative agent 
may be accomplished in phases. In this stepwise approach 
to cure, the gentamicin-PMMA beads are expedient 
stepping stones. 
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Chapter 18. Dutch summary / Samenvatting 
18.1 Inleiding 
De bijzondere aandacht voor het probleem van de infectie 
in de orthopaedische chirurgie wordt gerechtvaardigd door 
de ernstige consequenties ervan Een toenemend aantal 
infecties van het skelet wordt veroorzaakt door een 
toenemend aantal geïmplanteerde endoprothesen en een 
toenemend gebruik van osteosynthesematenaal Bij de 
behandeling van deze infecties is het sinds 1976 mogelijk als 
aanvulling op de klassieke chirurgische maatregelen 
gentamicine-PMMA-kralen te implanteren Deze kralen 
staan in de wond een relatief grote hoeveelheid gentamicine 
af, die locaal bactericide werkzaam is 
In deze studie werd allereerst een overzicht van de literatuur 
gegeven, waarbij het probleem van de osteomyelitis en de 
geïnfecteerde endoprothesen werd besproken Tevens 
werden beschreven de eigenschappen van het antibioticum-
houdend cement, van gentamicine en van de gentamicine-
PMMA-kralcn Er werd vervolgens een klinisch onderzoek 
beschreven dat uiteen valt m een retrospectieve studie naar 
de resultaten van behandelingen voordat gentamicine-
PMMA-kralen werden gebruikt en een prospectief 
uitgevoerde studie naar de resultaten van de behandeling 
van intecties met gentamicine-PMMA-kralen Een 
statistische analyse ter vergelijking van beide behandelmgs-
soorten werd aan de hand van dit patientenmatenaal 
uitgevoerd Het derde deel van de studie richtte zich op 
mogelijke bijwerkingen van de gentamicine-PMMA-kralen 
op de nier of op het gehoor 
Literatuur 
18.2 Osteomyelitis 
In het kort werd ingegaan op het pathologische en klinische 
beeld van de endogene en exogene osteomyelitis De dia-
gnostiek werd besproken, waarbij met name werd ingegaan 
op de bacteriologische aspecten ervan correcte afname van 
de kweek en een goede uitleg van de kweekuitslag is 
essentieel 
BIJ de invoering van een nieuwe methode ter 
behandeling van osteomyelitis leek het goed de 
geschiedenis van die therapie te bespreken, waardoor werd 
geïllustreerd welke elementen van de nieuwe therapievorm 
al beproefd waren Beschreven werd hoe tot in de 19e eeuw 
de behandeling van osteomyelitis symptomatisch was Toch 
was sequestrectomie, drainage en rust een algemeen 
geaccepteerde behandeling Rond de laatste eeuwwisseling 
werden antiséptica toegepast en vanaf de Tweede 
Wereldoorlog antibiotica Steeds werden chirurgen die de 
genezing van de infectie door toepassing van alleen met-
chirurgische maatregelen verwachtten, teleurgesteld 
Antiséptica en antibiotica alleen genazen nimmer In de 
loop van de 20e eeuw bleek dat naast stabilisatie van het 
geïnfecteerde gebied vooral het voorkomen van de holte-
vorming essentieel voor de behandeling van osteomyelitis 
was 
De gentamicine-PMMA-kralen combineren de voordelen 
van de opvulling van holten, tesamen met de voordelen van 
locale antibiotische therapie In dit opzicht is het 'nieuwe' 
van de gentamicine-PMMA-kralen betrekkelijk 
18.3 Geïnfecteerde endoprothesen 
De botcementinterface herbergt bij de endoprothese vele 
problemen 
Hier wordt in de loop van de jaren na de implantatie 
van de prothese een toenemende loslating bij een 
toenemend aantal patiënten zichtbaar Tot op heden wordt 
een deel van deze loslatingen ten onrechte als een zuiver 
mechanisch probleem gezien het betreft in werkelijkheid 
vaak een low-grade infectie 
Na de bespreking van de Symptomatologie van de 
acute, latente en haematogene infectie van de 
endoprothese, is daarom uitgebreider ingegaan op de 
diagnostiek De bezinking vormt een zeer belangrijke 
parameter, vooral als deze regelmatig wordt bepaald Bij de 
acute of bij de foudroyante exacerbatie van de latente 
prothese-infectie, veroorzaakt het stellen van de diagnose 
doorgaans geen probleem Dit is echter wel het geval bij de 
latente, low-grade infectie Tot op heden is er geen enkele 
klinische onderzoeksmethode, die met zekerheid kan 
differentieren tussen de aseptische loslating en de loslating 
door cen low-grade infectie van de prothese Deze latente 
infectie kan alleen worden gediagnostiseerd door 
pcroperatieve afname van multipele monsters voor kweken, 
het liefst uit het weefsel, waarvan in ieder geval een aantal 
ook in anaëroob transportmedium 
Behandeling van de geïnfecteerde prothesen is in geval van 
een acute infectie het meest succesvol, indien vroegtijdig 
een uitgebreide nettoyage wordt uitgevoerd en langdurig 
wordt behandeld met antibiotica Dit geldt voor de acute 
oppervlakkige, maar vooral ook voor de acute diepe 
prothese-infectie 
De latente, low-grade infectie kan slechts in een 
beperkt aantal gevallen conservatief worden geholpen De 
enige definitieve genezing kan door verwijdering van de 
gehele prothese met alle cement worden verkregen Daarna 
moet worden gekozen voor een reimplantatie van een 
prothese of voor het verwijderd laten ervan (Girdlestone, 
arthrodese) Wordt een reimplantatie uitgevoerd, dan 
worden volgens de literatuur de beste resultaten verkregen 
met behulp van antibioticumhoudend cement De 
reimplantatie kan tijdens dezelfde operatie als de extractie 
en nettoyage worden verricht 'one-stage' reimplantatie 
Wordt een kortere of langere tijd gewacht met de 
reimplantatie, dan spreekt men van een 'two-stage' 
procedure Deze tussenperiode kan worden gebruikt voor 
de behandeling van de infectie Hier zou plaats zijn voor de 
gentamicine-PMMA-kralen Deze kunnen gedurende een 
korte tijd (10-14 dagen) bijdragen aan de behandeling van 
de infectie door een locale, zeer sterk werkzame bactericide 
behandeling met gentamicine 
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18.4 Antibioticumhoudend cement 
De ontwikkeling van het antibioticumhoudend cement was 
aanvankelijk geheel empirisch: Buchholz vermengde 
botcement met antibiotica om het infectiepercentagc van 
de prothese te vermineren. Nader onderzoek toonde dat 
antibiotica door diffusie uit het botcement konden worden 
afgestaan. Diverse onderzoekingen van verschillende 
combinaties van antibiotica en cementsoorten toonden dat 
de afgifte van antibiotica evenredig is met onder andere de 
oppervlakte van het cement en de concentratie van het 
antibioticum in het cement. 
Ook de omgevende vloeistof bepaalt hoeveel 
antibioticum uit het cement dilfundeert. Steeds betreft het 
een diffusie en is dus een waterig milieu vereist. 
Sommige antibiotica blijken niet geschikt om in 
botcement te worden verwerkt doordat ze niet hittestabiel 
of wateroplosbaar zijn. Voor klinische toepasbaarheid is van 
belang hoeveel van het antibioticum per tijdseenheid wordt 
afgestaan, waarbij van belang is of de bacteriologisch 
werkzame concentratie wordt bereikt. Wordt (op 
bacteriologische gronden) gekozen voor gen tam icine, dan is 
vermenging in palacos de beste combinatie. 
De werkzaamheid van antibioticumhoudend cement blijkt 
bij dierproeven vooral tijdens en kort na de operatie te 
moeten worden verwacht. Werkzaamheid langer dan 
ongeveer zes weken na de operatic, kon echter onvoldoende 
worden aangetoond. Bij klinische toepassing is daarom een 
beschermend effect alleen pcroperatief (tegen 
contaminatie) en kort postoperatief (tegen haematogene 
infecties) te verwachten. De goede resultaten na het gebruik 
bij 'one-stage' reïmplantatie, na verwijdering van 
geïnfecteerde endoprothesen, illustreren deze werking op 
goede wijze. 
18.5 Gentamicine-PMMA-kralen 
Bij vergroting van het oppervlak wordt uit 
antibioticumhoudend cement relatief meer antibioticum 
aan de omgeving afgestaan. Bij de gentamicine-PMMA-
kralcn wordt door dit grote oppervlak een zeer hoge 
gentamicine-concentratie rondom de kralen verkregen. De 
secretie van de wond blijft tussen de kralen door mogelijk. 
Ondanks een locaal zeer hoge concentratie van gentam icine 
in het wondsecreet resulteert dit toch slechts tot een zeer 
lage, doch continue serumconcentratie. 
Doordat de gentamicineconcentraties in de wond vele 
malen hoger kunnen worden dan de minimum remmende 
concentratie (MRC) of minimum bacteriedodende 
concentraties (MBC) van de verwekkers, is het noodzakelijk 
om het begrip 'resistentie' van een bacterie te preciseren 
door de MRC te bepalen. 
De afgifte van het gentamicine uit de kralen en de 
werkzaamheid ervan is 'in vitro' en 'in vivo' aangetoond. Bij 
toepassing in de kliniek zijn de praktische voordelen voor de 
patiënt en voor de verpleging van belang, vooral in 
vergelijking met de behandeling met een spoelsysteem. 
Ook in bacteriologisch en economisch opzicht zijn 
voordelen aanwezig. 
Naast toepassingen bij infecties van het skelet zijn ook 
ervaringen beschreven bij weke delen infecties. 
Absolute contra-indicaties worden genoemd, maar 
niet door alle auteurs onderschreven. Wel zijn relatieve 
contra-indicaties aanwezig, waarbij de voordelen van het 
gebruik der kralen tegen de nadelen van een andere 
behandelingsmethode afgewogen moeten worden. Zo zou 
de belangrijkste contra-indicatie graviditeitzijn. Ingeval van 
infectie echter moeten de mogelijke nadelen van 
gcntamicine-PMMA-kralen (voor de foetus) worden 
afgewogen tegen de nadelen van een andere behandeling. 
Andere relatieve contra-indicaties zijn: resistente bacteriën, 
nierfunctiestoornissen, allergie voor gentamicine, een open 
wond, sclerotisch bot en osteosynthesemateriaal in situ. In 
al deze gevallen zijn gentamicine-PMMA-kralen onder 
bepaalde voorzorgen wel toepasbaar. 
18.6 Gentamicine 
Het aminoglycoside gentamicine is een bactericide, breed-
spectrum antibioticum. De eliminatie in het lichaam 
geschiedt vrijwel geheel via de nier. In de nier wordt 
gentamicine volledig gefiltreerd in de glomerulus en voor 
een klein gedeelte geresorbeerd in de proximale tubulus. 
De haarcellen in de proximale tubulus vormen evenals de 
haarcellen in het gehoor- en evenwichtsorgaan, een 'diep 
compartiment', waarin de gentamicineconcentratie door 
accumulatie sterk stijgt, en waaruit het gentamicine 
vertraagd wordt afgegeven. De nefrotoxiciteit en de 
ototoxiciteit zijn gebaseerd op een tijdelijke of blijvende 
beschadiging van deze haarcellen. 
In de nier ontstaan door beschadiging van de 
proximale tubuluscel verhoogde depleties van diverse 
stoffen. Eén daarvan is het ß2-microglobuline. 
De beschadiging in het oor uit zich door een 
verhoogde toondrempel en door evenwichtsstoornissen. 
18.7 Probleemstelling 
Op basis van de literatuurstudie en op basis van het gebruik 
in de praktijk, rijzen de volgende vragen, waarop een 
antwoord is gezocht: 
1. Wat zijn de resultaten van de behandeling van infecties 
met behulp van gentamicine-PMMA-kralen? 
2. Is deze behandeling van de infecties succesvoller dan 
destijds, toen gebruik werd gemaakt van andere 
behandelingsmethoden? 
3. Zijn er andere overwegingen dan het genezingspercen-
tage, die van belang zijn bij de behandeling van infecties 
en op grond waarvan de toepassing van gentamicine-
PMMA-kralen wel of niet de voorkeur verdient? 
4. Zijn er nefrotoxische bijwerkingen te verwachten van de 
10 tot 14 dagen continu aanwezige lage serumconcen-
tratie en van de continue renale excretie van genta-
micine? 
5. Leidt de behandeling van gentamicinc-PMMA-kralen-
snoeren tot ototoxische bijwerkingen? 
Klinische studie 
18.8 De behandeling zonder 
gentamicine-PMMA-kralen 
Van 1962 tot 1977 zijn bij 198 patiënten 199 localisaties 
behandeld. Deze behandelingen waren alle zónder gebruik-
making van gentamicine-PMMA-kralen. De behandelingen 
werden retrospectief bestudeerd. 
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De diagnoses werden in vier hoofdgroepen ingedeeld 
- 115 osteomyelitiden 
- 41 geïnfecteerde cndoprothesen 
- 34 weke delen infecties 
9 endoprothesen, die achteraf met geïnfecteerd 
bleken 
In totaal werden 345 operaties uitgevoerd Vrijwel steeds 
werd een nettoyage, met sequestrectomie en eventueel een 
verwijdering van een endoprothese uitgevoerd In 70 % van 
de operaties werd tevens een systemische antibioticum-
behandelmg gegeven BIJ 87 van de 345 operaties werd 
bovendien een spoelsysteem ingebracht 
Na een follow-up van mediaan driejaar bleek 76 % van 
de patiënten, gedurende een periode die mediaan 28 
maanden bedroeg, vrij van recidief van infectie Daarbij zijn 
de patiënten uitgezonderd, waarbij achteraf bleek dat de 
endoprothese niet geïnfecteerd was 
Van 1962 tot 1977 werden 34 total hip prothesen 
behandeld voor infecties Bij 14 patiënten was een 
succesvolle réimplanta tie mogeijk, na een reimplanta tie was 
het succes onzeker Bij 18 patiënten eindigde de 
behandeling met een Girdlestone operatie, bij een patient 
met een arthrodese Incomplete verwijdering van een 
prothese leidde steeds (zes patiënten) tot een recidief van de 
ontsteking 
Bestudering van de 87 behandelingen met een 
spoelsysteem, tesamen met 14 spoelsysteembehandelingen 
uit hoofdstuk 9, toonde dat bij deze 101 behandelingen de 
meeste spoelsystemen na twee a drie weken werden 
verwijderd, doorgaans in verband met problemen van 
lekkage en verstoppen van de drains Een supennfectie trad 
bij 27 patiënten op 
18.9 Behandeling met gentamicine-
PMMA-kralen 
Van 1977 tot en met april 1981 werden 90 patiënten voor 93 
localisdties behandeld met gentamicine-PMMA-kralen 
- 39 osteomyelitiden 
- 41 geïnfecteerde endoprothesen 
- 4 weke delen infecties 
- 9 endoprothesen, die achteraf met geïnfecteerd bleken 
te zijn 
Er werden 147 operaties uitgevoerd Daarbij zijn ook de 
operaties meegeteld, voordat gentamicine-PMMA-kralen 
werden gebruikt om een volledig overzicht van de ziekte-
geschiedenissen van de patiënten te verkrijgen 
Bij 116 operaties werden gentamicine-PMMA-kralen 
geïmplanteerd Het gebruik van systemische antibiotica bij 
de behandeling van de infectie bleef beperkt tot 29 % van de 
147 operalies (in 16% van de 116 gentamicine-PMMA-
kralenoperaties) 
Bij een mediane follow-up van 13 maanden bleek 89% der 
patiënten gedurende een periode van mediaan 12 maanden 
vrij van recidief 
24 Patienten werden behandeld voor een diepe 
infectie van een totale heupprothese, uiteindelijk 
resulterend in negen succesvol gereimplanteerde prothesen 
en 15 Girdlestone-heupen 
Vergelijking van beide patiëntengroepen in eerste instantie 
zonder statistische analyse en zonder exacte uitselectenng 
van de operatietypen, toont dat vooral bij patiënten met een 
osteomyelitis met behulp van gentamicine-PMMA-kralen 
vaker 'genezing' kan worden bereikt dan zonder 
gentamicine-PMMA-kralen (92% tegen 72% recidiefvnj) 
Worden gentamicine-PMMA-kralen gebruikt dan tonen de 
ziektegeschiedenissen van de patiënten een kleiner aantal 
operaties, nodig om de genezing te bereiken 
18.10 Statistische analyses van de 
infectiebehandelingen 
In een statistische analyse zijn die operaties betrokken, die 
werden uitgevoerd voor een osteomyelitis of een 
geïnfecteerde endoprothese Daarbij is een onderscheid 
gemaakt tussen de operaties die nog door een andere 
operatie werden gevolgd, omdat er een recidief van de 
ontsteking optrad (tussenoperaties) en operaties die de 
laatste vormden in de ziektegeschiedenis (cindoperatics) 
Daarnaast zijn de operaties onderscheiden al naar gelang de 
soort behandeling gentamicine-PMMA-kralen, spoelzuig-
sysleem of 'overige' operaties 
Bij analyse van de tussenoperaties blijkt dat de kans op een 
recidietvnje periode na een operatie met gentamicine-
PMMA-kralen kleiner is dan na een operatie, waarbij noch 
gentamicine-PMMA-kralen noch een spoelsysteem werd 
gebruikt Als er een recidiefvnje periode optreedt zijn er 
aanwijzingen dat de duur van de recidiefvnje periode langer 
is bij vrouwen, bij een lange duur van de manifeste 
ontsteking en na gentamicine-PMMA-kralen-operaties De 
verklaring voor hel feit dat een recidief na tussenoperaties 
bij gebruik van gentamicine-PMMA-kralen of direct 
optreedt, of langer op zich laat wachten, wordt verklaard 
door de aktievere houding tijdens de behandeling met 
gentamicine-PMMA-kralen, bij verwijdering van de kralen 
wordt of direct besloten tot re-operatie omdat duidelijk is 
dat de behandeling geen succes had, of de behandeling lijkt 
succesvol en dan blijkt een recidief langer op zich te laten 
wachten Deze duidelijkheid wordt wellicht verklaard door 
het minder frequent systemisch gebruik van antibiotica 
Voor de eindoperaties geldt dat bij gebruik van 
gentamicine-PMMA-kralen de tijd die postoperatief 
verloopt voordat de patient genezen is, duidelijk korter is 
dan wanneer een spoelzuigsysteem of andere behandelings-
methoden worden gebruikt Hierbij is rekening gehouden 
met onvolledige follow-up en verschillen in variabelen De 
postoperatieve genezingsduur is bij geïnfecteerde 
endoprothesen korter dan na behandeling van een osteo-
myelitis 
Een hoge leeftijd en een lange manifeste duur van de 
ontsteking zijn daarnaast met bevorderlijk voor een korte 
postoperatieve genezingsduur (indien de patient na een 
operatie niet direct genezen is) Worden gentamicine-
PMMA-kralen gebruikt, dan is met name bij behandeling 
van een geïnfecteerde endoprothese de kans groter dat 
direct na de behandeling de patient als genezen kan worden 
beschouwd dan na behandeling met een spoelsysteem Dit 
vooral als de duur van de manifeste ontsteking lang is 
In het algemeen geldt dat als bij de behandeling 
gebruik is gemaakt van gentamicine-PMMA-kralen, dat 
postoperatief steeds het genezingspercentage van de 
patienter hoger is dan bij patiënten die met andere 
methoden zijn behandeling (spoelsysteem of 'overige' 
behandelingen) Hierbij is rekening gehouden met het 
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verschil in follow-up Dit verschil m genezmgspcrcentage 
blijkt bij nadere analyse niet door de achtergrondvanabelen 
verklaarbaar. 
Pharmacokinetisch en toxicologisch 
onderzoek 
18.11 De invloed van gentamicine 
op de renale excretie van ß2-micro-
globuline 
ß2-Microglobuline vormt een zeer gevoelige parameter voor 
beïnvloeding van de proximale tubulus in de nier De 
bedoeling was deze parameter te gebruiken voor een 
onderzoek naar een mogelijke bijwerking op de nier van een 
gentamicme-PMMA-kralenbehandeling. Daarvoor moest 
de meetmethode met behulp van ß2-microglobuline 
verfijnd en uitgewerkt worden 
Allereerst is daarvoor de invloed van diverse 
doseringen gentamicine op de renale klaring van p2-micro-
globuline onderzocht bij drie proefpersonen in vijf 
experimenten. Een dosis van 20,60,80 of 120 mg werd cén 
of twee maal intraveneus toegediend. Gevonden is dat de 
terugresorptie van ßs-microglobuline in de proximale 
tubuluscel dosis-afhankelijk wordt beïnvloed door 
gentamicine. De verklaring ervoor kan worden gevonden in 
een competitie tussen ß2-microglobuline en gentamicine 
voor resorptie in de 'brush-border'-membraan van de 
tubuluscel Bij de gezonde proefpersonen blijkt de 
normaalwaarde van de renale ß2-microglobuline-excretie 
100 ± 60 ng/min. Pas bij een renale excretie van 
gentamicine van meer dan 150 pg/min wordt een versterkte 
renale excretie van ß2-microglobulinc meetbaar. 
18.12 De invloed van een operatie 
op de renale excretiesnelheid van ß2-
microglobuline 
De invloed van een operatie werd nagegaan op de renale 
excretiesnelheid van ß2-microglobuline bij vier patiënten 
(drie voorste spondylodesen, eén carpaal tunnel release). In 
de eerste plaats werd een flow-afhankelijkheid gevonden-
de renale klaring van zowel ßs-microglobuline alsook 
creatinine vermindert bij een geringere unneflow. 
Daarnaast veroorzaakt het trauma van een operatie een 
sterke, tot zeer sterke stijging van de renale excretiesnelheid 
van ß2-microglobuline. Deze beïnvloeding wordt in 
hoofdstuk 13 bij nog eens 10 operaties bij vijf patiënten 
bevestigd De hoogte van de maximale renale excretie van 
ß2-microglobuline blijkt afhankelijk te zijn van de ernst van 
het trauma Worden de operaties onderling vergeleken door 
middel van een zogenaamde 'klinische traumascore' dan 
blijkt bij overschrijding van een traumascore van ongeveer 
50% de renale excretie van ß2-microglobuline sterk toe te 
nemen WIJ maten een maximum waarde van 110,000 
ng/min. 
De verklaring voor de toegenomen ß2-microglobuline-
excretie onder invloed van een trauma kan een verhoogde 
depletie uit getraumatiseerde weefsels zijn. Dit bij een 
gelimiteerde resorptiecapaciteit voor ß2-microglobuline in 
de proximale tubulus Ook is mogelijk dat andere stoffen 
door het trauma vrijkomen die in de proximale tubulus een 
competitie aangaan voor de gelimiteerde tubulaire 
reabsorptie. Deze door het trauma vrijkomende stoffen, 
zouden dan, evenals gentamicine, in het bezit moeten zijn 
van aminogroep(en). 
18.13 De invloed van behandeling 
met gentamicine-PMMA-kralen op de 
renale excretie van ß2-microglobuline 
De renale excretiesnelheid van ßs-microglobuline is bij vijf 
patiënten gedurende de gehele behandeling bestudeerd. BIJ 
de 10 operaties die deze vijf patiënten ondergingen, werd de 
invloed van het trauma op de renale excretie van ß2-micro-
globuline gevonden, zoals in hoofdstuk 12 beschreven BIJ 
de 10 operaties die werden uitgevoerd bij deze vijf 
patiënten, bleek opnieuw de emst van het trauma bepalend 
voor het maximum van de renale excretie van ß2-micro-
globulme 
De 10 tot 14 dagen durende behandeling met 
gentamicine veroorzaakte naast dit trauma-effect geen 
meetbare beïnvloeding van de ß2-microglobuline-excrctie 
Wij concluderen hieruit dat er geen beïnvloeding van de 
continue gentamicine-uitscheidmg op de proximale 
tubulusfunctic gemeten kon worden. De glomerulaire 
filtratie liet tijdens de behandeling evenmin beïnvloeding 
door de gentamicine zien. 
Dit pharmacokinetisch onderzoek toonde bij alle vijf 
patiënten aan hoe de gentamicine'PMMA-kralen een echt 
'slow-release' systeem vormen gedurende de gehele 
behandeling werd een constante afgifte geregistreerd De 
serumconcentratie bleef daarbij steeds onder 1 pg/ml en de 
urineconcentratie was doorgaans beneden 10 pg/ml. De 
renale excretiesnelheid van gentamicine was 4 tot 12 
μg/min na implantatie van 48 tot 90 gcntamicine-PMMA-
kralen. 
Een benadering van de halfwaardetijd van 
gentamicine m vivo geeft weer hoe lang het duurt voordat 
50 % van de hoeveelheid gentamicine vanuit de kralen via de 
wond aan het lichaam wordt afgestaan en in de nier 
geëlimineerd Deze halfwaardetijd bleek 6 tot 10 dagen te 
zijn, in tegenstelling tot de in vitro bekende halfwaardetijd 
van 3,3 dagen De 'in vivo' halfwaardetijd wordt mogelijk 
beïnvloed door de ligging van de kralen en door de soort 
weefsels er omheen 
18.14 De invloed van een behande-
ling met gentamicine-PMMA-kralen 
op het gehoor en het evenwichtsorgaan 
Bij vijf patiënten werd een toondrempel-audiogram vemcht 
vóór en tijdens de behandeling BIJ drie van hen kon een 
nystagmografisch onderzoek worden verricht vóór en 
tijdens de behandeling, 
Wij vonden bij het audiometrisch onderzoek geen 
tekenen van ototoxiciteit en bij het vestibulair ondezoek 
evenmin 
Alhoewel uit deze oriënterende studie naar 
ototoxiciteit geruststellende resultaten worden verkregen, 
zou bij patiënten met een verhoogd risico voor ototoxiciteit 
dienen te worden gecontroleerd op beschadiging van het 
gehoor Dubbelzijdige beschadiging van het gehoor is 
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immers anders dan beschadiging van het evenwicht, niet te 
compenseren. Deze controle op otoloxiciteit kan het beste 
geschieden door middel van alleen audiometrie. Patiënten 
zonder verhoogd risico zouden tijdens een behandeling met 
gentamicine-PMMA-kralen niet gecontroleerd hoeven te 
worden. 
18.15 Casuïstiek 
Aan de hand van de ziektegeschiedenissen van 10 patiënten 
wordt geïllustreerd welke problematiek zich in het 
algemeen bij de behandeling van botinfecties voordoet, en 
wat de plaats van de behandeling van gentamicine-PMMA-
kralcn in de ziektegeschiedenissen was. Steeds was deze 
behandeling een onderdeel van een vaak langdurige 
behandeling. 
Bij drie patiënten zijn concentraties van gentamicine 
bepaald in serum, urine en/of exsudaat. De bepalingen 
waren anders dan in het onderzoek uit hoofdstuk 13, niet 
bedoeld om klaringen te berekenen. Bij de eerste twee 
patiënten werden de scrumconcentratics van gentamicine 
tijdens een langdurige periode van nierinsufficiëntie 
gemeten. Beide patiënten toonden, ondanks een zeer 
slechte nierfunctie, slechts lage serumconcentratics van 
gentamicine. 
De patiënten met infecties van endoprothesen 
illustreren hoe de ziektegeschiedenis onnodig kan worden 
verlengd, doordat een infectie van de prothese als zodanig 
niet wordt onderkend of inadequaat wordt behandeld. De 
korte periode die - ook bij statistische analyse - nodig blijkt 
om een vaak al langdurig bestaande infectie te elimineren, 
staat daarmee in schril contrast. 
Van de patiënten met osteomyelitis is een keuze 
gemaakt uit de verschillende soorten osteomyelitis: 
haematogene en posttraumatische osteomyelitis en een 
osteomyelitis veroorzaakt door decubitus. 
18.16 Slotbeschouwing 
Infecties van het skelet blijven ernstig en vaak moeilijk te 
genezen. Ze zijn vaak sterk invaliderend en door het 
chronisch karakter vormen ze veelal een zware psychische 
belasting. De behandeling van geïnfecteerde 
endoprothesen en vooral ook van osteomyelitis is vaak 
moeizaam en langdurig. 
Op grond van onze studie menen wij dat deze 
behandeling op een aantal belangrijke punten kan 
verbeteren door gebruik te maken van antibioticum-
houdend cement met name in de vorm van gentamicine-
PMMA-kralen. De resultaten van behandeling met 
gentamicine-PMMA-kralen zijn gelijkwaardig, mogelijk 
zelfs beter dan met andere behandelingsmethoden, zoals 
het spoclzuigsysteem. 
Een belangrijk verschil met andere behandelings-
methoden ligt ook in het beloop van de ziektegeschiedenis. 
De patiënt krijgt een behandeling gedurende een vaste 
periode van twee weken. Is het effect op de ontsteking niet 
direct gunstig, dan kan deze periode één of enkele keren 
herhaald worden. Met gentamicine-PMMA-kralen is het 
echter sneller bekend of die behandeling succesvol is. Is de 
behandeling succesvol, dan blijft een recidief langer uit. 
Voor de patiënt is daarnaast de locale behandeling 
aangenamer, daar deze geschiedt bij een gesloten wond, 
met een mogelijkheid van goede mobilisatie en doorgaans 
zonder het systemisch gebruik van antibiotica. 
De bestudering van 288 ziektegeschiedenissen en de 
bestudering van de literatuur leiden ook tot conclusies in 
meer algemene zin. 
Een goede bacteriologische diagnostiek is de sleutel 
bij de behandeling van osteomyelitis en geïnfecteerde 
endoprothesen. Maar al te vaak worden endoprothesen, die 
door een low-grade infectie loslating vertonen, behandeld 
als een zuiver mechanisch probleem. Hierdoor wordt dat 
probleem slechts tijdelijk opgelost, de genezing vertraagd 
en moeilijker gemaakt. Van groot belang is een verfijning 
van de prae-operatieve diagnostiek, waarbij moet worden 
gezocht naar een betere differentiatie tussen septische en 
aseptische loslating. Met name doet zich het gemis aan 
zekerheid in de diagnostiek voelen bij revisie van een 
pijnlijke prothese, waarbij één component los blijkt te zitten 
en een andere component nog goed verankerd is. 
De behandeling van osteomyelitis gebeurt in stappen. Soms 
lukt het de patiënt in één stap te genezen. Vaak zijn echter 
meerdere grotere en kleinere stappen noodzakelijk. 
Welbewust kan van dit gegeven een positief gebruik worden 
gemaakt zonder dat men zich laat ontmoedigen door een 
recidief. Een complete nettoyage en een eliminatie van de 
verwekker kan in fasen worden bereikt. De gentamicine-
PMMA-kralen vormen een aanwinst in deze stapsgewijze 
weg naar de genezing, ook doordat de stappen op die weg 
meer geaccentueerd kunnen worden gezet. 
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